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Abstract  
Baked milk challenges and milk ladders have recently become a well-recognized part of cow’s 
milk allergy management, used to determine the development of tolerance to baked milk. 
However, there is relatively limited research regarding current and appropriate practice in 
this area. Hence, the aims of this research were (i) to explore attitudes and practice of 
healthcare professional’s use of baked milk challenges and milk ladders in a clinical setting 
(ii) to explore mothers’ experiences of introducing baked milk into their child’s diet and (iii) 
to evaluate if immune markers can identify IgE-mediated cow’s milk allergic children able to 
pass milk challenges.  
This research consisted of three separate studies: (i) a multi-national survey explored the 
current clinical practice of healthcare professionals using baked milk challenges and the milk 
ladder (ii) a qualitative study explored mothers’ perspectives. (iii) a quantitative study 
explored if immune markers such as SPT and milk sIgE can predict milk challenge outcomes 
in IgE mediated CMA.  This research found that while healthcare professionals largely 
considered the potential for severe reactions when making decisions about the appropriate 
venue for baked milk reintroduction there were inconsistencies regarding this, and the 
guidelines that were followed. Increased parental anxiety was reported for both baked milk 
challenges and milk ladders. Furthermore, mothers experienced confusion about the 
different versions of milk ladders and their practical implementation, and disappointment 
with healthcare support. They also expressed concerns regarding the lack of healthy and 
alternative food options in each stage of the milk ladder. Regarding the appropriate time of 
baked milk reintroduction, this research found that skin prick test and milk sIgE had poor 
value as predictive tools in the identification of milk challenge outcomes.  
In the first in-depth exploration of this new area of practice in the management of cow’s milk 
allergy, this research has provided novel results, which have important implications for 
healthcare professionals and researchers working with cow’s milk allergy. Any changes to 
practice arising from these will benefit cow’s milk allergic children and their families in the 
future.  
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Chapter 1. General Introduction 
1.1 Background 
Cow’s milk allergy (CMA) is one of the most common food allergies in early childhood. It 
generally has a good prognosis and cow’s milk (CM) is usually successfully re-introduced in 
the child’s diet within the first 1- 5 years of life following a milk elimination diet (Fiocchi, 
Brozek, et al., 2010). Current research indicates that foods containing baked milk (BM) such 
as biscuits/cookies, cakes, muffins, waffles, could be introduced before uncooked CM re-
introduction in children with CMA (Nowak-Wegrzyn et al., 2008). Re-introduction of BM 
utilises two different methods/protocols: baked milk challenge (BMC), in which a full portion 
of BM-product is introduced in increasing amounts over a day in a hospital/office, or a milk 
ladder (ML), in which case baked milk containing foods are re-introduced gradually (typically 
at home) over a period of days, weeks, months or years (+Venter, Brown, Shah, Walsh, & 
Fox, 2013). Successful re-introduction of BM-containing foods may accelerate milk allergy 
resolution and assist in establishing a normal diet, by avoiding unnecessary elimination diets 
which impair proper nutrient intake and affect socialisation (Meyer et al., 2017). This 
provides benefit not only to children’s health status, but also to the quality of life of both 
children and parents (Dupont, 2013). However, in many cases children are following a strict 
milk free diet unnecessarily as they are unaware that they are baked milk tolerant.  
CMA has an adverse nutritional impact on the children and negative psychosocial impact on 
the child and their families. The potential for re-introduction of baked milk and eventual 
tolerance of fresh milk is high. It is surprising therefore that so little is understood about the 
practice and impact of BMC and milk ladders from either a health care professional or parent 
perspective. Additionally, while immune markers such as Skin Prick Test (SPT) and milk 
specific Immunoglobulins E (sIgE) may provide some useful prognostic information for the 
appropriate timing for introduction of BM-containing food in IgE-mediated CMA (Bartnikas, 
Sheehan, Hoffman, et al., 2012), there are currently no clear clinical or laboratory criteria 
established that can predict which patients are likely to pass a BMC or certain steps on the 
milk ladder. Hence, this important field urgently needs further research to provide answers 
not only to healthcare professionals (HCPs) but also to parents on how to properly use these 
foods for the management of CMA. 
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1.2 Thesis layout  
To inform the current thesis, Chapter 2 reviews literature relevant to the use of BM-
containing foods in the management of CMA. It first sets out to define CMA and discuss its 
prevalence, natural history, diagnosis, and management, in children with this allergic 
disorder. The second section discusses the current research regarding the re-introduction of 
BM into children’s diets and introduces the use of BMCs and gradual re-introduction of BM 
(milk ladder) in IgE-mediated CMA and mild to moderate non-IgE-mediated CMA. This thesis 
does not include milk challenge/reintroduction for Eosinophilic Esophagitis (EoE) and Food 
Protein Induced Enterocolitis (FPIES). Current guidelines in the treatment and management 
of CMA are discussed. The final part defines immune markers such as SPT and milk sIgE and 
discusses their role in the management of IgE-mediated CMA.  
Current studies are reviewed examining whether immune markers can predict the outcome 
of re-introducing-BMC and the timing of tolerance development. Chapter 2 reviews the 
literature in order to provide the background and rationale to this thesis. The literature 
review suggests that for many reasons the re-introduction of BM-containing foods into the 
diet of milk allergic children before reintroducing “raw” milk is of interest not only to the 
United Kingdom (UK) but also internationally. Currently, the theory and practice of “how” to 
re-introduce BM-containing foods has not been well-described in literature. The overall aim 
of this research therefore is to understand current clinical practice in BM-reintroduction, the 
impact of BM-reintroduction on parents of children with CMA, and the extent to which 
biomarkers might be able to identify potential candidates for BM- reintroduction.  
In line with the overall aim, Chapter 3 presents a survey that explores what guidelines and 
approaches are currently being used by HCPs across the world and what their experiences 
have been in introducing BM-containing foods in IgE-mediated CMA and mild to moderate 
non-IgE-mediated-CMA. This is the first published study that provides systematically 
collected clinical data on the use of BM-containing foods from HCPs’ perspectives across the 
world.   
Moving on from understanding HCPs’ use and experience of BM re-introduction, Chapter 4 
presents a qualitative study that explores mothers’ experiences in using a milk ladder 
approach at home (gradual reintroduction of BM-containing foods) and the impact of these 
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foods in the management of their child’s CMA. This is the first study that has investigated 
(using semi-structured individualised phone interviews) mothers’ attitudes regarding the re-
introduction of BM-containing foods at home and the outcomes of this approach in the 
management of IgE and mild to moderate non-IgE-mediated CMA. Thus, it has provided 
important information regarding the usefulness, appropriateness, acceptability, 
practicability, and safety of BM-reintroduction from mothers’ perspectives. This valuable 
data could be used to improve the BM-reintroduction approach providing not only better 
patient care but also to help parents to feel less anxious and more confident during this 
process.   
Moving on from understanding parents’ use and experience of BM re-introduction, Chapter 
5 presents a quantitative study that analyses a retrospective subset of data from a larger 
research project being coordinated by the Cincinnati Children’s Hospital Medical Centre 
(CCHMC) in the USA to determine if immune markers such as SPTs and milk sIgE are 
appropriate tools in predicting oral milk challenge outcomes and hence help HCPs to identify 
children who will be optimal cow’s milk allergic patients for baked milk or raw milk- 
reintroduction. Identifying valuable tools could provide useful information for the milk 
tolerant status of the patient and contribute to the avoidance of unnecessary exposure to 
the milk allergen through the challenge and thus reduce the risk of any reactions. In addition, 
milk challenges have a long waiting list for patients, are time consuming and expensive and 
if they can be replaced by other validated predictive tools this could benefit not only patients 
and parents but also allergy services.      
Finally, Chapter 6 discusses the overall findings of the research, by collating the results of the 
three studies together. The implications for the gradual re-introduction of BM-containing 
foods in the management of IgE and mild to moderate non-IgE-mediated CMA are discussed. 
Strengths and limitations of the research are addressed and further research needs are 
outlined.    
In summary, this PhD research represents the first in-depth exploration of the reintroduction 
of BM-containing foods into cow’s milk allergic children’s diets; a new area of practice in the 
management of cow’s milk allergy. This research has provided novel results, which have 
important implications for healthcare professionals and researchers working with cow’s milk 
allergy. Understanding HCPs and parents’ perceptions and establishing reliable cut off values 
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for immune markers that can predict milk tolerance are of the utmost importance in terms 
of the validity of any future guidelines, and it could contribute to an effective CMA dietary 
management. Any changes to practice arising from these will therefore benefit cow’s milk 
allergic children and their families in the future. 
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Chapter 2. Literature review of Cow’s Milk Allergy & Immune 
Markers 
2.1 Overview of chapter    
This chapter reviews the current research related to the management of cow’s milk allergy 
in children and the use of baked milk containing foods in the development of tolerance to 
cow’s milk. The first section introduces the prevalence, prognosis, symptoms, diagnosis, and 
management, of CMA. Understanding of CMA treatment with the use of baked milk 
containing foods into the diet of children with IgE and mild to moderate non-IgE-mediated 
CMA is related to the worldwide survey (presented in Chapter 3) that provides information 
on the use of baked milk challenges and gradual reintroduction of milk in IgE and non-IgE-
mediated CMA from healthcare professionals’ perspectives. The second section discusses 
the role of baked milk containing foods in terms of their appropriateness and safety. It also 
presents the guidelines followed by HCPs before they decide to introduce baked milk 
containing foods into the diet of children with CMA.  This section is related to the qualitative 
research study (presented in Chapter 4) that discusses data on the impact of introducing 
baked milk containing foods into children’s diet from mothers’ perspectives. The final section 
discusses the role of immune markers (SPT, milk specific IgE levels) for identifying potential 
IgE-mediated CM allergic patients able to tolerate milk containing foods. Understanding the 
role of immune markers in predicting milk challenges is related to the study presented in 
Chapter 5, which evaluates whether immune markers can predict oral milk challenges in 
children with IgE-mediated CMA. The protocol of the search strategy and methodology of 
this review is summarised in appendix 5.   
2.2 Cow’s Milk Allergy  
2.2.1 Definition 
Milk allergy is defined as a reproducible adverse immune reaction to one or more proteins 
of milk (Fiocchi, Schunemann, et al., 2010). Cow’s milk is the usual cause of such an allergic 
reaction, but other kind of milk such as sheep, goat, buffalo or other mammals can also cause 
an abnormal immune response in human’s (Host & Halken, 2014). Casein and whey are the 
major milk proteins that can cause an allergic reaction. Of the total milk protein, 80% is casein 
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protein fraction (alphaS1, alphaS2, beta and kappa-caseins) and 20% is whey (alpha-
lactalbumin, beta lactoglobulin, bovine serum albumin) (Wal, 2002). It has been reported 
that casein is heat resistant and is responsible for persistent milk allergy i.e. milk allergy that 
is not outgrown during childhood (Järvinen et al., 2002). Whey proteins are heat labile and 
are commonly implicated in transient milk allergy i.e. milk allergy that is outgrown (Bloom et 
al., 2014). Based on the National Institute of Allergy and Infectious Disease (NIAID) guideline 
(Burks et al., 2011), cow’s milk allergy is classified as: 
1. IgE-mediated CMA that occurs immediately and up to 2 hours after exposure to 
cow’s milk proteins and causes the rapid release of mediators from effector cells 
(mast cells, basophils), resulting in acute skin, airway and gastro-intestinal (GI) 
symptoms. 
2.  Non-IgE-mediated CMA that can take place up to 4 to 72 hours after ingestion of the 
offending food. Clinical symptoms are subacute or chronic in nature and usually 
present with isolated GI symptoms. There are different forms of non-IgE-mediated 
food allergies such as mild to moderate non-IgE-mediated CMA, eosinophilic 
esophagitis, eosinophilic gastritis and gastroenteritis, food protein-induced 
enterocolitis syndrome (FPIES), and allergic proctocolitis. Figure 2.1 shows the 
different types of CMA.    
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Figure 2.1: Different types of Cow’s Milk Allergy   
This PhD research project is focused on IgE mediated CMA and mild to moderate non-IgE 
mediated CMA.   
 2.2.2 Epidemiology and prognosis   
The prevalence of CMA ranges from 1.9 to 4.9% in children, making this type of allergy the 
most common food allergy in the paediatric population (Fiocchi, et al., 2010).  In the 
developed world, it is approximately 2 to 3% and these percentages are mainly referring to 
IgE-mediated CMA (Sicherer, 2011). The prevalence of non-IgE-mediated CMA is still not well 
known. UK data from 2008 estimated that the prevalence of CMA is 2-3% in young children 
aged 1-3 years old and that the majority of these children suffer from non-IgE mediated CMA 
(Venter et al., 2008). Further evidence from the UK showed that the majority of non-IgE-
mediated CMA cases present with mild to moderate allergic reactions to cow’s milk (Venter 
et al., 2013).  However, conclusions from a 2015 systematic review meta-analysis indicate 
that it is difficult to estimate the actual prevalence of cow’s milk allergy in children due to 
IgE-mediated CMA   Non-IgE mediated 
CMA 
Mild to moderate 
non-IgE-mediated 
Food Protein 
induced 
Eosinophilic 
Esophagitis  
Other forms of non-
IgE-mediated CMA 
e.g. cow’s milk 
enteropathy 
Cow’s Milk Allergy (CMA) 
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the heterogeneity of paediatric population between the studies and the lack of uniformity of 
CMA diagnostic criteria (Schoemaker et al., 2015).  
Cow’s milk allergy prognosis is usually considered to be good and the majority of children 
outgrow their CMA by 3 years old (Venter et al., 2008). However, the actual time of 
resolution varies in infants and children, hence they are re-evaluated at 6 to 12 monthly 
intervals for the development of tolerance (Luyt, Ball, et al., 2014). In 2002, Host et al 
followed a cohort of 1740 new-borns and found a good prognosis of CMA with a total 
recovery of 56% at 1 year, 77% at 2 years, 87% at 3 years, 92% at age five years and 97% at 
age 15 years (Host et al., 2002).  They reported that children with non-IgE-mediated-CMA 
had a better prognosis compared with young children with IgE-mediated CMA, who had a 
higher risk of persistent allergy, and of suffering from other food allergies and conditions 
such as asthma and rhinoconjunctivitis (Host et al., 2002). In 2014, Host et al reported that 
45-50% of children tolerated milk by one year of age, 60-75% by two years, and 85-90% of 
participants by three years of age.   Other studies reported that 15% of children with IgE-
mediated CMA had persisting milk allergy at the age of eight, while those children with non-
IgE mediated CMA had outgrown their allergy at age of five (Saarinen, Pelkonen, Mäkelä, & 
Savilahti, 2005). A United States study in IgE-mediated CMA children reported that the rates 
of acquired tolerance were 19% by 4 years, 42% by 8 years, 64% by 12 years, and 79% by 16 
years (Skripak, Matsui, Mudd, & Wood, 2007). Hence, published data regarding the age at 
which children outgrow their milk allergy is inconclusive, due to different study populations, 
diagnostic criteria, and types of CMA. The exact mechanism of tolerance development is still 
unclear and depends on several factors including the type of CMA (IgE or non-IgE-mediated 
CMA), genetic predisposition, nature and dose of the allergen, age at first antigen exposure, 
and frequency of delivery of the food allergen (Nowak-Wegrzyn & Sampson, 2011). 
2.2.3 Pathogenesis and symptoms  
Cow’s milk allergy usually presents in infancy and the most affected children develop  
symptoms before  6 months of age. The onset of symptoms starts rare after the 1st year of 
life (Sampson & Anderson, 2000). The lack of microbial exposure during the first year of life 
has been associated with risk of allergic sensitisation (Burbank, Sood, Kesic, Peden, & 
Hernandez, 2017). Most infants manifest CMA symptoms within 1 week after ingestion of 
milk-formula ( Host & Halken, 2014). Cow’s milk allergy may be developed in both breastfed 
 
 
9 
 
and cow’s milk formula fed infants, and it usually involves two or more symptoms in two or 
more organ systems. The main systems that are affected are the skin (50-70% of individuals) 
gastrointestinal (50-60%) and respiratory systems (20-30%) (Host et al., 2014). The 
pathogenesis of CMA is complicated and depends on the genetic predisposition, 
environmental factors, conditions of exposure to milk allergen and the features of the 
causative allergen (Lee et al., 2017).  
The immunological mechanism regarding the development of CMA is not very clear. It is 
known that CMA is caused by both IgE and non-IgE-mediated mechanisms and it results from 
either the failure to develop normal tolerogenic processes or their later breakdown (Vitaliti 
et al., 2012). Different factors may affect the development of IgE and non-IgE-mediated 
reactions to food in infancy and early childhood. In a large cohort of 1140 infants, eczema, 
rhinitis and dietary pattern were identified as risk factors in IgE-mediated-CMA, whilst in 
non-IgE-mediated CMA the risk factors were pets in the home, dietary pattern, maternal 
consumption of probiotics during breastfeeding and age at first solid food introduction 
(Grimshaw et al., 2015). The underlying mechanism of CMA also results in different symptom 
presentation between IgE and non-IgE-mediated CMA as follows: 
IgE-mediated-reactions and symptoms  
In IgE-mediated CMA, milk specific T helper cells type-2 (Th2) are activated and lead to the 
production of milk specific IgE. Patients release IgE antibodies (Abs) from B cells when milk 
proteins or peptides pass through the skin and penetrate the gastrointestinal or respiratory 
lining. The allergic response to antigen (e.g. milk protein) entrance takes place in two stages 
(Nakanishi, 2010): 
1st stage - Sensitisation or antibody induction: 
Mast cells are found on mucosal epithelia and their number is increased at sites of Th2 during 
the allergic response. IgE immunoglobulins are bound to mast cells, blanketing the plasma 
membranes of these immune cells. Half a million IgE molecules coat the surface of mast cells 
and bind to the high-affinity IgE receptors (Hong et al., 2016). 
2nd stage: Elicitation or effector phase 
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An exposure to the same allergen cross-links the cell-bound IgE complex and leads to 
degranulation of mast cells within 5 to 16 minutes. The degranulation of mast cells 
induces the release and synthesis of important inflammatory mediators (vasodilation, 
bronchoconstriction, cellular localisation, eosinophil attraction) which are responsible for 
the characteristic symptoms of Type 1 hypersensitivity (Forsythe, 2016; Hong et al., 2016).  
 
 IgE-mediated-CMA presents with early onset symptoms that occur within minutes to 2 hours 
after ingestion of milk proteins. Histamine that is released in the circulation may cause 
oedema of the mouth and throat, rhinitis, red skin, angioedema, breathing difficulties, or an 
asthma attack (Fiocchi et al., 2010; Forsythe, 2016). Gastrointestinal symptoms such as 
diarrhoea, nausea, vomiting, and abdominal pain may be accompanied by symptoms of 
other organs (Eigenmann, 2007). IgE-mediated reactions are responsible for severe 
symptoms such as hypotension, vascular collapse, cardiac dysrhythmia and anaphylactic 
shock. Anaphylaxis is a life-threating reaction and its treatment is based on early 
administration of adrenaline. An untreated anaphylactic reaction may be fatal for the patient 
(Eigenmann, 2002). The severity of reactions cannot be predicted by the degree of past 
reactions and allergy tests such as the size of the SPT wheal and levels of milk specific IgE, 
due to their poor predictive value as a screening tool (Luyt, Ball, et al., 2014). The coexistence 
of other atopic conditions such as asthma, atopic eczema, the patient’s age, and the degree 
of sensitisation may also influence the severity of the reaction (Burks et al., 2011). The 
symptoms of IgE-mediated CMA are usually manifested after the offending food intake and 
can be identified quite easily (Table 2.1).  
Mild to moderate non-IgE-mediated reactions and symptoms  
The exact mechanism of non-IgE-mediated CMA is unknown. Non-IgE-mediated CMA 
reactions are thought to be due to Th1-mediated inflammation. The Th1- cells secrete the 
cytokine interferon-γ and activate inflammatory pathways mainly via macrophage activation. 
Sensitisation of T-cells and production of cytokines may cause inflammation, tissue damage 
and formation of epithelial and giant cells (Vitaliti, 2012). T-cell mediated response to milk 
proteins may exacerbate conditions such as eczema, asthma, and rhinitis in children with 
CMA (Host et al., 2002).  Non-IgE-mediated responses are characterised by delayed 
hypersensitivity reactions where the clinical symptoms may be manifested 2-48 hours after 
consumption of cow’s milk.  However, in some cases, non-IgE-mediated CMA symptoms may 
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occur within days/weeks after ingesting milk or milk products. These types of symptoms are 
usually accompanied by other conditions such as eczema or respiratory disorders (Sicherer 
& Leung, 2013). Clinical symptoms are subacute or chronic in nature and usually present with 
isolated GI symptoms. The severity of a reaction to a food allergen varies according to the 
form of the food (raw, cooked or processed), amount ingested, and the co-ingestion of other 
foods (Burks et al., 2011). The clinical features of IgE and mild to moderate non-IgE-mediated 
CMA are summarised in Table 2.1. 
Table 2.1: Clinical features of CMA 
Organ Systems  IgE-mediated-CMA Non-IgE-mediated-CMA 
Skin  • Pruritus  
• Erythema  
• Acute urticaria  
• Pruritus 
• Erythema 
• Atopic eczema 
Gastrointestinal  • Angioedema (lips, 
tongue, palate) 
• Oral pruritus 
• Diarrhoea  
• Nausea 
• Vomiting 
 
• Gastro oesophageal reflux 
• Food reflux/aversion  
• Abdominal pain/infantile colic 
• Pallor and tiredness 
• Loose/frequent stools 
• Constipation 
• Perianal redness  
• Faltering growth in conjunction 
with at least one or more 
gastrointestinal symptoms 
above (with or without 
significant atopic eczema) 
Respiratory  
333 
• Nasal itching  
• Rhinorrhoea 
• Sneezing  
• Congestion  
• Chest tightness  
 
 
 
12 
 
Organ Systems  IgE-mediated-CMA Non-IgE-mediated-CMA 
 
 
 
 
• Wheezing   
Other • Signs or symptoms 
of anaphylaxis or 
other systemic 
allergic reactions  
 
 
Differentiating CMA from lactose intolerance 
In routine clinical practice, lactose intolerance may be confused with milk allergy, not only 
from a carer’s point of view but also from that of GPs. However, the management of these 
conditions are completely different and an inappropriate recognition may lead to 
unnecessary dietary restriction. Lactose intolerance is a non-immunological response and it 
is caused by enzyme deficiencies, pharmacological agents or other substances (Fiocchi et al., 
2010).  Τhis PhD research is not focused on lactose intolerance.     
2.2.4. Diagnosis   
There is a worldwide debate in the diagnosis and management of CMA, due to the lack of 
specific symptoms and reliable indicators and tests. Cow’s milk allergy may be over-
diagnosed or under-diagnosed in many cases by healthcare professionals, due to the 
confusion of presented symptoms. In 2015, Lozinsky et al published a study regarding the 
experience of GPs and parents on recognition and management of CMA. They reported a 
lack of awareness of guidelines and training of GPs in the diagnosis of CMA, whereas parents 
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had different perceptions from GPs on the presentation and improvement of CMA symptoms 
(Lozinsky et al., 2015). The findings above are supported by other studies that found CMA 
diagnosis was often delayed, taking four to nine weeks (Sladkevicius & Guest, 2010; 
Sladkevicius, Nagy, Lack, & Guest, 2010). A further study found that parents may incorrectly 
perceive their children to have experienced an allergic reaction to milk (Elizur, Cohen, 
Goldberg, Rajuan, & Katz, 2013). An early and correct diagnosis of CMA is important to 
prevent ongoing symptoms and avoid unnecessary dietary restrictions from the diet of 
infants or children. In clinical practice the patient’s history and clinical examination is 
important to evaluate the different form of cow’s milk allergy.   
IgE-mediated CMA 
The clinical diagnosis in IgE-mediated CMA is based on a combination of typical presenting 
symptoms and evidence of sensitisation by the results of immune markers such as SPT and 
sIgE levels:   
- Skin Prick Test (SPT) 
Is used to identify sensitisation to an allergen(s) by measuring the specific IgE bound to the 
mast cell. The location of each allergen is marked with a pen on the forearm. The distance 
between two tests should be ≥2cm to avoid contamination which may result in a false-
positive reaction. A drop of either commercial or natural food solution is placed on the skin 
in identical order and it is immediately pricked.  The wheal response is measured after 
transfer to paper from the skin with translucent tape. Measurement is undertaken in 
standard fashion, measuring the largest wheal diameter and the diameter orthogonal to it. 
The mean wheal diameter is calculated. Results are classified as positive if the mean diameter 
is 3 mm or more in the presence of a negative control (0.9% saline, Soluprick SQ allergens) 
and a positive histamine (10 mg/mL, Soluprick SQ allergens) reaction after 15 minutes 
(Bartnikas, Sheehan, Schneider, & Phipatanakul, 2012).  
- Milk Specific IgE immunoassay blood testing  
It has been used in CMA diagnosis for many years. It is a blood test that measures the amount 
of the circulating IgE antibody in the serum produced when the individual is exposed to a 
 
 
14 
 
specific food protein. Like SPT, blood testing can detect the presence of IgE, but a positive 
result does not in itself make a food allergy diagnosis. SPT and specific IgE testing can be used 
as a single test or in combination. A blood allergy test is used in cases of severe atopic 
dermatitis (eczema), extreme sensitivity, or the need to continue antihistamine therapy as 
SPT is not indicated. Blood samples are collected for measurement of specific IgE antibody 
levels to milk, casein and β-lactoglobulin. Serum specific IgE levels are considered positive at 
levels of ≥0.35 kUA/l. Clinical performance is expressed as sensitivity, ranging from 85-95% 
and specificity, ranging from 86%-94%. Sensitivity and specificity have been reported from 
multi-center studies including several hundred patients tested for a range of different 
allergens.  Commercially available tests and reagents are used according to the instructions 
of the manufacturer (Bartnikas, Sheehan, Schneider, et al., 2012).     
The individualised clinical assessment may include the patient’s history, physical 
examination, trial elimination diet, diet diaries, oral food challenges, SPT with fresh milk or 
commercial reagents, and IgE measurements for determining milk-specific serum IgE against 
milk proteins such as casein, α-lactalbumin and β-lactoglobulin (Boyce et al., 2010).  
- Food challenges 
The double-blind placebo-controlled challenge is the gold standard in CMA diagnosis, but in 
practice this process cannot be used because it is expensive and time-consuming.  Currently, 
in clinical practice a medically supervised oral (open) food challenge is conducted for the milk 
allergy diagnosis and it is often required to confirm the diagnosis of CMA because of the 
limitation in the diagnostic accuracy of the SPT and specific IgE testing, even in combination 
with the clinical history (Dambacher, de Kort, Blom, Houben, & de Vries, 2013). In oral food 
challenge fresh milk is usually used rather than baked milk for the CMA diagnosis. Oral milk 
challenges are carried out according to a hospital protocol in a well-equipped place in the 
clinic and supervised by a clinician (Fiocchi et al., 2010). A small and incremental amount of 
challenge food is administered within a period of 2-3 hours, followed by 2 hours of 
observation. In case of allergic reaction, the process is usually interrupted and necessary 
treatment is provided. Oral food challenge is called “positive” when the patient has an 
allergic reaction to food and “negative” when the milk challenge is completed without an 
allergic reaction. Oral milk challenges are used to determine if a patient has outgrown an 
existing milk allergy or to confirm CMA when the history or the allergy tests are unclear (Luyt,  
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et al., 2014). However, oral food challenges are time consuming and include the risk of 
anaphylaxis. SPT and sIgE cut-off values are being explored as they are cheaper, easier and 
less invasive (Hill, Heine, & Hosking, 2004; Sporik, Hill, & Hosking, 2000). A positive SPT or 
specific serum IgE test is not used to confirm the diagnosis because they indicate 
sensitisation to allergens (Calvani et al., 2007; Celik-Bilgili et al., 2005; Verstege et al., 2005). 
These tests should be combined with a clear history of an allergic reaction to confirm the 
diagnosis (Costa-Pinto & Basso, 2011).   
Mild to moderate non-IgE-mediated CMA 
The clinical diagnosis in non-IgE-mediated CMA considers the development of delayed 
gastrointestinal or cutaneous symptoms that improve or resolve with exclusion and reappear 
with reintroduction of cow’s milk (Koletzko et al., 2012). Home milk-containing food 
reintroduction challenges are used to confirm the diagnosis and determine the tolerance to 
milk in mild to moderate non-IgE-mediated CMA (Venter, Laitinen, & Vlieg-Boerstra, 2012). 
In severe forms of non-IgE-mediated CMA, food challenges are not recommended at home 
and these patients are referred to secondary/tertiary care (Venter et al., 2013). Currently, 
the elimination and reintroduction of the milk/milk containing food is the only reliable 
diagnostic tool, due to the absence of validated diagnostic skin or blood tests (Luyt et al., 
2014). Table 2.2 summarises the main characteristics of IgE and non IgE—mediated CMA.  
Table 2.2: Main characteristics of IgE and non-IgE-mediated CMA 
Characteristics 
 
IgE-mediated CMA 
 
Non-IgE-mediated CMA 
Diagnosis  Allergy tests (IgE, SPT, 
food challenge taken in 
combination with clinical 
history) 
Clinical history and Food 
challenge 
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Time of exposure to 
reaction 
From minutes to 2 hours 
 
From several hours to days 
 
Severity of symptoms  
 
Mild to anaphylaxis 
 
Mild to moderate 
 
Duration of CMA May persist beyond 1 
year of age 
Usually resolved by 1 year 
2.2.5. Management and treatment    
The mainstay of CMA management is based on individualised avoidance of cow’s milk and 
foods containing cow’s milk from the patient’s diet.  The allergen avoidance helps in resolving 
the symptoms within approximately 2 weeks (Ludman, Shah, & Fox, 2013). Nutritional 
counselling and education regarding the management of allergic reactions are essential 
during CMA treatment (Venter et al., 2012). Children on prolonged milk free diets may be at 
risk of protein and energy malnutrition if specialised dietetic input is not provided (Meyer et 
al., 2013).  Specialised allergy or paediatric dietitians play an important role in choosing milk 
formulas; monitoring of nutritional status; suggesting nutritional supplements; providing 
dietary advice for the breast-feeding mothers and infants; providing appropriate weaning 
advice; and recommending which foods should be omitted and which foods could be added 
to/tolerated in the diet of children with CMA (Groetch & Nowak-Wegrzyn, 2013; Mehta, 
Groetch, & Wang, 2013). Leaflets with written advice regarding suitable substitutes and 
recipes, online information and education regarding the food labels and lifestyle adjustment 
is an additional part of dietetic support (Venter et al., 2012). Children, who usually remain 
on the elimination diet for at least six months or one year, are individually assessed by the 
medical team for reintroduction of Cow’s Milk (Burks et al., 2011). In formula-fed infants an 
extensively hydrolysed formula (EHF) and amino acid formula (AAF) are available for the 
management of CMA because they are less likely to trigger an allergic reaction. EHF consists 
of cow’s milk proteins (casein or whey) that are broken down in smaller peptides while AAF 
are composed of pure synthetic amino acids (Host & Halken, 2004).  Studies have shown that 
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AAF and EHF may provide a balanced nutrition with normal growth and development of 
infants suffering from CMA (Agostoni, Terracciano, Varin, & Fiocchi, 2016; Dupont, Hol, 
Nieuwenhuis, & group, 2015; Vandenplas, De Greef, Hauser, & Group, 2014).  
Oral immunotherapy treatment (OIT) or oral tolerance induction is a possible option for IgE-
mediated CMA treatment in the future. OIT involves the ingestion of increasing amounts of 
milk allergen on a regular basis to desensitize and help patients to develop tolerance. Some 
studies have used OIT and found that it provided effective sensitisation in young children 
with CMA (Chen & Land, 2017; Longo et al., 2008; Staden et al., 2007; Tripodi et al., 2013). 
However, immunotherapy for cow’s milk is still under investigation and not considered as 
part of routine clinical practice because severe allergic events occur during oral 
immunotherapy (Pajno et al., 2017; Taniuchi, Takahashi, Soejima, Hatano, & Minami, 2017). 
Prospective control studies are required to investigate and compare the effectiveness of the 
development of tolerance to milk via introducing of natural baked milk containing foods or 
as a form of OIT.  
2.2.6 Effects of CMA on patients and family - Impact of food challenges   
 Patients with a food allergy experience social and food restrictions and the constant 
vigilance required to manage their disease may impair their health-related quality of life.  
Research indicates that parents/caregivers of children with food allergies report that they 
and their children have a low quality of life compared with parents of healthy children or 
children with chronic diseases such as diabetes mellitus type 1, asthma, rheumatoid arthritis 
or other long-term conditions (Flokstra-de Blok et al., 2010). Another study demonstrated 
that parents or caregivers avoided including their child in social events, parties or any other 
family activities due to their concerns about any potential allergy food trigger exposure for 
their child (Bollinger et al., 2006). Having a child with food allergy can also impact the well-
being of parents. Having a child who experiences unpredictable severe reactions and 
anaphylaxis has been associated with increased anxiety and stress in parents/caregivers (Lau 
et al, 2014). Additionally, there is evidence to suggest that parents of children with food 
allergy report increased anxiety, stress and depression compared with parents of children 
with no food allergy. Some parents have higher stress and anxiety due to the uncertainty of 
not having a medical diagnosis of their children’s food allergy or lack of information related 
to the food allergy management from healthcare professionals (Birdi et al., 2016). Family  
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quality of life may be influenced by different factors such as age of the child, severity of 
reactions, food allergy trigger, previous life threatening reactions, having other concomitant 
allergy (eczema, asthma, other food allergy or multiple food allergy) (Antolín-Amérigo et al., 
2016).  
 
A well-conducted study has found that limited (or lack of) access to appropriate national 
health service primary and specialist care and inadequate support for effective long-term 
management of food allergy is associated with increased anxiety and stress for parents and 
their children (Akeson et al, 2011). Another study found that providing newly-diagnosed food 
allergic patients, and their families, with accurate and easily accessible (via a website) food 
allergy management information written by specialised healthcare professionals improved 
parents’/caregivers’ and patients’ quality of life (Vagras et al 2007).  Family quality of life may 
be influenced by environmental factors such as lack of allergy awareness or lack of access to 
appropriate healthcare (Antolín-Amérigo et al., 2016). Hence, based on the evidence above, 
effective communication between parents/caregivers/patients and healthcare 
professionals, and access to accurate and comprehensive information related to health-
decisions could benefit parents and patients to improve their quality of life and reduce stress 
and anxiety.                
 
Interestingly, food challenge outcomes (both positive and negative) seem to have a 
beneficial role in the psychological condition of parents and children. Recent studies report 
that food challenge outcomes in peanut/egg allergic children reduced parental concerns and 
anxiety and improved their quality of life even when the outcome of a food challenge was 
positive (Howe, Franxman, Teich, & Greenhawt, 2014; Kemp, Allen, & Campbell, 2009; 
Zijlstra et al., 2010). Knibb et al (2012) observed that allergy patients who undertook a food 
challenge had improved health- related quality of life and reduced parental anxiety 
compared to food allergic children that did not undergo a food challenge. A recent meta-
analysis assessed seven studies related to the effects of food challenges on food allergy 
health-related quality of life and found that food challenges are associated with improved 
food health-related quality of life of patients and reduced parental concerns and burden 
regarding the food allergy management of their children (Kansen et al., 2018). 
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  Looking specifically at the impact of milk allergy on patient and family quality of life, there 
is limited evidence regarding its impact. However, one study has found that milk or egg 
allergy is associated with worse total and domain-specific caregiver QoL scores versus peanut 
or tree nut allergy (Howe et al., 2014). This is understandable given that  food allergy triggers 
like milk and egg are hidden in a variety of foods and are mainly associated with severe 
reactions and anaphylaxis in children (Anagnostou, 2018). In children, most deaths that have 
been reported were caused by hidden food ingredients to which the patient was highly 
allergic. Interestingly, a recent review of studies demonstrates that cow’s milk and 
seafood/fish are the main allergy food triggers that provoke fatal 
reactions in many countries (Pouessel et al., 2018). The very severe nature of IgE- mediated 
milk allergy means that there is likely a great impact on QoL, although a limited number of 
studies have explicitly explored this.  
 
Hence, parents’ and children’s quality of life is affected by the constant threat of exposure 
to food allergy triggers and the vigilance required to avoid any undesirable exposure or food 
contamination during daily social or family activities such as family and school meals, parties, 
eating out. Also, the potential difficulties regarding access to resources and information 
regarding how to cope with stress during CMA management, and uncertainty regarding 
reliability of the given information may add further stress for caregivers and patients. Despite 
the increased use of gradual allergen introduction as a potential treatment for patients with 
food allergy there is however a lack of studies that demonstrate the effects of long-term 
gradual allergy food introduction on children’s and their parents’ quality of life.    
 
In particular, there is no data regarding the impact of home baked milk introduction on 
children and their families despite this being a staple of milk allergy management and 
treatment. Due to the research gap in this field, one of the purposes of this research is to 
listen carefully to parents that gradually introduce baked milk products into the diet of their 
milk allergic children and understand their experience, fears, concerns and needs during this 
process. Understanding of parents’ concerns and needs can contribute to the improvement 
of resources such as clear and concise leaflets or a design of a comprehensive milk ladder 
plan, and any other educational materials that would likely reduce parental stress during the 
management and treatment of their children milk allergy.    
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2.3. Use of baked milk in the management of IgE and mild to moderate 
non- IgE-mediated CMA  
The milk-free diet may help CM allergic children to prevent milk allergic reactions and 
inflammation, but may have a negative impact in the adequate intake of essential nutrients. 
Undernutrition may not only have consequences in children’s development and growth, but 
also impair proper socialisation and family quality of life (Meyer et al., 2017). Children usually 
remain on the elimination diet for at least six months or one year and are individually 
assessed by the medical team for reintroduction of cow’s milk at regular intervals (Burks et 
al., 2011). Current research indicates that tolerance to cow’s milk is developed with time and 
this process can be helped with the gradual re-introduction of small amounts of baked milk 
or baked milk containing foods into the diet of children who are still allergic to milk (Dupont, 
2013). However, the appropriate timing of baked milk reintroduction and place 
(hospital/clinical setting or home/outside the clinical setting) to conduct the first 
reintroduction of cow’s milk are challenging questions for healthcare professionals and 
carers/patients. The process of assessment of the suitability of candidates for baked milk re-
introduction depends on the type of CMA.  
For IgE-mediated-CMA, clinically supervised oral food challenge (Jarvinen & Sicherer, 2012) 
and immune markers assessment including SPT and milk specific IgE (Boyce et al., 2010) in 
combination with the medical history are used to identify candidates’ potential to tolerate 
CM. In IgE-mediated-CMA there is a risk of anaphylaxis and oral food challenges must be 
carried out under medical supervision in a well-equipped area suitable for treating severe 
reactions, close to an intensive care unit (Fiocchi et al., 2010).  Hospitals follow a specifically 
designed protocol which includes criteria for determining allergic reactions, parental 
informed consent forms and information regarding the challenge food and process (e.g. 
dose). Milk challenges usually form the first step of a gradual re-introduction of milk or milk-
containing foods. In recent years, CM allergic children are challenged using baked milk 
products (which are less allergenic) before moving on to challenges using fresh milk-
containing products where appropriate. Baked milk challenge is a process of using baked milk 
or a milk-containing food (biscuits/muffin/pizza) in increasing doses over a period of one day 
(e.g. eating the same cake in increasing amounts) to perform a food challenge (Venter et al., 
2013). Research is increasingly informing us that food processing such as baking or cooking 
at high temperatures, exposure to low pH or enzymatic digestion may destroy specific milk 
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proteins and help many children to tolerate baked milk-containing foods such as biscuits, 
breads, cakes, waffles and macaroni cheese (Nowak-Wegrzyn et al., 2008). However, there 
are children who may react to baked milk and an initial challenge to very small amounts of 
baked milk should be undertaken with support from a child’s doctor or dietitian. Table 2.3 
summarises the dietary management differences between IgE and mild to moderate non-
IgE-mediated CMA.  
   
Table 2.3: Differences between dietary management in IgE and non-IgE-mediated 
CMA 
IgE- mediated CMA  Mild to moderate non-IgE-mediated 
CMA  
Initial elimination/avoidance of cow’s 
milk and milk containing foods in a 
period of 2- 4 weeks – In long: 6 months 
to 1 year 
Initial elimination of cow’s milk and milk 
containing foods in a period of 6 months 
to 1 year 
 
Maternal avoidance of milk and milk 
products may be required in breastfed 
infants   
Maternal avoidance of milk and milk 
products may be required in exclusively 
breastfed infants 
Complete avoidance including “traces” No need to avoid “traces” 
Potential tolerance to small amounts of 
milk/milk containing foods 
Potential tolerance to small amounts of 
milk/milk containing foods 
Potential tolerance to baked milk/baked 
milk foods  
Potential tolerance to baked milk/baked 
milk foods 
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2.3.1 Guidelines in the use of baked milk  
This section will discuss what guidelines have been developed to aid healthcare professionals to 
decide who CMA patients are optimal candidates for baked milk introduction in the 
management of IgE and non- IgE mediated CMA. This section is not a part of the systematic 
review.  
 
Guidelines in IgE-mediated CMA  
 Currently, the only guidelines that are focused on IgE-mediated cow’s milk allergic patients 
and help healthcare professionals to select, monitor, and prepare appropriately, potential 
candidates for baked milk reintroduction are published by the British Society of Allergy & 
Clinical Immunology (BSACI) (Luyt et al., 2014).  The BSACI guidelines for the diagnosis and 
management of CMA state that baked milk challenges could be used before fresh milk 
introduction because the reaction to baked milk is less likely to be severe during food 
challenges (Luyt et al., 2014). They suggest that baked milk reintroduction might be 
attempted in hospital or at home for children with IgE-mediated CMA according to the 
clinical criteria outlined in Table 2.4. 
Table 2.4: Criteria taken into consideration in the baked milk reintroduction 
Home -baked milk reintroduction/milk 
ladder  
Hospital-baked milk reintroduction/baked 
milk challenge  
• Children that had only cutaneous 
symptoms on a mouthful milk allergen 
exposure  
• Reduction of milk specific IgE and Skin 
Prick Test 
• No reaction to milk in the past 6 
months 
• Poorly controlled asthma and regular 
asthma preventative inhaler treatment  
• Multiple or complex allergy 
• Parents/carers who find it difficult to 
comprehend and comply with the 
protocol 
• Less severe reaction with trace of milk 
allergen exposure 
• Previous CMA symptoms affecting 
breathing, gut or circulation 
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Guidelines in mild to moderate non-IgE-mediated CMA 
Currently, the only published guidelines related to baked milk introduction in mild and 
moderate non-IgE-mediated CMA have been introduced by the “ MAP Guidelines (2013)” 
and its updated version “the iMAP Guidelines (2017)” (Venter et al., 2017; Venter et al., 
2013). These guidelines not only enhance the knowledge of healthcare professionals in 
primary care and provide more help in recognising and differentiating between potential IgE-
mediated CMA and non-IgE-mediated CMA but also confirm that all those remaining children 
diagnosed as mild to moderate non-IgE mediated CMA are suitable for home baked milk 
introduction (Venter et al., 2017).  For the management of mild to moderate non IgE -
mediated CMA the MAP and iMAP guidelines have suggested a baked milk food protocol that 
is also called a milk ladder (appendix 6) for gradual reintroduction of milk containing foods 
into the diet of non-IgE mediated CMA children at home. There are a variety of milk ladders 
that are distributed to patients or their caregivers by hospitals. However, none of these milk 
ladders have been validated by a clinical trial.  A rationale for a milk ladder classification is 
presented in Figure 2.2. The scale starts in the first stage with less allergenic foods (lower 
dose of protein and more denatured) and completes gradually with more allergenic foods 
(higher protein dose and less denatured).   
 
  
Stage 1
Small quantity 
Baked AND 
Matrix effect
e.g small crumb 
of biscuit <1g of 
CMP per biscuit. 
Build up to whole 
biscuit over 5 
weeks 
Stage 2 
Larger quantity 
Baked AND Matrix 
effect OR Traces 
without matrix or 
with minimal 
heating 
e.g other baked 
products 
containing CMP 
e.g. biscuits, cakes, 
muffins, waffles, 
scotch pancakes. 
Butter, margarine. 
Cheese powder 
flavouring
Stage 3 
Larger quantity Less 
heating AND Less 
matrix OR All with 
some degree of 
protein change with 
heating or 
manufacturing
e.g.products 
containing cooked 
cheese or whole 
cow’s milk as heated 
ingredient e.g. pizza, 
cheese sauce, 
custard, rice 
pudding. Chocolate; 
chocolate coated 
items Fermented 
desserts Yogurt
Stage 4
Fresh milk products
e.g uncooked cheese 
Uncooked non-yogurt 
desserts e.g. ice-cream or 
mousse Cow’s milk UHT 
milk followed by 
pasteurised milk and then 
unpasteurised milk (if 
preferred)
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Figure 2.2:  Classification of a milk ladder  (Luyt, Ball, et al., 2014) 
However, there are a variety of milk ladder versions available that are distributed by 
hospitals and there is not any milk ladder that has been validated by a clinical trial. In 
addition, hospitals follow their own baked milk challenge protocols based on different 
methods and guidelines (there is a lack of standardisation in the practice, process and dose 
regimes), and these different approaches may have different immunological effects (Upton 
& Nowak-Wegrzyn, 2018). In particular, baked milk tolerant children may react to milk and 
their reactivity could be unpredictable and severe (Bartnikas, Sheehan, Hoffman, et al., 2012; 
Nowak-Wegrzyn et al., 2008; Upton & Nowak-Wegrzyn, 2018). For this reason, many 
researchers suggest medical supervision for the initial baked milk introduction in children 
with IgE mediated CMA. The MAP guidelines (2013) suggest that no child with IgE-mediated 
food allergy should have a challenge in primary care or community settings (Venter et al., 
2013).  
European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 
guidelines (2012) recommend to not prolong unnecessary dietary restrictions and suggest 
supervised CMP challenges (Koletzko et al., 2012). WAO Guidelines (2010) recommend that 
all interventions and avoidance strategies be re-evaluated on a yearly basis and oral food 
challenges should be carried out under medical supervision (Fiocchi et al., 2010). However, 
in contrast to these guidelines, as mentioned above, the BSACI milk allergy guidelines suggest 
home introduction of milk using a “milk ladder” in IgE-mediated CMA (Luyt et al., 2014; Luyt, 
Krishnan, Huber, & Clark, 2016). Hence, the lack of a national or international agreement 
regarding the baked milk containing food introduction could lead to different advice that 
could confuse caregivers and expose IgE-mediated cow’s milk allergic children to the risk of 
an accidental reaction. 
- Mild to moderate non-IgE-mediated CMA 
The only guidelines related to BMC and ML in mild and moderate non-IgE-mediated CMA are 
the MAP Guidelines (2013) and its updated version “the iMAP Guidelines” (2017) (appendix 
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8) that suggest that all those remaining children diagnosed as mild-moderate  non-IgE 
mediated CMA are suitable for home baked milk introduction (Venter et al., 2017; Venter et 
al., 2013). The international iMAP recommendations enhances the knowledge of healthcare 
professionals in primary care and provides more help in recognising and differentiating 
between potential IgE-mediated CMA and non-IgE-mediated CMA (Venter et al., 2017).  
2.4. Role of baked milk in the development of milk tolerance in CMA   
A literature review taking a systematic approach has been conducted to identify and critically 
evaluate studies that have investigated the effects of baked milk challenges on the 
development of milk tolerance in children with IgE and non-IgE mediated CMA and the role 
of immune markers (SPT and milk sIgE) in predicting oral milk challenge outcomes in IgE-
mediated CMA. The purpose of this review is to explore what is known about the 
introduction of baked milk in milk allergic patients specifically regarding the usefulness and 
safety of this procedure, and which immune markers are currently used to identify the 
development of tolerance to milk containing foods in IgE-mediated CMA.     
 
2.4.1 Methods of the systematic review  
Data source - Search Strategy for identification of relevant studies  
Published studies were identified by using Web of Science, PubMed (U.S National Library 
of Medicine & National Institutes of Health), CINAHL Heading and also Cochrane Central 
Register of Control Trial (CENTRAL) databases from 1995 until 2018. The search was 
performed by a combination of Medical Subject Heading (MeSH) algorithms (appendix 5) 
and the following keywords: Cow’s milk allergy, baked milk challenges, heated milk foods, 
baked milk tolerance, milk ladder. Citation searching was also carried out using the search 
engine Google Scholar and Scopus citation database to identify peer-reviewed articles, 
abstracts and full-texts. The bibliographic software EndNote Reference Manager was used 
to manage and record references.  
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Study Design 
Study selection including initial screening of titles and abstracts was performed to identify 
potentially relevant papers. The selection of included full papers was based on the 
following inclusion or exclusion criteria:    
 
 Inclusion criteria: 
This review considered:  
• All studies that used baked milk challenges and immune markers to diagnose CMA 
or identify tolerance to cow’s milk protein or baked milk in children and adults with 
any study design (Observational case control - cross sectional – Prospective and 
retrospective cohorts and Randomized Control Trials).    
• Published and unpublished articles and monographs,  
• “Grey literature’’ that includes organisational project papers and clinical guidelines 
{National Institute for Health and Clinical Excellence (NICE) guideline, British Society 
of Allergy and Clinical Immunology (BSACI) guidelines for the Diagnosis and 
Management of Milk Allergy, European Academy of Allergy and Clinical Immunology 
(EAACI) guidelines and American Academy of Allergy, Asthma and Clinical 
Immunology (AAAAI) recommendations in the management of food allergen 
introduction.  
• Full reports of studies during the period 1990-2018.  
 
  Exclusion criteria 
Studies which did not involve baked milk challenges/introduction of baked milk containing 
foods to diagnose or determine development of tolerance to cow’s milk were not included 
in this review.   
 
Study Selection 
The identified references for which the title and abstract appeared to meet the 
predetermined inclusion criteria were obtained and their full papers were evaluated.  
Eligible studies were those relevant to the use of baked milk challenges and protocols in 
the diagnosis of CMA or in determining tolerance development to baked milk. Studies 
related to the role of immune markers (Specific milk IgE immunoglobulins and Skin Prick 
Test) in predicting food challenge outcomes in forms of baked milk were evaluated.  
Duplicate publications of research results were assessed. The search results were imported 
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into EndNote, a reference management software program. A flow diagram is provided 
below with the number of articles reviewed at each stage according to the PRISMA 
(Preferred Reporting Item for Systematic Review) group (reference needed here to the 
PRISMA guidelines).  
  
  
 
    
                                 
                                                               
                           
         
                                             
  
 
                                          
                                      
                  
 
   
 
 
 
 
 
 
Figure 2.3: Flow chart of study selection 
Web of science data 
base (n)*=1267 
 
 Pub Med database                
(n)*=4548 
Cochrane Library           
(n)*=0 
      (n)*=2020 duplicated studies removed, 
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(n)*= 3795 articles 
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(n*)= 98 full text articles are relevant and 
included as references in the study  
(n*)=276excluded-not 
related with baked milk 
challenges 
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n*=8 original articles are eligible and 
evaluated with a systematic way 
 
(n*)=2 retrospective, 
observational studies (2012) 
 
(n*)= 6 Cohort prospective, 
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(2008,2011,2012,2013,2014,2016)  
CINAHL 
Headings(n)*=0 
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Data extraction – Quality assessment 
The population characteristics and study design, exposure-outcome measurements, 
assessments and findings of the reviewed studies are presented in Table 2.5 and Table 2.6 of 
the next section 2.4.2.  Quality assessment was carried out on each included study using an 
adaptation of the CASP (Critical Appraisal Skills Program) approach which involved an 
assessment of internal and external validity.("CASP Appraisal Tools Links with PHRU link. 
http:www.phru.nhs.uk/pages/PHD/resources.htm,"). Aspects, such as risk of bias caused by 
study design, conduct or analysis, statistical issues (odds ratio, P-value, confidence intervals etc) 
and choice of outcome measures were considered.    
 
2.4.2 Discussion of findings    
This section is divided into three parts and presents the findings of the studies that have been 
reviewed using a systematic approach.  In the first part of the section, the baked milk challenge 
outcomes of children with CMA are discussed. In the second part of the section the role of 
immune markers in predicting baked milk challenge outcomes in IgE-mediated CMA is 
introduced. In the last part of the section the clinical symptoms that have been observed in CMA 
children who underwent a baked milk challenge in order to evaluate the safety of the baked milk 
dietary intake is presented.   
 
Baked milk challenge outcome studies  
 All the studies that explored the impact of baked milk challenges on the development of milk 
tolerance in children with CMA have been reviewed and summarised in Table 2.5.   
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Table 2.5: Population characteristics, study design, exposure-outcome measurements, 
assessments and findings of the reviewed baked milk studies 
References Design-
Population 
Exposure 
&assessment 
measures 
Preparation of 
baked milk 
products for 
testing      
 
Findings 
Nowak-
Wegrzyn 
et al. 2008 
Prospective-case 
control study 
N=100 children 
aged 2-17yrs 
(median age: 7.5 
(2.1–17.3) 7yrs) 
Approval by IRB 
Mount Sinai, USA  
 
SPT≥ wheal 8mm 
milk specific IgE:   
>5KUA/L if ≤2yrs   
or >15KUA/L if 
>2yrs    
 
1.3 g of milk 
protein from non-
fat dry milk 
powder in a 
muffin baked at 
350 °F for 30 min. 
1.3 g milk protein 
(cooked in a 
waffle maker at 
500 F for 3 min) 
68 (68%) participants 
were heated milk- 
tolerant, 
9 (9%) participants 
tolerated heated & 
unheated milk,   
23 (23%) participants 
showed reaction to 
heated milk  
 
Kim et 
al.2011 
Prospective-case 
control study,  
 N=89 participants 
aged 0.5-21yrs 
(median: 6.6 (2.1–
17.3)  
Comparison 
group:N=60 
Approval by IRB 
Mount Sinai,USA 
(June 2004-Oct 
2007) 
 
 SPT≥ wheal 8mm 
milk specific IgE:   
>5KUA/L if ≤2yrs   
or >15KUA/L if 
>2yrs    
 
1.3 g of milk 
protein from non-
fat dry milk 
powder in a 
muffin baked at 
350 °F for 30 min. 
Cheese pizza 
containing 4.6 g 
of milk protein 
(baked at 425 F 
for 13 min or 
longer) 
From 65 children 
initially tolerant to 
heated milk (HM), 39 
(60 %) tolerated 
unheated milk. From 
the HM reactive group 
(n = 23), 2 (9 %) 
tolerated unheated 
milk, 3 (13 %) 
tolerated HM and 
baked cheese, 
whereas the majority 
(78 %) avoid milk 
strictly. Children 
initially tolerant to HM 
were more likely to 
become unheated milk 
tolerant compared 
with HM reactive 
children (p < 0.001) 
and those who 
incorporated dietary 
baked milk were more 
likely than the 
comparison group to 
become unheated milk 
tolerant (p < 0.001)  
Bartnikas 
et al. 2012 
Retrospective 
observational 
study 
N=35 children 
aged 3 -18yrs,  
Medical records: 
Allergist-
documented 
history of allergic 
reaction to milk 
1.3 g of milk 
protein from non-
fat dry milk 
powder in a 
muffin/cupcake 
83 % (29/35) children 
passed BMC & 
17%(6/35) failed BMC 
Most children allergic 
to cow’s milk tolerated 
baked milk. 
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Median age: 8.1 
(3.1–18) 
Approval by IRB 
Boston Children’s 
Hospital, USA 
(Sep 2009-Sep 
2011) 
and/or positive 
testing:  
SPT positive 
>3mm & 
34(97.1%) out of 
?? participants 
had SPT to casein  
-sIgE to milk 
lowest limit 
35kUA/L& 33 
(94%) out of ?? 
children had sIgE 
to casein, a-
lactoalbumin 
&/b-lactoglobulin   
baked at 350 °F 
for 30 min. 
 
  
Caubet et 
al. 2013 
 
  
2 Cohorts – 
Prospective study  
N=97 children 
from Nowak-
Wegrzyn et al 
(2008) study  
N=128 children 
from Nowak-
Wegrzyn et al 
study 
Total N=225 from 
Kim et al (2011) 
study  
Median Age of 
HM tolerant 
group: 7.5 (4.0–
11.0) Age of HM 
reactive group: 
8.0 (4–10) 
 
Allergic reaction 
to milk in past 
6 months and 
positive testing 
(SPT or sIgE), or 
highly predictive 
testing (sIgE 
>5 kUA/L if 
<2 years or 
>15 kUA/L if 
>2 years, or SPT 
wheal 8 mm) 
1.3 g of milk 
protein from non-
fat dry milk 
powder in a 
muffin baked at 
350 °F for 30 min. 
1.3 g milk protein 
(cooked in a 
waffle maker at 
500 F for 3 min) 
69 % (83/121) passed 
baked milk challenges.  
Mehr et 
al.2014 
Prospective study  
N=70 
HM tolerant 
median age: 4.5 
(2.5–8) 
HM reactive 
median age: 7.3 
(4.9- 7.3) 
Allergic reaction 
to milk in past 
12 months and 
positive testing 
(SPT or sIgE), or 
SPT wheal >7 mm 
if >2 years or 
>5 mm if <2 years 
0.5 g of milk 
protein in a 
muffin baked at 
180 °C for 20 min. 
51 (73 %) passed the 
BMC and incorporated 
BM into their diet. 19 
children (27 %) 
reacted to their 
challenge and 4 (21%) 
from 21 developed 
anaphylaxis and 
required 
intramuscular 
adrenalin. Predictors 
of clinical reactivity to 
BM were asthma and 
a history of CM 
anaphylaxis 
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In 2008, Nowak-Wegrzyn et al. reported a study in which they food challenged 100 CMA 
children (average age 7.5 years, range 2.1-17.3 years) and found that the majority (75%) of 
participants became tolerant to baked/heated forms of CM such as muffin, cakes, breads 
and waffles before they became tolerant to pure/uncooked forms of CM. Growth and 
intestinal permeability were also monitored and no differences were observed in baked milk 
tolerant children (Nowak-Wegrzyn et al., 2008). In this prospective-case control study they 
excluded children with negative SPT, undetectable milk sIgE, unstable asthma, allergic 
rhinitis or atopic dermatitis, milk-induced eosinophilic gastroenteropathy, and patients with 
a recent reaction to baked milk.     
 Kim et al. (2011) conducted a follow up prospective - case control study and challenged 88 
IgE mediated CMA children (average age 6.5 years, range 2.1-17.3 years) between 2004 and 
2007. In 2011, they reported that among 88 children, 65 (74%) tolerated their initial muffin 
challenges, 39 (60%) of those children became tolerant to unheated milk within the 5-year 
Ford et 
al,2013  
Prospective study 
N = 132, median 
age: 7.6 (4.0–
11.0) Prospective 
SPT≥ wheal 8mm 
milk specific IgE:   
>5KUA/L if ≤2yrs   
or >15KUA/L if 
>2yrs    
 
1.3 g of milk 
protein from non-
fat dry milk 
powder in a 
muffin baked at 
350 °F for 30 min. 
Pizza (4 g of milk 
protein baked at 
425 F for at least 
13 min), rice 
pudding (7.7 g of 
milk protein 
baked at 325 F for 
90 min) 
95(72 %) CMA 
patients tolerated 
some forms of HM in 
their diets. 
 
 
Kwan et al 
2016 
Prospective study 
N=30 
Median age:  
median age: 7.5 
(2-16) 
SPT:8-14mm 
slurry muffin 
Included patients 
with SPT≥8mm -
excluded 
SPT≥15mm 
Optimal casein 
specific IgE: 
6KUA/I  
Negative decision 
point casein 
IgE:1KUA/I   
1.3 g of milk 
protein from 
muffin baked at 
350 °F for 30 min. 
The doses of one 
muffin:1/8, 
1/8,1/4,1/4,1/2, 
and finally ¾, 
giving a total of 
two muffins 
(2.6grof milk 
protein) 
 
 
18(60%) tolerated 
muffin challenges. 
Predictors of baked 
milk reactivity were 
asthma, asthma 
requiring preventer 
therapy, IgE-mediated 
clinical reactions to 
more than 3 food 
groups, and a history 
of CM anaphylaxis. 
The powder milk was 
not helpful  
 
 
32 
 
follow up period, 18 (12%) children tolerated a cheese-pizza challenge and 8 (12%) children 
chose to avoid milk. Interestingly, these researchers found that baked milk-tolerant children 
were more likely to become unheated milk tolerant compared with baked milk-reactive 
children (P<.001). They consequently argued that the inclusion of baked milk products in the 
children’s diet at regular intervals may accelerate the development of tolerance to CMA 
compared to those children who follow milk exclusive diets.  
In 2011 and 2013, Cubet et al. analysed data collected prospectively from 225 patients 
(average age 7 (2-17) years between 2004 and 2010. Two separate cohort studies were 
conducted in the same clinical research centre but in different periods. In the first cohort 
that was conducted between 2004 and 2007, among 97 children that undertook baked milk 
challenges, 23(24%) children reacted to baked milk, 66(68%) patients tolerated baked milk 
and 8(8.3%) children tolerated baked and unheated milk.  In the second cohort that was 
conducted between 2008 and 2010, among 128 children that undertook baked milk 
challenges, 38(30%) children experienced an allergic reaction and failed the challenge, 
83(65%) patients tolerated baked milk and passed the challenge, and 7(5.5%) children 
tolerated baked and unheated milk and passed both baked and unheated challenges.     
 
In 2013, Ford et al conducted a prospective study and among 132 CMA children (average age 
7.6 (4-11 years) that were challenged 95(72%) tolerated a variety of baked milk foods. This 
study confirms the findings of the studies above that the majority of patients with CMA are 
able to tolerate some baked milk containing foods and include them into their diet.  
    The four prospective studies above (all conducted in the USA) have similar and promising 
results regarding the development of baked milk tolerance in CM allergic children, but these 
studies need substantiation from randomised control trials that could compare different 
phenotypes of CMA or age groups, doses of the baked milk, and unheated food challenges. 
In these studies, the average age of participants was 7-8 years old and no sufficient data for 
infants and younger children were provided. The food doses that were administered during 
baked milk challenges were lower compared with the doses of unheated milk challenges and 
this may confound the findings of the studies. In addition, these studies did not determine 
whether the children outgrew their CMA because of either a repeated exposure to baked 
milk products or because they were suffering from a less severe type of CMA. Interestingly, 
none of these participants were challenged to fresh milk before they undertook a baked milk 
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challenge. Therefore, the high rates of baked milk tolerant children may include those who 
had already outgrown their CMA. Selection bias may present in data collection because the 
food challenges that underwent the children were not double blind placebo controlled 
challenges which are the gold standard in the allergy tests (Bock & Atkins, 1990).      
   
In 2012, Bartnikas et al reported a study in which they challenged 35 CMA children (average 
age 8 (3-18) years) and observed that 29 (83%) children passed muffin/cupcake challenges 
and 6 (17%) children failed muffin/cupcake challenges. This retrospective chart review 
collected and analysed data from all patients who underwent hospital baked milk challenges 
between 2009 and 2011. Participants had a previous allergic reaction to baked or unheated 
milk and positive SPT or detectable milk sIgE. Children were challenged with home-made 
muffin/cupcake that was prepared by caregivers. The baked milk challenge protocol (food 
recipes and doses of challenge food) was based on previous method that was published by 
Nowak-Wegrzyn et al (2008).   
Bartnikas et al is also a USA study and its results were similar to other USA studies. However, 
due to the retrospective design, longitudinal data was not available regarding the baked milk 
containing foods that children had at home and their progression to tolerance of fresh milk. 
The diagnosis of baked milk allergy was based on history and allergy tests, and it was not 
confirmed by an oral food challenge at entry of the study. Therefore, there is a possibility 
that some of the children who tolerated a muffin/pancake might also have been tolerant to 
unheated milk.    
In 2014, Mehr et al challenged 70 CM allergic children (median age: 5.3 years) with muffin; 
51 (73%) children tolerated baked milk at challenge and incorporated this baked milk food 
into their diet. An interesting finding of this study is that a large number of children (58%) 
with prior severe reaction to baked milk or anaphylaxis to unheated milk tolerated the baked 
milk challenge.  
In 2016, Kwan et al challenged 30 children with CMA [average age 7 (2-16)] years and from 
those 8 (60 %) children were baked milk tolerant. Authors reported that gender, history of 
asthma or eczema, and history of anaphylaxis did not predict oral baked milk challenge in 
their sample (Kwan et al., 2016). 
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The USA studies described reported that those CMA children with the combination of 
multiple-IgE-mediated food allergies, asthma and prior anaphylaxis to milk were at risk of 
reacting to baked milk. However, the Australian and  Canadian studies outlined above found 
that some children with a history of severe reaction to baked milk or anaphylaxis to unheated 
milk  were tolerant to baked milk and a history of asthma/eczema/anaphylaxis was not a 
predictive factor for a reaction to baked milk. However, the main limitation for both studies 
was that CMA children were not challenged to cow’s milk to confirm their milk allergy before 
they experienced a BMC.            
In summary, the findings of this section of the review indicate that: the majority of children 
with CMA tolerate baked milk, although there are contradictory findings regarding the 
predictive indicators of a BMC outcome; there are few studies that have explored baked milk 
introduction in IgE mediated CMA and the majority of the studies were conducted in the 
USA;  there are no studies that have investigated the effects of baked milk introduction in 
IgE and non-IgE mediated CMA at home; there are no studies that have evaluated the long-
term effects of baked milk ingestion on growth and other atopic diseases in IgE and non-IgE 
mediated CMA.  
 
The studies that have explored the effectiveness of baked milk introduction in IgE mediated 
CMA have found that the majority of CMA children passed the baked milk challenges and 
were able to tolerate baked milk. These studies provided baked milk challenge protocols in 
terms of food doses during a challenge and a practical guide with baked milk food recipes 
that may be used by other healthcare professionals and adapted in their research or clinical 
practice.  They have provided evidence that CMA children who pass a baked milk challenge 
may be tolerant of a variety of products that contain baked milk and may outgrow their milk 
allergy quicker compared with those CMA children who react to baked milk or baked milk 
containing foods. However, further studies with a high-quality design are required to provide 
robust evidence to assess whether repeated exposures to baked milk products can help 
some children with CMA to outgrow their milk allergy quicker than other children and 
whether any effect observed can be explained by different phenotypes of milk allergy 
(persistent or transient cow’s milk allergy).  Interestingly, the findings of these studies 
indicate that baked milk introduction may expose some patients at risk of severe reactions 
or anaphylaxis. In the Mehr et al, (2014) study four children reacted sufficiently to require 
IM adrenaline and indeed all those who failed a BMC in these studies had by definition 
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experienced an allergic reaction.  Further investigation is required to provide evidence 
regarding reliable indicators that could predict baked milk challenge outcomes. Furthermore, 
these studies have not provided data regarding the long-term effects of introducing baked 
milk containing foods in children at home and the type of baked milk containing food - 
protocols that were suggested to parents/ caregivers and continued at home need 
consideration and further investigation in term of their feasibility, efficacy and safety. All 
findings above need to be validated by multicentre clinical trials because they were 
conducted in a single centre (tertiary care) with a limited age range of participants. Food 
challenge protocols used in future studies also need to be standardised in terms of milk 
protein amounts, administered doses during challenge, and preparation and reasonable 
texture of challenge foods to avoid selection bias that may confound challenge outcomes.  
Additionally, diagnostic criteria need to be established (e.g confirmation of CMA diagnosis or 
milk tolerance status of a CMA child before starting the study) to avoid not only selection 
bias during the recruitment of participants but also observer bias that may be a result of the 
investigator’s knowledge and expertise that may influence the way data is collected, 
measured or interpreted for each group of participants.  
   
Safety of baked milk introduction: Symptoms associated with baked milk challenges 
While it seems that staged introduction of baked milk may be successful in the development 
of milk tolerance, it is also important to consider the short and long-term safety of this 
treatment.  Of the studies examined in the previous section, only four presented data about 
the range of clinical symptoms experienced during the baked milk challenges. Although 
reporting data indicated that there were participants who experienced adverse reactions 
(i.e. failed the baked milk challenges) in all the studies that have been outlined in the previous 
table, authors have not reported the specific symptoms experienced by patients. Clinical 
symptoms that have been reported in baked milk challenge studies are summarized in Table 
2.6.  
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Table 2.6. Clinical symptoms observed during baked milk challenge   
References  Symptoms  Baked milk challenge   
Nowak-Wegrzyn et al. 
2008 
 
Oral pruritus, Atopic 
dermatitis flare, rash, hives 
or angioedema, sneezing, 
rhinoconjunctivitis, throat 
symptoms or cough, 
wheezing, shortness of 
breath or respiratory 
distress (gasping, cyanosis, 
decreased oxygen 
saturation), abdominal pain, 
nausea, vomiting or 
diarrhoea, dizziness, loss of 
consciousness or 
hypotension, anaphylactic 
shock  
 
Baked milk, muffin,   
homemade breads 
&waffles  
Kim et al.2011 Anaphylactic shock, oral 
symptoms, wheeze, cough   
Cheese omellete waffle, 
pizza, muffin    
Bartnikas et al. 2012 Rhinorrhea, hives, tongue 
itching, oral pruritus,  
1 patient developed 
anaphylaxis at home with 
hives, lip swelling & vomiting 
& treated with epinephrine   
A late reaction to ongoing 
baked milk exposure at 
home occur 
Muffin, cupcake  
Mehr et al.2014 Anaphylactic shock 
Urticaria & angioedema 
(47%) 
Itchy mouth or tight throat 
(53%) 
Abdominal pain (20%) 
Vomiting and/or acute-onset 
diarrhoea (13%)   
3 children developed 
symptoms at homme with 
ongoing exposure 1 week 
later (itch, abdominal pain, 
and flaring of eczema) 
   
Muffin  
In 2008, Nowak-Wegrzyn et al. reported that a child developed oral pruritus to homemade 
bread and waffle, and two other participants developed mild oral symptoms to homemade 
waffle and pizza during home reintroduction. They also reported anaphylaxis in both groups; 
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baked milk tolerant [ 3.2% (5 of 65 children)] and baked milk reactive children ranged from 
[17% (3 of 23 children)] to [35%(8 of 23 children)] during baked milk challenges in hospital. 
However, baked milk-reactive children experienced more severe reactions compared with 
baked milk-tolerant children during their challenge to fresh milk and received epinephrine. 
Children who reacted to baked milk challenges had a history of asthma or multiple food 
allergy. In this study has been reported that in IgE mediated CMA baked milk challenges need 
to be approached with caution and performed in a clinic with all safety measures and 
supervised by a clinician, due to the risk of severe reactions or anaphylaxis.  
 
Hence, these findings indicate an association between reactions to baked milk challenges 
and a history of allergic diseases and highlight that baked milk reactivity and history of severe 
allergy disorders could be a predictor of a more severe and persistent CMA phenotype.  
Therefore, for patients with IgE mediated CMA, there is evidence to suggest that baked milk 
should be conducted in hospital under medical supervision.     
 
Bartnikas et al (2012) reported that three children who passed baked milk challenges in clinic 
reacted to ongoing exposure to baked milk containing food at home. These finding are in line 
with the results of Nowak-Wegrzyn et al who also reported reactions to ongoing exposure to 
baked milk containing foods at home. However, it is difficult to determine the exact reason 
for this. In particular, standardisation is difficult to achieve in a home environment. It is not 
clear if parents followed the recipe exactly in terms of time and temperature of baking and 
the amount of milk protein content.     
     
Kim et al, (2011) reported that overall 6 children had anaphylaxis during baked milk 
challenges in hospital. Regarding the safety of dietary baked milk intake at home, this is the 
only study that considered the long-term safety of baked milk introduction (at 12-month 
follow-up), and found that the incorporation of baked milk products into children’s diets 
doesn’t appear to cause any changes in underlying allergic diseases (no increase in the 
severity of chronic asthma, atopic dermatitis, or allergic rhinitis), intestinal permeability, or 
in the growth of patients. However, these are certainly plausible conclusions given the study 
findings and further investigation with longitudinal cohort studies is required to confirm the 
long-term effects of baked milk introduction in health-related quality of life of children with 
CMA.      
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Mehr et al.,(2014) reported that the children who reacted to baked milk were more atopic 
with multiple other food allergies, asthma and a higher rate of previous anaphylactic 
reactions to cow’s milk compared with children who tolerated baked milk. The authors  
concluded that children with a multiple IgE-mediated food allergies, asthma and prior 
anaphylaxis to other foods appear to be at risk to experience an anaphylactic reaction to 
baked milk  and recommended that the initial baked milk introduction should be conducted 
in hospital under a medical supervision. These results confirm Nowak-Wegrzyn et al findings 
that demonstrated an association between reactions to baked milk challenges and 
concurrent asthma or other foods allergies. Mehr et al reported also that a small proportion 
of children that had passed a baked milk challenge in hospital developed symptoms with 
ongoing exposure to the same doses of food that was tolerated in hospital. These results are 
in agreement with the findings that are reported by Bartnika et al study and indicate that 
healthcare professionals need to emphasise the improtance of accurate baking and quantity 
of milk proteins in the milk containing foods during the baked milk re-introduction at home 
and provide a detailed list of instructions to help parents or caregivers during this process.    
Hence, it seems that adverse reactions are relatively common during the introduction of 
baked milk, particularly in those who have a history of reacting to baked milk prior to 
treatment and/or who have asthma or multiple food allergies. Thus, this procedure requires 
medical supervision and should only be conducted in an environment where any severe 
reactions could be managed. Even when a CMA child has passed a baked milk challenge this 
cannot guarantee future tolerance of baked milk containing foods or exclude the possibility 
of any allergic reaction to the same doses of this food. The majority of the baked milk 
challenge studies demonstrate that healthcare professionals and parents/caregivers need to 
be aware about the possibility of late reactions to ongoing baked milk exposure and monitor 
CMA children over time to ensure that baked milk tolerance is still maintained.  
 
Role of immune markers in predicting food challenge outcomes 
Milk proteins and development of milk tolerance    
Looking at milk proteins, casein is implicated as the offending protein in persistent milk allergy 
whereas whey proteins, such as β-lactoglobulin and α-lactalbumin, are implicated in patients 
with transient milk allergy (Jarvinen et al., 2002). Cow’s milk contains sequential/linear and 
conformational epitopes and cow’s milk allergic individuals may produce specific IgE antibodies 
against both conformational and sequential epitopes (Vila et al., 2001). Children with persistent 
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IgE mediated CMA have shown significantly higher ratios of specific IgE to linear versus 
conformational epitopes compared with children who have achieved tolerance (Skripak et al., 
2007). Nowak-Wegrzyn et al (2008) and Bartnikas et al (2012) reported that patients with 
transient IgE-mediated CMA produced milk specific-IgE-antibodies against conformational 
epitopes that are destroyed during heating of milk or milk containing foods. 
  
The caseins and α-lactoalbumin are more heat stable compared with β-lactoglobulin and other 
whey proteins (Taheri-Kafrani et al., 2009). Bloom et al (2014) found that casein is heat-resistant 
while β-lactoglobulin and α-lactalbumin are heat labile. Heating of milk may affect protein 
conformational structure and modify conformational epitopes that leads to a change in the 
allergenicity of milk products. In addition, the heating of a complex food causes interaction of 
milk proteins with other food components such as wheat (e.g. muffin, cupcake) and may reduce 
the milk protein allergenicity (Nowak-Wegrzyn & Fiocchi, 2009). The assessment of milk allergy 
resolution differs between IgE-mediated-CMA and non-IgE-mediated CMA.  In IgE-mediated 
CMA, the reduction of the SPT wheal size or specific IgE levels may indicate tolerance to baked 
or “raw” milk (Kido et al., 2016). Therefore, monitoring for the potential development of 
tolerance through evaluation of milk specific-IgE levels and wheal size of SPT may provide useful 
information regarding the most appropriate time at which to conduct a milk challenge. This 
review aimed to identify and present studies that evaluated the association between immune 
markers and milk containing food challenge outcomes.    
 
Immune markers studies    
This review identified few studies that have evaluated the predictive value of immune markers 
in helping to determine the development of milk tolerance in children with CMA. Table 2.7  
summarises and presents the studies that investigated immune markers as predictors of baked 
milk challenge outcomes.  
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Table 2.7: Population characteristics, study design, exposure-outcome measurements, assessments and findings of the reviewed immune marker studies 
Study  HM-
tolerant-SPT 
(median)mm 
HM-
reactive- SPT 
(median)mm 
HM-
tolerant- 
Milk sIgE 
median 
(kUA/L)  
HM-
reactive- 
Milk sIgE 
median 
(kUA/L) 
HM-
tolerant- 
Casein sIgE 
median 
(kUA/L) 
HM-
reactive- 
Casein sIgE 
median 
(kUA/L) 
Findings  
Nowak-
Wegrzyn et 
al. 2008 
N=100 
children 
77 (77 %)- 
 7 (2.5–19) 
23 (23 %)- 
9.5 (5–24) 
77 (77 %)- 
2.43(0-79) 
11.6(0.69-
101) 
 
77 (77 %)- 
1.41(0-101 
23 (23 %)- 
14.15(0.75-
101) 
HM reactive group  had significantly larger SPT wheals and higher milk-specific and 
casein-IgE levels than other groups 
Bartnikas et 
al.2012  
N = 35 
 
29 (83 %)-10 
(0–20) 
 
6 (17 %)-15 
(7–20) 
 
 
 
29 (83 %)-
1.93 (<0.35–
20.6)- 
 
 
 
 
6 (17 %)-
2.39 (<0.35–
31.0) 
 
 
 
 
29 (83 %)-
1.05 (<0.35–
10.3)- 
6 (17 %)-
1.07 (<0.35–
31.5) 
The levels of   IgE to CM- casein and β-lactoglobulin were significantly higher in 
HM reactive group compared with HM tolerant group. Casein-specific IgE had the 
highest positive and negative predictive values compared with specific IgE to CM 
or b-lactoglobulin, and casein and b-lactoglobulin specific IgE/IgG4 ratios were 
significantly higher in HM-reactive group with compared with HM -tolerant group 
 
 
Milk protein SPT wheal may be more reliable than sIgE level in predicting 
outcomes of baked milk challenges. 
Faraj et 
al.,2012 
N=58 
55(94.8%) 3(5.2%) N/A N/A N/A N/A  The majority of participants who tolerated the muffin challenge negative SPT 
(NPV=94.8%) 
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Caubet et al, 
2013  
N = 97, 
N = 128. 
29 (83 %)-10 
(0–20) 
83 (64.8 %)-
NA 
6 (17 %)-15 
(7–20) 
38 (29.7 %)-
NA 
 
83 (64.8 %)-
(0.2–42.3) 
38 (29.7 %)-
11.9 (0.8–
50.5) 
 
83 (64.8 %)-
2.3 (0.2–
30.5) 
 
38 (29.7 %)-
12.2 (0.5–
67.0) 
 
The levels of   IgE to CM- casein and β-lactoglobulin were significantly higher in 
HM reactive group compared with HM tolerant group. Casein-specific IgE had the 
highest positive and negative predictive values compared with specific IgE to CM 
or b-lactoglobulin, and casein and b-lactoglobulin specific IgE/IgG4 ratios were 
significantly higher in HM-reactive group with compared with HM -tolerant group 
 
Ford et 
al,2013 
N = 132, 
95 (72 %)-NA 37 (28 %)-NA 95 (72 %)-
NA 
37 (28 %)-
2.4 (0.6–
43.6) 
95 (72 %)-
NA 
37 (28 %)-
13.75 (0.36–
49.9) 
Casein- and milk-specific IgE level, milk-specific basophil reactivity, and milk SPT 
wheal diameter are all significantly greater among patients with milk allergy who 
react to HM than among those who tolerate it 
        
Kwan et al 
2016 N=30 
median age: 
7.5 (2-16) 
18(60%) 
3.08 (0.0–
13.8) 
12(40%) 
6.33 (3.83–
8.33) 
18(60%) 
6.91 (0.99–
>100) 
 
12(40%) 
25.5 (1.82–
>100) 
18(60%) 
4.5 (0.35–
>100) 
12(40%) 
19.7 (1.08–
>100) 
All participants with negative SPT (>3mm) to baked milk tolerated muffin 
challenges   
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In a prospective study, Nowak-Wegrzyn et al (2008) reported that children who tolerated 
baked milk products and included these foods into their diet on a daily basis, had significantly 
smaller milk-SPT mean wheal diameters, and lower milk and casein-sIgE immunoglobulins 
compared with their baseline measurements after three months of baked milk products 
consumption.  
 
In a prospective follow up study, Kim et al (2011) reported that children who tolerated baked 
milk foods had significantly (p<.001 and p = .02, respectively) reduced casein and β-
lactoglobulin sIgE levels compared with baked milk-reactive children over time. However, no 
differences were observed in milk–sIgE levels between baked milk–tolerant children and 
baked milk-reactive children over time from their baseline characteristics to final follow up 
(p = 0.07). This study indicates that high levels of casein and β-lactoglobulin may predict 
reactivity to baked milk or unheated milk in CMA children while milk sIgE levels appear to be 
a poor predictive tool. However further investigation is required to confirm these results. 
In a retrospective study, Faraj et al (2012) collected and analysed data from the records of 
an allergy clinic and evaluated if a negative SPT is a predictive value of an oral food challenge 
outcome. They found that the majority of CMA patients with a negative SPT to extensively-
heated milk were able to tolerate a baked milk food (muffin) and concluded that baked milk-
SPT may be a reliable predictor tool for a baked milk challenge outcome.  
In a retrospective study, Bartnikas et al (2012) collected and analyse data from the records 
of an allergy research centre and evaluated if the immune markers, milk and casein -SPT, 
milk- sIgE are reliable predictive values and can identify children who are able to pass a 
baked milk challenge.  They found that α-lactoalbumin,  β-lactoglobulin sIgE measurements 
were poor predictors of baked milk challenges and milk-SPT wheal size was a better 
predictive value compared with casein-SPT wheal size and milk-sIgE  measurements.     
Cubet et al, (2013) combined the results of immune markers from both cohort studies and 
found that casein-sIgE measurement had a significantly greater accuracy for predicting 
baked milk reactivity in children compared with measurements of milk and β-lactoglobulin 
sIgE.     
In a prospective study, (Ford et al, 2013) attempted to identify immune markers that could 
help to predict patients who may be able to tolerate baked milk containing foods by exploring 
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differences in the levels of these between children who tolerated or reacted to baked milk. 
These authors reported that milk and casein-sIgE, milk-SPT mean wheal size and milk-specific 
basophil reactivity were significantly (p<.001, p<.005, p<.001 respectively) higher in the 
baked milk – reactive children.  
In a prospective study, Kwan et al (2016) conducted a prospective-case control study and 
challenged 30 CMA children (median age 7.3) to evaluate if a muffin slurry-SPT and immune 
markers such as milk and casein-sIgE measurements can predict a baked milk challenge 
outcome. They found that all CMA children [18(60%)] who had negative (wheal size<3mm) 
muffin-SPT successfully passed a baked milk food challenge to muffin and concluded that a 
slurry muffin-SPT is a reliable predictive value in helping to identify milk allergic children that 
are able to tolerate a baked milk food.  Authors also suggested that casein-sIgE measurement 
had a significantly greater accuracy for predicting a baked milk challenge outcome compared 
with the measurement of milk-sIgE.               
The majority of the studies above had a prospective design and concluded that SPT, milk 
and casein-sIgE measurements appear to predict milk containing-food challenge outcomes, 
whilst a-lactalbumin-sIgE and b-lactoglobulin-sIgE seem to be poor predictor markers in 
determining the development of baked or milk tolerance.  However, there are differences 
between the results of the studies above and it is difficult to compare their findings due to 
variation of the study design, inclusion criteria, population, and methods regarding the 
preparation of foods for challenges or SPT.  
Bartinkas et al (2012) and Faraj et al (2012) studies have a retrospective design and the data 
were not collected for the purpose of their research. In both studies, CMA diagnosis was not 
confirmed by milk challenges and they included participants with relatively small 
measurements of SPT (wheal size <5mm). The above parameters may confound the findings 
of the studies because it is possible some participants were not truly allergic to cow’s milk. 
Faraj et al did not challenge milk allergic patients who had positive muffin-SPT and therefore 
the specificity of the muffin-SPT was not well established. In addition, the sample size was 
not homogenous because Faraj et al included   a larger cohort of egg allergic patients as well. 
In both studies, the challenge foods were prepared by caregivers and therefore there was 
no control to ensure that there was equal amounts of milk proteins and temperature of 
baking of the challenge food. The reliability of the SPT and sIgE measurements is also 
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questionable because they were not obtained close to the time of the performance of food 
challenges.                  
 All studies collected data only by one centre and this reduces the generalizability of their 
findings. A multi-centre trial is required to include a larger number of participants that come 
from different geographic locations with a wider range of population groups and compare 
the findings among the centres. No clear diagnostic criteria were defined in the majority of 
studies and most participants were identified as milk allergic based on history and laboratory 
tests and their diagnosis was not confirmed by failed unheated milk challenges. Thus, some 
participants who passed the baked milk challenges may be tolerant to unheated milk as well. 
There was a lack of blinding of any party.  
Except from both cohorts that were conducted by Cubet et al (2013), all other studies 
evaluated a relatively small sample size for each group of participants and that possibly did 
not ensure sufficient power to allow validated calculations of positive predictive values, 
sensitivity and specificity of immune markers. Another consideration is related with the 
similar age of participants in the studies. The majority of studies provided data for a 
population with median age from 7 to 9 years. This data is not representative for younger 
children with CMA and this should be considered when generalising these results in 
community practice.   
According to the studies above, reliable predictors of a successful baked milk challenge are 
still not well established and oral food challenges should not therefore be replaced by these 
allergy tests. Immune markers such as SPT and casein-sIgE values may be able to predict 
baked milk tolerance or reactivity, although these findings have not been validated by large-
scale clinical trials examining a greater range of group ages and across different medical 
centres. 
 
Inconsistencies in baked milk introduction  
The review of baked milk challenge studies demonstrates that there is a lack of consensus in 
the use of food protocols during baked milk challenges in research setting (Kwan et al., 2016; 
Nowak-Węgrzyn, 2016). In clinical routine hospitals and specialist allergy healthcare 
professionals follow their own baked milk challenge protocols based on different methods 
and guidelines due to the lack of standardisation in the practice, process and dose regimes. 
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These different approaches regarding the type of foods or quantities, frequency of 
consumption and the variety of protocols may have different immunological effects on the 
rate of allergy resolution and uncertain impact on reaction during an exposure to baked milk 
food (Upton & Nowak-Wegrzyn, 2018). The review of immune markers studies in the 
previous section showed that SPT and milk sIgE measurements can help stratify risk of 
allergic reactions to a milk challenge, although there is limited data available to their 
predictive value regarding baked milk challenge outcome (Bartnikas, Sheehan, Schneider, & 
Phipatanakul, 2012; Ford et al., 2013). Food challenges still remain the only allergy test to 
evaluate the tolerance to baked milk but they carry the risk of inducing life-threatening 
anaphylaxis in children with IgE-mediated CMA. Therefore, according to the findings of the 
review of baked milk studies discussed in Section 2.4.2 , due to the current lack of reliable 
predictive indicators that could identify optimal candidates for baked milk challenges, baked 
milk challenge should be untertaken in a clinical setting where any allergic reactions could 
be managed in patients with IgE mediated CMA.  
However, there is still a debate regarding the place (hospital or home) of baked milk 
introduction in IgE-mediated CMA (Leonard, Caubet, Kim, Groetch, & Nowak-Węgrzyn, 
2015).  As mentioned in Section 2.4.2  above (table 2.5), baked milk introduction is associated 
with unpredictable allergic reactions that include skin, gastrointestinal, respiratory, and 
cardiovascular symptoms that in some cases may be life-threatening for milk allergic patients 
(Bartnikas, Sheehan, Schneider, et al., 2012; Mehr et al., 2014; Nowak-Wegrzyn et al., 2008).  
For this reason, many researchers suggest medical supervision for the initial baked milk 
introduction in children with IgE mediated CMA (Bartnikas, Sheehan, Hoffman, et al., 2012; 
Mehr et al., 2014; Nowak-Wegrzyn et al., 2008). An update of nutritional guidelines in the 
management of CMA reports that a baked milk challenge should be performed in a clinic and 
supervised by a medical staff (Dupont et al., 2018). In addition, the MAP guidelines (2013) 
and iMAP guidelines (2017) suggest that no child with IgE-mediated food allergy should have 
a challenge in primary care or community settings (Venter et al., 2013)(Venter, Mazzocchi, 
Maslin, & Agostoni, 2017). European Society for Paediatric Gastroenterology, Hepatology 
and Nutrition (ESPGHAN) guidelines (2012) recommend to not prolong unnecessary dietary 
restrictions and suggest supervised milk challenges (Koletzko et al., 2012). The World Allergy 
Organization (WAO), the Adverse Reactions to Food Committee of the American Academy of 
Allergy, Asthma and Immunology (AAAAI) and European Academy of Allergy and Clinical 
Immunology (EAACI) have published guidelines regarding the unheated milk re-introduction 
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in IgE-mediated CMA. They recommend that milk challenges should occur under medical 
supervision in an environment where severe reactions can be appropriately managed, but 
the guidelines are not yet focussed on the introduction of baked milk.   
In contrast to the guidelines and recommendations mentioned above, the BSACI milk allergy 
guidelines suggest home introduction of baked milk using a “milk ladder” in IgE-mediated 
CMA patients who had only cutaneous symptoms on a mouthful milk allergen exposure, 
reducing milk sIgE and SPT, and no reaction to milk in the past 6 months (table 2.6,). 
However, Kawn et al reported that asthma and previous anaphylaxis did not predict milk 
challenge outcomes. Mehr et al found that a child with a previous anaphylaxis passed a baked 
milk challenge. Bartnikas et al and Mehr et al also found that children who passed a baked 
milk challenge in hospital reacted at home when they continued to consume the same doses 
of baked milk food that was tolerated in hospital. In addition, baked milk challenge studies 
have shown that a minority of children with reducing IgE and SPT measurements reacted 
during a baked milk challenge (Kwan et al., 2016). Therefore, allergic reactions to baked milk 
appear to be unpredictable and even though current research indicates that a small 
proportion of children may react, health care professionals and parents need to act with 
caution during baked milk introduction because in IgE mediated CMA there is a risk of severe 
reactions and anaphylaxis.           
Hence, the lack of agreement regarding the appropriate place (hospital or home) of baked 
milk containing food introduction and the use of a standardised gradual milk introduction 
protocol could lead to different advice that could confuse not only healthcare professionals 
but also patients/caregivers and expose IgE-mediated cow’s milk allergic children to the risk 
of an accidental reaction. More robust evidence is required to update guidelines regarding 
the appropriate place of baked milk introduction, an optimal standardised and validated 
gradual milk introduction protocol   and the optimal age of CMA children for this approach.    
According to this literature review there is robust evidence that the majority of CMA children 
can tolerate baked milk during a baked milk challenge. However a number of questions have 
been raised regarding the use of baked milk products in the management of CMA: What 
guidelines finally inform healthcare professionals decision to introduce gradually baked milk 
products into the diet of their CMA patients? “Where” (hospital/home), “when” (appropriate 
time of baked milk introduction)  and “how” (baked milk challenge or milk ladder) healthcare 
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professionals introduce these foods? Is baked milk introduction a safe process in clinical 
practice? Is a graded milk introduction protocol such as a milk ladder appropriate, 
acceptable, practicable, and safe? Are SPT and milk sIgE measurements valuable predictor 
tools to help healthcare professionals to identify the appropriate time of baked milk 
introduction and replace a baked milk challenge?  This PhD research has attempted to 
provide answers to the important questions above.          
2.4.2. Safety of the baked milk containing foods 
While it seems that staged introduction of baked milk may be successful in the development 
of milk tolerance, it is also important to consider the short and long-term safety of this 
treatment. In mild to moderate non-IgE-mediated CMA, there is a lack of studies that have 
evaluated the impact of the introduction of baked milk food into the children’s diet in terms 
of appropriateness, acceptability, suitability and safety. In IgE-mediated CMA, only one study 
has considered the long-term safety of this treatment (at 12-month follow-up), and found 
that the incorporation of baked milk products into children’s diets doesn’t appear to cause 
any changes in underlying allergic diseases (no increase in the severity of chronic asthma, 
atopic dermatitis, or allergic rhinitis), intestinal permeability, or in the growth of patients 
(Kim et al, 2011). However, in a cohort study, adverse reactions during the introduction of 
baked milk have been reported.  Clinical symptoms that have been reported in baked milk 
challenge studies are summarized in Table 2.8. 
 In one study, a child developed oral pruritus to homemade bread and waffle, and two other 
participants developed mild oral symptoms to homemade waffle and pizza during home 
reintroduction (Nowak-Wegrzyn et al., 2008). In another study, three children developed 
symptoms at home a week later, after eating a muffin that was the same as they had been 
exposed to in a hospital-baked milk challenge in terms of milk protein and temperature of 
baking (Mehr et al., 2014). In addition, several studies have reported severe reactions and 
treatment with epinephrine during baked milk challenge. Anaphylaxis has been reported in 
both groups; baked milk tolerant [ 3.2% (5 of 65 children)] and baked milk reactive children 
ranged from [17% (3 of 23 children)] to [35%( 8 of 23 children)] during baked milk challenges 
in hospital (Nowak-Wegrzyn et al., 2008). However, baked milk-reactive children 
experienced more severe reactions compared with baked milk-tolerant children during their 
challenge to fresh milk and received epinephrine (Nowak-Wegrzyn et al., 2008).  According 
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to these findings the researchers of the cohort above suggested that baked milk reactivity 
could be a predictor of a more severe and persistent CMA phenotype. In addition, they 
reported that disorders such as asthma or multiple food allergy could be also a predictor of 
severe and persistent CMA because they found an association between reactions to baked 
milk challenges and asthma or multiple food allergy (Nowak-Wegrzyn et al., 2008). These are 
certainly plausible conclusions given the study findings.   Hence, it seems that adverse 
reactions are relatively common during the introduction of milk, particularly in those who 
have a history of reacting to baked milk prior to treatment and/or who have asthma or 
multiple food allergies. Thus, this is a procedure that requires medical supervision and should 
only be conducted in an environment where any severe reactions could be managed. 
Table 2.8: Clinical symptoms during baked milk challenges  
References  Symptoms  Baked milk challenge   
Nowak-Wegrzyn et al. 2008 
 
Oral pruritus, Atopic dermatitis 
flare, rash, hives or angioedema, 
sneezing, rhinoconjunctivitis, 
throat symptoms or cough, 
wheezing, shortness of breath or 
respiratory distress (gasping, 
cyanosis, decreased oxygen 
saturation), abdominal pain, 
nausea, vomiting or diarrhoea, 
dizziness, loss of consciousness or 
hypotension, anaphylactic shock  
 
Baked milk, muffin,   
homemade breads &waffles  
Kim et al.2011 Anaphylactic shock, oral 
symptoms, wheeze, cough   
Cheese omellete waffle, pizza, 
muffin    
Bartnikas et al. 2012 Rhinorrhea, hives, tongue itching, oral 
pruritus,  
1 patient developed anaphylaxis at 
home with hives, lip swelling & 
vomiting & treated with epinephrine   
A late reaction to ongoing baked milk 
exposure at home occur 
Muffin, cupcake  
Mehr et al.2014 Anaphylactic shock 
Urticaria & angioedema (47%) 
Itchy mouth or tight throat (53%) 
Abdominal pain (20%) 
Vomiting and/or acute-onset diarrhoea 
(13%)   
3 children developed symptoms at 
homme with ongoing exposure 1 week 
later (itch, abdominal pain, and flaring 
of eczema) 
   
Muffin  
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2.6 Summary  
Cow’s milk allergy is the most prevalent type of food allergy in children, with an estimated 
prevalence of 0.2-4.9% in the worldwide paediatric population. Allergic reactions may 
present with cutaneous, respiratory and gastrointestinal symptoms that occur immediately 
or after many hours/days. Cow’s milk allergy is classified severe or mild to moderate 
according to clinical expressions of IgE and non-IgE-mediated reactions. This research has 
focussed on IgE and mild to moderate non-mediated IgE CMA. The diagnosis of IgE-mediated 
CMA is based on a combination of patient’s history and confirmation of allergy tests like SPT, 
serum milk specific - IgE values and oral milk challenge. However, the gold standard for CMA 
diagnosis is the oral milk challenge that should be conducted under medical supervision in 
an environment with available resuscitation facilities, due to the high risk of severe 
reactions/ anaphylaxis. For mild to moderate non-IgE-mediated CMA diagnosis there are no 
validated tests and diagnosis is based on a good clinical history of symptoms and avoidance 
followed by reintroduction of milk containing foods to determine whether the symptoms 
improved on avoidance. Early and reliable diagnosis of CMA is very important to initiate 
appropriate dietary treatment, avoiding unnecessary diet restriction and alleviating 
symptoms.   
The mainstay of CMA management is the elimination of cow’s milk and milk containing foods. 
However, there is evidence that many children who react to fresh milk, cheese and yoghurt 
may tolerate baked milk containing foods such as cakes, biscuits, muffins, waffles, pizza. 
Baked milk, especially when it is mixed with flour and fat makes the milk less likely to cause 
allergic reactions. Processing of milk proteins such as through baking may reduce their 
allergenicity and enhance tolerance to baked milk. Several studies have shown that the 
majority of CM allergic children may tolerate milk in baked forms before they become 
tolerant to fresh milk and milk products. The incorporation of baked milk products into 
children’s diets appears therefore to accelerate the development of milk tolerance, which 
may also improve children’s nutritional status and quality of life.  
The oral milk challenge remains the best method to determine development of tolerance to 
milk. In IgE-mediated-CMA a hospital based baked or unheated milk/milk containing food 
challenge is usually offered and in mild to moderate non-IgE-mediated-CMA, tolerance is 
usually assessed by a gradual reintroduction plan (milk ladder) at home. However, there is 
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limited data regarding the appropriate time for baked milk reintroduction in IgE and mild to 
moderate non-IgE mediated CMA. Additionally, there is a lack of evidence by which to 
determine best practice in home baked milk introduction in IgE mediated CMA.  
Hence, in current clinical practice, the decision regarding baked milk reintroduction is based 
on an individual clinical assessment and depends on the type of CMA. Current data also 
indicates that reliable predictors such as SPT or milk sIgE of a successful baked milk challenge 
are still not well established. Some studies have reported anaphylaxis and treatment with 
epinephrine during baked milk challenge in IgE-mediated CMA; it is not therefore a risk-free 
procedure. Hence, at present, the decision regarding baked milk reintroduction is based on 
an individual clinical assessment and depends on the type of CMA. Hence, there is a gap in 
the literature that needs to be addressed regarding the guidelines that are followed before 
baked milk containing foods are introduced into the diet of milk allergic children. What 
protocols are used during baked milk reintroduction and where a baked milk challenge or 
milk ladder is conducted.   
In brief, the findings of this literature review indicate that there is a paucity of evidence 
regarding the practice and impact of BMC and milk ladders from either a health care 
professional or parent perspective. Additionally, further investigation is required to assess if 
immune markers such as Skin Prick Test and milk sIgE can provide some useful prognostic 
information for the appropriate timing for introduction of BM-containing food in IgE-
mediated CMA.  
2.7 Aim & Objectives    
The overall aim of this PhD is therefore to investigate three key aspects of this important, 
and currently under-researched, area of paediatric food allergy. Firstly, to explore current 
clinical practices of HCPs regarding the use of BMCs and gradual re-introduction of BM-
containing foods (milk ladders) and what guidelines they use before they decide upon a 
baked milk re-introduction.  Secondly, to explore parents’ perspectives regarding the use of 
baked milk containing foods into their child’s diet. Finally, to evaluate if immune markers 
such as SPT and milk sIgE can predict milk challenge outcomes in children with IgE mediated 
CMA and help HCPs to identify those who might benefit from baked milk re-introduction.  
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Objectives 
1. To evaluate the attitudes and practices of HCPs on the conduct of BMCs and graded 
re-introduction of BM/milk ladder in IgE and mild to moderate-non-IgE-mediated 
CMA. 
2. To explore parents’ experience of the re-introduction of BM-milk containing foods 
into the diet of their child who has been diagnosed with IgE and non-IgE-mediated 
CMA.  
3.  To assess immune markers (SPT, milk sIgE) prior to baked or unheated milk 
challenge and evaluate if there is an association between these immune markers and 
milk challenge outcomes in children with IgE-mediated CMA. 
These were addressed as follows:  
1. A multi-national survey explored the current clinical practice of healthcare 
professionals using baked milk challenges and the milk ladder  
2. A qualitative study using semi-structured interviews were conducted in mothers 
with children diagnosed with IgE or non-IgE mediated CMA 
3. As a part of a larger quantitative study, data was extracted and analysed regarding 
the immune markers and milk challenge outcomes of children diagnosed with IgE-
mediated- 
4. CMA  
2.8 Possible implications of the findings of this research   
The findings of this research could potentially have clinical implications regarding the need 
to standardise and validate BMC and milk ladder protocols in IgE and non-IgE-mediated CMA 
and -provide clear guidance and information regarding the most appropriate place (home or 
hospital) to conduct baked milk challenges or milk ladders for IgE-mediated CMA. Moreover, 
the findings could also help to determine when is the appropriate time to recommend BMC 
and gradual BM-re-introduction based on immune markers such as SPT versus milk sIgE, in 
IgE-mediated CMA.  “Standardised” and “validated” prognostic indicators such as BMC and 
immune markers can be very useful in clinical practice: improving allergy services, providing 
high quality personalised and specialised care in children, and avoiding unnecessary 
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restriction of milk containing foods. Additionally, understanding parents’ needs during the 
re-introduction process of BM-containing foods can improve the communication between 
parents and HCPs, facilitating this approach and improving the process of BMC and gradual 
re-introduction of milk (milk ladder) in terms of its appropriateness, acceptability, 
practicability and safety.    
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Chapter 3: Methodology  
3.1 Overview 
The overall aim of this chapter is to outline the methodological approach taken to guide the 
collection and analysis of data for the purpose of the PhD research. The epistemological 
beliefs that guide and justify the methodological approach of the research are presented. 
The quantitative and qualitative methods that were used to design and plan the studies of 
this research are also discussed.  The individual design and analytical techniques of 
participants’ recruitment, data collection and analysis are presented in each relevant 
chapter.      
 
3.2 Epistemological position of the research  
Understanding the relationship between the epistemology and the methodology and 
methods used for this research was fundamental to ensure a coherent rationale 
underpinning the design of the studies conducted for the purpose of this project.  
Epistemology refers to the assumptions that are made related to how knowledge is viewed, 
how we can communicate knowledge to others, and how the researcher’s epistemological 
approach can influence the research outcome (Burrell & Morgan,1979). The epistemological 
position of the researcher guides and influences the methodological approach of the 
research in terms of the choice of tools/techniques and protocols that are used to design 
and frame the research (King & Horrocks, 2010). Many authors suggest that researchers 
should reveal the paradigms that guide their thinking and planning process and their 
perceptions of what is real and what can be known{Kuper, 2008, An introduction to reading 
and appraising qualitative research} (Kuper, Reeves & Levinson, 2008; Tavallaei & Abu Talib, 
2010).  
 
Positivist and interpretivist paradigms guide this research and they have been used 
complementarily to address the research questions using a multi-method approach. The 
ontological position of positivist epistemology is that we can discover knowledge related to 
an objective reality and can attempt to identify causes that influence the outcomes. The 
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scientific method is in line with a positivist standpoint, and as such, seeks to test predictions 
and make generalizations (Neuman, 2011). In this paradigm, the assumption is that, since 
there is one objective reality, research results can be replicated from different researchers 
(if they collect, analyse and record the same data in the same way) and can be generalised 
to other populations (Scotland, 2012). The positivist paradigm typically uses quantitative 
methods and aims to gather objective and precise data. 
 
The ontological position of interpretive epistemology is relativism i.e. that reality is 
individually constructed and differs from person to person.  The interpretive epistemological 
standpoint is that, in contrast to positivism, reality is subjective and therefore different 
people may construct meaning and interpret the same phenomena in different ways (Black, 
2006). Interpretivism is an approach that uses qualitative methods to explore and 
understand the reality of individuals or groups or cultures through their experiences and 
perceptions (Creswell, 2009). Qualitative research attempts to understand and explain 
actions from participants’ perspectives and can utilise a number of methods of data 
collection such as survey, observational studies, case study with data collection tools such as 
focus groups, interviews, and open-ended questionnaires (Nind &Todd, 2011). According to 
the interpretivist paradigm, researchers assert their beliefs when they select what and how 
to research and how to interpret their data (Kalos, 2010). They study the social reality from 
the perspective of the participants and prefer to work with qualitative data which provides 
rich descriptions of social constructs and use a narrative form of analysis to describe with 
details the social reality (Neuman 2011).  The interpretivist paradigm allows the researcher 
to seek answers, construct and interpret his/her understanding from the gathering data and 
explore the world by interpreting the understanding of individuals. Thus, research conducted 
within an interpretivist paradigm produces highly contextualized data, and interpretations 
of this data involve subjective individual constructions (Scotland, 2012).  
 
 
This research presents a multi-method approach, deriving from the different epistemological 
perspectives outlined above (positivist paradigm and interpretive paradigm) and 
methodological approaches that complement one another: quantitative data analysis 
regarding the feasibility and safety of baked milk challenges and milk ladders from healthcare 
professionals perspectives’; qualitative data regarding the practicability, acceptability, 
suitability and safety of milk ladders from parents’ perspectives; and a quantitative study 
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attempting to inform the appropriate time of baked milk introduction by identifying valuable 
tools that could provide useful information about the milk tolerant status of milk allergic 
children. 
 
Four dominant paradigms have been associated with multi- and mixed-methods research, 
namely positivism/post-positivism, constructivism/interpretivism, transformative, and 
pragmatic .  While mixed methods research can prove challenging from a paradigmatic 
standpoint (because the aim is to integrate the findings of qualitative and quantitative 
studies) it has been argued that this is not as difficult in multi-methods research because it 
can utilise the appropriate paradigm in line with the single type of data being collected 
(Morse,2003). Multi-methods can therefore involve a different combination of 
methodological and philosophical components:  
- Single method and single paradigm 
- Multiple methods within a single paradigm 
- Multiple methods within multiple paradigms 
 
This multi-method research programme accommodates three single studies and each single 
study uses a single method within a single paradigm. The qualitative study used semi-
structured interviews analysed using thematic analysis within the interpretivist paradigm. 
The survey involved a quantitative questionnaire and inferential statistical analysis within 
positivist paradigm to collect and analyse data; and in the third study quantitative secondary 
data was analysed using inferential statistics again within the positivist paradigm. Further 
details regarding the multimethod approach of this research are referred in the next sections 
3.3 and 3.4.        
 
 
This research approach provides a holistic view regarding the usefulness and safety of baked 
milk introduction in clinical and home settings. As a practicing dietitian in food allergy I am 
familiar with the use of baked milk products in routine clinical practice, although there is 
limited knowledge based on evidence regarding the safety of this process in terms of the 
appropriate time and place (hospital/home) of the baked milk introduction and its feasibility 
in terms of acceptability, practicability, and safety at home. Furthermore, there is a lack of 
specific recommendations, based on evidence, that guide the baked milk introduction 
process. Therefore, exploring other healthcare professionals’ perspectives could provide 
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information in a better understanding of baked milk challenge and milk ladder approach. In 
addition, due to the complexity of this process, parents’ experiences and perspectives were 
explored to offer a deeper knowledge on the usefulness and impact of baked milk products 
into milk allergic children’s diets at home.      
 
3.3 Using a multi-method design for research  
Using more than one method of data collection and analysis is well-established in social 
science research (Alexander et al, 2008). Several authors became interested in the use of 
multi-method or mixed-method research in healthcare services because this approach offers 
a deeper understanding and a more holistic view examining different aspects of the same 
question or problem (Creswell and Plano Clark, 2011).  In mixed-methods research both 
qualitative and quantitative research strategies are applied to the same research question(s). 
Investigators collect and analyse the data and integrate their findings using both qualitative 
and quantitative methods in a single study or a programme of research (Tashakkori and 
Creswell, 2007). In a mixed-method approach, different research designs can lead to 
different understandings of the problem and provide alternative findings and explanations 
of the research question(s) (Blackman  and  Benson,  2004).  
Multi-method research design, known also as multiple method design, involves combining 
any different methods and collects data from several resources. For instance, it can include 
two or more exclusively qualitative approaches, two or more quantitative approaches, or a 
combination of qualitative and quantitative approaches, hence multi-methods research. It 
has therefore been argued that mixed method research is in fact one category of multi-
method research (Creswell & Plano Clark, 2007; Dunning, 2016). In multi-method studies 
multiple types of qualitative or quantitative data are collected while in mixed method studies 
both qualitative and quantitative data are incorporated (Creswell & Plano Clark, 2007). 
However, the main difference between mixed-method and multi-method approaches is that 
in mixed-methods the findings of quantitative and qualitative research should be integrated 
and evident throughout the presentation and interpretation of the results while there is no 
analytic integration of the findings of qualitative and quantitative in multi-methods studies 
(Creswell & Plano Clark, 2007). 
.  
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Proponents of a multi-method approach have argued that using more than one method to 
address the research question(s) produces results that are more robust and compelling than 
single method studies, and enhance the validity of the research (Jamieson, 2011). The 
usefulness of multi-method research has also been recognised as a way to capture the 
complexity or different aspects of a phenomenon (Mason, 2006). The strength of a multi-
method research design is that it offers a way of making the research more meaningful, 
complete and purposeful than is the case when using either a singular qualitative or 
quantitative approach. In addition, weaknesses in one method can be counter-balanced by 
strengths in another (Boyer, 2008).  
 
3.4. Utilising a multi-method design for this PhD research project 
As outlined in Section 3.3, a multi-method design was chosen for this PhD research project 
because, while baked milk introduction is widely practiced with milk allergic children, the 
topic has been the subject of surprisingly little research. There are some important questions 
about its practice which have not yet been explored by research, and these must be 
considered as a matter of urgency. Hence, a multi-methods approach will help us to develop 
a more comprehensive understanding of a range of research questions related to the 
introduction of baked milk in terms of its usefulness, safety, appropriateness, compliance, 
acceptability, and practicability from healthcare professionals’ and parents’ perception and 
indications of immune markers and food challenge outcomes:  
- What are healthcare professional’s perceptions about the usefulness of a baked milk 
challenge and a milk ladder as a dietary management of children with CMA?  
- Where (hospital/home setting) and how to introduce a baked milk containing food 
into the diet of children with CMA?  
- What are parents’ perceptions about the usefulness of a milk ladder plan as a dietary 
management of their children’s CMA?  
- When is the appropriate time of baked milk introduction? Are there reliable tools to 
identify optimal candidates for baked milk introduction?    
In line with a multi-method design, three different methods were employed to answering 
three objectives independently in terms of data collection, analysis and interpretation of this 
research: 
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1. A survey of healthcare professionals utilising an online questionnaire to collect 
quantitative data regarding the healthcare professionals’ attitudes and views in the 
use of baked milk introduction to understand “where” (hospital/home) and “how” 
the baked milk introduction (in the form of food challenges or a milk ladder 
approach) is conducted and also “what” guidelines are followed before healthcare 
professionals decide to introduce baked milk containing foods.    
2. A qualitative study utilising semi-structured telephone interviews to understand 
parents’ experiences in introducing baked milk containing foods into the diet of their 
children who are still allergic to cow’s milk.  
3. A retrospective study utilising secondary quantitative data collected from electronic 
patient records to evaluate validated tools that could be able to predict the outcome 
of the baked milk introduction and hence, they identify potential candidates for 
baked milk challenges or milk ladders. 
These three complementary studies utilising a multi-method approach were designed to 
provide a holistic approach to gaining an understanding of the introduction of baked milk 
products into the diet of children with CMA.       
 
 Healthcare professionals involved in the management and treatment of CMA and adult 
mothers of children with CMA were recruited to participate in this research. Ethical 
considerations informed the planning of the 
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methods for this research.  All participants were provided with information about the 
purpose of the study and their involvement in the research and their right to withdraw from 
the study was clearly explained by the participant information sheet. All participants were 
encouraged to ask questions about the study and were given time to consider their 
participation. Participants’ details were kept confidential and that any names collected (e.g. 
via informed consent forms for the qualitative study) were kept separately from the data. 
Further details regarding the ethics have been provided in the chapter of each study. 
 
3.5 Introduction to data collection and data generation methods for 
this PhD research project 
3.5.1 Quantitative study: Survey 
Quantitative research generally aims to gather information from a relatively large number of 
participants and focuses on generating numerical data. In the social sciences, quantitative 
methods such as surveys are used to quantify attitudes, opinions, behaviours, and other 
defined variables in a given aspect.  Numerical data can be collected through questionnaires, 
and surveys, or by manipulating pre-existing statistical data using computational techniques 
(Schmied {Schmied, 2012, Effect of Heat-Killed Escherichia coli`, Lipopolysaccharide`, and 
Muramyl Dipeptide Treatments on the Immune Response Phenotype and Allergy in Neonatal 
Pigs Sensitized to the Egg White Protein Ovomucoid}, 1993).  
     
This quantitative study used a survey to gather information from a pre-defined group of 
respondents that were familiar with the content of questions and able to provide answers.   
In surveys, questionnaires are the most widely used data collection method (Ponto,2015). In 
this study data was collected by using an online questionnaire. A self-completed 
questionnaire was constructed by the researcher and all respondents were asked the same 
set of questions.  Respondents accessed the questionnaire through their web browser by 
using a hyperlink. The questionnaire was designed to address the objectives of the study 
(Chapter 4 ) The questionnaire was constructed with the help of healthcare professionals 
(dietitians, paediatricians, allergists/immunologists and nurses) who were involved in the 
management of CMA in primary/secondary/tertiary care. The design and content of the 
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questionnaire was based on a careful review of the literature discussion with healthcare 
professionals working in this field. The majority of questions were closed questions for ease 
of completion and thus to facilitate a higher response rate. The questionnaire could be 
completed within 20 minutes. A broad range of data were collected regarding the opinions, 
attitudes and beliefs of healthcare professionals about the re-introduction of baked milk 
products in the management of IgE and non-IgE CMA.  Numerous questions were asked 
about the baked milk challenges and milk ladder. The content validity of questions was 
assessed by healthcare professionals located in different regions of the world who assessed 
whether each question was essential, necessary, and useful.  
 
In the first page of the online questionnaire was a welcome section which explained to 
respondents the purpose of the research, their voluntary and anonymised participation, and 
guidance for questionnaire completion. The questions of the survey were classified in five 
sections. The first section collected information about the background and characteristics of 
healthcare professionals such as speciality, country and place of their practice. The second 
and third sections collected data related to the use of baked milk challenges and milk ladders 
(such as guidelines considered before the baked milk reintroduction), and place 
(clinic/home) of baked milk introduction. The fourth section collected data regarding any 
potential allergic reactions during a baked milk challenge or milk ladder such as what type of 
symptoms were observed and how frequent they were. The last section collected data 
regarding the safety of baked milk challenges and the milk ladder process at home, and 
whether, according to the perspective of the healthcare professionals, parents were anxious 
during the reintroduction of baked milk products. Finally, respondents were thanked for 
completing the questionnaire.      
 
 
Strengths and limitations 
Through the survey, a broad range of data were collected regarding the opinions, attitudes 
and beliefs of healthcare professionals about the use of baked milk products in the 
management of IgE and non-IgE CMA. Bias derived from the researcher’s subjectivity was 
eliminated because all participants were provided with the same standardised 
questionnaire. Written definitions were provided with any questions that required further 
explanation to ensure that participants had a consistent understanding of these questions 
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and to thereby enhance the rigour of the data collected. The respondents had the chance to 
use a text answer if they wanted to provide further information or clarification.         
 
Before distributing the questionnaire, its content validity was ensured by submitting the 
questions to careful review (evaluating whether each question was essential, necessary and 
useful) by healthcare professionals located in different regions of the world. Their feedback 
was used to revise the questions where necessary. The questionnaire was pilot tested to 
ensure that the respondents could answer the questions without any problems and data 
could be effectively reported. The questionnaire was tested in terms of the time taken for 
completion, clarity of instructions, questions and layout, and omissions of respondents’ 
answers.  
 
In general, a major limitation of surveys is that the number of respondents who choose to 
respond may be different from those who chose not to respond and data bias may be derived 
from non-responses of the questionnaire. Even though the questions of the questionnaire 
are very well-formulated, there is still a chance that some respondents may interpret 
differently or incorrectly some questions and provide unclear data biasing the results. 
Another limitation is that respondents may not be fully aware of their reasons for all their 
answers due to the lack of expertise or memory on a subject, and data errors can thus occur.   
Another weakness of a survey is that it is inflexible compared to interview questions because 
it is not possible to follow up further on individual respondent’s answers.   
 
3.5.2 Qualitative study: Semi – structured interviews & thematic analysis  
In the last few decades qualitative methods have gained an important place in the health 
sciences. As discussed in Section 3.2, the main difference between quantitative and 
qualitative studies is that quantitative research collects numerical data and generates 
statistics while the qualitative methods collect qualitative data related, for example, to 
experiences or feelings, and analyse these at a conceptual level typically with a focus on 
understanding the richness of the data (Rhodes, 2014). In addition, qualitative research is 
more flexible compared to quantitative research because it allows greater adaptation of the 
interaction between the researcher and participants, and participants are free to express 
themselves in their own words and provide responses in greater detail. Qualitative research 
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involves an examination of variables or phenomenon with a naturalistic and interpretative 
approach that seeks to provide an in-depth and complex understanding of how people see 
and interpret their social world (Snape & Spencer ,2003). Qualitative research can be 
conducted in various ways (methods) that have been categorised into five groups: 
ethnography, narrative, phenomenological, grounded theory, and case study (Tong, 
Sainsbury, & Craig, 2007).  The most common qualitative data collection tools are:  
• Participant observation that is appropriate for collecting data on naturally occurring 
behaviours of participants  
• In-depth interviews that are appropriate for collecting data on individuals’ personal 
histories, perspectives, and experiences, particularly when sensitive topics are being 
explored.  
• Focus groups that are effective in eliciting data on the cultural norms of a group and 
in generating broad overviews of issues of concern to the cultural groups or 
subgroups represented.  
    
Qualitative research typically generates data such as field notes, audio or video recordings 
and associated transcripts.  Exploratory, qualitative, semi-structured in-depth interviews 
were used in this study to explore parents’ experiences and perspectives regarding the 
introduction of baked milk products into the diet of their children with IgE and non-IgE 
mediated CMA. These interviews provided the opportunity to understand parents’ attitudes, 
opinions and experiences related to the use of baked milk products at home. The interview 
schedule included a list of topics and some key questions to give a rough guide to follow in 
the interview; however, their exact use varied from interview to interview.  In addition, the 
order of questions depended on the flow of conversation and the exact questions varied 
from person to person (Rubin 1995). The interviews were conducted on a one to one basis 
by telephone or a call via the Internet between the researcher and a single participant. 
According to ethical considerations, participants were informed about the length of time 
needed for the interview and had understood the content and purpose of the study before 
they consent to be interviewed. Interviews were arranged at a time that mothers were under 
least pressure. Mothers had the right to decline to answer any questions.        
  
Data Analysis: Thematic Analysis 
There are different methods of data analysis in qualitative research such as Grounded Theory 
(GT), Thematic Analysis (TA), and Interpretative Phenomenological Analysis (IPA). This 
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research used thematic analysis to analyse the qualitative data because there is no need of 
detailed theoretical and technical knowledge and this form of analysis is suitable for new 
researcher in a qualitative research career. Primarily, however, thematic analysis was chosen 
as it is a method that offers an accessible, useful and theoretically flexible approach to 
identify patterns or themes and analyse qualitative data without being bound to a particular 
epistemological or theoretical perspective (Braun & Clarke 2006). It has the advantage of 
providing a usable and clear framework on how to analyse qualitative data. The goal of 
thematic analysis is to identify important and interesting patterns (themes) in the data and 
use these themes to address the research question of the study. Braun & Clarke (2006) 
provide a six-phase guide which is a very useful framework for conducting thematic analysis. 
Further details for each step is provided in Chapter 5.  
 
Strengths and limitations   
A key strength of qualitative research is that it provides rich data and an in-depth 
understanding of an experience. A semi structured interview method can provide complex 
textual descriptions of how people experience a given research issue and help the researcher 
to interpret and understand the complex reality of a given situation. For instance, 
researchers can gain information related to contradictory behaviours, beliefs, opinions, 
emotions, and relationships of participants. Interviewees have the opportunity to ask if some 
questions are not very clear and discuss their experiences without needing to write anything 
down and they also receive feedback and personal assurance on how the researcher will use 
the information received.  
In the manner in which they react and ask questions the interviewer may have an impact on 
the data collection. Bias may be derived from the interviewer’s comments, tone or non-
verbal behaviour and the way that participants’ responses were interpreted by the 
researcher. However, these issues were overcome in this research due to the fact that the 
researcher was an allergy dietitian with interview skills and therefore able to manage the 
interaction between interviewer and interviewee.  It is also important to note that, in this 
study, participants’ willingness to participate in an interview may have been reduced due to 
their high family and work commitments, and this may cause data biases because the 
researcher might be more likely to gather the perspectives of mothers who have fewer 
commitments.  It was a fact that the majority of mothers had limited available time for the 
interview due to their work and family commitments, although this issue was overcome by 
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arranging a suitable time according to mothers’ availability. Sometimes it was required to 
interrupt the interview and complete it at a later time. The interview did not include 
questions related to sensitive information. To increase the validity of the semi-structured 
interviews, the clarity of the topics and questions had been reviewed by colleagues and 
parents before conducting the interviews. In addition, data entry was performed by the PhD 
student who is an experienced dietitian and reviewed from colleagues to prevent any bias at 
the coding stage.  
 
3.5.3. Quantitative study: Secondary data analysis  
According to the National Institute of Health (NIH) in the United States, “‘primary data 
analysis is limited to the analysis of data by members of the research team that collected the 
data, which are conducted to answer the original hypotheses proposed in the study. All other 
analyses of data collected for specific research studies or analyses of data collected for other 
purposes are considered as secondary data, whether or not the persons conducting the 
analyses participated in the collection of the data” (Cheng HG, 2014). Thus, secondary data 
analysis is a research method that analyses an existing dataset that was collected initially for 
some other purpose. Further analysis of existing data may provide additional knowledge, 
interpretation or conclusions (Bulmer et al 2009).  
 
To meet the third objective of this research (Chapter 2, section 2. 7), a secondary analysis of 
an existing dataset that was obtained for a larger research project was carried out. The data 
was collected by the allergy team of the Children’s Hospital Medical Centre in Cincinnati for 
a larger high-quality research project conducted in the USA. This data included electronic 
patients’ records related to measurements of immune markers’ in milk allergic children and 
their food challenge outcomes. The data that was sent to the University of Portsmouth was 
coded and anonymous and it was provided in an encrypted flowsheet database email.  
Frequency tables and cross-tabulation were run for all variables that were included in the 
main analysis of data to identify potential missing values of each variable in the dataset.   
Further analysis of this data could provide additional knowledge to healthcare professionals 
and parents about the milk tolerant status of milk allergic children and help them to decide 
when is the appropriate time and what form of milk containing food to re-introduce into the 
diet of children with CMA.   
 
 
65 
 
 
Strengths and limitations 
The major advantages of a secondary analysis of existing data is that it can be developed in 
less time with a relatively low cost compared with other methods of data collection. It is 
also a sensible and ethical use of research data, as similar datasets are not duplicated, and 
thus additional time and resources not invested in collecting data that already exists. It was 
a great opportunity for this PhD research to obtain access to such dataset from a large-
scale population research in the USA.  
 
However, one limitation of the secondary analysis of existing data is that the researcher who 
is analysing the data has not been involved in the data collection and therefore cannot 
control or influence the data collection, and specific information regarding the data 
collection may not have been reported.  In addition, the data has not typically been collected 
to address the research question of the particular study and some important variables may 
not be available for the analysis. Furthermore, some specific variables such as age, race or 
ethnicity of participants may not be available due to confidentiality.  
 
3.6 Summary  
A multi-method design was used to achieve the overall aim of this research and thereby 
provide a holistic view on the use of milk-containing foods from healthcare professionals’, 
mothers’ and milk allergy tools’ perspective.  Two quantitative studies and a qualitative 
study were separately used to explore current practice according to healthcare 
professionals’ opinions, the impact of baked milk introduction at home according to 
mothers’ experience, and if immune markers such as SPT and milk sIgE can predict the milk 
tolerant status of children with CMA and help HPC to identify the appropriate time of 
baked milk containing food introduction.  A survey with a mix of closed-ended and semi-
closed questions was used to explore healthcare professionals’ attitudes and experience. 
Semi-structured individualised phone interviews were used to explore mothers’ 
experiences and opinions.  A secondary analysis of existing data that was collected from a 
larger research carried out to determine if immune markers such as SPT and milk sIgE can 
identify children who will be optimal cow’s milk allergic patients for milk containing food 
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reintroduction. The key strength of this research is that it considers important questions 
about the guidance and practice of baked milk introduction from clinical and parental point 
of view; a common area of practice in the management of cow’s milk allergy for which 
there has been little previous research.  
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Chapter 4: Use of baked milk challenges and milk ladders in 
clinical practice: a multinational survey of healthcare 
professionals 
4.1 Overview 
According to the systematic review in chapter 2, there is a need to understand how HCPs use 
a BMC or ML in clinical practice, when and where these challenges are performed and what 
guidelines are followed by HCPs before they decide to recommend the baked milk 
introduction in the management of IgE and mild to moderate non-IgE CMA.  
The overall aim of this chapter is to provide information regarding the baked milk challenge 
and gradual re-introduction of milk (or milk ladder) from healthcare professionals’ 
perspectives.  According to the findings of the literature review in the previous chapter, 
current research suggests that graded introduction of cow’s milk, starting with baked milk-
containing foods such as biscuits/cookies, cakes and waffles, may be used as a prognostic 
indicator for outgrowing cow’s milk allergy. This chapter examines the experiences and 
opinions of HCPs and what guidelines they follow before deciding to proceed to a BMC 
and/or milk ladder. This was achieved by administering an electronic questionnaire to HCPs 
across the world. Health organisations and associations such as the British Society for Allergy 
and Clinical Immunology and the World Allergy Organisation identified HCPs involved in CMA 
management and distributed the survey questionnaire via emails. The main questions 
related to: participants’ characteristics; where the BMC and/or ML were conducted; 
symptoms observed during challenges; guidelines followed by HCPs before deciding to 
proceed to a BMC and/or a milk ladder; and HCPs’ perspectives regarding the safety of a 
BMC/ML and parental feelings during BM re-introduction. The findings are discussed in 
terms of their contribution to an agreement for universal guidance on the use of BM-
containing foods for the management of IgE and non-IgE-mediated CMA and clinical 
implementation related to the development of safe BM-reintroduction plans.  The findings 
of this study were peer-reviewed and published (appendix 1).     
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4.2 Background  
4.2.1 Rationale for the study 
 In the past, the cornerstone of CMA treatment was strict elimination of cow’s milk and foods 
containing CM from the patient’s diet (Fiocchi et al., 2010). However, the appropriate 
prevention and management of CMA is still debated. There is a more recent theory that strict 
avoidance of milk proteins may contribute to the persistence of CMA and the 
recommendation for strict milk avoidance due to a lack of effective and approved treatment 
of CMA (Kim & Sicherer, 2010; Vandenplas, 2017). Hence, some in paediatric allergy research 
and clinical practice argue for a modification of the existing milk-restricted diet in favour of 
an individualised approached based on the tolerance to milk in the forms of baked milk 
products (Kim et al., 2011; Sampson et al., 2013). Indeed, the importance of BM-
reintroduction into the diet of children with CMA has become well-recognized as a part of 
CMA management (Nowak-Węgrzyn, 2016). Current research regarding the use of BM-
containing foods has been reviewed and reported in Chapter 2, Section 2.2.1. Interestingly, 
it has been demonstrated that the majority (75%) of children who participated in baked milk 
studies tolerated the BM- containing foods, and, of particular note, were 28 times more likely 
to become tolerant to “raw” cow’s milk compared to those children who were not able to 
tolerate these baked milk products (Kim et al., 2011; Nowak-Wegrzyn et al., 2008). 
Furthermore, the ingestion and incorporation of BM-containing foods into the children’s diet 
seemed to accelerate the resolution of CMA without any adverse effects on children’s 
growth, intestinal permeability, or the severity of coexisting diseases such as asthma, atopic 
dermatitis and allergic rhinitis (Bartnikas et al.,  2012). The use of BMC and ML may therefore 
help to avoid an unnecessary restriction of BM-containing foods or to prevent a severe 
reaction that could be provoked with uncooked milk; children reactive to BM appear to be 
at higher risk of systemic reaction than those children that tolerate BM but still remain 
allergic to uncooked milk (Nowak-Wegrzynet et al., 2008) and perhaps help to induce 
tolerance. 
In the United Kingdom, CM is one of the most common foods responsible for fatal 
anaphylactic reactions in children less than 16 years of age, and food allergy is the main cause 
of a fatal anaphylactic reaction outside the hospital setting (Turner et al., 2015; Wang & 
Sampson, 2007). It is difficult to estimate how many people die each year from food 
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anaphylaxis and to confirm the trigger that caused these tragedies. In the past two years, 
three children (two boys, who were 3 and 13 years old, and a 9-year-old girl) died due to a 
fatal anaphylactic reaction following a bite of a milk-containing food outside of healthcare 
settings in the United Kingdom (UK). (Fleicher, 2017; O’Çarroll 2017; Robinson, 2017). In the 
USA, a 3-year-old boy has tragically died following a severe anaphylactic reaction during a 
routine baked milk challenge (Smith,2017). These tragic events emphasize that the safest 
procedure should be in place during food challenge in terms of set-up, staffing, supervision, 
and protocols.  Importantly, the decision to challenge at home should not be taken lightly as 
there is a risk of severe reactions, even anaphylaxis, in IgE-mediated CMA.  
At the time of completion of this survey, few guidelines were available on BM-reintroduction.  
In the UK, the MAP Milk Allergy guidelines for mild to moderate non-IgE-mediated CMA and 
the BSACI guidelines for home introduction of BM-containing foods in IgE-mediated CMA 
were first published at the end of the survey period (details on the descriptions of these 
guidelines are referred to Chapter 2, Section 2.2.3) (Luyt et al., 2014; Venter et al., 2017; 
Venter et al., 2013).   
However, there are no studies indicating which patients are optimal candidates for home 
introduction of BM. Additionally, there is no universal agreement for the criteria used to 
classify the severity of allergy symptoms as mild, moderate, or severe and no reliable 
biomarkers have been determined which could be used to indicate the safety of home 
introduction of milk-containing foods. In the absence of universally agreed guidelines, it was 
not clear “how”, “when” and “where” BM-reintroduction was being conducted in practice. 
This is a novel study which explored what guidelines and approaches are currently being used 
by HCPs across the world and what their experiences have been in introducing a full portion 
of a BM product as a challenge (BMC) over 1 day or as a more gradual introduction over a 
number of days/weeks before moving on to other baked milk foods, as per a ML approach.  
4.2.2 Aims & Objectives  
The aim and objective of this study were as follow:  
Aim: To evaluate the attitudes and practices of HCPs on the conduct of BMCs and graded re-
introduction of BM/milk ladder in IgE and mild to moderate-non-IgE mediated CMA. 
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Objective: A multinational survey explored the current clinical practice of healthcare 
professionals using baked milk challenges and the milk ladder  
4.3 Methods 
4.3.1 Study design 
A web-based global survey was conducted to explore and capture the current clinical practice 
and views of healthcare professionals, using a baked milk challenge and/or a milk ladder in 
the management of IgE and non-IgE-mediated CMA. An online questionnaire (appendix 7) 
was developed consisting of 23 short questions which could be completed within 
approximately 15 minutes.  
The main sections of the questionnaire were:  
- Characteristics of HCPs including: professional background and level of allergy 
training, practice setting (private/hospital-primary/secondary/tertiary care), 
proportion of HCPs working time devoted to seeing patients with food allergy 
amount of time spent consulting patients with food allergies, country of residence, 
guidelines that HCPs considered before they made the decision about the setting of 
BMC/ML. 
- Were these challenges used and where were these challenges performed? 
- What was the HCPs’ opinion on the safety of home-BMC and ML? 
- What was the HCPs’ opinion on parental anxiety in BMC/ML process?   
- What symptoms were observed?   
The literature was reviewed carefully prior to designing the questionnaire and the 
questions were discussed with healthcare professionals such as allergists, dietitians, and 
allergy nurses who shared their experience and queries on baked milk introduction. The 
questions were designed to collect data that answer the research question and address 
the objectives of this research. It was designed to collect demographic variables that 
included data related to characteristics of respondents such as education, occupation, 
place of work and workload that can be used to check if the data collected is 
representative for the general population. It was also designed to collect attitudes and 
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opinions variables related to the clinical practice of healthcare professionals. The validity 
and reliability of the questionnaire were assessed by healthcare professionals and 
colleagues. CMA experts reviewed the questionnaire and provided feedback on the 
representativeness and suitability of the questions.   
 
The questionnaire included a combination of open and closed questions. Closed 
questions are usually quicker and easier to both answer and analyse. Open questions 
gave respondents the opportunity to provide answers in their own way and give context 
to their answers. In terms of closed questions, the questionnaire included: a list of items 
and respondents could select any of these items; a category of responses where the 
respondent could select only one response; and a matrix, where responses to two or 
more questions could be reported using the same grid. Each person was asked the same 
set of questions in a predetermined order. 
To increase the validity, reliability and response rate of the questionnaire (i) a clear 
explanation about the purpose of questionnaire was provided (ii) the questions were 
carefully designed and presented (iii) the delivery and return of the completed 
questionnaire was carefully planned (iv) a covering email that summarised the research 
was sent by the Health organisations and associations to healthcare professionals to 
ensure a high level of responses and (v) a pilot test was conducted before the 
questionnaire was distributed to participants. The questionnaire was self-completed by 
the respondents in their own time and they accessed it through their web browser using 
a hyperlink sent by email. The first part of the questionnaire had a welcome screen and 
explained the purpose of the survey and why it is important the respondent to complete 
the questionnaire. At the end of the questionnaire, respondents were thanked for 
completing the questionnaire.  
An initial pilot testing of the survey was carried out on a group of HCPs practising in different 
parts of the world to ensure the clarity of questions. Although related to healthcare, this 
study did not recruit NHS patients and did not therefore require review by an NHS research 
ethics committee. Advice received at the start of this research study indicated that no ethical 
review was required by the University of Portsmouth Science Faculty Ethics Committee, 
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however, it has since become apparent that such review should have been sought. This has 
been discussed with the current Science Faculty Ethics Committee Chair and Members, who 
agreed that this was a genuine oversight/misunderstanding, and issued the letter attached 
in appendix 8.   
4.3.2 Justification of the online questionnaire  
Electronically administered questionnaires are an inexpensive way to collect data for 
research purposes (Kelley, Clark, Brown, & Sitzia, 2003). However, the main benefit of using 
online questionnaires is that this data collection method is less time consuming compared to 
a paper questionnaire or telephone interview approach. Participants’ responses are 
processed automatically, and the results are accessible at any time. It is also particularly 
suited to collecting data from across the world, as posting questionnaires worldwide would 
be very expensive and coordinating a series of telephone interviews across time zones while 
also taking account of participants’ other commitments could be logistically problematic. The 
Bristol Online Survey software was a convenient tool with which to develop the 
questionnaire and the participant had the choice to skip optional questions that were not 
suitable for them and provide answers to mandatory questions. Data was automatically 
analysed using descriptive statistics and it was instantly available to be transferred into the 
SPSS statistical software or spreadsheets for further statistical analysis. The margin of error 
was reduced with the online survey because HCPs could enter their responses directly into 
the system. Participants were able to complete the online survey at a time convenient to 
them. This survey was designed to be sent to HCPs whose current practice involves the 
management of CM patients. To summarise, the survey approach by means of online 
questionnaire was chosen for this study primarily because it was the most practical approach 
for a worldwide survey, but also because the results could be produced quickly while 
minimising the risk of human error; the data could be transferred and analysed in various 
applications to appropriately answer the research question; it could be achieved with low 
budget; and, finally, it required less time compared with other quantitative methods.    
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4.3.3 Recruitment of Participants  
HCPs involved in the diagnosis and management of IgE and non-IgE-mediated CMA were 
invited to complete the online questionnaire. The participants were identified through the 
following international professional organisations:  
- Food Allergy and Intolerance Specialist Group of British Dietetic Association (FAISG) 
- British Society for Allergy and Clinical Immunology (BSACI) 
- American Academy of Asthma Allergy and Immunology (AAAAI) 
- American Dietetic Association (ADA) 
- International Network for Diet and Nutrition in Allergy (INDANA) 
- Allergy Society of South Africa (ALLSA) 
- Dietitians Association of Australia (DAA) 
- Australasian Society of Clinical Immunology and Allergy (ASCIA) 
- World Allergy Organisation (WAO) 
The above-mentioned associations and organisations were conducted and asked to 
distribute to their members who involved in the management of CMA an email with the 
questionnaire link. A reminder email was sent 4 weeks later. An example of a contact 
invitation email is attached in appendix 9.   
Inclusion Criteria 
All healthcare professionals that were involved in the diagnosis and management of IgE and 
non-IgE-mediated Cow’s Milk Allergy, using baked milk challenges in clinical practice and/or 
gradual re-introduction of milk (milk ladder) were eligible to complete the online 
questionnaire.  
4.3.4 Data safety and monitoring  
At the beginning of the online questionnaire, there was a section that informed respondents 
about the purpose of this survey and provided directions for the completion of the 
questionnaire.  HCPs were aware that the data will be anonymous and confidential and 
stored according to Data Protection Act 1998.  Respondents could save their responses and 
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complete the questionnaire at a later date.  Each respondent was allocated a study number 
for data analysis and dissemination of outcomes. All computer files/electronic records were 
password protected on a secure drive. Only the researcher and academic supervisors had 
access to the encryption key. No sensitive data or patients’ data were collected by this study.       
4.3.5 Data Analysis 
The Bristol Online Survey software was used to analyse and describe the results. Descriptive 
statistics were used to summarise data using a combination of tabulation and graphical 
description. For further statistical analysis data were entered and analysed using IBM SPSS 
Statistics for Windows version 22.0. Pearson’s chi-square test was used:  a) to determine 
whether or not there was a statistically significant association between the use of BMC and 
ML; b) to test whether or not a statistically significant association exists between the settings 
(clinical/home) in which BMC/ML were performed and the types of CMA (IgE and non-IgE-
mediated CMA) being evaluated.  A p-value less than 0.05 was considered statistically 
significant.  
4.4 Results 
4.4.1 Characteristics of participating HCPs 
A total of 114 HCPs completed the questionnaire and provided data on their clinical practice 
regarding using either a BMC and/or a ML in both IgE- and non-IgE-mediated CMA. The 
largest groups of respondents were dietitians with an interest in allergy (52 (46%)) followed 
by paediatric allergists/immunologists (46 (40%)). The majority of participants (106 (93%)) 
indicated that they were involved in the management of IgE- and non-IgE mediated CMA in 
infancy and childhood. Most of the participants were based in the United Kingdom (56 
(49%)), followed by the United States (20 (18%)), and were practicing in secondary 
care/hospital (52 (39%)) followed by tertiary care/specialist centres (42 (37%)). The majority 
of HCPs reported that they based their decision regarding BM introduction on an 
individualized clinical assessment (history of symptoms, SPTs, laboratory tests) and a smaller 
number of HCPs reported that this decision was based on national/regional/international 
guidelines. Demographic features of all respondents are shown in Table 4.1.  
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Table 4.1: Characteristics of participating HCPs 
Characteristics  Options Respondents 
(n=114) (%)   
Professional background   Dietitian 
Paediatric 
Allergist/Allergist/Immunologist 
Paediatrician with Allergy interest   
Other* 
52(46) 
32(28) 
14(12) 
16(14) 
 Practice Settings  Secondary Care/Hospital 
Tertiary Care/Specialist Centre 
Private Practice 
Primary Care/Community 
Other** 
 
52(39) 
42(37) 
19(14) 
16(12) 
    4(3) 
Allergy training Work-based experiential learning  
Speciality in Allergology/Immunology 
Postgraduate Diploma in Allergy 
MSc in Allergy 
PhD in Allergy 
Postgraduate Certificate in Allergy 
Other*** 
50(38) 
36(27) 
10(8) 
  8(6) 
  8(6) 
  4(3)   
16(12) 
 Food allergy patients as proportion 
of weekly workload  
>50% 
≤50% 
62 (54) 
52 (46) 
CMA patients seen by HCPs  Infants/children 
Adults 
106(93) 
 37 (32) 
Country  United Kingdom  
North & South America 
Oceania, Africa, Asia 
Europe  
56(49) 
24 (21) 
20(18) 
14(12) 
Guidelines for hospital -BMC Medical history/SPT/sIgE 
Regional/National 
International 
Hospital policy 
40(35) 
24(21) 
12(11) 
  9(8) 
Guidelines for hospital -BMC Medical history/SPT/sIgE 
Regional/National 
International 
Hospital policy 
40(35) 
24(21) 
12(11) 
  9(8) 
Guidelines used to direct home-
BMC 
Medical history/SPT/sIgE 
Regional/National 
International 
Hospital policy 
39(34) 
26(23) 
  6(5) 
  5(4) 
Guidelines used to direct hospital-
ML 
Medical history/SPT/sIgE 
Regional/National 
International 
Hospital policy 
24(21) 
26(23) 
  4(4) 
  3(3) 
Guidelines used to direct home-ML Medical history/SPT/sIgE 
Regional/National 
International 
Hospital policy 
22(19) 
30(26) 
  4(3) 
  4(3)   
*Other:  Pharmacists, Nutritionists, Allergy Paediatric Nurses, Physicians, General Practitioners  
**Other: Ministry of Health & Welfare, Research 
***Other: Research, Continued Professional Development (CPD) & Continuing Medical Education (CME) resources, allergy 
training, completed allergy modules       
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4.4.2 Settings (hospital/home) of BMC and ML in children with CMA based on HCPs 
reports 
Descriptive statistics was used to describe what type of milk challenges (BMC/ML) used 
healthcare professionals in IgE and non-IgE CMA and where these challenges were 
performed (hospital or home)/.  
IgE mediated CMA 
The number of healthcare professionals’ responses regarding the use of BMC and ML in 
hospital or home in IgE mediated CMA was graphically presented in Figure 1.   
 
Figure 4.1: Settings (hospital/home) of BMC and ML in children with IgE-mediated CMA  
Ninety-three (82%) HCPs indicated that they used BMC to identify patients with IgE-mediated 
CMA able to tolerate BM products before tolerating uncooked milk. Fifty-two (56%) 
respondents stated that they conducted these challenges in a clinical setting, 8 (9%) in a 
home-based setting, and 33 (35%) reported using both settings (Figure 4.1). For ML, 68 (60%) 
HCPs stated that they used this approach to determine the development of tolerance to BM 
in different forms. Nineteen (28%) respondents reported that they used the ML approach in 
a clinical setting, 22 (32%) in a home setting, and 27 (40%) in both settings (Figure 4.1).  
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Non-IgE-mediated CMA 
The number of healthcare professionals’ responses regarding the use of BMC and ML in 
hospital or home in non-IgE mediated CMA was graphically presented in Figure 4.2. 
 
 
 
 
 
 
 
Figure 4.2: Setting (hospital/home) of BMC and ML in children with non-IgE-mediated 
CMA 
Eighty-six (75%) of the respondents stated that they used BMC to determine the 
development of tolerance to BM in patients with non-IgE-mediated CMA. Eight (9%) HCPs 
reported that they challenged their patients in a clinical setting, 51 (59%) used home-based 
challenges, and 27 (31%) reported using both settings (Figure 4.2). In terms of using the 
ladder approach (ML), 77 (68%) HCPs reported that they used the ML to identify children 
able to tolerate a range of BM-containing foods. Three (4%) HCPs reported that they used 
ML in a clinical setting, 56 (73%) at home, and 18 (23%) reported using both settings (Figure 
4.2).  
 
Statistical analysis was performed using Pearson’s Chi Square test to indicate whether there 
was an association among the type of CMA (IgE or non-IgE mediated CMA) and the choice of 
setting where a BMC or ML was performed by HCPs (Table 4.2). Statistical tests and Chi-
Square values are referred to the appendix 10.    
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Table 4.2: Percentages of HCPs responses regarding the choice of BMC setting in IgE and 
non-IgE CMA  
BMC settings in IgE and non IgE-CMA reported by HCPs   
BMC Setting 
Total Responses 
(N=179)  
 
IgE mediated 
CMA 
Non-IgE mediated 
CMA 
p value 
(Pearson chi-
square test) 
   <0.001 
Hospital 52 (56%) 8 (9%)  
Home 8 (9%) 51 (59%)  
Both 33 (35%) 27 (31%)  
A greater number (52 (56%)) of hospital-based BMC responses were indicated in IgE-
mediated CMA, with a larger number (51 (59%)) of home-based BMC being used in non-IgE-
mediated CMA (Table 4.2).  Pearson’s Chi -Square test (appendix 10) indicated that the 
choice of BMC setting (clinic/home) was statistically significantly (p < 0.001) associated with 
the type of CMA (IgE-/non-IgE-mediated). 
 
 
Table 4.3:Percentage of HCPs responses regarding the choice of ML setting in IgE and 
non-IgECMA  
ML settings in IgE and non-IgE mediated CMA reported by HCPs 
ML Setting 
Total Responses 
(N=145)  
 
IgE mediated 
CMA 
Non-IgE mediated 
CMA 
p value 
(Pearson chi-
square test) 
   <0.001 
Hospital 19 (28%) 3 (4%)  
Home 22 (32%) 56 (73%)  
Both 27 (40%) 18 (23%)  
 
A considerable number of respondents used ML challenges/introductions at home in both 
IgE- {22 (32%)} and non-IgE-mediated CMA {56 (73%)}. In IgE-mediated CMA a reduced 
number {19 (28%)} of healthcare professionals suggested a ML challenge/introduction in 
hospital, while in non-IgE mediated CMA a very small number {3(4%) of healthcare 
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professionals suggested a ML challenge or introduction in hospital. Pearson’s Chi -Square 
test (appendix 10) indicated that the decision about where to perform a ML 
challenge/introduction (hospital/home) was also statistically significantly (p < 0.001) 
associated with the types of CMA (IgE/non-IgE-mediated).  
4.4.3 Safety of BMC and ML at home/outside the medical settings in IgE and non-
IgE mediated CMA     
Descriptive statistics was performed to describe graphically which place (hospital or home) 
was safe for a BMC or ML introduction according to healthcare professionals’ opinions 
(Figure 4.3).  
    
 
 
 
 
 
 
 
Figure 4.3: Participants' views regarding the setting where BMC & ML are conducted in 
patients with IgE and non-IgE mediated CMA 
In terms of IgE-mediated CMA, 30 (26%) respondents stated that the home was a safe place 
to conduct BMC or ML, whereas 65 (57%) HCPs (Figure 4.3) considered the home/outside 
the clinical setting as a non-safe place to conduct both BMC and ML, due to the potential for 
severe symptoms (Table 4.5). 
In n terms of non-IgE-mediated CMA the majority of HCPs (71 (62%)) considered the 
home/outside the clinical setting as a safe place to conduct both BMC and ML. A small 
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proportion of respondents {15(13.2%)} reported that the home was not a safe place for 
either BMC or MLs (Figure 4.3). 
Statistical analysis  was performed to identify whether the type of CMA (IgE or Non IgE-
mediated CMA) has influenced HCPs’ recommendation regarding the appropriate setting for 
the performance of BMC or ML. Pearson’s Chi Square test (appendix 10) indicated that HCPs 
responses regarding the safety of milk challenges was statistically significantly (p < 0.001) 
associated with the types of CMA (IgE/non-IgE-mediated)(Table 4.4).   
 
Table 4.4: Percentage of HCPs responses to home safety of milk challenge in IgE and non-
IgE mediated CMA 
 
 
 
 
 
 
Table 4.5: Summary of the most frequently reported symptoms by HCPs for BMC & ML  
Clinical Symptoms                     IgE mediated CMA  
  Clinical setting *N (%)  Home *N (%)       P value (Pearson chi-     
                                                                                   Square test)      
                                                                                  
BMC                ML                 BMC           ML            (p=0.3)        
Urticaria  
Vomiting  
Angioedema 
Runny nose & eyes 
Nausea  
68 (60)         34(30)            32(28)          25(22) 
55 (48)         24(21)            33(29)          22(19) 
49 (43)         23(20)            10(9)              9(8) 
49 (43)         19(17)            13(9)            12(11)  
48 (42)        20(18)            16(14)          22(19) 
HCPs responses regarding home safety of milk challenges in IgE and 
non-IgE mediated CMA 
Milk Challenges 
(BMC & ML) 
Safety 
Total Responses 
(N=181)  
 
IgE mediated 
CMA 
Non-IgE 
mediated CMA 
p value 
(Pearson chi-
square test) 
   <0.001 
Safe at home 30 (26%) 71 (62%)  
Non safe at 
home 
65 (57%) 15 (13%)  
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Wheezing  
Diarrhoea 
Anaphylaxis  
39 (34)         15(13)             3(2)              4(3) 
34 (30)         17(15)            42(37)          35(31) 
32 (28)         9(8.0)                  -                    -  
Symptoms                Non- IgE mediated CMA 
 Clinical setting *N (%)         Home *N (%)              P value (Pearson     
                                                                                     square test   
  BMC           ML              BMC                   ML          p=0.8 
Atopic eczema 
Abdominal pain  
Diarrhoea 
Gastro-oesoph. 
reflux 
Colic 
Food aversion 
Constipation 
20(18)         8(7)            43(38)                37(32) 
18(16)         4(3)            41(36)                32(28)   
15(13)         6(5)            37(32)                35(31) 
12(11)         4(3)            32(28)                30(26)                         
  7(6)            2(1)            22(19)                17(15) 
  6(5)            4(3)            17(15)                12(10) 
  5(4)            4(3)            43(38)                29(25) 
 
In IgE mediated CMA, the respondents reported that urticaria and vomiting were common 
symptoms during hospital and home BMC and ML. Angioedema usually occurred in hospital-
BMC/ML and diarrhoea at home-BMC/ML. Thirty-two (8%) respondents reported 
anaphylaxis in hospital-BMC and 9 (5.2%) participants in hospital-ML (Table 4.5).  
In non-IgE mediated CMA, the participants stated that symptoms like atopic eczema, 
abdominal pain and diarrhoea often occurred in hospital-BMC/ML while constipation, atopic 
eczema, abdominal pain, diarrhoea and gastroesophageal reflux commonly occurred at 
home-BMC/ML (Table 4.5).    
Differences between symptoms and setting of a BMC or ML in IgE and non-IgE CMA 
Statistical analysis was performed to evaluate whether there were differences between a 
BMC or ML setting (hospital and home) and symptoms in IgE mediated CMA. Pearson’s Chi 
Square test (appendix 10) indicated that symptoms in children with IgE mediated CMA 
were statistically significantly (hospital versus home BMC :p < 0.001 and hospital versus 
home ML ) associated with the place that a BMC and ML were conducted (table 4.6).   
According to HCPs’ responses a larger number (table 4.5) of symptoms was observed in 
 
 
82 
 
hospital BMC and ML compared to the symptoms at home BMC and ML in IgE-mediated 
CMA. These findings indicated that the majority of HCPs performed BMC and ML in hospital 
in children with IgE-mediated CMA due to complicated and serious allergic reactions. 
However, the results showed that a significant number of symptoms were observed at 
home BMC and ML in children with IgE -mediated CMA, according to HCPs’ reports.    
 
In mild to moderate non-IgE mediated CMA, Pearson’s Chi Square test (appendix 10) did not 
indicate a statistically significant (hospital versus home BMC: P value=0.3 and hospital versus 
home ML: P value=0.8) association between symptoms and a BMC or ML setting (table 4.6).   
According to HCPs’ responses a larger number (table 4.5) of symptoms was observed at 
home BMC and ML compared to the symptoms in hospital BMC and ML in non- IgE mediated 
CMA. These findings indicated that the majority of HCPs indicated BMC and ML at home in 
children with mild to moderate non- IgE mediated CMA due to less complicated and serious 
allergic reactions.    
 
Table 4.6: Associations between IgE and non-IgE mediated CMA symptoms and setting 
(hospital/home) of BMC and ML 
Symptoms     Settings: Hospital versus home   P value (Pearson   Chi 
Square test)                                                             
IgE-mediated CMA Baked Milk Challenges  
Milk Ladder 
 <0.001 
 <0.001 
Non-IgE mediated CMA Baked Milk Challenges  
Milk Ladder 
    0.3 
    0.8 
 
  
     
4.4.4   Parental anxiety associated with BMC and ML as reported by HCP 
Descriptive statistics was conducted to show graphically parental anxiety according to HCPS’ 
responses during a baked milk challenge or milk ladder introduction. Among the 114 HCPs, 
18 (15.8%) HCPs reported that parents were anxious with hospital-BMC; 24 (21.1%) with 
home-BMC; 46 (40.3%) with BMC either in hospital or at home (both settings); 16 (14.0%) 
with hospital-ML; 26 (22.8%) with home-ML and 41 (36.0%) with ML in both settings. The 
majority of HCPs reported that parents are anxious during the procedure of BMC/ML either 
in hospital or at home (Figure 4.4).  
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Figure 4.4: HCPs’ views regarding parental anxiety and milk challenge setting 
(home/hospital)  
Statistical analysis was conducted to assess whether the type of milk challenge (BMC or 
ML) has influenced parental anxiety in the different settings (hospital/home). Pearson’s Chi 
Square test (appendix 10) indicated that HCPs responses regarding parental anxiety during 
a milk challenge was not statistically significantly (p < 0.86) associated with the type of milk 
challenges (BMC/ML) (Table 4.7.)  
Table 4.7: Percentages of HCPs responses related to parental anxiety in hospital or home 
BMC and ML  
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Parental Anxiety 
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BMC ML P value 
(Pearson chi-
square test) 
   0.863 
Hospital 18 (16%) 16 (14%)  
Home 24 (21%) 26 (23%)  
Both 46 (40%) 41 (36%)  
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4.4.5 Differences across countries regarding the setting of BMC and ML in IgE and non-IgE 
mediated CMA 
Statistical analysis was conducted to assess if there is an association among milk challenge 
setting preferences and HCPs’ country of residence in IgE and non-IgE mediated CMA. In the 
UK and USA, a considerable number of HCPs reported that they preferred home BMC in IgE 
– mediated CMA and non-IgE mediated CMA. However, Pearson’s Chi Square test (appendix 
10) indicated that there was not a statistically significant (association among different 
countries and BMC/ML settings in IgE and non-IgE CMA. HCPs responses regarding parental 
anxiety during a milk challenge was not statistically significantly (p < 0.86) associated with 
the type of milk challenges (BMC/ML) (Table 4.6).    
From the rest countries, in IgE mediated CMA the majority of HCPs reported that preferred 
to perform a BMC in the hospital (table 4.8).   However, there was not found any significant 
statistical association among the countries and setting of preference of BMC and ML 
performance. Statistics tests are presented in appendix 10.    
Table 4.8: Percentages of BMC setting preferences across HCPs’ country of residence in 
IgE and non-IgE mediated CMA    
                                                                       BMC setting preference  
                          IgE –mediated CMA                                         Non-IgE-mediated CMA  
Country Hospital Home Both  Hospital Home Both 
USA 19% 25% 18%  13% 19% 18% 
UK 33% 63% 53%  25% 49% 57% 
REST 48% 13% 29%  63% 32% 25% 
 
In the UK and the USA, a considerable number of HCPs reported that they preferred home-
BMC in IgE and non-IgE CMA. From the rest countries, the majority of HCPs reported that 
preferred to conduct a BMC in the hospital (table 4.8)      
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Table 4.9: Percentages of ML setting preferences across HCPs’ country of residence in IgE 
and non-IgE mediated CMA                 
                                                                     ML setting preference 
                         IgE -mediated CMA                                         Non-IgE mediated CMA   
Country Hospital Home Both  Hospital Home Both 
USA 26% 32% 7%  33% 19% 16% 
UK 32% 32% 64%  33% 43% 68% 
REST 42% 36% 29%  33% 68% 16% 
 
Table 4.10: Association among milk challenge setting preferences and HCPs’ country of 
residence in IgE and non-IgE mediated CMA. 
Countries (USA,UK,Rest) Settings (hospital versus home  P value (Pearson chi-
square test) 
IgE-mediated CMA  Baked Milk Challenges 
Milk Ladder 
0.17 
0.87 
Non-IgE mediated CMA Baked Milk Challenges 
Milk Ladder 
0.38 
0.32 
 
4.4.5 Guidelines used in BM introduction 
The majority of HCPs reported that a combination of medical history (MH), skin prick test 
(SPT)/milk specific IgE levels, and severity of symptoms were considered in order to decide 
whether and where to carry out BMC/ML, due to the inconsistencies in guidelines. The 
minority of HCPs reported following international guidelines or a hospital policy. The  
valuable number of participants reported that they follow national/regional guidelines and 
they referred to the MAP or BSACI guidelines that had been published at the time of the 
survey (table 4.11) (Luyt et al., 2014; Venter, Brown, Shah, Walsh, & Fox, 2013) 
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Table 4.11: Indicators and clinical guidelines used in conducting a Baked Milk Challenge 
and Milk Ladder   
   
 
Clinical Guidelines              Hospital * (N (%)) 
      BMC                   ML 
N=85(97)         N=63(72) 
       Home *(N (%))  
   BMC                     ML 
N=81(92)           N=59(67)                                                   
 Medical History/SPT/sIgE/ 
Severity of symptoms 
40(47)                  23(45)   34(45)                22(37) 
National/Regional/Local 23(27)                  19(37) 25(33.3)             29(49) 
International 
 
12(14)                6(12) 8(11)                    4(7) 
Hospital policy 9(11)                   3(6)      5(7)                      4(7) 
   
*N=Total number of responses  
4.5 Discussion  
This is the first study that has investigated how and where HCPs introduce BM-containing 
foods for the management of IgE and mild to moderate non-IgE mediated CMA. According 
to the findings of this study the majority of HCPs use BM-containing foods in the form of a 
BMC/ML not only to determine tolerance to baked milk but also to help children introduce 
increasing amounts of these foods into their diet to develop milk tolerance and outgrow their 
milk allergy.  However, HCPs reported that some children may experience an immediate or 
delayed IgE or non-IgE-mediated allergic reaction during the introduction of BM- containing 
foods.  
 This study provides a statistically significant (P<0.001) data regarding the IgE 
mediated CMA symptoms and settings of BMC and ML. According to this data, a larger 
number of symptoms are observed in the hospital compared to symptoms that take place at 
home during a BMC or ML. This means that the majority of HCPs ’prefer to perform a BMC 
or ML in hospital in children with IgE-mediated CMA due to complicated and severe allergic 
reactions.  One important result from this study is the finding that in IgE mediated CMA 32 
(28%) HCPs reported anaphylaxis in clinic-based BMC and 9 (8%) in clinic-based ML 
challenges, but there were no reports of anaphylaxis in BMCs/MLs conducted at home. This 
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finding is consistent with previous studies, which have reported the development of 
anaphylaxis in some IgE-mediated CM allergic children after ingestion of BM-containing 
foods in hospital (Kim et al., 2011; Mehr et al., 2014). Mehr et al (2014) identified clinical 
predictors of reactions to baked cow’s milk. These predictors included children with asthma 
requiring preventer therapy, IgE-mediated clinical reactions to more than three foods, a prior 
history of anaphylaxis to cow’s milk, and highly atopic children. The study involved BM 
challenges in which increasing amounts of BM were introduced over a number of BM were 
introduced over a number of hours over the same day; 27% of children did not pass these 
oral food challenges. This shows that baked milk challenges carry a risk in those with IgE-
mediated CMA, and in a number of children with severe forms of non-IgE-mediated CMA. 
Hence, these findings suggest that, as argued by Mehr et al (2014), it is not safe for children 
with these clinical indicators to undergo BMC or ML at home; such procedures should always 
be carried out in a hospital setting where such indicators are present. The findings from this 
survey highlight that in IgE-mediated CMA, there were no cases of reported anaphylaxis at 
home during baked milk challenges. This could be due to successful individual risk 
assessment and HCPs having chosen an appropriate setting accordingly. This is supported by 
the fact that there were more IgE-mediated reactions associated with baked milk challenges 
in the clinical setting compared with the home.  
Our survey did not identify a significant (P value=0.8) association among milk challenge 
setting preferences and HCPs’ country of residence in IgE and non-IgE mediated CMA. This 
may be due to the fact that in the USA and UK the use of baked milk is more well-known in 
the management of CMA compared to the rest countries of the world. However, further 
investigation is required to explore HCPs’ experiences related to the use of BMC and ML in 
the rest countries of the world. Healthcare systems differ between countries and many 
European countries may not be able to provide food challenge facilities for all food allergic 
patients as considerable hospital resources are required (Muraro et al., 2014). Such 
challenges are time-consuming with long waiting lists, a major problem in many allergy 
clinics. For practical reasons, allergy services attempt to address this issue by suggesting 
initial introduction of BM-containing foods at home based on a clinical assessment. The 
findings from this survey indicate that the decision regarding the location of challenges in 
the majority of cases is based on an individualized clinical assessment looking for such 
specific parameters as: sIgE levels, skin prick tests, severity of previous symptoms, severe 
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forms of non-IgE-mediated CMA such as Food Protein-Induced Enterocolitis Syndrome or 
mixed IgE- and non-IgE-mediated CMA.  
In terms of guidelines that were considered by HCPs for the use of BM products in clinical 
practice, this research highlights that there is inconsistency of guidelines on the optimal 
management/treatment of patients with CMA for the introduction of BM-containing foods.  
The results of this study indicate that the place (hospital/home) chosen by HCPs for the 
introduction of BM-containing foods depends upon the type of CMA (IgE or non-IgE-
mediated) and severity of symptoms (mild/moderate/severe). The majority of respondents 
reported that home is not a safe place for the introduction of BM-containing foods in IgE-
mediated CMA, whereas this procedure could be safely carried out at home in cases of mild 
to moderate non-IgE-mediated CMA. These findings are consistent with the National 
Institute for Health and Care Excellence (NICE,2011) UK Food Allergy Guidelines that do not 
recommend food challenges to be conducted at home in IgE mediated CMA, but that do say 
that in mild to moderate non- IgE-mediated CMA the challenge food can be safely introduced 
at home (Mendonça, Cocco,  Oselka, Sarni & Solé, 2011). In contrast, the BSACI guidelines 
recommend that, for selected IgE mediated milk allergic children (those without poorly 
controlled asthma, multiple/complex allergy, or severe reactions with trace of milk allergen 
exposure), a BM-containing food introduction protocol can be implemented at home (Luyt 
et al., 2014).The debate regarding the introduction of BM-containing foods for the 
management of IgE-mediated CMA will be discussed further in Chapter 7, Section 7.1. 
Looking beyond the UK guidelines, the findings of this survey have also clearly highlighted 
the inconsistency of international guidance on food challenge and/or the gradual 
introduction of baked cow’s milk in a matrix or milk ladder. The WAO and EAACI recommend 
that milk challenges should be conducted in a safe, well-equipped environment that is 
supervised by a medical team, and have published guidelines for milk oral food challenges. 
However, these guidelines do not provide any specific guidance on conducting baked milk 
challenges or implementing milk ladders (Fiocchi et al., 2010; Muraro et al., 2014; Sampson 
et al., 2012).  
Another Important finding of this study is that there is a significant association (P 
value<0.001) between the type of CMA (IgE and non-IgE) and BMC or ML settings 
(home/hospital). This means that HCPs’ decision about the appropriate and safe place of a 
BMC or ML performance is influenced by the children’s type of CMA (IgE or mon IgE-
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mediated CMA).  However, choosing the safest challenge setting remains a difficult decision 
that concerns not only HCPs, but also carers. 
Parental anxiety is another factor that was considered by HCPs reports in this study.  Our 
findings indicated that parental anxiety is not statistically significantly (P value=0.8) 
associated with the setting of a BMC or ML.  A considerable number of HCPs reported that 
the families were anxious when BMC (46 (40%)) or ML (41 (36%)) were conducted, whether 
at home or in a clinical setting.  This data is consistent with the findings of previous studies, 
which have shown enhanced parental anxiety for the procedure and the risk of reaction on 
the day of a food challenge (Knibb et al., 2012; Soller, Hourihane, & DunnGalvin, 2014). 
Parental anxiety is usually related to the severity of symptoms and the possibility of fatal 
anaphylaxis in IgE-mediated CMA (Lau et al., 2014). Additionally, a study found a positive 
post challenge effect in patients’ and their families’ food allergy health-related quality of life, 
although this effect declined over time in parents/patients thus emphasising the need for 
regular clinical contact with carers and patients after food challenge (Soller et al., 2014).  
However, there is no published data on the experience and psychological impact of BMC/ML 
protocols (standardised process and doses of challenged foods) in parents and CM allergic 
children.  Due to the fact that the BM-containing food introduction can be a long process 
(some children follow the milk ladder for more than 2 years), a better understanding of 
parents’/children’s perceptions regarding the BM-introduction would be helpful for HCPs to 
provide optimal care to children and support parents throughout this approach.  
4.5.1 Strengths and limitations  
This is the first study that has systematically collected data about how BMCs and MLs are 
conducted in practice and this data provides a baseline which could be used to examine any 
changes that occur in this practice over time. All data collection, analysis and interpretation 
were conducted by the same researcher to minimise the effect of researcher bias. Another 
strength of this survey is that the majority of the responders are specialised/have practical 
experience in paediatric food allergy and their patients are mainly infants and children with 
IgE-and non-IgE mediated CMA. Most participants work in secondary and tertiary care and 
more than 50% of their weekly workload consisted of patients with food allergy (Table 3.1). 
The sample reflects the range of different clinical roles who may have responsibility for the 
care of CMA patients. 
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There are several limitations of this study. Although this is a global study, our sample size is 
relatively small and respondents were mainly from the UK and USA; there were more limited 
number of responses from HCPs working in other European countries and in other countries 
around the world. Thus, the data may be most representative of these populations. 
Additionally, although the questionnaire included all the appropriate definitions 
(classification of IgE and non-IgEmediated- CMA, BMC, ML), a limitation may be derived from 
the different criteria that HCPs used regarding the recognition, diagnosis and management 
of the complex clinical expression and presentation of CMA across the world. If the survey 
were repeated, the data from UK respondents may now be different because after the 
completion of this study, the MAP Milk Allergy Guidance (2017) and the BSACI Guidelines 
(2014) were published (Luyt et al., 2014; Venter et al., 2017) and may have resulted in 
changes to practice. Further studies with an enhanced participation of healthcare 
professionals worldwide could provide internationally comparable data on the use of baked 
milk challenges and graded reintroduction of foods in a larger population.  
4.5.2 Conclusion  
Due to the limited information on the reintroduction of BM-containing foods within and 
outside of the clinical setting, a global survey of HCPs was conducted to provide data 
regarding their perspectives and clinical practice in this area; the first of its kind. The key 
finding of this study was that there is the potential for severe/anaphylactic reactions in BMC 
and ML, and, in recognition of this, HCPs seemed to make decisions about the appropriate 
venue for a BMC/ML taking this into account. In addition, the results indicate a huge 
discrepancy in the decision making of HCPs regarding “where” and “when” BMC/ML should 
be carried out. There is still a debate regarding the appropriate place (home/hospital) in IgE-
mediated CMA and clinical trials are required to provide evidence on the safety of this 
procedure at home.  
 Furthermore, HCPs reported increased parental anxiety in both approaches, either during 
BMC or ML. According to these findings clear guidelines are required for “where” 
(hospital/home) and “when” (appropriate time for BM-reintroduction) to challenge BM-
containing foods based on risk factors such as asthma and IgE-testing (SPT, milk sIgE). 
Moreover, “standardised “and “validated” BMC and ML protocols are needed to guide HCPs 
and enhance the safety of this approach.  The development of safe home-based, baked milk 
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introduction plans based on individualised risk assessment could help many countries who 
may not be able to provide food challenge facilities due to limited hospital resources. Further 
research is required to explore country-specific advice and compare different settings and 
clinical practices regarding the use of BM-containing foods. A larger sample size with a 
sampling frame inclusive of more countries and clinicians from tertiary, secondary, and 
primary care should be conducted. In summary, the findings of this novel study demonstrate 
that there is a clear need for universal guidance, considering country-specific needs, on the 
safe introduction of baked milk products.  
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Chapter 5. Investigating parents’ experiences regarding re-
introducing baked milk foods in children with Cow’s Milk 
Allergy in the United Kingdom  
5.1 Overview 
In chapter 4, HCPs study showed that in many cases a baked milk introduction takes place at 
home in IgE and mild to moderate non-IgE CMA according to HCPs reports. However, there 
are not studies that have investigated how and when parents or caregivers conduct these 
challenges at home, what type of support and guidance have been given by HCPs, what are 
their opinions about a milk ladder plan, and what suggestions they could provide  for 
improving a milk ladder plan.   
This chapter describes a qualitative study that explored parents’ experiences, understanding, 
and their level of satisfaction in using milk in baked goods and the impact or outcomes of 
these products in the management of their children’s milk allergy. Semi-structured 
individualised phone interviews were conducted with mothers in the UK who have children 
with IgE-and Non-IgE-mediated Cow’s Milk Allergy and who were introducing baked milk 
foods into their child’s diet. Participants were recruited via social networking sites and their 
data has been analysed using thematic analysis. 
5.2 Background 
5.2.1 Rationale for the study 
 Two things led me to decide to conduct this study. The first was the HCPs opinions regarding 
the parental anxiety during a BMC process. The majority of HCPs participated in my survey 
responded that parents were anxious during a BMC (chapter 3, section 4.4.5). The second 
thing was a post in the UK website of Mumsnet chat room. A mother with a CM allergic child 
asked ‘Has anyone else heard of the Milk Ladder? My son is two and his paediatrician wants 
me to start the milk challenge from home.  Any ideas, have you heard any research on the 
use of baked milk foods? I realized that listening to and understanding mothers’ perceptions 
on the impact of BM-reintroduction in their children’s diet could provide useful data to 
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examine the usefulness, effectiveness, appropriateness, acceptability and safety of BMCs 
and milk ladders.  
In the UK, paediatric allergy clinics suggest home reintroduction of baked milk products 
either with or without a formal oral food challenge in hospital.  Different versions of milk 
ladders, based on clinician preferences, are given to parents of children with CMA to help 
them to start gradually re-introducing baked milk in the diet of their children at home (Luyt 
et al., 2014).  However, as the survey of HCPs described in Chapter 3, home baked milk re-
introduction is not appropriate for all children and for several cases it is still unclear which 
patients are optimal candidates for undertaking a baked milk challenge in hospital or 
following a milk ladder process at home.  In addition, there is not universal agreement 
regarding the process, optimal recipes and doses to use for these challenges (Venter et al., 
2013).   
Several important issues prevent clinicians from ensuring that optimal outcomes could be 
achieved in the use of baked milk for CMA children. In particular, there are no clinical trials 
that have evaluated the efficacy and safety of a ML process and “when” and “where” (clinical 
setting vs home) these challenges should be conducted. The appropriate place (clinical 
setting versus home) for the introduction of baked milk foods and the association of these 
foods with acceleration of milk tolerance development are the subject of much controversy 
(Dang, Peters, & Allen, 2016; Leonard, 2016; Leonard, Caubet, Kim, Groetch, & Nowak-
Węgrzyn, 2015). In IgE mediated CMA, several studies have reported anaphylactic reactions 
and treatment with epinephrine during introduction of baked milk foods (Bartnikas et al., 
2012; Mehr et al., 2014; Turner & Boyle, 2014; Turner et al., 2013).   
Food anaphylaxis is associated with maternal anxiety and mothers of food-allergic children 
are more anxious compared with mothers of children with no chronic diseases (Lau et al., 
2014; Mandell, Curtis, Gold, & Hardie, 2005). A substantial number of studies have reported 
that paediatric food allergy has an impact on health related-quality of life, daily family 
activities, social events and emotional well-being of parents/carers (Allen & Martin, 2010; 
Knibb, Barnes, & Stalker, 2015; Knibb et al., 2012; Soller et al., 2014; Williams & Hankey, 
2015); (Indinnimeo et al., 2013). Uncertainty by experts also contributes to increased worry 
and concern for parents and lower self-efficacy around CMA management. In particular, 
although dietitians that are experts in food allergy can provide advice and sufficient 
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information in the management of CMA, they may not be trained to manage the emotional 
needs of parents of CMA children. Health care professionals need to undertake a training on 
emotional support or a psychologist may be required to provide this kind of support in an 
allergy clinic. (MacKenzie, Grundy, Glasbey, Dean, & Venter, 2015; McHenry & Watson, 
2014).”    Findings from a recent quantitative survey (based on a postal questionnaire) 
demonstrated that the majority of parents whose children have been diagnosed with IgE 
mediated egg and milk allergy reported that having baked milk and egg challenges conducted 
in tertiary care (rather than at home) alleviated their concerns about the dietary 
management of their child’s allergy (Lee, Mehr, Turner, Joshi, & Campbell, 2015).  
In summary, for IgE mediated CMA the introduction of baked milk products in the home 
versus a medically supervised setting remains a challenging question that concerns not only 
healthcare professionals but also parents. The range and doses of BM-containing foods given 
in the ML are not standardised and validated in IgE and mild to moderate non-IgE-mediated 
CMA. In the UK, different versions of milk ladders, based on hospital’s own individual 
protocols, are given to parents of children with IgE and non-IgE- mediated CMA to help them 
to start gradual re-introduction of baked milk at home. While there are some quantitative 
studies on this issue, there are no qualitative studies to enhance our understanding of how 
parents experience and manage the reintroduction of milk at home.  
This study aimed to address this gap utilising a qualitative research approach since this is 
well-suited to explore parents’ perceptions and experiences regarding compliance, 
acceptability, practicability and safety related to the use of baked milk containing foods at 
home.  Understanding parental perceptions is of utmost importance in terms of assuring the 
validity of any future guidelines and will contribute to an effective CMA dietary management 
and to better targeting of dietary advice to parents/carers, whose children will be candidates 
for a BMC or a ML plan in the future. Additionally, the evidence from this study is expected 
to help allergy services and healthcare professionals to provide optimal care to children 
during reintroduction of baked milk foods and contribute to the eventual standardisation of 
tools used for this purpose.   
5.2.2 Aims and objectives  
The aims and objectives of this study were as follows: 
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Aim: To explore parents’ perspectives regarding the use of baked milk containing foods into 
their child’s diet. 
Objective: To conduct interviews with a selected sample of parents of children diagnosed 
with IgE and non-IgE-mediated CMA in order to qualitatively explore and analyse parents’ 
experiences, perceptions, and concerns on the use of baked milk containing foods (a milk 
ladder plan), in the UK.  
In order to meet the objective of the study the following questions have been addressed 
using a qualitative approach:  
I. How do parents experience the impact or outcome of the home-reintroduction of 
baked milk foods (milk ladder) into their children’s diet at the time that they are still 
allergic to “raw” milk? 
II. What are parents’ perceptions about the usefulness of a milk ladder plan as a dietary 
management of their children’s CMA?  
III. What are parents’ concerns associated with the home-reintroduction of baked milk 
products (milk ladder)?  
5.3 Methods 
5.3.1 Rationale for a qualitative approach  
This study has followed a qualitative methodology using a thematic analysis approach to 
meet the objective above. The focus of this research is to elicit participants’ experiences and 
their perceptions, perspectives and interpretations of a particular situation. Qualitative 
methods have been used to investigate and describe the participants’ perceptions, beliefs, 
opinions and experiences in their own terms (Snape & Spencer, 2003). Qualitative research 
seeks new information and knowledge in order to improve therapies or services and it can 
be conducted with a range of methods and traditions (Tong, Sainsbury, & Craig, 2007). There 
are many approaches to qualitative research (e.g. grounded theory) and many methods of 
data collection (e.g. interviews). The researcher’s self-reflection and pre-understanding are 
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essential parts in planning and analysing qualitative research in order to minimise bias issues 
of his/her own influence (Watts et al., 2017).   
This study conducted in-depth interviews with individuals. In-depth interviews are an 
excellent way of generating new insights rather than imposing existing knowledge or 
preconceptions and qualitative methods provide the best way to understand patients’ or 
caregivers’ needs and concerns (Wann-Hansson, Hallberg, Klevsgård, & Andersson, 2005). 
The in-depth and extended discussion was guided by the interviewer using a semi-structured 
interview style with predefined questions and specific topics of discussion that allowed open-
ended responses and clarification of the research context (Kallio, Pietilä, Johnson, & 
Kangasniemi, 2016). The information gathered using this approach could facilitate our 
understanding of the effects of home -baked milk reintroduction and its impact in children 
with IgE and non-IgE mediated CMA from the perspective of parents.  
5.3.2 Study design  
Semi-structured one-to-one interviews were carried out to allow the researcher to be 
flexible in exploring any relevant and interesting materials that might be mentioned by the 
parents.   An interview schedule (section 4.3.5, Table 4.1) was designed for the purpose of 
this study. Using open-ended questions, the researcher allowed parents to respond in their 
own words and provide meaningful, rich and naturally explanatory responses. The 
participants were given a choice of Skype, Messenger call, video conferencing and/or 
telephone call, depending on their availability.  All interviews were anonymised and digitally-
recorded.   
5.3.3 Identification and eligibility of participants 
Potential participants were identified and recruited through social networking sites, such as 
parental groups and forums. Recruitment mainly took place through online platforms, such 
as personal blogs, Facebook and Instagram.  A significant benefit of on-line recruitment from 
social networking sites is the ability to target people who share a strong interest in a 
particular area. This study recruited parents who have experienced BMCs or a ML process 
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for the management of their children CMA. A selected sample of parents who are primary 
caregivers was used. Participants were included in the study if they met the following criteria:  
Inclusion Criteria  
Participants satisfied eligibility criteria if they were parent(s)/guardian(s), who:   
o have introduced baked milk products/or a milk ladder plan with their 
child/children who have been clinically diagnosed with CMA 
o have children diagnosed with concomitant allergies  
o are willing to be interviewed via telephone, messenger, skype or video-
conferencing 
o are able to communicate verbally   
o are UK residents  
Exclusion criteria 
Exclusion criteria were as follows: 
o parents who have not introduced baked milk containing foods/a milk ladder plan in 
their children’s diet  
o parents who were not able to give informed consent  
o parents who were unable to speak English 
5.3.4 Recruitment and informed consent 
Administrators of social media groups were provided with information regarding the study 
and were asked whether they would be willing to post an advertisement for participants on 
their group page. An advertisement poster (appendix 11) was designed specifically for this 
study, which contained a brief description of the study, a clear statement of the participants’ 
inclusion criteria and the researcher’s contact details to request further information and/or 
express interest in participating in this study. Interested participants were briefly screened 
for eligibility. If they met all study criteria, a participant information sheet (appendix 12) that 
gave a detailed explanation of the study and invited parents to participate in the audio-taped 
interview, the interview schedule (Table 5.1), the demographic questionnaire (appendix 13), 
and a consent form with a reply slip (appendix 14) were sent via email. The interview date, 
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time and the means by which the interview would be conducted (e.g. by telephone), were 
scheduled according to participants’ preferences, convenience and availability. All 
documents provided adequate information and made sure that potential participants were 
fully informed before signing the consent form and participating in the study. Parents had 
two weeks to consider the study information and decide if they wish to participate. 
Participants were asked to sign and return the written consent from with the reply slip and 
the demographic questionnaire to me by email. Those interested in participating were sent 
an email, thanking them for their willingness to participate and confirming the interview 
arrangements.  
The interviews were carried out between February and July 2017. Participants’ involvement 
was no more than the length of an interview.  Each interview was anticipated to last 
approximately 30 minutes, depending on how much the parents wished to share, and took 
place over phone/messenger call.  Participants who attended the interview received a 
voucher of £10 as a gesture of thanks.  
5.3.5 Sampling Strategy 
Several studies suggest that saturation is essential to qualitative sampling (Ando, Cousins, & 
Young, 2014; Guest, Bunce, & Johnson, 2006; Latham, 2013). According to the theory of 
saturation, the collection of new data from additional participants does not provide any 
further insights on the issue under investigation, and thus data collection can cease (Mason, 
2010).  Saturation is the gold standard to ensure that adequate and quality data are 
collected. In qualitative analysis, the number of participants may vary from one to a hundred 
or more and represent a suitable and sufficient sample size, since this decision is based on 
the achievement of a rich and convincing analytical narrative rather than on statistical logic 
(Crouch & McKenzie, 2006). Indeed, many qualitative studies have achieved data saturation 
with fewer than twenty interviews therefore in thematic analysis a relatively small sample is 
likely to be adequate to understand common perceptions and experiences among a group 
of relatively homogeneous individuals (Mason, 2010); Guest et al., 2006). Hence, there are 
no clear guidelines as to the exact number of participants required to reach data saturation. 
Instead, a number of factors such as heterogeneity of the population, the number of 
selection criteria, the scope of the study, the nature of topic, type of data collection methods 
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use and the budget and resources available, might influence the sample size and therefore 
saturation of a qualitative study (Baker & Edwards, 2012). 
The concept of saturation was used to justify the sample size in this study. It was assumed 
that data saturation could reasonably be expected in this study because the participants 
were recruited according to some common criteria such as homogeneous group of 
participants (parents of children diagnosed with CMA, UK residents, and all participants have 
used baked milk challenges/a milk ladder approach for the management of their children’s 
CMA) and also all participants were asked a similar set of questions.  At the beginning of the 
recruitment it was not known how many participants were required to reach data saturation 
for this study.  The recruiting process was open to new information being presented. When 
the research questions were answered the recruiting process closed.  
5.3.6 Data collection    
Prior to starting the interviews, basic demographic data was collected for parents and their 
children. Individual interviews were conducted verbally by telephone or Facebook 
messenger call and lasted between 20 and 30 minutes. The use of semi-structured interviews 
helped to explore some relevant and interesting matters mentioned by parents. The 
interview schedule (table 5.1) was developed based on the existing literature with 
consideration of the research question, and was refined with the help of the academic 
supervisors and an external academic advisor with experience in qualitative research. All 
interviews were digitally recorded, transcribed verbatim, and anonymized. The interview 
schedule (table 5.1) was developed based on the existing literature (Braun and Clark, 2006) 
with consideration of the research questions. The interview schedule consisted of four topics 
that were driven by the research questions. Each topic included narrow questions that were 
part of the broader overarching research questions. These questions were designed to 
inform analysis and provide answers to the overall research question regarding the parental 
experience of baked milk introduction. The semi-structured design of the interview aimed to 
use the schedule to ensure that the broad topics of interest were covered with all 
interviewees, however, the individual questions were selected according to each participant 
case. Hence, not all interviewees were asked the same questions; the approach was tailored 
for each interview according to the flow of the guided conversation. The semi-structured 
interview therefore provided a guide for the interviews and   facilitated a conversation 
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between the researcher and interviewee, and allowed a degree of freedom and adaptability 
in gathering data about the experience of the interviewee.  
The questions were prepared ahead of time of the interview to help the interviewer: to be 
prepared, well-organised, and competent during the telephone interview; to achieve 
optimum use of interview time; to explore the topic with interviewees comprehensively; and 
to keep the interview focused on the desired topic. The interview schedule was divided into 
two parts. The first part included a set of open-ended questions and aimed to explore the 
mothers’ experience with baked milk challenge(s) conducted in hospital. The second part 
included five topics and each topic had a set of 4 to 5 prompts related to different aspects of 
mothers’ experience with the use of a milk ladder during the management of their children’s 
CMA. Some mothers were asked questions from part one, and others from part two 
(depending on the method of baked milk introduction). The interview schedule thus 
provided a long list of questions from which the interviewer selected those appropriate to 
the discussion. The main topics that was attempted to cover the interview are outlined 
below:  
- Mothers’ experiences during the implementation of the milk ladder 
- What kind of support have mothers received during the baked milk products 
introduction?  
- What impact has the introduction of baked milk products into the diet of their 
children had? 
- How does the implementation of the milk ladder influence the mothers’ daily life? 
- What are mothers’ concerns during the process of milk ladder implementation? 
- What ideas have mothers to improve this process? 
- What are mothers’ preferences regarding the place and time of baked milk products 
introduction?    
The interview schedule was piloted to assess how long it would take. The semi-
structured guide was designed to cover the duration of 20-30 minutes; a comfortable 
length for a telephone interview.  The interview schedule was refined with the help of 
the academic supervisors and an external academic advisor with experience in 
qualitative research. All interviews were digitally recorded, transcribed verbatim, and 
anonymised.  
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Table 5.1: Interview Schedule 
Topics 
A. Use of Baked Milk Challenge (BMC) 
 I am going to ask you some questions about your experience and your child’s experience 
of the baked milk challenge.  
1. Why did your child have the baked milk challenge? 
2. How long ago was the challenge?  
3. What was the venue of challenge?  
4.  Which food(s) was/were used in the challenge(s)?  
5. Were you/your child a bit anxious before the challenge?    
6. What happened on the day of challenge? 
- Was the baked milk challenge process well explained to you? 
- Were you/your child nervous/anxious during/after the challenge? If yes so did the 
nurse/doctor put you/your child at ease?  
7. Did your child have any problems with eating the challenge foods due to taste?   
On a scale of 1-10, how nice did it taste to your child? 
8. Has your child experienced an allergic reaction during the challenge(s) or later? If yes 
so could you tell me about that?  
-  What impact has it had on the child?   
- Has your child received any medication or adrenalin at the end of the challenge?   
- Any other problems for your child since the challenge? 
 B. Use of a Milk ladder process 
Appropriateness of the milk ladder process and the place that it is carried out        
 I am going to ask you some questions about your experience and your child’s experience 
of the milk ladder. 
1. How did you decide to take up the milk ladder challenge? Who recommended you 
the milk ladder that your child undergoes/underwent?  
2. Was the milk ladder process well explained to you?  Were you nervous / anxious 
about doing it? If yes so why? 
3. How did you explain what would happen to your child? How did your child react? 
4. Did it become easier to do? Why? How long did that take? Why? 
5. Which place (home/hospital) do you think that would be more suitable for this 
process to be carried out and why?  
Compliance 
1. What kind of baked milk containing food did you use at the beginning of the milk 
ladder process? 
2. What foods of the milk ladder did your child tolerate?  
3. In which order have you used the baked milk containing foods throughout the milk 
ladder process?   
4. How long have you used/been using the milk ladder and how easy or difficult did you 
find it? 
5. Is there anything that could have made your experience better? 
Acceptability 
1.  Did your child have any problems with eating the challenge foods due to taste?   
On a scale of 1-10, how nice did it taste to your child? 
2. According to your opinion what are the advantages/disadvantages in the use of the 
baked milk products?  
For example:  
- What about the cost of baked milk products?  
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- What about the palatability of these products?  
-  Did you observe any changes in your child’s eating behaviour and health after use of 
the baked milk products? 
- Was your family quality of life influenced by any of these changes? 
  
Practicability  
1. Which kind of baked milk products would you prefer to give your child and why?  
2. Was it easier for you to use commercial or homemade baked milk products? Did you 
face any difficulties to identify/prepare these foods?  
2.  Did you find helpful (or not) the recipes and doses of the baked milk products and 
why? 
3. What was your knowledge about the amount of milk protein in the baked milk 
products that you have used?  (Before and after introducing the baked milk products) 
4. What type of support did you have during the use of baked milk containing foods?  
- Was the information provided helpful to you? What was most helpful/what was not? 
 
Safety 
1. How was the overall experience for you and your child? Has the milk ladder 
experience changed how you and your child feel about risk?  If yes so in what way?  Are 
you and your child feeling less anxious overall? Can/did you manage better your child 
condition?   
2.  Has your child experienced any allergic symptoms during the milk ladder process?  If 
yes so has your child received any medication following the allergic reaction?   
3.  Have you got any concerns about the milk ladder process?  
4. Do you think that you could improve the milk ladder that you have used and if yes so 
how?          
5.  How would you advise other mothers about introducing baked milk products in their 
children’s diet?                
5.3.7 Data analysis 
Data was analysed using thematic analysis as described by Braun and Clarke (2006). Thematic 
analysis is the most common form of a qualitative analytic method that are conducted in six 
phases as it has been described in Figure 5.1 (Braun & Clarke 2006).  
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Figure 5.1: Thematic analysis according to Braun & Clarke's (2006) approach 
Thematic analysis was used to answer the research questions related to parents’ 
experiences, perceptions and views about the usefulness of a milk ladder plan as a dietary 
management of their children’s CMA. In this study, an inductive approach has been used to 
identify, analyse, and report themes that come from parents’ data (King 2004). A second 
researcher checked the accuracy of transcriptions going through the recording while reading 
the transcriptions.  After checking the accuracy, the transcripts were read twice prior to their 
analysis. Qualitative data analysis software NVivo 11 (QSR International Pty Ltd; Doncaster, 
Victoria, Australia) was used for the coding of data. NVivo is a computer-assisted qualitative 
data analysis software package that has been used to facilitate the management and analysis 
of data. 
In the first stage, the interviews were transcribed immediately after each interview and 
transcripts were read to familiarise myself with mothers’ data. In the second stage, initial 
codes were generated for each individual transcript in the nodes of NVivo. The initial codes 
were broad and detailed. All texts that were relevant to research questions were coded. A 
list of codes was produced and similar or identical codes were grouped. In the third stage 
Stage 1
• Familiarising with the data 
Stage 2
• Generating codes
Stage 3
• Searching for themes and subthemes
Stage 4
• Reviewing themes and subthemes
Stage 5
• Defining and naming themes
Stage 6
• Producing report 
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conceptualisation between codes and different levels of themes was initiated and the major 
themes were described.  In the fourth stage, themes were reviewed, rephrased, and 
reorganised and also subthemes were created. Themes were compared with coded text 
passages to check if they represented the actual content of the transcript. Themes provided 
an explanation of the important experiential items that were found during the process of 
analysis.  In the next stage, themes were defined and refined by writing a short summary for 
each individual theme and subtheme. At this stage, the development of themes and 
subthemes were discussed with my academic supervisors to check for clarity, and agree on 
final themes. In the final stage, a report was written that presented in the section of the 
results and illustrated themes and subthemes and participants’ experiences with their own 
words and my interpretative commentary. 
5.3.8 Ethics considerations  
The Science Faculty Ethics Committee (SFEC) of the University of Portsmouth approved this 
study, on 25th May 2016 (appendix 15). In qualitative research, informed consent, 
confidentiality and trust are the main considerations. All participants received written 
information about the study and signed a consent form.  In the participant information sheet, 
it was clearly stated that the participant was free to withdraw from the study at any time for 
any reason, and with no obligation to give the reason for withdrawal. In the consent form it 
was clearly stated that parents would get the opportunity to discuss with the Investigator 
before making a decision about their participation in the study. This research study followed 
the policy for Research Data Management as described in the Research Data Management 
Policy published in April 2015 at the University of Portsmouth.   
Participants were aware that the data will be anonymous and confidential and stored 
according to Data Protection Act. Each participant was given a study number for data analysis 
and dissemination of outcomes.  All collected data, including digital recorded telephone 
interviews, and hard copies of the transcripts, were secured in a locked cabinet and any 
electronic records were stored in password protected files. Only the researcher and 
authorised academic supervisors have access to the encryption key.  
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5.4 Results  
5. 4. 1 Characteristics of participants 
The study recruited mothers that followed a BM-reintroduction approach, from different 
parts of the UK, through social networking sites.  In total twenty-two semi-structured 
individualised phone or Messenger call interviews were conducted. Fifteen mothers that 
participated in this study had children suffering from mild to moderate non-IgE-mediated 
CMA and seven mothers had children with IgE-mediated CMA. The mothers were well 
educated with over a third having a graduate or postgraduate qualification and the majority 
of them worked part time. The mothers’ ages ranged from 21 to 44 years (median = 
34.5years) and the age of children ranges from 15 months to 8 years (median = 2.5 years). 
Over a third of children were diagnosed by a combination of the clinical symptoms history 
and SPT, IgE, and/or oral milk challenge, and more than a half of the children had a 
concomitant allergy either food allergy such as egg, peanut, sesame, shellfish, multiple food 
allergy or eczema/asthma. The majority (20 (91%)) of mothers reported that they didn’t have 
an initial BMC in hospital. From the total of seven IgE-mediated CMA patients, only two 
children had baked milk challenge in hospital before they commenced reintroduction of 
baked milk foods at home. Children had completed different steps of the milk ladder.  One 
child had reacted in step 1 (malted biscuit), 6 children passed steps 2-4 (digestive 
biscuits/cupcakes) and reacted to Scotch pancakes/muffins, 7 children passed steps 5-7 step 
(shepherd pies/lasagne/pizza) and reacted to chocolate, 3 children passed 9-11 
(yogurt/cheese/sterilised milk) and reacted to pasteurized milk, and 5 children completed 
the milk ladder. The time spent during the process of the milk ladder ranged from 0 - 
36months (median = 12 months). The majority of children experienced skin reactions during 
BM-reintroduction. Characteristics of mothers and their children are detailed in Table 5.2.     
Table 5.2: Characteristics of participants 
Characteristics  Total Number of Participants 
(N)=22  
Education: 
Postgraduate 
Undergraduate  
College  
 
 9 
 8 
 5 
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Characteristics  Total Number of Participants 
(N)=22  
Employment: 
Part time  
Stay home  
Full time  
 
15 
  3 
  4 
Child’s gender; 
Male  
Female 
 
13 
  9 
Diagnosis: 
Non-IgE-mediated Cow’s Milk Allergy 
IgE-mediated Cow’s Milk Allergy 
 
15 
  7 
Method of diagnosis: 
History of symptoms 
History of symptoms & SPT/IgE/Oral milk challenge   
 
 9 
13 
Child’s other food allergy: 
Not any  
Soya 
Multiple food allergies 
Egg 
Sesame  
Peanut 
Wheat 
Egg & selfish  
Egg & peanut  
 
 9 
 4 
 2 
 2 
 1 
 1 
 1 
 1 
 1 
Other health conditions: 
Eczema  
Not any 
Asthma 
Asthma & Eczema 
 
11 
  6 
  3 
  2 
Hospital Baked Milk Challenges: 
No 
Yes 
 
 20 
   2 
Different steps of the milk ladder had completed by 
children: 
0 (reacted to the 1st step) 
2-4 steps 
5-7 steps 
11 steps 
Completed  
 
 
         1  
         6 
         7 
         3 
         5 
Symptoms experienced children during BM-
reintroduction: 
Skin reactions   
Itching 
Loose stools 
Abdominal pain 
Behaviour changes-hyperactivity 
Vomiting  
Sleeping disturbances 
No symptoms 
 
  18 
    4  
    5 
    5 
    5 
    2 
    4 
    1 
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The coding process of this study was documented using the approach outlined by Ando et 
al., (2014). In the first stage, codes that provided information relevant to the research 
questions were collated and a codebook was generated to ensure saturation of data. 
During the coding process, some codes were repeated and thus, they were clustered under 
the same codes.  An initial coding was carried out to reduce any loss of data related to 
questions of research. The codebook comprised 36 codes in 5 themes. Table 5.3 shows the 
codebook with the initial coding, contributory codes and themes.  
Table 5.3: The Codebook with the initial coding, contributory codes and themes 
Initial Coding from individuals 
n=total number of participants 
Contributory 
codes  
Themes & Sub-themes  
Different types of milk ladders (n=7) 
 
Confusion with different milk 
ladders (n=7)  
 
Lack of healthcare support (n=17) 
 
Advice from other parents (n=10) 
 
Delayed diagnosis of CMA (n=7) 
 
Lack of follow up  
(n=10) 
 
Limited time of HCP's appointment 
 (n=4) 
 
No clear explanation about the 
baked milk introduction (n=7) 
 
Use of social media to gather 
information and get answers to milk 
ladder queries (n=17) 
 
Delayed CMA 
diagnosis  
 
Confusion with 
different types of 
milk ladders for 
reintroduction of 
milk in baked 
forms 
 
 
 Lack of 
communications 
between parents 
and healthcare 
professionals  
 
Gathering 
information from 
media and CMA 
supporting 
groups  
 
Theme: Understanding the 
milk ladder 
implementation – a lack of 
clarity and support 
 
 
 
 
 
Subtheme: Which ladder, 
and when to stop and 
when to climb? 
 
 
 
 
 
 
 
Subtheme: It’s one 
appointment, then you’re 
on your own  
 
 
 
 
 
 
Increased anxiety (n=14) 
 
Anxiety for next steps (n=7) 
 
 
 
 
 
Theme: Introducing baked 
milk at home: Inexpertise 
and anxiety 
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Nervous due to painful symptoms 
(n=9) 
 
A list with a description of potential 
reactions and guidelines how to 
cope with these (n=5) 
 
Lack of directions regarding the 
delayed reactions (n=2) 
 
Confused with the causes of 
symptoms (n= 10) 
 
Changes of behavour or awake at 
nights (n=3) 
 
Confused with the dose of food trial 
and any association with side 
effects (n=5) 
 
Difficult to communicate with the 
toddler and recognize side effects 
due to the trial food (n=5) 
 
Place of food re-introduction (n=15)  
 
Confidence with hospital food 
introduction (n=10) 
 
Convenient with home food 
introduction (n=10) 
 
 
Dealing with the balance between 
milk ladder step up and step back 
based on side effects of foods (n=3) 
 
Time spent in each step of the milk 
ladder (n=8) 
 
A list with a 
description of 
potential 
reactions and 
guidelines how to 
cope with these 
 
 Confused with 
the causes of 
symptoms 
 
Increased anxiety 
with allergic 
reactions 
associated with 
baked milk 
 
Nervous due to 
painful symptoms 
 
Reluctant to milk 
ladder due to the 
lack of 
communication in 
young children     
 
 
 
Confidence with 
hospital food 
introduction – (all 
mothers with IgE 
mediated CMA 
children & some 
mothers who had 
experienced 
severe reactions    
 
Convenient with 
home food 
introduction – all 
mothers with 
non-i9IgE 
mediated CMA 
children 
 
Uncertainty 
regarding the 
time spent on 
 
Subtheme: Discriminating 
between a reaction and an 
illness 
 
Subtheme: Making them 
poorly to make them 
better 
 
 
 
 
 
 
 
 
 
 
 
 
Subtheme: Preferences on 
the milk ladder setting 
(hospital/home)  
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each stage of the 
ML 
 
 
Confusion with 
time spent in 
each step of the 
milk ladder 
 
Food choices (n:22)  
 
Negative mothers’ experience with 
food choice in the milk ladder 
(n=22) 
 
Foods in the milk ladder do not 
always cater to concomitant food 
allergies (n= 10) 
 
Frustrated with the reading of the 
food package labels (n=7) 
 
Frustrated with the unhealthy food 
options (n=14) 
 
Lack of a list with recipes and 
further details regarding the 
quantity of milk, cooking time and 
temperature for the foods in each 
stage (n=12) 
 
Lack of alternative or equivalent 
food options (n=15) 
 
Lack of knowledge regarding the 
amount of milk protein in the 
products (n= 16) 
 
Time consuming to organise the 
food introduction (n=3) 
 
Positive mothers’ experience with 
food choices in the milk ladder 
(n=20)  
 
Children happy with the taste of 
most foods (n=8) 
 
Less concerns eating out or nursery 
or as a family (n=8) 
Foods in the milk 
ladder do not 
always cater to 
concomitant food 
allergies 
 
 
Lack of 
alternative/equiv
alent/healthy 
food options 
 
Lack of 
knowledge 
regarding the 
amount of milk 
protein/temperat
ure & time of 
baking/quantity 
of milk for each 
step/list of 
recipes 
 
Frustrated with 
the reading of the 
food package 
labels   
Theme: Living with the milk 
ladder: making it work 
 
 
 
Subtheme: Balancing the 
rigidity of the milk ladder 
with the demands of real 
life 
 
Subtheme: Returning to 
normality – removing the 
restrictions of a dairy free 
diet 
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In the stage of generating the initial codes I coded each segment of data that was relevant 
to or addressed the research questions. I did not have pre-set codes and did not code every 
piece in the text. The initial codes were developed as I worked through the coding process.  
All the potential codes were identified and highlighted, and all relevant data was 
systematically coded. A long list of the different codes was produced and provided a 
preliminary idea about data. Next, all the quotes related to each individual code were 
compared and, as result, some codes were modified, and some new codes were generated.  
The next stage was focused on the broader level of themes and involved sorting the different 
codes into potential themes. All codes identified were grouped under potential themes and 
subthemes. As Braun & Clarke (2006) explained, a theme is characterised by a pattern that 
captures something significant or interesting about the data or research questions. The 
codes were evaluated and those codes that appeared to fit together were grouped together 
to make an initial theme. For instance, several codes related to mothers’ concerns regarding 
the limited information provided by healthcare professionals, and insufficient time for milk 
ladder consultation.  
’ I collated these codes in an initial theme called “Understanding the millk ladder 
implementation – a lack of clarity and support’. Other codes were around mothers’ concerns 
related to allergic reactions during baked milk introduction and the safety of this process. I 
collated these codes in an initial theme called ‘Introducing baked milk at home: Inexpertise 
and anxiety’. Other codes were related to mothers’ experiences regarding the impact of milk 
ladder foods on their children’ diet. I collated these codes in an initial theme named ‘Living 
with the milk ladder: making it work’. Some codes formed main themes and other codes 
formed subthemes. At this point a collection of a list of themes and subthemes was 
produced. All codes identified were grouped under potential themes and subthemes. The 
themes and subthemes were then reviewed to ensure that the quotes underpinning them 
and experiences they described were coherent. At this stage, one of the initial subthemes 
was remove. In particular the subtheme related to ‘”delayed CMA diagnosis”  was 
subsequently removed since, on further reflection, it described a part of mothers’ general 
experience of having a child with CMA but not specifically to baked milk introduction.  The 
exact grouping of subthemes and the titles of these and the themes were revisited to ensure 
that they accurately reflected the full story of the mothers’ experiences.   
 
Low cost of foods (n=20) 
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5.4.3 Description & interpretation of results 
According to the qualitative findings, the milk ladder appears to be simple to implement in 
theory but mothers experienced difficulties to implement it in real life. Not only that but the 
support they got from HCPs was minimal both in helping them to understand the theory but 
also in supporting them to apply it in practice. This made it an anxious and rather lonely 
journey for the mothers.  
Based on the thematic analysis three themes and six sub-themes emerged and are presented 
in this section, with quotations to illustrate them. The themes are presented in a 
chronological progression through the findings: (1) initial understanding of the milk ladder 
implementation (2) starting the milk ladder and (3) managing the milk ladder in day-to-day 
life.  
The symbol (q) indicates the interview from which the quotation originates and if it is derived 
from a mother of children with IgE or non IgE-mediated CMA.  
Theme 1: Understanding the millk ladder implementation – a lack of clarity and support  
The majority [77%] of mothers expressed that there was limited healthcare support during 
the implementation of the milk ladder, and they needed further clarification for the 
introduction of baked milk containing foods into the diet of their children with IgE and non-
IgE mediated CMA. This theme is divided into 3 subthemes:  
 
Subtheme 1: It’s one appointment, then you’re on your own  
This subtheme describes mothers’ experiences of starting out with the milk ladder, the 
information they received from HCPs during the process, and the support (or lack of) that 
they received to implement the milk ladder. At the start of the milk ladder journey mothers 
were not familiar with it, and, understandably, looked to HCPs for information about the milk 
ladder and how to implement it. However, mothers commented that during the initial 
consultation they were not given sufficient time to become familiar with the new 
information provided for the baked milk reintroduction or to ask questions regarding this 
process. A sheet with the milk ladder and written guidelines on how to complete this process 
were given, but mothers felt they needed more time to digest all the information, to 
understand how it can be used and how they could go through the milk ladder step by step. 
Mothers described their experience as follows:  
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“I was given the paper of the milk ladder when we had got the consultant and dietitian 
appointment. We had limited time for a quite lot of information to be shared, so I left not 
knowing how long to spend in each level of the milk ladder and I did not have access to anyone 
to get an answer to that.” (q3, non-IgE CMA) 
  
‘Our dietitian provided us just some basic things ….she actually gave us a sheet with the twelve 
step milk ladder and advised us to go through very slowly with this. She said all the information 
is written on the paper and if I had a problem to contact them by phone’ (q21-IgE mediated 
CMA) 
Some participants expressed their preference for a follow up plan that could give them the 
opportunity to be educated by healthcare professionals and get as much information as they 
could regarding the development of their children’s milk tolerance via the gradual 
reintroduction of baked milk foods. Some of them mentioned that there was a lack of dietetic 
support for allergy management in their hospital or community setting, and there were long 
waiting lists for allergist/paediatrician appointments in the clinic. They complained that the 
milk ladder is a long process and they required further health care services support either via 
phone or email to feel confident with this process. Mothers expressed their disappointment 
as follows:  
 
“We had an annual paediatric consultant appointment. So, for two years we managed to see 
the consultant. Unfortunately, our dietetic services, there should be five dietitians but there is 
not anyone in post.”(q3, non-IgE)      
        
 “The support is still there with the dietitian b# 
#ut is more driven by me ... so if I contacted them saying okay we just tried the milk ladder and 
had a reaction they are like okay fine stay and try again for another six months but they are 
not very proactive… anymore ... in terms of contacting us... review things... which makes me 
feel quite isolated.”(q14, non-IgE) 
 
“I think that they actually could plan for us to go back again but nobody contacted us about 
it.” (q10, IgE CMA)       
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Hence, the limited time during the initial consultation seems to be a barrier between the 
communication of mothers and healthcare professionals about the milk ladder. Although 
mothers were provided with written guidelines, they realised at home that additional 
practical information was required. For the majority of mothers, the baked milk introduction 
was a difficult and long process and they felt that further healthcare support, either in the 
form of follow-ups or phone/email contact would be incredibly helpful. In essence, the 
mothers expressed an experience of loneliness and lack of support for managing the milk 
ladder process. They felt inexpert at managing this process, but could not gain regular access 
to dietetic support for working with the milk ladder.  
 
 
Subtheme 2: Which ladder, and when to stop and when to climb? 
Following on from the lack of ongoing support for implementing the milk ladder, mothers 
also expressed their experience of disconnect between the theoretical implementation of 
the milk ladder and the reality. While they initially found the information that they have 
given by healthcare professionals clear, when they started the milk ladder, they found it 
difficult to implement in practice. For example, it wasn’t always clear to them how and when 
to move between the stages of the milk ladder.  
 
“I thought it was clear ... but then when we intended to do it ... then actually I realised that it 
was not particularly clear in terms of how long you leave between you know moving to each 
stage... and how 
much you give for how long… so it has been quite trial and error … specifically to my little boy 
and how he reacts to make sure going slowly enough for him … does that make sense?” (q14, 
non-IgE CMA) 
 
“Our dietitian provided us with some basic things. She gave us a sheet with the twelve-step 
milk ladder and advised us to go through very slowly with this. She said: the information is 
written on the paper and if I had a problem to contact them by phone or email…..” (q21, IgE 
CMA)    
 
Due to the lack of communications with healthcare professionals highlighted in subtheme 1, 
some participants joined support groups in social media to find answers to their queries. 
Some mothers mentioned that the use of social media was an excellent way to gather 
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information for the milk ladder and food reintroduction. They had the opportunity to discuss 
their concerns or queries with other parents who had similar experiences and obtain 
practical solutions for any issues that arose during the introduction of baked milk products. 
Interviewees believed that mothers who had used a milk ladder plan had better experience 
and could provide better help during this long process than could healthcare professionals. 
They felt that someone needs to have first-hand experience of implementing a milk ladder 
to really understand what it involves: 
 
“ Not at all ... What I had was from the CMPA charity that I joined... that’s the only support ... 
And that’s fantastic support because all moms that have been through it or are going through 
it and they know more they seem to know more than doctors and other professionals … I think 
you have to experience it yourself to totally understand it” (q2, non-IgE CMA)  
 
Mothers commented that they were aware of the different types of milk ladders, and several 
participants attempted to complete different milk ladders to identify which ladder could 
benefit their children.  They reported that HCPs recommended alternative versions of a milk 
ladder. For instance, some mothers reported that their healthcare professional provided 
them with the 12-step milk ladder that worked better for their children’s desensitisation 
compared with the 4 or 5 stages milk ladder. In particular, they expressed this as follows: 
 
“We received a different version of the milk ladder initially from the dietitian, which was only 
5 steps.  We didn’t get the MAP version and that [the version given] failed very fast in terms of 
jumps between the stages. So, I decided to use the MAP version because my son is quite 
allergic. He reacts to very small amounts of milk...” (q14, non-IgE CMA)  
 
“There are differences between milk ladders, and this is very confusing. It should be one 
standard milk ladder that all hospitals within the country should follow because this is so 
confusing. (q6, non-IgE CMA)   
 
Mothers with IgE-mediated CMA children said that they used a milk ladder to introduce 
baked milk foods into the diet of their child and they were confused with the different 
version of milk ladders and they did not know which milk ladder was more suitable for their 
child. However, according to the iMAP guidelines the milk ladder can only be followed by 
infants and children with a mild to moderate non-IgE-mediated CMA (Venter et al., 2017). 
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There is still no evidence that supports the use of the milk ladder in IgE-mediated CMA that 
may result in severe or immediate type allergic reactions. HCPs usually rely on BSACI 
guidelines that suggest the use of a milk ladder with caution at home (Luyt et al., 2014).   
 
“The difficulty is that I found that it has been varied in the types of milk ladders. There is not 
just a generic milk ladder, there is one that has got 12 steps, and there is one has got 4 or 5 
steps. And then the difficulties that I got is that for now she is on stage 2 in a milk ladder or 
stage 3 according to different type of milk ladder… I suppose my main concern is that it doesn’t 
seem like a standard milk ladder, everyone uses their own milk ladder and it doesn’t feel that 
there is enough information to go with it.” (q7, IgE-CMA)  
 
Hence, the experiences of these mothers are that following a milk ladder can be a confusing 
experience complicated by the existence of multiple different milk ladders. Moreover, the 
mothers were often not sure how to know when to climb the milk ladder by moving onto the 
next stage. The lack of sufficient information regarding the BM-reintroduction led mothers 
to seek advice from sources such as social media or other parents with CM allergic children 
and even to switch to a different milk ladder than that given to them by their HCP. The 
majority of mothers found support in social media such as Facebook/Instagram instead of 
healthcare services because they needed additional information to increase their 
knowledge, for instance regarding the amount of milk protein in the BM product, time spent 
in each step, alternative/equivalent food options in milk ladder and recipes. This perspective 
emphasises the need to improve healthcare support during this long period of baked milk 
introduction and ensure not only the efficacy of the milk ladder approach but also the safety 
of this procedure. Another important issue indicated by these results is that mothers felt 
confused with the different versions of milk ladders and expressed that they would have 
preferred a standardised approach for the baked milk foods reintroduction with standard 
guidelines that could optimise the milk ladder process in terms of practicability, acceptability 
and safety for their children.    
 
Theme 2: Introducing baked milk at home: Inexpertise and anxiety 
Mothers described great apprehension about introducing baked milk at home. Generally 
speaking, they described the concerns they had about their ability to recognise potential 
allergic symptoms during reintroduction of baked milk foods into their child’s diet. They were 
also concerned about how they could cope and manage an allergic reaction at home. 
 
 
116 
 
 
Subtheme 1: Discriminating between a reaction and an illness 
Mothers described their lack of knowledge or criteria to help them to distinguish between 
an allergic reaction and an illness. They also highlighted that several allergic symptoms are 
similar with common conditions in infancy or early childhood and that this could be 
confusing. For example, mothers said it was very hard to distinguish the difference between 
an allergic reaction and a cold or teething because some symptoms seemed so similar and 
their children were too young to provide a detailed description of their condition. They felt 
that the management of allergic reactions during food trials should be based on recognition 
of symptoms and not on assumptions of them. They discussed that a list with a description 
of potential symptoms during reintroduction of baked milk food would help them in 
identifying symptoms and providing better care for their children. Some mothers expressed 
this as follows:    
 
“Sometimes we think like you know gastro- symptoms could be caused by different things. We 
don’t really know…just guessing a lot…..”(q5, IgE-CMA) 
 
“It would be very helpful if we could have a full description of the potential reactions when we 
are doing the milk ladder.”(q18, non-IgE CMA)    
 
“I felt that we would be unable to identify if he was having a reaction to the milk ladder trial 
or to an unidentified allergen…Between the ages of 12-24 months there wasn’t really a time 
where he was settled and not suffering either with a food related reaction, teething or 
cold/viral illness so during this time I didn’t attempt the milk ladder.”(q22, non-IgE CMA)  
 
 
Other parents had to deal with the balance between milk ladder step up and step back based 
on side effects of milk containing foods.      
 
 “…the symptoms that we look for in order to know whether or not to proceed…Sometimes, 
they are not specific, and they are difficult to separate from another…The actual impact for a 
child with an IgE CMA is looking for symptoms in order to know that it could conflict with the 
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next step up is difficult because the symptom is so difficult to be clear….so, it is quite difficult 
for me as a parent.” (q5 IgE CMA) 
 
Hence, the recognition of symptoms during an allergic reaction to a baked milk containing 
food was not clear from mothers’ perspective. They need education how to recognise and 
manage symptoms through the milk ladder process.      
 
Subtheme 2: Making them poorly to make them better 
Mothers described the fears and anxiety they experienced during their children’s milk 
reintroduction, due to the possibility for allergic reactions. They felt responsible for any pain 
caused to their child and found it incredibly difficult to observe their child in pain.  Mothers 
described feeling nervous and anxious because they observed their child suffering symptoms 
after baked milk food consumption; a situation in which they felt helpless to provide 
appropriate care.  
  
“Yes, it makes me very anxious, it makes me nervous. I feel sick because I know I am potentially 
giving a substance that is going to make him very poorly and then if he reacts and he did react 
we have to watch him in pain…”(q6, non-IgE) 
 
Some mothers assumed that their children avoided eating the trial food because they 
associated discomfort or pain with this food. The young age of children was another 
important barrier between the communication of mothers and children. Following an 
unsuccessful baked milk food trial, some parents with young children were reluctant to 
engage with the milk ladder and avoided re-attempting food reintroduction. They reported 
that it is very hard for them to expose their children to pain:     
 
“He is too young to communicate so he could be crying because he is in pain or he could be 
crying because he is teething or because for any other reason…it is very difficult for me. At 
present the milk ladder should be left until he is an age that he can talk and he can tell that 
there is pain or feels uncomfortable. I don’t want to put him back in pain until he is able to 
communicate with me. As mum I don’t want to put him through a pain again.”(q6, non IgE 
CMA)   
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Mothers further commented that they felt distressed because they had already experienced 
their child’s allergic reaction prior to diagnosis. Some mothers were nervous in the first steps 
of the milk ladder and when they became more familiar with the process they felt relaxed 
with the good progress of their children.      
 
“I felt guilty for feeding these foods and causing his suffering. The more we failed the more I 
became stressed with labels on food and anxious about reintroducing…I figured out what I was 
doing but psychologically it was hard. I had to tailor the ladder attempts to my son. Instead of 
trying for three days then moving on, which is what I was told to do, I noticed my son would 
react anywhere from six hours with hives or tummy pain to seven days with eczema. By day 5 
the reaction was appearing even when I stopped then it was still causing reactions and would 
take weeks to manage his skin. I learned to try one meal wait a week. Then try another meal 
and wait a week, try a meal again and every other day if ok after that third week consider a 
pass. It took longer but in the long run this worked better for his skin as I could manage it 
quickly when we failed a step” (q20, non-IgE CMA) 
 
“I was also anxious to feed my child something that I know has previously caused him a great 
deal of pain, discomfort and suffering…I worry that if I continue to attempt the milk ladder and 
it continues to cause pain then my son would develop a food aversion.” (q22, non-IgE CMA)   
 
Hence, mothers were reluctant to engage with the milk ladder and believed that it would be 
better to attempt this process later when their children will be able to communicate and 
express properly their discomfort.  Interestingly, some mothers reported that their children 
associated pain with the challenge food and avoided eating this food. These mothers 
reported being satisfied with the milk- free dietary plan, and they did not want to expose 
their children to a painful process and potential risk of allergic reaction by introducing BM-
products. Most of these children had experienced severe reactions and their mothers did not 
want to see them to suffer from reactions once more. 
 
Subtheme 3: Preferences on the milk ladder setting (hospital/home)  
 
Mothers with non-IgE mediated-cow’s milk allergic children were aware that their children 
were not at risk of severe reaction and found home to be a more convenient place for the 
baked milk introduction.   
 
 
119 
 
 
“I think he would panic... I think trying at home is better... unless they have a severe reaction. 
I think if you can do it at home it is better for the child, that’s unless yeah there is really severe 
reaction. I would prefer my boy to be here.” (q16, non-IgE-CMA) 
 
“…[I] feel comfortable that we did it at home but if I had had any concerns i.e. anaphylaxis I 
would have requested a hospital trial” (q18, non-IgE CMA) 
  
However, mothers of children with IgE mediated- cow’s milk allergy appeared to experience 
increased anxiety with home-food reintroduction compared to those mothers that had the 
opportunity to challenge their children in hospital. Those whose children were challenged in 
hospital preferred the safety provided by a hospital environment because they did not feel 
confident to manage any potential severe reactions at home.   
 
“I think if I hadn’t done it at the hospital, I would be really anxious about whole thing. And the 
fact we only do it in hospital gives me confidence and I know they are doing it. I know people 
in other authorities they need to do it at home.” (q12, IgE mediated CMA) 
 
“Actually, I would prefer a challenge for my child in the clinic and I cannot understand why they 
didn’t offer us a challenge in the hospital. During his first food trial at home I was watching his 
progress with a vigilant eye and thinking how to cope with any potential reaction…I felt really 
scared and so nervous.” (q19, IgE mediated CMA) 
 
Hence, different opinions were stated by mothers regarding the appropriate place for the 
milk ladder to be conducted. Mothers with non-IgE mediated milk allergic children had a 
different opinion regarding the setting (hospital or home) for the initial food trial of each 
step of the milk ladder compared to mothers who had children with non-IgE mediated CMA. 
Mothers of children with non-IgE mediated CMA were confident with the milk ladder process 
at home, due to their child having less severe reactions to baked milk. Mothers of children 
with IgE-mediated CMA were aware that there was a risk of a potential severe reaction to 
baked milk and wondered why the allergy healthcare services did not offer an initial baked 
milk challenge (each food of the milk ladder to be challenged firstly at hospital before it is 
introduced at home) in hospital.         
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Theme 3: Living with the milk ladder: making it work 
This theme describes mothers’ opinions regarding the practicability and acceptability of 
foods included in the milk ladder. The lack of flexibility in the foods to be used at each stage 
of the milk ladder made it very difficult for the mothers to implement the milk ladder in the 
face of the demands of real life with a young child. They described many difficulties in 
adapting the milk ladder to their child’s and family’s needs due to the very limited range of 
foods described in the milk ladder. However, they also described benefits to their child and 
their family once they started to progress through the milk ladder, and the restrictions of a 
diet free from cow’s milk were gradually removed. 
 
Subtheme 1: Balancing the rigidity of the milk ladder with the demands of real life 
There were a range of challenges that the mothers described when they came to implement 
the milk ladder. In particular, they described challenges that appear to relate to a mismatch 
between the rigidity of the foods given at each stage of the milk ladder, and the demands of 
real life with a young child. For example, most mothers expressed concerns about the 
amount and quality of baked milk foods such as biscuits, cakes, muffins, pancakes, pizza, 
chocolate buttons etc. used in the milk ladders. They were concerned that these foods are 
high in sugar, fat, and salt (according to paediatric healthy food guidelines, these foods 
should not be given in large amounts or with great frequency). Some had worked hard to 
cultivate healthy eating habits in their child, only to be faced with offering them what they 
felt were large amounts of unhealthy foods in the milk ladder. Mothers expressed their 
concerns as follows:  
 
“The most frustrating was the choice to start with unhealthy…we had such a healthy diet for 
her...I remember on day 8 she looked to me and said “Mummy, this is too many biscuits… 
though you know we hadn’t biscuits. I understand that 2 or 3 biscuits are high fat and high 
sugar diet and she hadn’t had anything like that before... I would like to see 3 or 4 suggestions 
per step and including some healthier options of food based on lower sugar.” (q3, non-IgE 
CMA) 
 
“If a child eats even a chocolate muffin for every day for three weeks it is not good for them. 
And I find a lot of food in the milk ladder as well, at the bottom anyway, they are all very sweet. 
I suppose now to be in the stage that we have to give her all these cakes and biscuits and stuff. 
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Even that have milk she really does not feed very well, but I don’t think we have any other 
option.”(q7, IgE CMA)  
 
Mothers whose children also had allergies to other foods commented that foods in the milk 
ladder do not always cater for concomitant food allergies and that this could make it 
particularly challenging for them to integrate into their child’s diet:  
 
“For the milk ladder even we had not completed the stage 1…that I found it very complicated 
at all, just because you know he’s got so many allergies and I am not just looking for the dairy, 
I am looking for soya, I am looking for lecithin which is a stabilizer for many products 
anyway…”(q6, Non-IgE CMA) 
 
“So basically, she can eat mini muffins now but the problem that I got is that there are a lot of 
milk ladders that contain egg, so I really struggle and the stage for now to give her a wide 
variety of things that comes in that specific level because they got a lot of egg in.  They need 
to give options to the people who have problems with dairy and eggs, give options to people 
who perhaps, I don’t know, have problem with soya. Because soya is a massive problem, we 
haven’t an issue with soya - but some people do.”(q7, IgE CMA)  
 
Some mothers also described the challenges that they had experienced in getting the milk 
ladder to work when their child was not keen to taste the foods prescribed in the milk ladder. 
When this happened mothers described that they had struggled to find alternative food 
options.  
 
‘My son is not happy with sweet taste of foods, he refused biscuits, cakes, and snacks like 
that.…I didn’t have other food options in the first steps of the milk ladder. For example, he loves 
savoury snacking’….. q21, IgE-CMA           
 
Mothers also found it difficult to identify equivalent foods that they could use at the 
appropriate stages of the milk ladder adding time and complexity to their food shopping. 
They noticed that the process of identification of equivalent foods in the shops was time 
consuming and, furthermore, that often it was impossible to find equivalent or alternative 
foods. In addition, mothers reported that the information provided in the food labels of the 
products were not comprehensive and sufficient to help them to make proper food choices. 
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For instance, terms such as milk powder/semi-skimmed milk/whole milk/casein/whey 
confused mothers because they didn’t know which of them was suitable for their child. 
Furthermore, they highlighted that many food labels don’t clarify the amount of milk protein 
present in a product.   
 
“I get really quite irritated about being in the supermarket and looking labels all the time. My 
daughter spends the majority of her life in the supermarket and I am looking at labels.” (q7, 
IgE CMA) 
 
“Take a packet of biscuits. Reading and reading the packages takes long. This takes too much 
time and I am frustrated, and I need a biscuit that contains milk, no wheat powder and is right 
for the milk ladder step.” (q3 non-IgE CMA) 
 
‘When I started to go and buy digestive biscuits, stand in the shop and pick up all the packets 
some didn’t have any milk, some got milk powder, some soya milk, some of them had whey 
powder, and I would stand up in the shop for a long time and they didn’t give you that 
information. That was what I found out so I have to be back and think what I have to buy. If 
you add brands on the milk ladder which again it couldn’t be probably allowed to but at least 
everybody knows what they use….’. (q12, IgE-CMA) 
 
Some mothers therefore suggested that it would be useful for some food brands to be added 
in each step of the milk ladder to help the select correct foods for the appropriate step, and 
to save time when food shopping. 
 
When preparing their own foods for the milk ladder, mothers were also frustrated with not 
having been provided with meal recipe ideas that clearly detailed the appropriate 
temperature and time of heating according to each step of the milk ladder.  
 
“It would be really helpful if in the information that they gave you it said “when you make these 
things make sure that heating them to e.g. I don’t know 250 C. That’s all they need to do, they 
need just to put cooking information in a leaflet and if would make it simple. It really would be 
helpful to have alternative products in a list. Even I use a Facebook group support occasionally 
for a few suggestions but I need a comprehensive list.”(q3 non-IgE CMA) 
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“…when we get the stage 3 they need to be specific about the temperatures, it needs to be 
clearly labelled on the leaflet. So, I wasn’t given any recipes by the dietitians, the only recipes 
that I come across had been through on my research on the internet and by joining different 
groups on Facebook where people share information. If I hadn’t done that then I would not 
have any idea how to progress.  Actually, a lot that I learnt about the milk ladder comes 
through my research and through my group.”(q7, IgE CMA) 
 
Hence, mothers felt disappointed with several food options in the milk ladder and they found 
it very difficult not only to feed their children, but to convince them to consume these 
products. An improved milk ladder should consider a concurrent food allergy such as wheat 
or egg allergy and provide alternative and healthy food choices during baked milk containing 
foods introduction. Lack of clear instructions and additional information related to food 
labelling, baked milk food recipes, and brand names of suitable baked milk products in terms 
of milk protein content and degree of baking caused difficulties for the mothers to help their 
child to follow their milk ladder plan.      
 
Subtheme 2: Returning to normality – removing the restrictions of a dairy free diet 
Mothers perceived there to be benefits of the introduction of BM-containing foods into their 
children’s diet. They felt that even though the milk tolerance is slowly built up in their child’s 
digestive system and this process takes longer, it was worth following a milk ladder plan.  
The majority [73%] of participants mentioned that the introduction of baked milk foods into 
their children’s diet had a positive impact in the budget and social life of the family. They said 
that these products are cheaper compared with milk substitute foods and can liberate their 
children’s diet enabling them to join family during meal time and eating out. Some mothers 
expressed this as follows:   
  
“It’s cheaper to buy milk products than imitation milk products. Yes imitation 
cheese/milk/yogurt that we buy they are all more expensive per litre pot. The dairy free 
yoghurt/chocolate are really very expensive so the cost on the left seems very 
reasonable…”(q3, non-IgE CMA) 
 
“Yes, we can go out to eat more without any barrier on which restaurant he can eat in. When 
we went out we didn’t have to worry about taking lot of special allergy foods. It generally 
makes our daily life easier.” (q9, non-IgE CMA) 
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“As a family we don’t feel any more concerns about food when we go out…Just in these steps 
we are all able to join in and eat as a family.” (q11, non-IgE CMA) 
The majority of mothers discussed that they would encourage other parents to undertake to 
implement a milk ladder plan. They explained that while this process may in some cases take 
a long time to complete the beneficial effects outweigh the negative effects such as a 
reaction or the slow development of tolerance to milk. The mother quoted below had almost 
completed the milk ladder with her child, and she felt happy about having gone through the 
process and was motivated to help other mothers. She felt that it was important that a 
mother should be confident during the milk ladder process, control her anxiety and has less 
concerns for any potential reactions (non-IgE-mediated CMA) that could affect her effort and 
her child during the milk ladder implementation. She expressed as follows:       
‘I do advise quite a lot because we have almost completed it and I stay on the page to help...I 
always say go into it confident...don’t worry and stress...because you are gonna affect your 
child…don’t look for reactions because you are going to convince yourself…it doesn’t matter 
how long it takes...a lot of people go a lot slower than we did...just do what you can...just ask 
a lot of questions...and just watch for support around you...and to see where you are 
getting…there is nothing else you can do really…‘ (q1-Non-IgE mediated CMA) 
Hence, although in the subtheme above mothers described the difficulties they had 
experienced in implementing the milk ladder, there were benefits once their child began to 
progress through the milk ladder. In particular, being able to use baked milk products 
(previously off limits to their child) helped their child’s diet to become less restricted and 
more interesting and enjoyable. It also gave both the child and their family greater scope to 
engage in social activities related to foods such as enjoying meals out as a family. In addition, 
these findings show that mothers were able to worry less about their child’s diet and safety 
as their child climbed the milk ladder. Despite the practical difficulties that mothers coped 
with the milk ladder implementation, they were satisfied with the outcomes of the milk 
ladder and they would be happy to recommend this intervention to other parents starting a 
milk ladder and share their experience.     
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   5.5. Discussion 
This is the first study that has explored the impact of baked milk introduction in children with 
IgE and non-IgE CMA from mothers’ perspective.  Overall, this study emphasises the 
importance of the milk ladder’s improvement, as a tool of BM-introduction, and mothers’ 
awareness and support for them during the introduction of baked milk foods into the diet of 
their children with IgE and non-IgE-mediated CMA. Taking an overview of the findings 
resulting from the thematic analysis, three themes and seven subthemes emerged. These 
are related to the key aspects of the process of milk reintroduction from the mothers’ 
perspective (figure 5.2)    
 
 
 
 
 
 
Figure 5.2: Lack of support for implementing the milk ladder: understanding theory and 
managing reality 
•Subtheme 1: It’s one appointment, then you’re 
on your own 
•Subtheme 2: Which ladder, and when to stop 
and when to climb?
Theme 1: Understanding the 
milk ladder: a lack of clarity
•Subtheme 1: Discriminating between a 
reaction and an illness
•Subtheme 2:Making them poorly to make 
them better
•Subtheme 3:Preferences on the milk ladder 
setting (hospital/home) 
Theme 2: Introducing baked 
milk at home: Inexpertise and 
anxiety
•Subtheme 1: Balancing the rigidity of the milk 
ladder with the demands of real life
•Subtheme 2:Returning to normality – removing 
the restrictions of a dairy free diet
Theme 3: Living with the milk 
ladder: making it work
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In this section, each theme will be discussed in relation to the implications of the findings 
in the context of the wider literature.  
   
5.5.1 Understanding the milk ladder – a lack of clarity 
The main findings that will be discussed in this section is the lack of clarity of the obtained  
information and the limited time during HCPs’ consultation and the lack of follow ups during 
the milk ladder implementation.  One important finding from the mothers’ study related to 
the lack of clarity of the information that mothers received before they started to introduce 
baked milk products into the diet of their children via a milk ladder.  The findings of this 
study not only confirm that a variety of milk ladders are used in baked milk re-introduction, 
but also highlights that mothers are confused with the different versions of milk ladders.  
As has been discussed in Chapter 2 (literature review, section 2.3.2), many allergy clinics in 
the UK recommend a milk ladder protocol based on their own hospital policy. There is still 
no national agreement on the use of a standardised milk ladder based on scientific 
evidence. The main issue is that the milk ladder is not suitable for all children with CMA. 
Certain groups of CMA children should undertake a baked milk challenge in hospital under 
medical supervision because they may react to any cow’s milk protein and experience a 
severe reaction. The safety of a milk ladder intervention is discussed below in section 5.5.3. 
Other practical issues were related to the quantity and frequency of the trial food during 
the milk ladder implementation. In particular, what are the appropriate doses of the 
administered trial food (how much and how should they be giving a baked milk containing 
foods such as muffin, per day/week/month and for how long), and when is the appropriate 
time to move from one step of the milk ladder to the next one.      
 
Some mothers argued that their child had benefitted from exposure to low doses of milk 
protein over a longer period, but this argument has not yet been investigated in any 
systematic way through research. There is still a paucity of data regarding the doses used in 
BM-food trials and the time spent in each step before children move to the next step. NHS 
allergy clinics usually recommend to move on the next step on the milk ladder once the 
child is able to fully tolerate the BM-containing food in the step they are on. This means 
that the child has been able to eat the food more than once, in the quantities suggested on 
the milk ladder, without suffering any allergic reactions as a result. Sometimes, it can take 
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up to 2 or 3 days for allergy symptoms to appear after eating a food. Therefore, it is 
advisable to allow at least 3 days on a step before considering whether to continue 
the next step of the milk ladder. However, the recommendations above are based in a 
theory regarding the milk ladder and the experience of healthcare professionals. A recent 
study suggests that even when a child has successfully passed a BMC this cannot guarantee 
that the child will continue to be tolerant to the same food or will not react in the future to 
the same doses of this food at which they passed the BMC (Dunlop, Keet, Mudd, & Wood, 
2018). Hence, the number of steps in the milk ladder seems to be crucial for milk allergic 
children during BM-reintroduction because it determines the doses of a variety of BM- 
containing foods consumed by children and the time spent in each step and on the total 
process of BM-reintroduction. However, clinical trials need to assess and determine the 
optimal doses and the time spent in each step of the milk ladder before the CMA child 
moves on the next step.  
 
Mothers also experienced insecurity regarding the preparation of homemade BM-foods 
because they were not clear how long to cook the foods and at what temperature. 
Furthermore, mothers were disappointed that they did not receive any information about 
appropriate commercial BM-products that could be used at each stage of the milk ladder 
(e.g that were equivalent to the homemade BM-foods in terms of the amount of milk 
protein they contained). They also found reading food labels very complicated and time 
consuming These findings indicate that further clarification is required during consultation 
related to the practical issues of the milk ladder implementation. There is also a need for 
parents to have access to additional clear written instructions related to the quantity and 
frequency of administered food trial for each step. Furthermore, information should be 
provided that can familiarise parents with specific terms such as milk protein and to help 
them understand how much milk protein is required for each step of the milk ladder. In 
particular, specific guidance should be given to parents on how to ensure the quantity of 
milk protein contained in homemade foods, and how to recognise the content and amount 
of the milk protein ingredients in the food labels of commercial baked milk products.  
  
This research highlights that for some mothers’ social media is the main source of 
information about the introduction of baked milk products due to the limited support by 
healthcare services. Group online support seems to be easily accessible and appears to 
provide not only materials such as recipes, ideas for food alternatives, help in recognition 
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and management of allergy symptoms in baked milk food reaction, but also emotional 
support between mothers who have common concerns related to their children’s food 
allergy management.   However, mothers emphasize that in reality they would prefer better 
support from healthcare services to ensure the efficacy and safety of implementing the milk 
ladder. Current research suggests that the internet and social media have become a source 
of important information in Allergy and Immunology (Dimov & Eidelman, 2015). A 
systematic review of studies has shown that social media improves education and provides 
information for disorders such as food allergy, especially platforms such as Facebook, You 
Tube and Twitter (Patel, Chang, Greysen, & Chopra, 2015). However, the quality and 
reliability of information provided by social media regarding the management and 
treatment of food allergy are still questionable and further investigation is required to 
provide robust evidence (Dimov, Gonzalez-Estrada, & Eidelman, 2016).  
 
A combination of online support run by healthcare professionals may benefit parents and 
patients in the management of CMA. There are online educational programs led by HCPs 
that may improve parents’/caregivers’ knowledge and support them during long-term 
treatments such as the milk ladder. Online healthcare support with friendly technology 
(educational videos, online forums, and live video chats) can provide direct information and 
allow HCPs/food allergy trained educators to reach and support parents, caregivers and 
patients from distance (Ruiz-Baqués et al., 2018).  In food allergy, education is an essential 
factor for improving patients’ and their family’s quality of life. If HCPs, parents/caregivers 
and patients work together, they can enable greater trust and enhance the effectiveness of 
the treatment (Ruiz-Baqués et al., 2018).   
 
Another finding from the study is that there is a barrier between the communication of 
mothers and HCPs due to the limited time during their initial appointment in the allergy 
clinic. The majority of mothers discussed that they need more time during their visit in clinic 
to obtain practical advice and discuss any aspects related to the process of baked milk 
introduction.  This finding is consistent with a number of studies in primary healthcare 
services that have found the length of consultation varies among the countries and is 
usually determined by healthcare professionals’ and patients’ characteristics (H. Britt, 
Valenti, & Miller, 2002; H. C. Britt, Valenti, & Miller, 2005; Cape, 2002; Hutton & Gunn, 
2007; Martin, Banwell, Broom, & Nisa, 1999). The majority of these studies showed that 
the average consultation time in a primary care setting range between 10 to 15 minutes 
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while the patients reported that they preferred a longer consultation. Interestingly, these 
studies also found that healthcare professionals that provided a longer consultation 
prescribed less and offered more advice on health-promoting activities and a healthy 
lifestyle. However, the length of consultation should be individualised and adapted 
according to patients and caregivers needs. Appropriate time spent during the clinic 
appointments and especially in the first appointment could help to facilitate better 
recognition and management of health, social and/or psychological problems and provide 
enough information and advice to caregivers.  There is currently very little literature 
examining patient and parental/caregiver satisfaction with the clinic services provided to 
allergy patients. These findings highlight the need for effective communication between 
HCPs and parents during the period of milk ladder treatment. Improved communication 
could be achieved if parents were given the opportunity to contact HCPs through phone or 
email in case that they had an emergent issue such as an unexpected allergic reaction or a 
practical query regarding the implementation of the milk ladder.      
 
In addition, mothers expressed their preference for there to be a range of follow-ups from 
HCPs during baked milk introduction that would help them to implement the milk ladder. 
The mothers’ experience of a lack of follow-ups with HCPs is concerning because it suggests 
that, in these cases, there has been no assessment of patients’ recovery (e.g. stage of milk 
tolerance), no examination of parents’ concerns during the treatment, and no monitoring 
of whether healthcare professionals’ advice was addressed in the period of therapy. The 
completion of a milk ladder can involve a long process of desensitisation. Indeed, in this 
study so the mothers had been following a milk ladder for their child for more than two 
years. Where this is the case, regular follow-ups are required to monitor the growth and 
nutritional status of milk allergic children, assess the long-term effects of baked milk 
introduction, and examine milk tolerance Campbell, Park, Kueber, Lee and Hagan (2015) 
examined how a follow-up visit affects outcomes in patients who received emergency 
treatment for potentially life-threatening reactions. They found that improving follow-up 
rates can ensure that the anaphylaxis trigger has been accurately identified and patients 
had understood which allergy trigger to avoid so to reduce the risk of re-exposure to this 
allergen or prevent unnecessary food avoidance. This evidence indicates that reassessment 
and follow-ups can lead to more effective management of patients’ food allergy. This is 
because they can benefit from additional information, education and advice, and they 
receive further food allergy action plans and documentation including practical guidance 
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for social activities such as eating out, school, travelling (Campbell et al., 2015)). Thus, while 
health care follow-ups are a key part of good management of cow’s milk allergy and the 
milk ladder process, it is clear from this study that they are not always available for families. 
This is potentially dangerous, and leaves a great deal of responsibility for managing the milk 
ladder on mothers’ shoulders; something that they may not feel qualified for. Finally, as 
highlighted above, it also removes the opportunity for mothers to discuss their queries and 
concerns with healthcare professionals and get more concrete advice (in response to their 
real-life experience of trying to implement the milk ladder) about how to work with the milk 
ladder. This study found that, right at the start of the process, mothers were disappointed 
with the length of consultation and limited information provided about baked milk 
introduction by healthcare services.  
 
Hence, one of the major recommendations emerging from the findings above is that there 
is a need for improvement in quality of healthcare support as follows:  
-  Provision of detailed written and verbal information and guidance to ensure the 
safety of baked milk introduction  
- Standardisation of the milk ladder   
- Appropriate time given during clinic visits to provide effective communication 
between healthcare professional and parents about the principles and practice of 
the milk ladder 
- Adequate monitoring of milk tolerance progress, compliance with the milk ladder 
treatment, parents’ comprehensiveness during the implementation of milk ladder 
is required 
- Development of an explicit nationally-recommended milk ladder protocol that all 
healthcare professionals can adhere to, and provide standardised advice to 
parents/caregivers during the gradual milk introduction process at home 
 
The specific issues that should be addressed by HCPs and clarified with parents during a 
milk ladder intervention are as follows: the time spent in each step, options for alternative 
and healthier food choices, recipes for homemade food options, and education on the 
reading of food package labels and how to recognise allergic symptoms caused by BM-
reintroduction. Interventional research (clinical trial) is required to investigate the optimal 
doses of the food trial and the time spent in each step before the patient moves on the next 
step. Additional research is required to evaluate how healthcare services can help milk 
allergic patients and caregivers to have appropriate information and a plan to recognise 
allergic symptoms and management of allergic reactions.   
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5.5.2 Introducing baked milk at home: ‘Inexpertise’ and anxiety 
 
The main findings that will be discussed in this section is the difficulties experienced by 
mothers with regard to how to recognise and manage allergic reactions experienced by 
their child during the introduction of baked milk foods at home.  This is also linked to the 
findings around mothers’ reluctance to introduce these foods in young children who are 
not able to communicate with their parents and express their discomfort or the reason for 
crying. Furthermore, this relates to the preferences expressed by the mothers in this study 
related to the setting (home/hospital) for baked milk introduction according to the type of 
CMA (IgE or non-IgE mediated).    
 
An important finding of this study was that mothers felt nervous about giving their child 
baked milk and responsible for the symptoms caused by the challenge food. This finding is 
in line with other research in the field of food allergy that provides evidence that mothers 
may feel responsible for controlling triggers and for vigilance around their child’s diet, and 
they believe that they may have to deal with unexpected reactions in their child’s food 
allergy (Rouf, White, & Evans, 2012). The main symptoms that mothers in the current study 
observed during their child’s BM-reintroduction were eczema, loose/frequent stools, 
abdominal pain, vomiting, and sleep disturbances. Previous studies have shown nocturnal 
awakening of children affected by atopic diseases such as mild to moderate non-IgE 
mediated gastrointestinal allergies and eczema (Camfferman, Kennedy, Gold, Martin, & 
Lushington, 2010; Foong et al., 2017). There is a lack of studies investigating the association 
between food allergies and changes to children’s behaviour. An association of food allergy 
and brain activity, leading to changes in emotion and behaviour, has also been identified 
(Costa et al, 2012). Pain or discomfort caused by food allergic reaction appears to increase 
anxiety and stress in children, activating brain areas associated with emotional and affective 
behaviour responses (Costa et al., 2012). However, there is still a paucity of data in this field 
and clinical trial interventions are required to determine whether there is truly an 
association between food allergies and changes in children’s behaviour.          
  
The findings of this study indicate an association between mothers’ anxiety and potential 
reactions during BM-reintroduction. Mothers experienced distress related to the prolonged 
milk ladder process and associated symptoms during baked milk food introduction at home. 
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These findings are in line with current research evidence that indicates parents/caregivers 
with food allergic children experience increased anxiety and stress due to the unpredictable 
risk of allergic reactions and also the risks of undertaking food challenges (Lau et al., 2014; 
Shaker, Schwartz, & Ferguson, 2017).  
 
As has been reported in section 5.5.1, that mothers in this study were disappointed with 
the limited information that had received from healthcare services in terms of food labels 
on the commercial baked milk products, clear instruction regarding homemade recipes and 
alternative foods choices to meet eating habits of their children or any potential recurrent 
food allergy). In previous studies parents/caregivers have also expressed dissatisfaction 
with the labelling of allergic food products.   
It has been found that inappropriate labelling or misunderstanding of labels’ information is 
associated with parental anxiety and a risk of accidental exposures and unexpected allergic 
reactions (Ju, Park, Kwak, & Kim, 2015; Sheth et al., 2010). Parents experience increased 
anxiety in handing responsibility over to their child such as reading food labels of the 
products, doing cooking, and taking control of the food allergy themselves (Knibb & 
Semper, 2013). Another qualitative study identified that participants tended to stick to 
familiar brands/food to reduce the risk of allergic reactions. They also emphasised the 
importance of individualised advice, which takes into account psychological and 
environmental factors that may influence the food choices of parents/carers/patients in 
food allergy (Sommer, Mackenzie, Venter, & Dean, 2012). The findings of this study are in 
line with the literature that indicates that allergy healthcare services appear to provide 
limited help in the reduction of parents’ stress and in some cases, parents experience 
prolonged and increased levels of anxiety, especially when there is risk of a life-
threatening anaphylactic reaction (Akeson, Worth, & Sheikh, 2007).   
 
Hence, parents who suffer from anxiety during a milk ladder intervention should be 
supported by healthcare services for example by providing clear information about how to 
select appropriate foods. This might also help to alleviate some of the anxiety and stress 
mothers experience when following a milk ladder for their child. Furthermore, adequate 
education of parents/caregivers regarding the proper choice or preparation of BM-
containing foods may reduce their chances of making a mistake when choosing foods for 
the milk ladder, and reduce the risk of any potential allergic reaction. Based on the 
experience of mothers in this study, clear education regarding how to recognise and 
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distinguish allergy symptoms from other symptoms commonly experienced during infancy 
and early childhood, such as teething or colds, and how to identify the amount of milk 
protein in commercial milk-containing products may reduce their anxiety and stress. 
Indeed, there is evidence that educational intervention providing accurate information 
regarding how to manage the risk of allergic reactions can reduce anxiety and stress in 
mothers of children with food allergy (Boyle et al., 2017). 
  
According to the iMAP guidelines the milk ladder can only be followed by infants and 
children with a mild to moderate non-IgE-mediated CMA. It is not suitable for children with 
an IgE-mediated CMA that results in severe or immediate type allergic reactions (Venter et 
al., 2017). Although there is no clear evidence for the use of the milk ladder in IgE-mediated 
CMA, this process is recommended in children that have only cutaneous symptoms on a 
mouthful of milk allergen exposure, reducing milk sIgE and SPT and no reaction to milk in 
the past 6 months (Luyt et al., 2014). Although not a quantitative study, one of the major 
findings to emerge from this study is that from the total of seven children with IgE-mediated 
CMA only two children had an initial formal BMC in hospital and thereafter they continued 
the milk ladder at home. The rest of the children (n=5) did not have any BMC in hospital. 
Their mothers had been advised to attempt the milk ladder at home. However, mothers 
with IgE-CMA children expressed their preference for a hospital-BMC because they were 
distressed about any potential severe reaction occurring at home. Most mothers argued 
that hospital is the appropriate place for BMC because medical care could be immediately 
provided if there is a risk of severe reactions. There is still a debate over whether BM-
reintroduction can take place at home or if BMC should be performed initially in the hospital 
and, if it is successful, to then continue with the milk ladder at home. Based on the literature 
review in chapter 2, the baked milk challenge studies have reported mild to moderate 
symptoms during BMC (Bartnikas et al., 2012), while other studies have described severe 
reaction and anaphylaxis in introducing a BM-containing food (Nowak-Wegrzyn et al., 
2008). Most researchers in IgE-mediated CMA suggest that (due to the potential risk of 
severe reactions or anaphylaxis) for these patients a supervised-BMC should be conducted 
in hospital before adding BM-containing food into the children’s diet at home (Dunlop et 
al., 2018; Leonard, 2016; Mehr et al.,2014).  In IgE-mediated CMA there are still 
inconsistencies between guidelines and controversies in the literature. On one hand, 
according to HCPs survey, healthcare professionals relied on a clinical assessment combined 
with a detailed medical history and immune biomarkers evaluation before they decided the 
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setting of the milk ladder.   On the other hand, according to the findings of this study, 
mothers prefer an initial baked milk challenge for each step of the milk ladder to be 
conducted in hospital, due to the association of baked milk introduction with severe 
reactions or anaphylaxis.         
 
 
Turning to the location of baked milk introduction for mild to moderate non-IgE-mediated 
CMA, as previously highlighted, the updated international iMAP guidelines recommend 
home-baked milk introduction and the use of the milk ladder at home for these patients 
(Venter et al., 2017). In this study, mothers with mild to moderate non-IgE mediated cow’s 
milk allergic children expressed their preference for home-baked milk introduction. This is 
both because their child is not at risk of severe reaction and because the home environment 
is more convenient and friendly than hospital.  Thus, in this case, the recommended 
practice and parental preference are in clear agreement.  
 
5.4.3 Living with the milk ladder: making it work 
The main findings that will be discussed in this section is related to practicability and 
acceptability of the milk ladder in real life: (1) The lack of food variety and 
alternative/equivalent food choices to meet needs of milk allergic children such as 
palatability and cater concurrent food allergies; (2) Difficulties in identifying suitable baked 
milk products in the food shops and recognising the appropriate ingredients such as the 
content of milk protein in the food labels; (3) benefits of the milk ladder based on mothers’ 
perspectives.  
 
 The mothers described many ways in which the lack of flexibility in the milk ladder became 
challenging for them in the face of the day-to-day realities of life with young child. One such 
challenge the mothers described, was feeding their child unhealthy foods on the milk ladder 
which conflicted with their desire to raise their children to follow healthy eating behaviours. 
Mothers expressed their dissatisfaction with the quality of BM-containing foods. They felt 
some of these products to be unhealthy due to their high sugar and fat content. Some 
mothers reported that they follow a healthy eating plan for their children, and they did not 
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include sugary foods such as biscuits, muffins and cakes into the diet of their children. They 
would have preferred to have been able to offer healthier food options that would 
contribute to a healthy balanced diet improve their children’s nutritional status, and 
promote their normal growth.  
 
Currently all milk ladders distributed by the hospitals are designed only to induce tolerance 
in CMA children and they do not prioritise healthy options and the promotion of healthy 
eating habits during the short period in which it is anticipated the milk ladder is used. In line 
with this priority, the milk ladders focus only on the amount of milk protein, and cooking 
time and temperature in order to improve children’s tolerance to milk containing foods. 
However, some mothers described that they had been following the milk ladder for more 
than 2 years (i.e. in these cases the milk ladder could not be considered a short-term 
intervention). Children’s eating patterns, food preferences, and eating behaviours are 
developed during the first years of life. Thus, in early childhood, children learn “what”, 
“when” and “how” to eat. Furthermore, the establishment and formulation of food 
preferences in early life influences nutritional habits in adolescent and adult life (Anzman-
Frasca, Ventura, Ehrenberg, & Myers, 2017). According to the review of current literature, 
however, no research has assessed the growth and development of children who have 
completed a milk ladder plan. Further research is therefore required to investigate if there 
is an association between refined sugary and fatty foods of the milk ladder and obesity in 
children who completed a milk ladder. However, there is certainly the potential that the 
regular consumption of unhealthy foods as part of the milk ladder may set up unhealthy 
eating behaviours in the longer-term, which could have an effect into adulthood.  Hence, 
this finding indicates that the milk ladder should be designed in a way that promotes 
healthy eating habits and includes a variety of healthy and alternative food options 
especially when it is used long-term so to ensure the normal growth and development of 
children.   
 
It is interesting that despite all the challenges mothers described with understanding and 
implementing the milk ladder, and the concerns and anxieties they experienced, those that 
had persevered with the milk ladder felt that the process was overall worthwhile.  The 
findings of the study highlight that the re-introduction of BM-containing foods had a 
positive impact in the diet of their children. This was because it increased the variety of 
their diet, improved their social life by enabling them to eat out without fears,  and reduced 
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the expense incurred buying dairy free products. Mothers highlighted that the 
incorporation of baked milk foods seems to be safe and well tolerated in general.     
   
Hence, according to mothers’ perspectives, the milk ladder intervention has a negative 
impact on the quality of the diet of their child related to the introduction of foods with high 
sugar and fat content, palatability and appropriateness, and suitability of these foods for 
concurrent food allergies. These findings suggest that the milk ladder should be improved 
by offering healthier food options, equivalent or alternative foods in case of palatability 
issues or concomitant food allergies. A list should be provided including brand names of 
suitable baked milk products and homemade recipes with all appropriate information 
regarding the content of milk protein in the baked milk containing food, time and 
temperature of baking, and alternative/equivalent recipes for homemade baked milk 
containing foods so that to meet any needs for concurrent food allergies.  Despite the 
practical difficulties, limited healthcare support, and stressful process, the majority of 
mothers were willing to encourage and support other parents that attempted to implement 
a milk ladder plan.   For them, the positive impact of the milk ladder intervention was 
associated with a less restricted milk diet and the possibility for children to enjoy foods in 
birthday parties, eating out, and join family meals. 
    
5.5.4 Implications of the findings for practice  
Understanding parental perceptions is of the utmost importance to ensure the validity of any 
future guidelines regarding the safety of BM-reintroduction in IgE-mediated CMA and 
improvement of the existing milk ladder for an effective dietary management of mild to 
moderate-non-IgE mediated CMA. It will also enable more appropriate dietary advice to be 
given to parents/carers of children who will be candidates for baked milk challenge or a milk 
ladder plan in the future. Additionally, the information from this study is expected to help 
allergy services and healthcare professionals to provide optimal care to children during 
baked milk challenges or gradual reintroduction, and may contribute to standardisation of 
these procedures/protocols. 
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5.5.5 Strengths and limitations 
The study has a number of strengths. Firstly, this is the first study that provide prospectively 
collected data regarding the impact of BM-reintroduction at home. The choice of a 
qualitative research approach to collect and analyse data for this important topic provided 
valuable information and an in-depth understanding about the needs of mothers that 
introduce BM-products into their child’s diet at home. During the semi-structured interviews 
mothers felt relaxed to tell the story regarding their BM-reintroduction journey. This allowed 
mothers to discuss what difficulties they had, what they found useful, what improvements 
could be applied to help their children to achieve a milk ladder completion, what symptoms 
their children experienced, and what additional information and support they require. 
Participants not only answered all the questions but also participated in a productive 
discussion providing a valuable data. Participants were aware that this was a PhD study and 
the student researcher is based only in the University of Portsmouth and she does not work 
as an allergy dietitian in a clinic. It was mentioned to avoid any obliged positive responses 
and it was also emphasised that their valued honest responses would be appreciated and 
contribute significantly in this research.  
The sample size was representative and homogenous and involved the two types, IgE-
mediated and non-IgE-mediated of CMA. It also included participants that had completed or 
found in different steps of the milk ladder obtaining information for mothers’ experience in 
different stages of the milk ladder. According to this methodological approach, information 
has been obtained for mothers’ experience at the first steps, in the middle and completion 
of the milk ladder.   
There are some limitations of this study that have been considered. Firstly, although both 
parents were invited via the post advertisement, only mothers consented to participate in 
the study.  However, this was understandable; during our discussion in the interviews it was 
clear that mothers had taken the responsibility for managing the BM-reintroduction and the 
dietary care of their milk allergic child. They spent time to prepare/or identify suitable BM-
containing foods for the trials, searched and gathered information via social media, and 
visited the allergy clinic to discuss with HCPs their child condition.  
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Secondly, this qualitative study had limited diversity, as most qualitative studies. The findings 
may not be generalizable to other populations because the majority of participants had 
similar social-economic, educational, and ethnic background.  However, interviews have 
been conducted from across England, representing mothers with access to a variety of levels 
and types of allergy support. Finally, mothers had a busy schedule (part time/full time work, 
responsibilities for housekeeping, care of their children/or their siblings) and some 
interviews were conducted during their lunch break at work, at home late at night when their 
child was sleeping or in the morning with their child/and siblings, so some unexpected 
interruptions took place that might influence not only the way of interviewer’s questioning 
but also the interviewee’s responding.   Hence, some interviews were rescheduled to another 
time or day suitable for mothers to deal with this issue. Mothers also were asked to contact 
me via email or phone if they wanted to add any further information.   
5.5.6 Conclusion   
This study has, for the first time, examined the experience of mothers of children with CMA 
who had introduced BM-containing foods into their child’s diet; any healthcare support that 
mothers had received during their attempting to introduce these foods; any difficulties that 
they had during this approach; what symptoms their children experience in the re-
introduction of BM-containing foods and the additional support that they would like to have 
during the BM-reintroduction.  
Mothers experienced concerns regarding: the lack of awareness on practical guidelines 
based on evidence for the BM-reintroduction and training in the recognition of symptoms 
and management of their child’s milk allergy; the confusion caused by the use of different 
version of milk ladders; the quality of care provided by healthcare services during the BM-
reintroduction; the BM-reintroduction at home for children with a milk allergy that results in 
severe or immediate type allergic reactions known as IgE-mediated CMA; the quality of food 
options to ensure a healthy balanced diet during the long process of the milk ladder; and the 
lack of alternative/equivalent food options to cater concomitant food allergies or other 
preferences of children.  
This could be rectified by providing further follow ups in allergy clinic or contact with a HCP 
by phone or email and a list with a description of common symptoms during BM-
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reintroduction and of alternative healthier food options including branded foods to help 
parents to choose appropriate BM-products.   Gradual milk reintroduction is usually a long 
process and the findings from this qualitative study suggest that mothers need an improved 
milk ladder based on national recommendations, and local healthcare support, to ensure the 
efficacy and safety of this process. Mothers need training and education to recognise and 
distinguish allergy symptoms from other common paediatric conditions such as teething, 
colic, or colds. Practical guidance on how to read food package labels and identify the 
suitable products for the gradual milk reintroduction and also a list of recipes with 
homemade BM-containing foods would ensure mothers follow and complete this process in 
a proper and safe manner. Finally, further research and clinical trials are required to 
investigate the appropriate doses of challenge foods in the milk ladder, the time spent for 
each step during BM-reintroduction for the optimal milk tolerance achievement and the 
appropriate place for the BM-food trials in IgE-mediated CMA to reduce uncertainty and 
anxiety of mothers and enhance the safety of this approach.  
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Chapter 6. A quantitative research study: Can immune 
markers predict milk challenge outcomes in children with 
IgE-mediated CMA? 
6.1 Overview  
Understanding of HCPs’ and parents’ attitudes could help to improve the efficacy and safety 
of a baked milk introduction. However, these studies did not provide data regarding the 
appropriate time of a baked milk introduction. Especially, parental study indicated an 
emergent need of the appropriate time of baked milk re introduction not only to identify 
children able to tolerate baked milk foods but also to avoid an unexpected baked milk allergic 
reaction. According to the systematic review in chapter 2, the evaluation of immune markers 
may provide information on the appropriate time of a baked milk introduction.   
  
The overall aim of this chapter is to assess if immune markers such as SPT and milk sIgE can 
predict milk challenge outcomes and if it is possible to establish a cut-off for sIgEs and SPTs 
to CM, that could predict whether a child with IgE-mediated CMA would react to an oral milk 
challenge. The literature review in Chapter 2 highlighted a variability of the suggested cut-
off values for SPT and milk sIgE to predict milk tolerance, due to different statistical methods, 
age of participants, different type/form of allergen. Therefore, no clear proposed cut-off for 
SPT and milk sIgEs for predicting milk challenge outcomes have so far been determined 
(Caubet et al., 2013; L. Ford et al., 2013).  This chapter examines the sensitivity and specificity 
of the immune markers versus milk challenge outcomes by analysing retrospective data from 
a prospectively collected cohort of paediatric patients seen in Cincinnati Children’s Hospital 
Medical Centre (CCHMC). Statistical analysis used Receiver Operating Characteristic curves 
to examine the ability of SPT to fresh milk and milk extract and also IgE to milk allergen, total 
IgE, IgE casein, and IgE β-lactoglobulin to predict baked or unheated milk challenge 
outcomes.  
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6.2 Background  
6.2.1 Rationale of the study 
Diagnosis of milk allergy is difficult in children. In clinical practice HCPs use several methods 
that include medical histories, clinical examinations, skin prick and serum-specific 
immunoglobulin E (IgE) tests, food challenge, and supervised elimination diet in order to 
properly diagnose CMA (du Toit et al., 2010). The clinical history of symptoms is the 
cornerstone of the initial diagnosis of CMA and it can be supported with the results of SPT 
and milk sIgE testing. These allergy tests and oral food challenge are used to describe food 
sensitization patterns, cross-reactions, and to aid in the diagnosis of a food allergy.  These 
tests may also help to indicate and determine if the milk allergy has been resolved (Luyt et 
al., 2014).  The milk sIgE antibody is produced as an immune response to the allergen, in this 
case milk proteins, and it can be measured using enzyme-linked immunoassay (ImmunoCAP, 
Phadia, Upsala, Sweden) which is approved by the Food and Drug Administration (FDA)(Ewan 
& Coote, 1990).  
Current research indicates that both allergy tests, SPT and sIgE, show a good sensitivity (the 
probability that a test will indicate 'disease' among those with the disease) but a low 
specificity (the fraction of those without disease who will have a negative test result) 
(Kianifar, Pourreza, Jabbari Azad, Yousefzadeh, & Masomi, 2016). In other words, a positive 
SPT/increased milk sIgE levels does not necessarily prove that the test results are clinically 
relevant. For instance, if the CMA diagnosis is based only on the SPT or sIgE test, children 
without milk allergy may undergo an unnecessary milk elimination diet.  Although an oral 
milk challenge remains the “gold standard” test for the confirmation of the CMA diagnosis, 
researchers are currently attempting to identify valuable biomarkers that could confirm the 
initial diagnosis or predict tolerance to milk. This is due to the fact that an oral milk challenge 
is an expensive and time-consuming process, and there is a potential risk for severe allergic 
reactions (Bartnikas et al., 2012).    
The review of the literature presented in Chapter 2, (section 2.3) identified a few studies 
which highlighted that clinical tolerance to baked milk has been associated with negative SPT 
measurement to baked milk and low levels of serum milk specific IgE levels in IgE-mediated-
CMA (Bartnikas et al., 2012; Ford et al., 2013; Nowak-Wegrzyn et al., 2008). They found that 
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the larger the wheal size of the SPT and the higher the serum milk sIgE levels the greater the 
possibility that children would react during the milk challenge. More recent studies have 
drawn conflicting conclusions on the value of skin prick tests, serum IgE, and age, as 
predictors of oral milk challenge outcome. Rolinck-Werninghaus et al. (2012) found that 
serum food IgE level, young age, and history of eczema, were predictors of a positive food 
challenge to milk (Rolinck-Werninghaus, Niggemann, Grabenhenrich, Wahn, & Beyer, 2012).  
However, there are not yet established SPT/milk sIgE diagnostic cut-off values able to predict 
milk tolerance without the need to perform a milk challenge.  
Published data indicates that serum food sIgE equal or less than 0.35 kUA/L achieves optimal 
negative predictive value for food allergy and a wheal average diameter of 3 mm is generally 
considered as a positive SPT cut-off value in clinical practice (García-Ara et al., 2001;Van der 
Valk et al., 2015).  However, no standardised cut-offs values and clear laboratory criteria exist 
to predict which (and at what age) children are more likely to pass a repeat (re-introduction) 
milk challenge. According to the reviewed studies in chapter 2, SPT and sIgE cut off values 
may be influenced by the age, the degree of cooking of the food (raw or baked) and the type 
of allergen used to perform a SPT (commercial extract vs. raw milk) (Bartnikas et al., 2012; 
Ford et al., 2013; Turner et al., 2013). Consequently, diagnostic/predictive tools such as SPT 
and sIgE testing cannot yet replace oral milk challenges due to conflicting published data and 
this important field needs further research. This study aimed to analyse an existing dataset, 
which was prospectively collected, and assess if SPT and milk sIgE can predict milk challenge 
outcomes and if it is possible to establish a cut-off for sIgEs and SPTs to CM, that could predict 
by itself whether a child would react to an oral milk challenge. Monitoring these allergy tests 
may provide valuable information for the appropriate time of a gradual milk reintroduction 
or milk ladder and the timing of milk tolerance development that would be extremely useful 
in daily clinical practice and might help to avoid an unnecessary milk elimination diet for 
children.      
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6.2.2 Aims and objectives  
This study had the following aim and objectives: 
Aim: To assess immune markers (SPT, milk sIgE) prior to baked or unheated milk challenge 
and evaluate if there is an association between these immune markers and milk challenge 
outcomes in children with IgE-mediated CMA. 
Objectives: As a part of a larger quantitative study, data was extracted and analysed 
regarding the immune markers and milk challenge outcomes of children diagnosed with IgE-
mediated- CMA  
6.3 Method 
6.3.1 Study design  
A subset of retrospective data that was collected prospectively was analysed, from a larger 
research project referred to as a “chart review” being coordinated by the CCHMC. This 
research project has been given approval by CCHMC’s Institutional Review Board (appendix 
16) and there was a data transfer agreement (appendix 17) between the CCHMC and the 
University of Portsmouth. The Science Faculty Ethics Committee (SFEC) of the University of 
Portsmouth recommended that there was no need to undertake a secondary ethical review 
at University of Portsmouth.  The decision letter of the SFEC is attached in the appendix 18. 
6.3.2 Data collection 
Retrospective chart review of patients undergoing oral food challenges (OFCs) prior to 
December 1, 2015 was performed by the allergy team in CCHMC. Information including 
clinical history, dietary history, exam findings, demographics, patient’s eczema and other 
atopic disease status, OFC procedures, OFC results, skin prick testing results, and allergen-
specific IgE levels prior to OFCs were collected through database analysis and ongoing review 
of the electronic medical record.  Selective data related to milk challenge outcomes and 
measurements of immune markers such as Skin Prick Testing (SPT) and milk sIgE CMA (i.e., 
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electronic patients’ records) were transferred into an encrypted flowsheet database and sent 
to the University of Portsmouth for further analysis. Names of participants were removed 
and coded, and anonymous data was used.  
6.3.3 Data Safety and Monitoring 
To safeguard confidentiality and protected health information (PHI), all research records 
identified subjects only by study ID number.  Paper copies of research records were 
maintained in a locked file cabinet at the Principal Investigator’s office in CCHMC.  Logs 
linking identifying information to research records were kept in a separate file locked in the 
Principal Investigator’s office. Access to the hard copy documents were monitored by the 
Principal Investigator. The computerized database identified subjects only by study 
identification number.  Computer files were password protected on a secure hospital drive, 
and only the study personnel had access to the database.  Investigators and research staff 
were instructed not to discuss study subjects except as necessary to carry out data collection. 
Published materials did not reveal the identities of any patient participating in the study.  The 
database will be maintained until all pertinent research has been concluded and published. 
All paper records were shredded, and all computer files were deleted. No data obtained from 
this research study was provided to a pharmaceutical, medical device, or biotech company. 
6.4 Data Analysis  
All statistical analysis was conducted by using IBM SPSS Statistics for Windows version 22.0. 
Descriptive statistics and frequencies were used to summarise clinical data regarding:  
Ø the number of children who passed or failed (negative=passed, positive=failed) the 
milk challenges  
Ø the number of children who had a positive or negative result (positive=milk reactive, 
negative=milk tolerant) to allergy tests. Negative SPT wheal size was defined as equal 
or lower than 3mm and positive SPT higher than 3mm. Negative milk sIgE 
measurements were defined as equal or lower than 0.35KUA/L and positive higher 
than 0.35 KUA/L. As described in the review of literature in Chapter 2 section 2.5:  
the cut-off of milk sIgE measurements and SPT wheal size above have been proposed 
by Nowak-Wegrzyn et al (2008).           
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All reported values, positive and negatives were included in the analysis and reported 
statistics. Pearson’s chi-square test was used for testing associations between immune 
markers (SPT and milk sIgE measurements) and milk challenge outcomes. A p value less than 
0.05 was considered statistically significant. 
The receiver operating characteristic (ROC) curve was used to evaluate the performance of 
immune tests (SPT to fresh milk, SPT to milk extract, total IgE, IgE casein, IgE β-lactoglobulin) 
versus milk challenge outcomes. In the Receiver Operating Characteristic (ROC) curve the 
true positive rate (Sensitivity) is plotted in function of the false positive rate (100-Specificity) 
for different cut-off points. Each point on the ROC curve represents a sensitivity/specificity 
pair corresponding to a particular decision threshold. 
6.5 Results  
6.5.1 Clinical characteristics of biomarkers (OFC, SPTs, milk sIgE) 
A total of 277 food challenges conducted over 2 years at CCHMC were reviewed and of these, 
191 were performed with milk (n=33) and baked milk (n=158). Out of the 191 challenges, 91 
(48%) were positive (failed the OFC), and 100 (52%) were negative (passed the OFC). 
Challenges were performed with different forms of milk. One hundred and forty-seven (77%) 
milk challenges were conducted with baked milk, of which 71 (48%) were positive and 76 
(52%) negative; 33 (17%) challenges were performed with fresh milk, of which 16 (48%) were 
positive and 17 (52%) were negative; 11 (6%) challenges were carried out with baked milk 
containing foods (cake, biscuit, muffin, crab, chocolate, wafer, yogurt), of which 4 (36%) 
challenges were positive and 7 (64%) were negative. Table 6.1 presents the mean that refers 
to the average of the participants’ immune biomarkers measurements (SPT fresh milk and 
SPT milk extract wheal sizes, and milk allergen, total IgE, casein-IgE and β-lactoglobulin levels) 
and summarises the results of immune biomarkers and milk challenge outcomes that were 
classified as positive (patients react to milk/baked milk) and negative (patients tolerate 
milk/baked milk. The statistical analysis is presented in appendix 19.     
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Table 6.1: Clinical characteristics of immune markers and oral milk/baked challenges 
Immune Markers  
         N=199 
Positive N (%) Negative N (%) Mean   
  
Oral Milk challenges  91 (48) 100 (52) - 
SPT -Fresh milk (mm)  53 (28) 138 (72) 2.621 
SPT-Milk extract (mm)  85 (45) 106 (55) 4.071 
Milk Allergen (KU/I) 109 (52) 82 (43) 8.352 
Total milk IgE (KU/I)  93 (49) 98 (51) 89.972 
IgE-milk casein (KU/1)  54 (28) 137 (72) 3.362 
IgE-β lactoglobulin (KU/I)  45 (25) 146 (76) 2.592 
¹ SPT wheal size (mm) 
²IgE levels ( kU/L) 
 
6.5.2 Sensitivity, specificity and ROC curves for immune biomarkers (SPTs, Milk 
Allergen, milk sIgE) in predicting milk tolerance in CMA children 
The validity of immune biomarkers was evaluated by calculating their sensitivity and 
specificity. Sensitivity is the ability of a test to identify patients with the disease and 
measures how often a test correctly generates a positive result for people who have the 
condition that is tested (true positive rates).  A test with 100% sensitivity correctly identifies 
all patients with the disease. A test with 80% sensitivity detects 80% of patients with the 
disease (true positives) but 20% with the disease go undetected (false negatives) (Trevethan, 
2017).  Specificity is the ability of a test to identify patients without the disease and measures 
how often a test correctly generates negative results for people who do not have the 
condition that is being tested (true negative rates). A test with 100% specificity correctly 
identifies all patients without the disease. A test with 80% specificity correctly reports 80% 
of patients without the disease as test negative (true negatives) but 20% patients without 
the disease are incorrectly identified as test positive (false positives) (Trevethan, 2017).  
 
AUC- ROC Curve is a performance measurement for classification problem at various 
thresholds settings. Received operating curve is a curve of probability and illustrates the 
diagnostic ability of a binary classification system (a pass or fail a test method) as 
discrimination threshold is varied.    
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The ROC curve shows the cut-offs between sensitivity and specificity. Classifiers that give 
curves closer to the top-left corner indicate a better performance. As a baseline, a random 
classifier is expected to give points lying along the diagonal. The closer the curve comes to 
the 45-degree diagonal of the ROC curve space, the less accurate the test Trevethan, 2017. 
AUC is calculated to summarise the performance of each classifier into a single measure and 
it is a general measure of predictive accuracy of a test Trevethan, 2017.    With regard to the 
interpretation of sensitivity and specificity, and ROC curves, it is important to note: 
 
Ø There is a trade-off between sensitivity and specificity (any increase of sensitivity is 
accompanied by a decrease in specificity)  
Ø The closer the curve follows the left-hand border and the top border of the ROC 
space, the more accurate the diagnostic test.  
Ø The area under the curve measures the test accuracy. An area of 1 represents a 
perfect test and an area of 0.5 represent a worthless test (i.e. no better than chance).   
Ø The tests are classified based on the areas under the ROC curve as follows 
(Florkowski et al, 2008):  
Areas Under the ROC curve 
(AUROC) 
Category 
0.9-1.0  Very good 
0.8-0.9 Good 
0.7-0.8 Fair 
0.5-0.7 Poor 
Less than 0.5  Fail (i.e no better than 
chance)  
 
The majority of milk challenge studies used cut-offs to determine positive tests as being more 
than 0.35 KU/I milk sIgE tests and 3mm for SPT (Bartnikas et al., 2012; Caubet et al., 2013). 
This study used the above values to categorise the SPT and immune markers as 
positive/negative to assess milk challenge outcomes. The statistics analysis was related to 
the established cut-offs above that are used in practice.  
 
A total of 191 SPTs, and laboratory tests (Milk Allergen, total IgE, casein-IgE and β-
lactoglobulin) were analysed against milk challenge outcomes by using the ROC curve. ROC 
curves were created in SPSS by plotting the true positive rate (sensitivity on the y-axis) of the 
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immune biomarkers against their false positive (1−specificity on the x-axis) for all possible 
cut -offs. The graphs of ROC curves for the immune biomarkers are presented in figure 6.1 
and 6.2.    
 
 
 
  
Figure 6.1: Sensitivity, specificity and ROC curves for fresh milk and milk extract SPTs in 
predicting milk challenge outcomes in children with IgE-mediated CMA (N=191). 
Description of ROC curve plotting related to sensitivity & specificity of SPTs  
SPT Fresh milk had a low sensitivity with a low percentage of true positives (50%) and a high 
specificity with a high percentage of true negatives (92%). This means that the SPT to fresh 
milk correctly detected 50% of those who failed a BMC (i.e. reacted to baked milk); 50% 
therefore, were undetected. SPT to fresh milk correctly identified 92% of children who 
passed a food challenge to baked/unheated milk (true negatives) but 8% of children that 
passed the BMC were incorrectly identified as test positive (false positives) (table 6.2).  In 
the ROC curve analysis, the AUC was 0.71 (95% CI=0.63-0.77) and according to the 
classification of the AUC results mentioned above, this value is categorised as fair indicating 
that the SPT fresh milk was not a reliable test predictor of BMC outcome (table 6.2).        
 
Similar results were demonstrated by the ROC plotting of SPT milk extract.  It had a low 
sensitivity with a relatively low percentage of true positives (69%) and a high specificity 
resulting in a moderate percentage of true negatives (78%). This means that the SPT to milk 
extract correctly identified 69% of those who failed the BMC (i.e. reacted to baked milk) but 
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31% of those who failed the BMC (i.e. reacted to baked milk) were not detected. The SPT to 
milk extract correctly detected 78% of children who passed the BMC (i.e. were tolerant to 
baked/unheated milk; true negatives) but 22% of children that passed the BMC were 
incorrectly identified as test positive (baked/unheated milk allergic- false positives) (table 
6.2). The AUC was 0.73 (95%CI=0.66-0.79) and according to the classification of the AUC 
results mentioned above, this value was ‘fair’ and thus indicated that the SPT milk extract 
was not a reliable test (table 6.2). Statistical analysis of both SPTs is referred to appendix 19.   
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Figure 6.2: Sensitivity, specificity and ROC curves for Milk Allergen, Total-IgE, Milk casein-
IgE-, and β-lactoglobulin-IgE in predicting milk challenge outcomes in children with IgE-
mediated CMA (n=191) 
 
Description of ROC curve plotting related to sensitivity & specificity of milk allergen, total 
IgE, casein-IgE, and β-lactoglobulin-IgE  
Milk Allergen laboratory test had a high sensitivity with a relatively high percentage of true 
positives (68%) and a low specificity resulting in low percentage of true negatives (53%). This 
means that the milk allergen test correctly detected 68% of children who failed the BMC (i.e. 
reacted to baked/unheated milk; true positives) but 32% children who failed the BMC were 
undetected by the milk allergen test (false negatives) (table 6.2). Additionally, the milk 
allergen test correctly detected 53% of children who passed the BMC (i.e. tolerated baked 
milk; true negatives) but 47% of children who passed the BMC were undetected (false 
positive). The AUC was 0.61 (95% CI=0.53-0.67) and according to the classification of the AUC 
results mentioned above, this value is ‘poor’ and thus indicates that the Milk Allergen 
laboratory test was not a reliable test due to poor value of AUC (table 6.2).        
Total IgE laboratory test had a sensitivity 58% and specificity 60%. This means that the test 
correctly identified 58% of children that failed the BMC (i.e. reacted to baked milk – true 
positives) and 42% of children were undetected (false negatives). The total IgE laboratory 
test correctly detected 60% of children who passed the BMC (i.e. tolerated BM; true 
negatives) but did not detect 40% of the children who passed (i.e. who did not react to BM; 
false positives) (table 6.2). The AUC was 0.59 (95% CI=0.51-0.66) and according to the 
classification of the AUC results mentioned above, this value is ‘poor’ thus indicating that the 
total IgE was not a reliable test (table 6.2).     
Casein-IgE laboratory test had a sensitivity of 41% and a specificity of 83%. The casein-IgE 
laboratory test thus correctly detected 41% of children who failed the BMC (i.e. reacted to 
baked milk; true positives) but 59% of children who failed the BMC were not therefore 
correctly detected (false negatives). The casein-IgE test thus correctly detected 83% of 
children who passed the BMC (i.e. tolerated baked/unheated milk; true negatives) but 17% 
children who passed the BMC were incorrectly identified as test positive (false positives) 
(table 6.2).   The AUC was 0.62 (95% CI=0.55-0.69) and according to the classification of the 
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AUC results mentioned above, this value indicated that the total IgE was not a reliable test 
due to poor value of AUC (table 6.2).  
Similar results were demonstrated by the ROC plotting of the β-lactoglobulin-IgE laboratory 
test. It had sensitivity of 31% and a of 84%. The β-lactoglobulin-IgE laboratory test thus 
correctly detected 31% of children who failed the BMC (i.e. reacted to BM; true positives) 
and therefore 69% of those children who failed the BMC were undetected (false negatives). 
The β-lactoglobulin-IgE laboratory test correctly detected 84% of children who passed the 
BMC (i.e. tolerated BM; true negatives) but 16% children were incorrectly identified as test 
positive (false positives). The AUC was 0.58 (95% CI=0.51-0.66) and according to the 
classification of the AUC results mentioned above, this value is ‘fair’ thus indicating that b-
lactoglobulin-IgE is not a reliable test (table 6.2). Statistical analysis of the immune 
biomarkers is referred to appendix 19. Sensitivity, specificity and AUC of immune biomarkers 
were summarised in table 6.2.  
Positive Predictive Values (PPV) and Negative Predictive Values were assessed using the 
online MedCalc’s software diagnostic test evaluation calculator. PPV is the percentage of the 
positive outcomes that were correctly classified/identified by the diagnostic test as positive.  
NPV is the percentage of negative outcomes that were incorrectly specified/identified as 
positive (False positive values) (table 6.2). Tests for which the PPV/NPV is close to 100 are 
characterised as reliable diagnostic/predictive tools.  As can be seen in Table 6.2, the PPsV 
for the immune biomarkers results ranged from 56.9% to 84.9% and NPVs from 57.5% to 
73.6% and indicated that these tests had not very good reliability.       
 Table 6.2: Sensitivity, Specificity and AUC of immune biomarkers in predicting milk 
challenge outcomes in children with CMA  
Immune 
Biomark
er tests 
Sensiti
vity (%)  
95%
CI¹ 
(%) 
Specifi
city 
(%) 
95%
CI¹ 
AU
C² 
95%
CI¹ 
PPV(
% 
95%
CI¹ 
NPV(
%) 
95%
CI¹ 
SPT Fresh 
milk    
49.4 38.8-
60.1 
92.0 84.8-
96.5 
0.7
1 
0.63-
0.77 
84.9 73.7-
91.9 
66.7 61.8-
71.2 
SPT Milk 
extract 
69.2 58.7-
78.5 
78.0 68.6-
85.7 
0.7
4 
0.66-
0.79 
74.1 65.9-
80.9 
73.6 66.8-
79.4 
Milk 
Allergen 
68.1 57.5-
77.5 
53.0 42.8-
63.1 
0.6
1 
0.53-
0.67 
56.9 50.7-
62.9 
64.6 56.2-
72.2 
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Milk 
total-IgE  
58.2 47.4-
68.5 
60.0 49.7-
69.7 
0.5
9 
0.51-
0.66 
57.0 49.6-
64.1 
61.2 54.1-
67.9 
Milk 
Casein-
IgE 
40.7 30.5-
51.5 
83.0 74.2-
89.8 
0.6
2 
0.55-
0.69 
68.5 56.9-
78.2 
60.6 55.9-
78.2 
Milk β-
lactoglob
ulin-IgE 
31.2 22.5-
42.5 
84.0 75.3-
90.6 
0.5
8 
0.51-
0.66 
64.4 51.4-
75.7 
57.5 53.5-
61.5 
¹Confidence interval 
6.6 Discussion 
This study describes a quantitative analysis of the immune markers, SPT wheal sizes and milk 
sIgE measurements in predicting milk challenge outcomes of milk allergic children. These 
allergy tests are used by allergists and immunologists to evaluate and manage patients with 
food allergy. A standard diagnostic approach in CMA uses a patients’ clinical history in 
combination with SPT and milk sIgE values (Jarvinen & Sicherer, 2012). These immune 
markers are not used only in the diagnosis of CMA, but also in the evaluation of the 
development of milk tolerance before re-introducing milk or suggesting/conducting a milk 
challenge in children with CMA (Shek, Soderstrom, Ahlstedt, Beyer, & Sampson, 2004).  Few 
studies have evaluated predictive factors for baked milk challenge outcomes. According to 
the review of the literature in Chapter 2, previous research indicates that the regular 
consumption of BM-containing foods may reduce SPT wheal size and milk sIgE values, 
although reliable predictors of a successful baked milk challenge are not yet well established 
(Bartnikas et al., 2012; Ford et al., 2013). The food challenge test remains the gold standard 
in diagnosing CMA and confirming food tolerance. Providing valuable and reliable predictor 
tools that can identify optimal milk allergic patients able to tolerate BM-containing foods is 
crucially important because, as has 
been mentioned in the previous chapters of this PhD thesis, these children may outgrow 
their milk allergy faster than those excluding milk completely (Nowak-Wegrzyn & Sampson, 
2011). 
This study evaluated SPT wheal sizes and milk sIgE values in a retrospective review of children 
who underwent BMC in the paediatric allergy clinic of CCHMC in the USA who all had IgE 
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mediated CMA and different forms of milk were used for the challenges. It was found that 
both SPTs (fresh milk, milk extract) and the immune markers casein-IgE and β-lactoglobulin 
had a high specificity and low sensitivity. These tests thus largely correctly detected children 
who failed the BMC (i.e. reacted to baked milk; true positives) but a number of children who 
failed the BMC were not therefore correctly detected (false negatives) (table 6.2).  Their PPV 
and NPV were generally low and indicated that the immune biomarkers results did not have 
a good reliability. In addition, the AUC accuracy for SPTs (0.71(95%CI=0.63-0.77)  and (0.74 
(95%CI=0.66-0.79)) for fresh milk and milk extract respectively) were classified as fair and for 
the laboratory tests (milk allergen 62 (95%CI=53-67), total IgE 59 (95%CI=51-66),  casein  0.62 
(95% CI=0.55-0.69),  β-lactoglobulin IgE  0.58 (95%CI=0.51-0.66))  as poor. Based on these 
findings this study cannot provide optimal values in predicting milk challenge outcome. 
These findings are consistent with previous studies that reported neither milk-sIgE or SPT to 
commercial milk extracts are reliable in identifying milk tolerance in children with CMA 
(Nowak-Wegrzyn, 2011). Another study showed that while the levels of milk-sIgE, casein-IgE 
and wheal sizes of SPT were significantly (p<0.001) different between patients who were 
baked milk-tolerant and baked milk-reactive none of these tests had high sensitivity and 
specificity (Ford et al., 2013). Bartnikas et al (2012) found that milk SPT wheal size was a 
better immune marker for BMC outcome compared to milk sIgE levels. Similar results were 
derived from this research; milk fresh and extract SPT wheal sizes were a more sensitive 
screening test in predicting milk challenge outcome compared to laboratory tests (milk sIgE 
levels and milk allergen).  According to the review of literature in Chapter 2 (section 2.5), due 
to the limited evidence regarding the reliability of immune markers, the decision of 
researchers/physicians about the choice of cut off values relies on individual risk assessment 
in terms of research setting values. A previous study found that BM-milk tolerant children 
had smaller wheal sizes (less than 3mm) and lower milk sIgE values (less than 0.35KU/L) 
compared with BM-reactive children (Nowak-Wegrzyn et al., 2008). However, the Bartnikas 
et al, 2012 study found that a child with undetectable serum milk sIgE levels and two children 
with negative milk SPT reacted to a BMC.  Another study reported no association between 
BMC and milk SPT wheal reaction and poor negative predictive value of milk SPT wheal 
reactions smaller than 7mm (Mehr et al., 2014). In contrast, Faraj et al 2012 and Kim et al 
2011 reported a high negative predictive value for a negative SPT reaction. In the Caubet et 
al., (2013) study it was argued that if a child has milk sIgE with a high negative predictive 
value (98%) but a low specificity (30%) this test cannot replace the food challenge because 
some children may react to BM-containing foods. On the other hand, if the negative 
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predictive value is relatively low (78%) and the specificity of the milk specific IgE test is 
increased (95%), then more children tolerant to BM-containing foods could be identified 
(Caubet et al., 2013).  
Taken together, the studies above suggest that predictive cut off values may be influenced 
by the age of patients, the cooking degree, the type of allergen and the population that are 
used to perform SPT. For instance, it has been indicated from the findings of this study that 
the use of SPTs (AUC<0.71 and <0.74) may be more accurate in identifying milk allergic 
children who might be able to tolerate baked or unheated milk than the laboratory tests 
(AUC less than 0.69). This is in line with Faraj et al, (2012) who argued that SPT Fresh milk 
may be a reliable marker for identifying milk allergic children who could potentially tolerate 
baked milk since in their study SPT fresh milk provided a very good NPV of 95%. However, 
the NPV for SPT fresh milk in this study was not so high at 66.7% (95% CI 61.8%-71.2%). 
Previous studies have demonstrated that commercial food extracts for SPT have not yet been 
standardised and they may contain differing concentration of relevant proteins that may 
confound the results of the studies (Tripodi et al., 2009; Verstege et al., 2005). Similar to SPT, 
milk sIgE predictive values may be different among populations. Proposed cut off values that 
have been suggested for milk sIgE vary among studies according to many factors such as 
patients’ ages, geographical differences, different criteria on milk challenge outcome 
interpretation, test characteristics and methodology, including use of different statistical 
tests. Therefore, cut off milk sIgE levels that are highlighted from different studies cannot be 
directly comparable.  
Some studies have shown that while larger wheal sizes of SPT and higher levels of serum sIgE 
are associated with food allergies, these tests cannot provide information about the severity 
of allergic reactions (Lieberman & Sicherer, 2011) . In addition, in many clinical cases allergic 
reactions have occurred with negative SPT or sIgE levels (false negatives) because either 
these tests could not detect the specific allergen or the allergy was non IgE mediated CMA 
(Sicherer & Sampson, 2014)  
 
  
Due to the limitations of the tests mentioned above (and as a reflection of the results of this 
study), oral food challenges are still required either to confirm the CMA diagnosis or the 
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development of tolerance to milk or milk containing foods. The Double-Blind Placebo-
Controlled Food Challenge (DBPCFC) is the gold standard for the diagnosis and detection of 
the baked/unheated milk tolerance but the disadvantages of these challenges are the 
potential risk of anaphylactic reactions and also it is a time-consuming and costly procedure 
(Yanagida, Sato, Asaumi, Ogura, & Ebisawa, 2017). For this reason, a number of other 
diagnostic/predictive tests are currently under investigation. Promising predictive tools that 
could potentially identify patients that would be able to tolerate baked milk foods appear to 
be the Basophil Reactivity Tests (BAT) and the Component-Resolved Diagnostics (CRD). 
According to the literature review in chapter 2, BAT seems to have promising predictive value 
as clinically useful test in the reintroduction of baked milk. It has been shown that it can 
distinguish different phenotypes of children that tolerate baked milk foods while they are 
still reacting to unheated foods from children who react to both heated and unheated milk 
(Ford et al., 2013).  Current studies have demonstrated that BAT could be useful in cases with 
unclear results of other diagnostic tests such as SPT or milk sIgE, before the clinician decides 
to conduct a food challenge 
(Santos & Lack, 2016).  A recent study found that the BAT had a sensitivity and specificity of 
100% (CI: 86%-100% and 68%-100%, respectively) in a small sample IgE-sensitized children 
(41% of the tested children N=36) (Ruinemans-Koerts et al., 2019).   However, the BAT is still 
not widely used in clinical practice because there is a need to define and validate diagnostic 
cut-offs values and standardise a protocol of methodology in a larger sample size in 
multicentre research base.  
In recent years the use of a molecular test named CRD (Component Resolved Diagnosis) is 
internationally accepted for the diagnosis of milk allergy and development of milk tolerance. 
A number of studies have supported that CRD can improve the specificity of allergy testing. 
In particular, they have reported that CRD used in CMA has shown greater specificity but 
lesser sensitivity when  compared to traditional SPT and serum specific IgE testing (Bartnikas 
et al., 2013; D'Urbano et al., 2010). CRD is currently used clinically in peanut allergy but 
requires further evaluation before being ready for implementation in clinical practice for milk 
allergy.   
However, the findings from these studies have varied, due to different study populations and 
methods, manners of sensitization, environmental exposures, and degree of sensitization to 
various food components and CRD cannot yet replace the use of food challenges in the 
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diagnosis and determination of baked/unheated milk tolerance. Their results should be 
validated by larger studies in different populations and with a greater age range of 
participants before applying them in clinical practice. The studies consistently recommend 
that the initial BM-containing food reintroduction should be based on challenge outcomes 
and not, yet, on the results of immune markers only because cut off values of SPT and milk 
sIgE are still under investigation and the current evidence presents inconsistent findings.  
To summarise, further multi-centre trials are required that include a larger number of 
participants that come from different geographic locations with a wider range of population 
groups and can compare the findings among the centres. Standardised clear diagnostic 
criteria need to be defined and a confirmation of the CMA diagnosis based on milk challenges 
is required at the beginning of the clinical trial to avoid children who might have developed 
tolerance to unheated and heated milk from being included in trials resulting in misleading 
findings. For instance, in previous studies some participants who passed the baked milk 
challenges may have been tolerant to unheated milk as well as this had not been tested. It is 
important also for all parties to be blinded. Further evaluation is required to validate 
promising tests such as CRD and BAT as reliable predictive tools in the determination of milk 
tolerance before they are ready for implementation in clinical practice. The majority of 
immune markers studies provided data for a population with median age from 7 to 9 years. 
Further studies are required to provide data representative for younger children with CMA 
(who constitute the majority of CMA patients and who may therefore be considered for 
baked milk introduction). In the majority of studies, the challenge food was prepared by 
caregivers and therefore there was no control to ensure that there was equal amounts of 
milk proteins and temperature of baking of the challenge food was standardised across 
participants. A standardisation of methods such as food challenge and immune test protocols 
could ensure that the findings of different studies could be meaningfully compared.   
6.6.1 Strengths and limitations  
The major strength of this study compared to the previous studies is that CMA diagnosis had 
been confirmed with milk challenges at the beginning of participants’ recruitment.   This 
ensured that those children who had outgrown their milk allergy entirely (and could 
therefore tolerate both baked and unheated milk) were not included in the study. The failure 
to do this has been a major issue in previous studies. Another important strength is that this 
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study utilised a larger sample size (N=191) than the other immune biomarkers’ studies that 
had been systematically reviewed in chapter 2 (a range between N=30 to N=132). 
Furthermore, this sample size was homogenous because the USA study included a cohort 
with only milk allergic children.  Regarding the statistics methods, this study used a higher 
level of inferential statistics, a ROC curve analysis to identify optimal cut off values of the 
immune biomarkers.   
 
An additional strength of this study is that the data was collected as part of a larger study 
and was stored in a format that was both easy and inexpensive to search. It was an important 
opportunity to investigate the ability of these immune markers to predict milk challenge 
outcome in American CMA children, within the limited budget and time constraints of a PhD. 
Making use of existing data collected over a period of time, using established methods, 
provided a larger sample with which to address the research question than would otherwise 
have been possible within the scope of a PhD. Given that the dataset was collected as part 
of a larger study, this is also a highly efficient use of research data.   
This study has some limitations that have been considered. This study used existing data that 
were not originally collected for the purpose of this research which meant that there may 
have been some inconsistencies in the methods used. As an example, it was impossible to 
control the challenge food preparation (e.g. degree of heating) and dose administration, 
therefore the doses of the challenge food might be over or underestimated. In addition, the 
decision of the food challenge outcomes, whether a child passed or failed the milk challenge, 
may differ among clinicians and influence the findings of the study. Different observers may 
have different opinions about symptoms during the food challenge tests even though a 
symptom score sheet is advised.  
Despite being collected from an established allergy centre and being the largest sample ever 
used in a study of its kind, a larger sample would have permitted for a more robust analysis 
of the positive predictive values, sensitivity and specificity of immune markers. However, 
given the relatively low frequency (in research terms) with which an individual allergy clinic 
will be conducting milk challenges, it would not be feasible to collect data on this scale 
without conducting a larger, and more expensive, multi-centre trial. This was beyond the 
scope of what is possible within this PhD. 
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Due to the retrospective nature of this study, there is no information available regarding 
whether the children who passed their milk challenges continued to tolerate BM-containing 
foods at home or “fresh” milk and dairy products, which would have been useful to provide 
further context to the findings. Further studies are needed to determine if the findings of 
this research are replicable in a larger sample. Larger multi-centre trials with a longitudinal 
prospective design are required to validate whether immune markers can predict/identify 
patients who are able to tolerate BM-containing foods/fresh milk.     
6.6.2 Conclusion 
This study was conducted to evaluate if SPT and milk sIgE values can predict milk challenge 
outcomes and development of tolerance to milk. It found that milk extract and fresh milk 
SPT were slightly better predictors of milk challenge outcomes compared with milk sIgE 
levels. However, this study found that both SPT and milk sIgE had poor predictive values for 
milk challenge outcomes and they cannot currently provide reliable information regarding 
tolerance development.    
The findings of this study are consistent with previous studies which have concluded that 
there are not currently immune markers that can accurately predict the probability of a 
positive/negative milk challenge outcome for either fresh or baked milk. Although a milk 
challenge is an expensive and time-consuming process with a high risk of severe 
reaction/anaphylaxis, it still remains an invaluable tool in the diagnosis of CMA and 
determining BM / unheated milk tolerance because of the poor practicability of the 
evaluated immune markers. Additional studies with a larger sample size, in different 
population and age groups need to evaluate and validate available immune markers that will 
be able to predict milk challenge outcomes and identify optimal children for BMC/unheated 
milk challenge or immunotherapeutic intervention so to reduce the risk of severe reactions 
or anaphylaxis during this process. Serum specific IgE tests or skin prick tests with a high 
sensitivity and specificity to predict milk challenge outcomes and tolerance development to 
both fresh and baked milk are urgently required. This will reduce cost to health care systems 
and improve patients’ quality of life in terms of their nutritional status, daily living and social 
life (family meals, nursery, school, eating out).  
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Chapter 7. General discussion of findings of this PhD                                                    
7.1 Overview 
This chapter collates the overall findings of the three studies of this PhD research, starting 
with a concise overview of the rationale and aims of the overall programme of research. The 
main findings of the three studies are summarized in relation to current literature and the 
strengths and limitations of this programme of research are considered. Bringing together 
these studies, in conclusion, the implications of the research findings are explained, and 
future research needs are outlined.   
7.2 Rationale and aims of this thesis 
CMA is the most common food allergy in childhood with a prevalence ranges from 1.9 to 
4.9% and has an adverse nutritional impact on the children and negative psychosocial impact 
on the child and their families (Fiocchi, et al., 2010; Lau, et al., 2014). Current research 
indicates that ssuccessful re-introduction of BM-containing foods may accelerate milk allergy 
resolution and assist in establishing a normal diet, by avoiding unnecessary elimination diets 
which impair proper nutrient intake and affect socialisation (Meyer et al., 2017). However, 
there is a limited data on the impact of BMC and milk ladders from either a health care 
professional or parent perspective. 
The rationale for this research was built on the need to explore important aspects if the use 
of baked milk containing foods used in the management of CMA, which has received little 
research attention to date. In previous years, the cornerstone of the management of CMA 
was solely based on the strict avoidance of all CM and food containing milk in the diet of 
patients (Fiocchi et al., 2010). However recent studies suggest that a majority (75%) of milk 
allergic children are able to tolerate baked milk products and may outgrow their CMA faster 
than those children who cannot tolerate these foods (Kim et al., 2011; Nowak-Wegrzyn et 
al., 2008). It is common practice in the UK and internationally that allergy clinics establish 
their own BMC and gradual milk introduction (milk ladders) protocols to assist cow’s milk 
allergic children. However, the problems with these are that both BMC and ML protocols 
have not been clinically validated and standardised and there is also a paucity of research 
investigating BM-reintroduction in children with IgE and mild to moderate non-IgE- mediated 
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CMA. Due to the lack of clear guidance regarding BM-reintroduction at home, the decision 
about a BMC and ML process is based on individual clinical assessment and clinical 
experience. It is still unclear which patients are optimal candidates for BM-reintroduction 
due to the lack of reliable indicators for identifying these. In IgE-mediated CMA, there is no 
universal agreement regarding “when” and “where” (clinical setting vs home) initial BM-
containing food introduction should be conducted. This PhD research therefore aimed to fill 
important gaps in our understanding around: (i) the use of BM-products in clinical practice 
and the guidelines that are followed by HCPs in the management of IgE and mild to moderate 
non-IgE CMA; (ii) the re-introduction of BM-containing foods at home and how mothers 
manage baked milk products into the diet of their children and also what guidance and 
support they have during this process; (iii) the use of immune markers such as SPT and milk 
sIgE and their ability to predict if a child passes or fails  an oral milk challenge.    
Three studies were conducted with the aim of providing urgent answers in these important 
aspects of cow’s milk allergy management using a quantitative and qualitative methodology 
approach:  
1. A survey was carried out to evaluate the attitudes and practices of HCPs on the 
conduct of BMCs and graded re-introduction of BM/milk ladder in IgE and mild to 
moderate-non-IgE mediated CMA. 
2. Semi-structured interviews were conducted as part of a qualitative study to explore 
mothers’ experience of the re-introduction of BM-milk containing foods into the diet 
of their children who are diagnosed with IgE and non-IgE-mediated CMA.   
3. As a part of a larger quantitative study (‘chart review”), data was extracted and 
analysed to assess immune markers (SPT, milk sIgE) prior to BMCs and evaluate if 
there is an association between these immune markers and milk challenge outcomes 
in children with IgE-mediated CMA 
Understanding HCP and parents’ perceptions is of the utmost importance in terms of the 
validity of any future guidelines, and this could contribute to an effective CMA dietary 
management and to a better targeting of dietary advice to parents/carers, whose children 
will be candidates for a BMC or a ML plan in the future. Additionally, the evidence from this 
study is expected to help allergy services and healthcare professionals to provide optimal 
care (further support with follow ups/phone calls/via emails, education in person or using 
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social media, detailed written advice and guidelines) to children during reintroduction of 
baked milk containing foods, and contribute to the eventual standardisation of tools such as 
validated milk ladder protocols and available reliable allergy tests used for this purpose.  
Validated reliable immune markers such as SPT and milk sIgE would help to provide valuable 
information for the appropriate time of BM-reintroduction and the timing of milk tolerance 
development that would be extremely useful in daily clinical practice and might help to avoid 
an unnecessary milk elimination diet for children. 
7.3 Summary and implications of findings  
Recently the introduction of baked milk containing foods into the diet of milk allergic children 
in the form of a milk ladder has become well-recognized as a part of CMA management. 
However, there is paucity of evidence regarding the efficacy and safety of the protocols such 
as milk ladders that are used in BM-reintroduction. Cow’s milk is one of the most common 
foods responsible for a fatal anaphylactic reaction in children and this emphasises the need 
to provide a safe procedure in terms of decisions regarding the place (hospital/home setting) 
and the appropriate time that BMC should be conducted, supervision by HCPs, and 
standardised protocols. The following sections present a summary of the research findings 
in the light of literature.          
7.3.1 Findings in relation to the use of BMCs and MLs by HCPs in clinical practice 
This research has provided the first research into of the use of BM-containing foods in clinical 
practice for the management of IgE and non-IgE-mediated CMA by HCPs worldwide.  The 
HCPs who participated in the survey reported that they use a BMC and ML to determine the 
development of tolerance to BM and unheated milk in milk allergic children who were 
following an elimination diet. This finding is in line with previous studies that suggest BM-
reintroduction should be the next step after a milk free diet not only to determine if children 
tolerate or still react to baked milk but also to help milk allergic children to develop tolerance 
more quickly (Dupont, 2013).  One of the key findings of this study was that BM-
reintroduction may cause severe allergic reactions and anaphylaxis in IgE-mediated CMA. 
This finding is consistent with previous studies that observed severe reactions and 
anaphylaxis during an initial BMC in hospital (Kim et al., 2011; Mehr et al., 2014).  Hence, 
these findings emphasize the need to perform an initial BMC under medical supervision in 
 
 
162 
 
hospital, prior to introducing BM-containing foods at home in IgE mediated CMA rather than 
at home, in the case of IgE mediated CMA.  
In this study, HCPs reported also that the most common symptoms at home were eczema, 
abdominal pain and diarrhea. Current studies reported similar symptoms such as abdominal 
pain, eczema, and pruritus at home, after passing a BMC at hospital(Bartnikas et al., 2012); 
Mehr et al., 2014) . Children experienced these symptoms one week later after eating the 
same challenge BM-containing food that they had tolerated in hospital. Hence, these findings 
indicate the need for home guidance on how to introduce BM-containing foods in the diet 
of milk allergic children in terms of time and degree of cooking, suitable recipes for 
homemade BM-foods, and list of appropriate commercial BM products available in food 
stores.         
This PhD research has highlighted discrepancies associated with the time (“when” to 
introduce BM products) and the appropriate place (“where” to introduce BM-products e.g. 
hospital/home) of BM-reintroduction. There were HCPs that reported home as a safe place 
for BMC in IgE mediated CMA and they reported that their decision was based on a detailed 
clinical assessment combined with allergy tests and the policy of the hospital. Since a 
majority of children can tolerate BM-products, there is still a debate over whether BM-
containing foods could be directly introduced at home or an initial BMC should be performed 
under medical supervision in hospital. Current guidelines regarding the BM-reintroduction 
led to more controversies than clarity of the appropriate place for a BMC.  
BSACI guidelines recommend in IgE-mediated CMA, home-BM containing food gradual 
introduction (milk ladders). In children who have had only mild symptoms (only skin 
symptoms) on noteworthy exposure (e.g. mouthful of fresh milk) and no reaction in the past 
6 months, and hospital-BM-containing food introduction in milk allergic children that had 
experienced previous CMA symptoms affecting breathing and gut or circulation, less severe 
reaction on trace exposure, severe or poorly managed asthma, multiple or complex allergy, 
no significant reduction in IgE  and their parents are  unable to comprehend or adhere to 
protocol  (Luyt et al., 2014). According to the finding of Luyt et al, (2016) the majority (80%) 
of HCPs (116 respondents) advised home-BMC in the UK current clinical practice (Luyt et al., 
2016). This finding is similar with the results of this research that found that 65% of HCP 
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suggest home-BMC in IgE-mediated CMA. BSACI guidelines and the results above indicate a 
huge discrepancy among current guidelines that suggested by:           
• WAO Guidelines (2010): … all dietary interventions and avoidance strategies be 
reevaluated on a yearly basis, ideally after oral food challenges carried out under 
medical supervision in hospital…. (Fiocchi, Brozek, et al., 2010) 
•  ESPGHAN Guidelines (2012): So as not to prolong unnecessary dietary restrictions, 
supervised CMP challenges are required... (Koletzko et al., 2012)  
•   MAP Guidelines (2013) and (2017):…no child with IgE-mediated food allergy 
should have a challenge in primary care or community settings. All those remaining 
children diagnosed as mild-moderate non-IgE mediated CMA are suitable for home 
challenge. (C. Venter, Brown, et al., 2017; C. Venter et al., 2013). 
Hence, a national and international agreement of BM-reintroduction guidelines based on 
current evidence is required to enhance feasibility, effectiveness, and safety of a BMC and 
milk ladder approach.         
7.3.2 Findings in relation to mothers’ experiences with the BM-reintroduction  
To our knowledge this is the first qualitative study to explore mothers’ perceptions, 
experiences, understanding and level of satisfaction in introducing BM-containing foods into 
the diet of their children.  Considering mothers concerns and suggestions on the use of BM-
containing foods, valuable data were obtained regarding  influences in mothers’ and 
children’s quality of life and psychological condition, allergy symptoms that their children 
experienced, the level of compliance during a completion of a milk ladder, the level of 
comprehensiveness of this procedure, the level of support from allergy services, difficulties 
in terms of food choices and taste, and difficulties with food availability and preparation.  
Mothers felt there were important benefits to BM-reintroduction, such as liberalisation of 
their child’s diet to include a variety of food rich in milk protein that would not only improve 
their child’s nutritional status but also their quality of life by allowing children to enjoy food 
without fears in birthday parties, nursery, eating out and enjoying family meals. However, 
mothers were disappointed with the quality of food options in the milk ladder. Many steps 
of the milk ladder included baked milk products with high content of sugar, fat and/or salt 
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such as cakes, biscuits, muffins, waffles, pizza etc. that they felt should be replaced by 
healthier food options. In addition, some of the participants had children with a concurrent 
food allergy or multiple food allergies and they had difficulties complying with the foods in 
the steps of the milk ladder, because they found it very difficult to identify baked milk 
products free of other food allergens such as egg or wheat. This study showed that gradual 
BM-reintroduction is a long process and in many cases its completion may take more than 3 
years. Healthier food options and alternative foods that meet the needs of those 
concomitant/multiple food allergies should be considered by allergy services. Healthier food 
choices in the milk ladder should be considered in all steps because eating patterns and 
behaviour are developed and established during the first years of life and influence 
nutritional habits in adolescent and adult life (Anzman-Frasca et al., 2017).  
Mothers with IgE-mediated CMA children expressed their concerns regarding the place of 
BM-reintroduction, and they wondered why allergy services did not offer a BMC in hospital.  
They preferred to introduce initially a BM-containing food in hospital because medical care 
could be immediately provided if any potential severe reaction occurred. The issue regarding 
the appropriate place and time for a BMC and also the guidelines followed by HCPs before 
they decide to introduce a BM-containing food have been discussed in the section 6.3.1. 
Generally, mothers were anxious about the side effects of BM-containing foods, especially 
those mothers that were in the first steps of the milk ladder. Education and a list of written 
information regarding the common symptom during BM-reintroduction could help mothers 
to recognise and distinguish allergy symptoms from common ailments in infancy, such as 
teething or colds. Current studies have shown that providing appropriate information 
regarding how to manage the risk of allergic reactions can reduce anxiety and stress in 
mothers of children with food allergy (Boyle et al., 2017).  
Increased anxiety of mothers was also associated with practical issues such as the lack of 
their knowledge regarding the quantity of milk protein and how they could identify this in 
the labels of food package or how to assess this protein in homemade foods. They felt that 
any misunderstanding of the reading of food labels or during the preparation of homemade 
BM-containing foods could be possible and might therefore cause an unexpected allergic 
reaction in their child. Hence, mothers need to be educated and informed how to read food 
labels, how the milk protein is indicated in the food package, what is the appropriate quantity 
of milk protein in each step of the milk ladder and gain any other practical guidance that 
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could facilitate the gradual introduction of BM-containing foods and ensure the safety of this 
process.  Mothers expressed also concerns about the different version of milk ladders.    
Many studies have highlighted the importance of individualised advising and a formulated 
nutritional intervention, providing appropriate information regarding dietary plans/dietetic 
protocols in combination with advice and education, considering psychological and 
environmental factors that may influence the food choices of parents/carers/patients in food 
allergy (MacKenzie et al., 2015; Sommer et al., 2012). Hence, a very important finding of this 
study is the limited communication between mothers and HCPs. Mothers reported that there 
was not enough time during consultation to discuss in detail the milk ladder process and the 
written information did not sufficiently address their queries. Consequently, they asked 
advice or discussed their queries with other parents having children with CMA through social 
media instead of healthcare services.  HCPs should consider a standardised milk ladder so 
mothers do not become confused and can be confident that provide proper care, based on 
scientific evidence, is being given to their child. Milk ladders should be validated regarding 
the number and ranges of steps, doses of BM-containing foods and the frequency that these 
foods should be given so to ascertain the milk ladder’s efficacy, feasibility and safety.   
7.3.3 Findings in relation to immune markers such as SPT or milk sIgE and their 
ability to predict milk allergic children that can tolerate immune markers. 
This PhD also evaluated and analysed a dataset related to the predictive ability of immune 
markers in the development of milk tolerance.  This study found that both SPT and milk sIgE 
had poor predictive values for milk challenge outcomes and it was not feasible to identify 
PPV for failing milk challenges in terms of SPT wheal sizes and milk sIgE levels.   It was not 
possible to identify specific positive cut off levels for SPT or milk sIgE that could predict a 
child’s reaction to milk.  
Current studies present inconsistent data regarding specific cut off values for SPT and milk 
sIgE that can predict milk tolerance or reactivity. Hence, reliable cut off values for these 
allergy tests are not established yet (Cuomo et al., 2017).  The variability of cut off values for 
the immune markers is due to heterogenicity of milk challenge protocols that are used from 
different research centres and the different characteristics of participants in each study. 
Factors such as the age of participants, allergen (milk extract/fresh milk/baked milk), cooking 
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degree of the challenge food, different quality of methodology regarding the sample size, 
statistical methods and variations in the chosen level of predictive value (e.g. 90% vs. 95%) 
may substantially change the proposed cut-offs. 
In a clinical setting, establishment of reliable immune markers such as SPT and milk specific 
IgE could replace food challenge and reduce the risk of severe reaction or anaphylaxis during 
challenges. Food challenge is usually an inconvenient and expensive process which may 
cause distress to young children and their parents as it is lengthy and potentially risky. In 
contrast, SPT is simple to apply, cheap and relatively safe with a very low risk of anaphylaxis. 
However, it cannot be conducted if patients use antihistamines, have serious atopic eczema 
or children are less than 4 years because may they feel distress with this process.   
Specific IgE can be measured reliably and reproducibly in the serum of children, regardless 
of their age, use of antihistamines or severe atopic eczema, and there is not any risk of side 
effects, making these two tests much more attractive for diagnosis of tolerance to milk 
containing foods than performing food challenges.  
7.4 Overall findings and implications for practice from this programme 
of research 
The findings of individual studies, and implications of these, have been discussed in the 
relevant chapters and previous sections. However, there are overall findings that can be 
drawn from examining this programme of research as a whole. These have important 
implications for the implementation of the milk ladder in practice. Specifically, while the 
individual studies examined questions about the what, where, how and when of baked milk 
introduction, taking into account the findings of the full programme of research allows us to 
discuss these questions more comprehensively. Thus, the following sections will examine 
what lessons the clinical evidence, healthcare professionals’ practices, mothers’ experiences 
and immune biomarkers’ evaluation derived from this thesis have for (i) whether and when 
baked milk should be introduced (ii) where baked milk should be introduced and (iii) how the 
ongoing process of baked milk introduction should be managed.  
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7.4.1. ‘Whether’ and ‘when’ should baked milk be introduced? 
Reflecting on the findings of all three studies in this research, there are some important 
findings related to the decision of whether and when baked milk should be introduced. The 
survey of HCPs indicated that it is a common clinical practice to challenge patients with baked 
milk products and include these foods into their diet in increasing quantities, although there 
is still very little known about the appropriate time of baked milk introduction and who are 
the optimal patients to start a milk ladder plan. According to the literature review in chapter 
3, section 3.5, immune markers such as SPT and milk specific IgE may be useful predictive 
tools because they could provide information regarding the appropriate time at which to 
conduct a milk challenge.  Healthcare professionals reported in the survey that they currently 
combine these tests with a clinical assessment to identify optimal patients for baked milk 
introduction.  However, the immune biomarkers study discussed in chapter 6 showed that 
SPT and milk specific IgE had poor predictive values for the outcome of food challenges and 
they are not therefore reliable tests to provide information regarding the appropriate time 
of baked milk introduction and identify children able to tolerate baked milk products.  
 
These findings therefore indicate that it is not currently viable for healthcare professionals 
to replace milk challenges with the measurement of immune markers to confirm if a child is 
tolerant to different forms of milk or milk products. Hence, BMCs and a milk ladder plan 
remain the most appropriate and reliable predictive tools to confirm the level of milk 
tolerance in children with CMA.  However, according to the literature review (section 3.5) 
and the findings of the USA study, SPT wheal sizes and milk sIgE levels can be considered 
with other predictive characteristics such as patients’ age and presence of other allergic 
diseases to identify patients who might be able to tolerate different forms of baked milk 
foods, and thus make good candidates for BMC and ML. However, the age of a child should 
be considered not only from clinical aspects but also from practical and ethical perspectives. 
The qualitative study highlighted that mothers’ experience an ethical dilemma in cases 
where baked milk introduction causes pain and discomfort in a young child un able to 
communicate and describe his/her condition and feelings.  According to the qualitative 
study, mothers worried about the right time of baked milk introduction and were reluctant 
to start a milk ladder due to the young age of their child and his/her inability to communicate 
any symptoms they might be experiencing. The lack of both reliable immune markers and a 
consensus approach among HCPs to deciding when to introduce baked milk indicate the 
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need for there to be clear guidance that should take into account parental feelings and 
preferences when deciding whether to start BM introduction.  
Nevertheless, despite the difficulties implementing the ML, mothers highlighted clear 
benefits to their child and family once their child started to develop tolerance. Milk allergic 
children could include a variety of milk products that provide a liberation of their diet and 
improved their nutritional status. It also helped to improve the quality of life of the child and 
their family.  
7.4.2. ‘Where’ should baked milk be introduced? 
From the survey of HCPs presented in Chapter 4, it was evident that HCPs introduce baked 
milk products in the form of BMC and ML both in hospital and at home. The HCPs’ decision 
about the appropriate place for the introduction of these foods mainly depended upon the 
type of CMA (IgE-mediated or mild to moderate IgE-mediated) in question. In IgE –mediated 
CMA, HCPs reported selecting the hospital as the appropriate place for BMC due to the 
potential severity of allergic reactions. The majority of HCPs reported that home is not a 
suitable place for BMC in IgE-mediated CMA again due to a risk of severe reactions and 
anaphylaxis that need medical support. However, there is a contradiction between these 
findings and those of the qualitative study examining mothers’ experiences of introducing 
baked milk. In particular, there were mothers whose children had IgE-mediated CMA but had 
followed a milk ladder plan at home without having undergone an initial BMC to determine 
tolerance in hospital. In these cases, mothers expressed that they would have preferred their 
child to undertake an initial BMC in hospital, but that their allergy clinic did not offer this. As 
discussed in the literature review (section 2.4.2) and in this chapter (section 7.3.1), the BMC 
procedure requires medical supervision because severe allergic reactions are associated with 
baked milk introduction in IgE mediated - CMA.  However, as has also been discussed (section 
7.3.1.), there is still a debate related to the appropriate setting for baked milk introduction. 
As demonstrated by the findings of the qualitative study, this lack of consensus seems to 
affect mothers’ quality of life and their psychological condition. Interestingly, the findings of 
the HCPs indicated that parents may be anxious about baked milk introduction regardless of 
the location; HCPs reported parental anxiety whether baked milk was introduced at hospital 
or at home. The qualitative study of mothers’ experiences had a similar finding; in particular, 
mothers of children with a non-IgE-mediated CMA preferred a home-based baked milk 
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challenge, whilst mothers of children with an IgE-mediated CMA felt more confident and 
secure with a hospital-based-MC. Therefore, allergy healthcare services not only should 
assess and individualise each case, but also consider mothers’ preferences in terms of BMC 
setting (hospital/home) to help them to feel confident with this process and reduce their 
anxiety and stress.      
 
HCPs also reported instances where children experienced symptoms at home during BMC. 
Such experiences were also highlighted during the qualitative study.  Mothers discussed not 
only the difficulties they experienced in recognising the symptoms of allergic reactions 
caused by baked milk introduction but also the lack of guidance by HCPs how to recognise 
and manage this. In the survey of HCPs, they identified common symptoms children that 
experience during baked milk introduction in hospital or at home in IgE and non-IgE mediated 
CMA. Allergy healthcare services could provide a list of these symptoms and a guidance how 
to manage these symptoms at home so that to help parents to provide better care to their 
children and control their anxiety caused during baked milk introduction at home.    
 
7.4.3. ‘How’ should the process of baked milk introduction be managed?  
Looking across the three studies, the findings of this programme of research highlight two 
key considerations for how baked milk introduction should be managed in practice. In 
particular, there are findings related to the information and support provided not only to 
mothers, but also to HCPs working with cow’s milk allergic patients. Additionally, this 
research identified issues with the (lack of) flexibility of the milk ladder to accommodate the 
real-world practicalities of baked milk introduction in young children, that should be 
reflected upon for practice.  
 
Provision of guidance, information and support during the milk ladder process  
A combination of discrepancies regarding the management of the baked milk introduction 
(as indicated by HCPs’ survey) and the lack of a milk ladder protocol based on evidence (as 
indicated by the literature review in chapter 2) may lead to limited guidance being provided 
to parents of children that follow a plan of baked milk introduction. HCPs require clearer 
national and international guidelines and a milk ladder protocol based on evidence in order 
to provide proper support in CMA patients and their parents during baked milk introduction. 
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This gap in allergy health services was also highlighted by mothers in the qualitative study of 
this research. Mothers’ anxiety was associated with the low quality of allergy health services 
in terms of limited parents’ education regarding not only the recognition of symptoms and 
management of allergic reactions in baked milk introduction, but also practical issues such 
as recipes and labelling of baked milk products, trial food doses and time spent in each step 
of the milk ladder, alternative or equivalent foods, and unhealthy food options in the milk 
ladder. HCPs and parents’ communication should be improved not only during consultation 
in the hospital visit, but further support is also required either with regular follow up 
arrangements or direct contact with a dietitian/allergist via phone or email. Mothers were 
usually confused about the side effects of a food trial and appeared to need direct guidance 
on questions such as: Is the symptom related to the reaction to food trial? Is it necessary to 
postpone the milk ladder for later? When is the appropriate time to re-attempt a food trial 
after a reaction to a step of the milk ladder? What medicine should I use to relieve the 
symptoms caused by a food trial? According to the findings of the qualitative study, for all 
the questions mentioned above, mothers sought to find out answers using social media due 
to the lack of clarity in the information provided by healthcare services and their 
communication with HCPs. Social media may be a good source of information. However, 
health care should not be provided by parental groups in social media. Each case is individual 
and there are many medical, social, and psychological factors that need to be taken into 
account for each milk allergic patient.  
Thus, HCPs’ input is essential throughout the implementation of the milk ladder to ensure 
the safety of the process and reduce parental anxiety. Until a national/international milk 
ladder protocol is established based on evidence, the milk ladders that are currently 
recommended to parents should include further healthy options and alternative/equivalent 
foods to meet the needs of children for a balanced diet and provide choices in case of other 
concomitant food allergies.  The milk ladder information should include recipes with the 
appropriate information related to temperature and time of heating, brand names of 
commercial baked milk products with label information regarding the protein milk content 
and any other related allergy ingredients so parents and caregivers would be able to identify 
the appropriate product when shopping. This research has shown that, the implementation 
and completion of a milk ladder may be a long process for some children. Hence appropriate 
guidance and healthcare support is required to help parents to follow all the steps of the milk 
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ladder safely and to reduce their anxiety and concerns improving quality of life of both 
mothers and children.   
Flexibility in the baked milk introduction for real-world implementation 
The survey of HCPs highlighted that they need to implement best practice with baked milk 
introduction in the context of limited resources and access for patients to specialists such as 
allergists/immunologists, allergy dietitians, psychologists and nurses. However, the 
qualitative study indicates that there is a need for HCPs to spend more time engaging with 
parents about the milk ladder. This is both spending time during the parents’ initial visit in 
the clinic clarifying information related to milk ladder completion and encouraging parents 
to directly contact them by phone or email if they have queries or any other issues during 
milk ladder implementation. Parents’ preferences on the appropriate time of baked milk 
introduction should be considered by HCPs and regular follow ups should be arranged when 
it is appropriate.  
 
In non-IgE mediated CMA, the guidelines such as MAP and iMAP guidelines are clear and 
enhance HCPs’ clinical practice in the management of baked milk introduction. However, 
modification of the milk ladders is required in terms of the introduction of healthy food 
options, alternative foods, and consideration of foods suitable for those with concurrent 
food allergies. Milk ladders should also be clearer about how much time should be spent in 
each step of the milk ladder. The ideal option would be to introduce only one milk ladder 
based on a national or even international agreement in order to avoid any confusion for 
parents or misunderstanding during the process. A list with potential symptoms and 
guidance about their management, also in addition to practical guidance regarding the 
implementation of the milk ladder should be provided by HCPs. Psychologist input may need 
to be recommended in cases in which mothers cannot control their anxiety during the milk 
ladder process. According to the literature review in chapter 2, in IgE mediated CMA, due to 
inconsistencies between the guidelines and lack of consensus from HCPs regarding the 
appropriate setting (hospital/home), an initial BMC should be undergone in hospital to test 
tolerability before a milk ladder plan is recommended at home. The immune biomarkers 
study described in Chapter 7 suggests that HCPs should not rely solely on a SPT or milk sIgE 
levels before they decide to introduce baked milk products because these immune 
biomarkers are not reliable predictors. A careful clinical assessment should be used 
combining immune markers assessment with a consideration of other predictive indicators 
 
 
172 
 
such as age, previous anaphylaxis to milk or milk products and other concurrent allergic 
diseases. The strong feeling around the location of baked milk introduction as highlighted by 
mothers in the qualitative study underline the important of considering parents’ preferences 
regarding the implication of the milk ladder before HCPs recommend a milk ladder plan at 
home.       
7.5 Future research needs 
The important findings identified by this programme of research into the introduction of 
baked milk highlights that milk ladder protocols need to be evaluated and validated in terms 
of the range of foods in the milk ladder, the doses of foods and the time spent in each step 
of the milk ladder.  
Further understanding is also required on the effect of the wheat and fat matrix in the baked 
milk containing foods and its importance in the allergenicity of milk. Additionally, clinical 
trials are needed to investigate the risk of recurrence of milk allergy once tolerance is initially 
achieved, and to evaluate whether the passing of BMC or completing of milk ladders provides 
a guarantee for prolonged tolerance to baked milk products or unheated milk.  Additional 
research might also explore how best to provide standardised information for parents 
regarding the gradual milk introduction at home. For example, in the Allergy UK site parents 
could be asked what changes they believe that are required in the IMAP milk ladder.    
There are a few studies that have investigated immune markers that can predict BMC and 
milk ladder’s outcome. There are not yet proposed cut-off values that can be used to predict 
tolerance to baked or unheated milk. Larger cohort studies and standardised BMC and milk 
ladder protocols are required to establish reliable immune markers that could predict 
reactivity to baked milk and unheated milk. Specific cut off values for SPT and milk sIgE values 
should be validated by clinical trials before they replace the baked or unheated milk 
challenge. Further clinical trials are required to assess how many children developed milk 
tolerance after the milk ladder intervention, how many children react, and what symptoms 
experienced the CMA children during a milk ladder process at home.  Growth and nutritional 
status of children that follow a milk ladder plan for a long period of time need to be assessed. 
Further qualitative studies are required to evaluate parental anxiety associated with the long 
process of a milk ladder plan. Parameters or characteristics that predict advancement of 
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baked milk intake in different forms, including milk challenge/milk ladder characteristics, 
immune markers such as IgE levels, age of patients, and presence of other allergic diseases 
need to be investigated  
7.5 Strengths and limitations 
This programme of PhD research has a number of key strengths. Firstly, this research 
included a representative population that provided generalisability of the study findings. The 
HCPs survey involved participants from different regions of the world and the qualitative 
study with mothers involved participants from different areas of the UK and they had 
experienced a different level of allergy services. Secondly, the use of a qualitative approach 
helped to gain an understanding of mothers’ perceptions regarding the efficacy and safety 
of a milk ladder process. During the interviews, mothers were keen to share their thoughts, 
feelings and experiences about this process. Although mothers had a busy schedule (work 
and family commitments), they showed a high interest for the topic and were happy to share 
with me their experiences related to BM-reintroduction into the diet of their milk allergic 
child. The children of the interviewees had achieved different steps in the milk ladder, and 
this gave the possibility to collect information regarding mothers’ experiences at the 
beginning, middle and completion of the milk ladder. Finally, prospective recruitment of 
participants occurred in all studies.  HCPs and mothers’ data were prospectively collected, 
thus limiting recall bias.  The data was collected, recorded and analysed by the same 
researcher to minimise researcher bias.  
Methodological issues and limitations have already been described in detail within the 
previous chapters. However, there are also some limitations to the research which are 
noteworthy when interpreting the study findings. Firstly, the participants of the USA study 
were patients seen in Cincinnati Children’s Hospital Medical Centre (CCHMC) so may not be 
representative of the larger allergic population and caution should therefore be applied 
regarding the generalisability of the study findings. However, a single clinic may be 
insufficient to recruit a viable sample size required to determine cut-off for SPT and milk sIgEs 
for predicting baked milk challenge outcomes.  
  Further multicentre trials could provide a better basis for the subsequent generalisation of 
findings. However, they are very expensive and complex in terms of co-ordination, quality 
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control and data management. Secondly, although as an allergy dietitian practised in this 
area I had the experience to interview and collect information of mothers’ experiences, my 
interpretation and conclusions may differ if the same data was collected and analysed by 
other researchers. In the qualitative studies, different interpretations and conclusions could 
be derived based on the same data by other researchers because they are based on the 
personal characteristics and individual skills of each researcher and the data could be more 
easily influenced by the researcher’s biases and idiosyncrasies (Bengtsson, 2016). This type 
of research is based on the opinions and judgment rather than statistical results and are 
unique in itself so it is difficult to replicate the findings. In addition, data was collected from 
residents living in the UK and the findings cannot necessarily be generalised to a larger 
population in different part of the world. Finally, the HCPs questionnaire was self-reported 
and the data may be biased by the time in which a HCP fill out the questionnaire. Usually, 
HCPs have a very busy schedule and many tasks so the understanding of questions and the 
quality of their responses could be biased by their limited time to complete the 
questionnaire. Although, HCPs were involved in the management of CMA, their responses 
may be influenced by their level of expertise and training and also the policy of the 
hospital/clinic that they were based on.  
Even though a major strength of self-report data is that it comes directly from participants 
and personalises data and facilitate elaboration of responses, a self-response bias may occur. 
As it was mentioned above, the respondent may be tired or feel time pressure, or had an 
understanding issue with the context of the question and further explanation was required. 
However, self-report data for both research methodologies, a survey and a phone semi-
structure interviews, are most suitable when attitudes and beliefs of participants are 
explored because personal opinions cannot be accessed and observed (Duffett et al., 
2012)                     
7.6 Overall conclusion 
This research has provided the first in-depth examination of the use of BM-containing foods 
in clinical practice for the management of IgE and non-IgE-mediated CMA by HCPs world-
wide; the first UK exploration of mothers’ experience of introducing BM-containing foods 
into the diet of their children with IgE and non-IgE mediated CMA; and an analysis of USA 
data derived from a large scale pediatric clinical allergy setting to provide information 
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regarding  immune markers’ ability to predict milk allergic children who might be optimal 
candidates for a gradual milk reintroduction or a milk ladder. There is growing evidence to 
suggest that introduction of BM-containing foods may be required to develop milk tolerance 
since regular consumption of BM-containing foods seems to promote the development of 
tolerance to milk containing products and unheated milk. Milk is an important source of 
protein in young children and unnecessary milk restricted diets should be avoided. Adding a 
variety of BM-containing foods rich in milk protein can broaden children’s diets, and has the 
potential to enhance their nutritional status and quality of life. A baked milk challenge is used 
to introduce a full portion of BM-containing food in a day in hospital and milk ladder to re-
introduce milk containing foods gradually at home over a number of 
days/weeks/months/years. It is a process that re-introduces milk products gradually in 
stages, starting with foods that contain only a small amount of well-cooked milk and 
progressing towards un-cooked milk products and fresh milk. However, there is still limited 
evidence related to the appropriate time to start baked milk re-introduction in IgE and mild 
to moderate non-IgE mediated CMA and a debate on “where” (hospital or home) to re-
introduce BM-products in IgE-mediated CMA. 
This PhD research provided data that indicates that immune markers such as milk extract 
and fresh milk-SPT and milk sIgE have poor predictive values for milk challenge outcomes 
and cannot currently provide reliable information regarding the appropriate time of a 
gradual milk reintroduction or a milk ladder and the development of milk tolerance. These 
findings are in line with previous studies which had concluded that BMC and unheated milk 
challenges remain the gold standard in determining baked or unheated milk tolerance 
because of the poor practicability of the evaluated immune markers. Further research is 
required to provide reliable cut-offs values for SPT and milk-sIgE to provide valuable 
information regarding the suitable time for a milk ladder in CMA. Providing reliable immune 
markers not only contribute in determining of milk tolerance but also in reducing the cost to 
healthcare service system and in improving milk allergic children’s health related-quality of 
life. Clear guidance is required to certain the feasibility and safety of BM-reintroduction and 
help HCPs in their decision regarding the appropriate place for this process in IgE-mediated 
CMA. Standardisation and validation of BMC and milk ladder protocols based on scientific 
evidence are fundamental to guide HCPs and parents/cares enhancing the safety of this 
approach. Education and practical guidance in mothers on how to complete the milk ladder 
could contribute to reduce mothers’ anxiety and uncertainty about this procedure and 
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encourage them to attempt and achieve the optimal milk tolerance achievement for their 
milk allergic children. Healthcare services support is essential during BM-reintroduction not 
only to educate parents/cares but also to psychologically support parents ensuring the 
efficacy and safety of the BM-reintroduction ta home.         
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Use of baked milk challenges and milk ladders in clinical 
practice: a worldwide survey of healthcare professionals 
P. Athanasopoulou1 , E. Deligianni2, T. Dean1, A. Dewey1 and C. Venter1 
1 2 
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To the Editor: 
In previous years, the cornerstone of the 
management of Cow’s Milk Allergy (CMA) was 
solely based on the strict avoidance of all cow’s 
milk (CM) and foods containing CM from the 
patient’s diet [1]. More recently, the importance of 
baked milk (BM) introduction into the diet of 
children with CMA has become well-recognized as 
a part of CMA management. Current research 
suggests that 75% of children become tolerant to 
baked/heated forms of CM such as muffin and 
waffles before they become tolerant to 
pure/uncooked forms of CM [2]. It has been 
demonstrated that children who tolerated BM 
were 28 times more likely to become tolerant to 
CM compared to those children who were not able 
to tolerate these foods [3]. Further, the ingestion 
and incorporation of BM-containing foods into the 
children’s diet seemed to accelerate the resolution 
of CMA without any adverse effects on children’s 
growth, intestinal permeability, or the severity of 
coexisting diseases such as asthma, atopic 
dermatitis and allergic rhinitis [4]. Identification of 
CMA children who are able to tolerate BM in a 
variety of forms can also contribute to a liberalized 
diet that improves the quality of life of patients. 
This strategy may additionally help to avoid an 
unnecessary restriction of BM-containing foods or 
to prevent a severe reaction that could be 
provoked with the uncooked milk; children reactive 
to BM appear to be at higher risk of systemic 
reaction than those children that tolerate BM but 
still remain allergic to uncooked milk [2, 5]. 
In the United Kingdom, CM is one of the most 
common foods responsible for a fatal anaphylactic 
reaction in children less than 16 years of age, and 
food allergy is the main cause of a fatal 
anaphylactic reaction outside the hospital setting 
[6, 7]. It is difficult to estimate how many people 
die each year from food anaphylaxis and to confirm 
the trigger that caused these tragedies. We are 
aware of a fatal anaphylactic reaction in a child 
following eating a milk product outside the 
healthcare 
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setting in the United Kingdom, two years ago. This 
further emphasizes that the decision to challenge 
at home should not be taken lightly and that there 
is a risk of severe reactions, even anaphylaxis. 
At the time of completion of this survey, few 
guidelines were available on BM introduction. In 
the United Kingdom, the MAP Milk Allergy 
guidelines provide information on the initial 
diagnosis and the management of mild to 
moderate non-IgE-mediated CMA in primary care 
using a milk ladder (ML) [8]. The British Society of 
Allergy and Clinical Immunology (BSACI) guidance 
for home introduction of BM-containing foods in 
IgE-mediated CMA was first published at the end of 
the survey period [9]. However, there are no 
studies indicating which patients are optimal 
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candidates for home introduction of BM. 
Additionally, there is no universal agreement for 
the criteria used to classify the severity of allergy 
symptoms as mild, moderate, or severe and no 
reliable biomarkers that can be used to indicate the 
safety of home introduction of milk-containing 
foods. This study was conducted to explore what 
guidelines and approaches are currently being used 
by healthcare professionals (HCPs) across the world 
and what their experiences have been in 
introducing a full portion of a BM product as a 
challenge (BMC) over 1 day or as a more gradual 
introduction over a number of days/weeks before 
moving on to other baked milk foods, as per a ML 
approach. 
Methods 
A web-based global survey was conducted to 
capture the views of HCPs using a BMC and/or a 
ML. An electronic questionnaire (see supporting 
information) was developed consisting of 23 short 
questions which could be completed within 
approximately 15 min. The main sections of the 
questionnaire were: 
• Characteristics of HCPs including: professional 
background and level of allergy training, practice 
setting (private/hospital-
primary/secondary/tertiary care) and amount of 
time spent consulting patients with food allergies, 
percentage of respondents from various countries 
and guidelines that HCPs considered before they 
made the decision about the setting of BMC/ML. 
2 Research Letter 
• Were these challenges used and where were these 
challenges performed? 
• What was the HCPs’ opinion on the safety of 
homeBMC and ML? 
• What was the HCPs’ opinion on parental anxiety in 
BMC/ML process? 
• What symptoms were observed? 
An initial pilot testing of the survey was carried 
out on a group of HCPs practising in different parts 
of the world to ensure the clarity of questions. 
Ethical permission of the study was provided by the 
University of Portsmouth Science Faculty Ethics 
Committee. HCPs involved in the diagnosis and 
management of CMA were invited to complete the 
online questionnaire. The participants were 
identified through international professional 
organizations [Food Allergy and Intolerance 
Specialist Group of British Dietetic Association 
(FAISG), British Society for Allergy and Clinical 
Immunology (BSACI), American Academy of Asthma 
Allergy and Immunology (AAAAI), American Dietetic 
Association (ADA), International Network for Diet 
and Nutrition in Allergy (INDANA), Allergy Society 
of South Africa (ALLSA), Australasian Society of 
Clinical Immunology and Allergy (ASCIA), Dietitians 
Association of Australia (DAA), Word Allergy 
Organisation (WAO)]. 
A reminder email was sent 4 weeks later. The 
survey was carried out between January and April 
2014. The Bristol Online Survey was used to analyse 
and describe the results. Descriptive statistics were 
used to summarize data using a combination of 
tabulation and graphical description. Further 
statistical analysis data were entered and analysed 
using IBM (IBM Corp., Armonk, NY, USA) SPSS 
Statistics for Windows version 22.0. Pearson’s chi-
square test was used: (i) to determine whether or 
not there was a statistically significant relationship 
between the use of BMC and ML; (ii) to test 
whether or not a statistically significant association 
exists between the settings (clinical/home) 
regarding where to perform BMC/ML and the types 
of CMA (IgEand non-IgE-mediated CMA). A P value 
less than 0.05 was considered statistically 
significant. 
Results 
Characteristics of HCPs study participants 
A total of 114 HCPs completed the questionnaire 
and provided data on their clinical practice 
regarding using either a BMC and/or a ML in both 
IgE- and non-IgEmediated CMA. The largest groups 
of respondents were dietitians with an interest in 
allergy [52 (46%)] followed by paediatric 
allergists/immunologists [46 (40%)]. The majority of 
participants [106 (93%)] indicated that they were 
involved in the management of IgE- and non-
IgEmediated CMA in infancy and childhood. Most 
of the participants were based in the United 
Kingdom [56 (49%)], followed by the United States 
[20 (18%)], and were practicing in secondary 
care/hospital [52 (39%)] followed by tertiary 
care/specialist centre [42 (37%)]. HCPs reported 
that they based their decision regarding BM 
introduction on an individualized clinical 
assessment (medical history, SPTs, laboratory tests) 
and national/regional guidelines. Demographic 
features of all respondents are shown in Table 1. 
Settings (hospital/home) of BMC and ML in children 
with CMA based on HCPs reports 
IgE-mediated CMA. Ninety-three (82%) HCPs 
indicated that they used BMC to identify patients 
able to tolerate BM products before tolerating 
uncooked milk. Fifty two (56%) respondents stated 
that they conducted these challenges in a clinical 
setting, 8 (9.0%) in a homebased setting, and 33 
(35%) reported using both settings. For ML, 68 
(60%) HCPs stated that they used this approach to 
determine the development of tolerance to BM in 
different forms. Nineteen (28%) respondents 
reported that they used the ML approach in a 
clinical setting, 22 (32%) in a home setting, and 27 
(40%) in both settings. 
Non-IgE-mediated CMA. Eighty-six (75%) of the 
respondents stated that they used BMC to 
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determine the development of tolerance to BM. 
Eight (9%) HCPs reported that they challenged their 
patients in a clinical setting, 51 (59%) used home-
based challenges, and 27 (31%) reported using both 
settings. In terms of using the ladder approach 
(ML), 77 (68%) HCPs reported that they used the 
ML to identify children able to tolerate a range of 
BM-containing foods. Three (4%) HCPs reported 
that they used ML in a clinical setting, 56 (73%) at 
home, and 18 (23%) reported using both settings. 
Choice of challenge setting (clinic/home) was 
statistically significant (P < 0.001) associated with 
the type of CMA (IgE-/non-IgE-mediated). A greater 
number [52 (56%)] of hospital-based BMC 
responses were indicated in IgE-mediated CMA, 
with a larger number [51 (59%)] of home-based 
BMC in non-IgE-mediated CMA. The decision about 
where to perform milk ladder challenges 
(hospital/home) was also statistically significantly 
(P < 0.001) associated with the types of CMA. A 
considerable number of respondents used ML 
challenges/introductions at home in both IgE- [22 
(32%)] and non-IgE-mediated CMA [56 (73%)]. 
However, choosing the safest challenge setting 
remains a difficult decision that concerns not only 
HCPs, but also carers. The majority of HCPs [71 
(62%)] considered the home/outside the clinical 
setting as a safe place to conduct both BMC and ML 
in non-IgE- 
© 2017 John Wiley & Sons Ltd, Clinical & 
Experimental Allergy, 1–5 
Table 1. Demographic characteristics of 
respondents 
Characteristics Options 
Respondents 
(n= 114) (%) 
Professional 
background 
Dietitians 
Paediatric Allergist/Allergist/ 
Immunologist 
52 (46) 
32 (28) 
 Paediatrician with Allergy 
interest 
14 (12) 
 Other* 16 (14) 
Practice settings Secondary Care/Hospital 
Tertiary Care/Specialist 
Centre 
52 (39) 
42 (37) 
 Private Practice 19 (14) 
 Primary Care/Community 16 (12) 
 Other† 4 (3) 
Allergy training Work-based experiential 
learning 
50 (38) 
 Speciality in Allergology/ 
Immunology 
36 (27) 
 Postgraduate Dip in Allergy 10 (8) 
 MSc in Allergy 8 (6) 
 PhD in Allergy 8 (6) 
 Postgraduate Cert in Allergy 4 (3) 
 Other‡ 16 (12) 
Food allergy 
weekly workload 
>50% 
<50% 
62 (54) 
52 (46) 
CMA patients 
seen by HCPs 
Infants/children 
Adults 
106 (93) 37 
(32) 
Participated 
countries 
United Kingdom 
North & South America 
56 (49) 
24 (21) 
 Oceania, Africa, Asia 20 (18) 
 Europe 14 (12) 
Guidelines for 
hospital BMC 
Medical history/SPT/IgE 
Regional/National 
40 (35) 
24 (21) 
 International 12 (11) 
 Hospital policy 9 (8) 
Guidelines for 
home-BMC 
Medical history/SPT/IgE 
Regional/National 
39 (34) 
26 (23) 
 International 6 (5) 
 Hospital policy 5 (4) 
Guidelines for 
hospital-ML 
Medical history/SPT/IgE 
Regional/National 
24 (21) 
26 (23) 
 International 4 (4) 
 Hospital policy 3 (3) 
Guidelines for 
home-ML 
Medical history/SPT/IgE 
Regional/National 
22 (19) 
30 (26) 
 International 4 (3) 
 Hospital policy 4 (3) 
*Other: Pharmacists, Nutritionists, Allergy 
Paediatric Nurses, Physicians, General Practitioners. 
† 
Other: Ministry of Health & Welfare, Research. 
‡ 
Other: Research, Continued Professional 
Development (CPD) & Continuing Medical
 Education (CME) resources,
 allergy training, completed allergy 
modules. 
mediated CMA because there is no risk of severe 
reactions, with an exception in the case of severe 
forms of non-IgE-mediated diseases, such as Food 
Protein 
© 2017 John Wiley & Sons Ltd, Clinical & 
Experimental Allergy, 1–5 Research Letter 3 
Induced-Enterocolitis Syndrome (FPIES). The most 
commonly reported symptoms experienced by the 
patients were reported as atopic eczema and 
abdominal pain in both hospital and home-based 
challenges (Table 2). In terms of IgE-mediated CMA, 
30 (26%) respondents stated that the home 
environment was a safe place to conduct either 
approach whereas 65 (57%) HCPs considered the 
home/outside the clinical setting as a non-safe 
place to conduct both BMC and ML, due to 
potential severe symptoms (Table 2). 
Discussion 
The results from this survey indicate that 32 (28%) 
HCPs reported anaphylaxis in clinic-based BMC and 
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9 (8%) respondents in clinic-based ML challenges, 
but none at home. This finding is consistent with 
previous studies, reporting that some children 
develop anaphylaxis after ingestion of baked milk-
containing foods such as a muffin/pizza in hospital 
[3, 10]. Mehr et al. identified clinical predictors of 
reacting to baked cow’s milk [10]. These included 
children with: asthma requiring preventer therapy, 
IgE-mediated clinical reactions to more than three 
foods, a prior history of anaphylaxis to cow’s milk, 
and highly atopic children. They indicated that such 
children should undergo BMCs in hospital. This 
study by Mehr involved challenges with increasing 
amounts of BM being introduced over a number of 
hours over the same day and 27% of children did 
not pass these oral food challenges [10]. This 
Table 2. Summary of the most frequently reported 
symptoms by the 
HCPs for BMC & ML 
 
 Clinical setting N 
 (%) Home N (%) 
Clinical symptoms BMC ML BMC ML 
IgE-mediated CMA 
Urticaria 68 (60) 34 (30) 32 (28) 
25 
(22) 
Vomiting 55 (48) 24 (21) 33 (29) 22 
(19) 
Angioedema 49 (43) 23 (20) 10 (9) 9 (8) 
Runny nose & eyes 49 (43) 19 (17) 13 (9) 12 
(11) 
Nausea 48 (42) 20 (18) 16 (14) 22 
(19) 
Wheezing 39 (34) 15 (13) 3 (2) 4 (3) 
Diarrhoea 34 (30) 17 (15) 42 (37) 35 
(31) 
Anaphylaxis 32 (28) 9 (8.0) – – 
Non-IgE-mediated CMA 
Atopic eczema 20 (18) 8 (7) 43 (38) 
37 
(32) 
Abdominal pain 18 (16) 4 (3) 41 (36) 32 
(28) 
Diarrhoea 15 (13) 6 (5) 37 (32) 35 
(31) 
Gastro-oesoph. reflux 12 (11) 4 (3) 32 (28) 30 
(26) 
Colic 7 (6) 2 (1) 22 (19) 17 
(15) 
Food aversion 6 (5) 4 (3) 17 (15) 12 
(10) 
Constipation 5 (4) 4 (3) 43 (38) 29 
(25) 
N, number of responses. 
4 Research Letter 
shows that baked milk challenges carry a risk in 
those with IgE-mediated CMA, and in a number of 
children with non-IgE-mediated CMA. The findings 
from this survey highlight that there were no cases 
of reported anaphylaxis at home during baked milk 
challenges. This could be due to successful 
individual risk assessment and choosing an 
appropriate setting accordingly. This is supported 
by the fact that there were more IgEmediated 
reactions associated with baked milk challenges in 
the clinical setting compared with the home. 
Healthcare systems differ between countries and 
many European countries may not be able to 
provide food challenge facilities for all food allergic 
patients as considerable hospital resources are 
required [11]. Such challenges are time-consuming 
with long waiting lists, a major problem in many 
allergy clinics. For practical reasons, allergy services 
attempt to address this issue by suggesting initial 
introduction of BM-containing foods at home based 
on a clinical assessment. The findings from our 
survey indicate that the decision regarding the 
location of challenges in the majority of cases is 
based on an individualized clinical assessment 
looking for such specific parameters as: sIgE levels, 
skin prick tests, severity of previous symptoms, 
severe forms of nonIgE-mediated CMA such as 
FPIES or mixed IgE- and non-IgE-mediated CMA. 
Parents’ and children’s anxiety is another factor 
that is considered by HCPs. A considerable number 
of HCPs reported that the families were anxious 
when BMC [46 (36%)] or ML [41 (36%)] were 
conducted either at home or in a clinical setting. A 
better understanding of parents’ perceptions 
regarding the use of BM forms would be helpful for 
HCPs to provide optimal care to children during 
introduction of BMcontaining foods. 
This survey has clearly highlighted the lack of 
international guidance on challenge/gradual 
introduction of baked cow’s milk in a matrix (ML). 
The World Allergy Organization, European 
Academy of Allergy and Clinical Immunology and 
PRACTALL consensus report recommends milk 
challenges in a safe, well-equipped environment 
that is supervised by a medical team and have 
published guidelines for milk oral food challenges 
but these guidelines do not focus on BMC or a ML 
process [1, 11, 12]. However, as the survey was 
completed, the BSACI guidelines were published 
and data from UK respondents may now be 
different. 
In conclusion, our findings suggest that there are 
a number of inconsistencies between the use of 
BMC and ML. We suggest that a larger sample size 
with a sampling frame inclusive of more countries 
and clinicians from tertiary, secondary, and primary 
care should be conducted. There is a clear need for 
universal guidance, taking into account country-
specific needs, on the safe introduction of baked 
milk products. 
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Appendix 2: Poster presentation ”Use of baked milk challenges in clinical practice: a 
worldwide survey” 
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Appendix 3: Poster presentation: “Establishing whether specific immune markers can 
predict tolerance/reactivity during food challenges to different steps of the milk ladder in 
children with IgE mediated Cow’s Milk Allergy” 
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Appendix 4: Poster presentation “Investigating parents’ experiences in re-introducing 
baked milk foods in children with cow's milk allergy” 
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Appendix 5: Used search terms for PubMed and Web of Science  
 
 Search Terms for Pub Med Search terms for Web of 
Science  
Keywords   
Baked milk challenges baked[All Fields] AND ("milk, 
human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("Challenge (Atlanta 
Ga)"[Journal] OR "challenge"[All 
Fields]) 
Baked or milk or challenges   
Food challenges 
protocol  
("food"[MeSH Terms] OR 
"food"[All Fields]) AND ("Plan 
Parent Chall"[Journal] OR 
"challenges"[All Fields]) AND 
protocol[All Fields] 
Challenge or protocol or “food 
protocol”  
Food challenges ("food"[MeSH Terms] OR 
"food"[All Fields]) AND ("Plan 
Parent Chall"[Journal] OR 
"challenges"[All Fields]) 
Food or challenge   
Milk tolerance ("milk, human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("immune tolerance"[MeSH 
Terms] OR ("immune"[All Fields] 
AND "tolerance"[All Fields]) OR 
"immune tolerance"[All Fields] 
OR "tolerance"[All Fields] OR 
"drug tolerance"[MeSH Terms] 
OR ("drug"[All Fields] AND 
"tolerance"[All Fields]) OR "drug 
tolerance"[All  
Fields]) 
 
Milk or tolerance or “immune 
tolerance” or immune 
Baked milk tolerance baked[All Fields] AND ("milk, 
human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("immune tolerance"[MeSH 
Terms] OR ("immune"[All Fields] 
AND "tolerance"[All Fields]) OR 
Baked or milk or tolerance or 
immune  
“immune tolerance” 
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"immune tolerance"[All Fields] 
OR "tolerance"[All Fields] OR 
"drug tolerance"[MeSH Terms] 
OR ("drug"[All Fields] AND 
"tolerance"[All Fields]) OR "drug 
tolerance"[All Fields]) 
Heated milk tolerance heated[All Fields] AND ("milk, 
human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("immune tolerance"[MeSH 
Terms] OR ("immune"[All Fields] 
AND "tolerance"[All Fields]) OR 
"immune tolerance"[All Fields] 
OR "tolerance"[All Fields] OR 
"drug tolerance"[MeSH Terms] 
OR ("drug"[All Fields] AND 
"tolerance"[All Fields]) OR "drug 
tolerance"[All Fields]) 
Heated or milk or tolerance or 
immune or “immune tolerance”  
Cow’s milk epitope cow's[All Fields] AND ("milk, 
human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("epitopes"[MeSH Terms] 
OR "epitopes"[All Fields] OR 
"epitope"[All Fields]) 
 
“Cow milk” or milk or epitopes 
Cow’s milk cow's[All Fields] AND ("milk, 
human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
Cow or “cow milk” or milk 
Cow’s milk allergy  cow's[All Fields] AND ("milk 
hypersensitivity"[MeSH Terms] 
OR ("milk"[All Fields] 
cow or“cow milk”  or “milk 
allergy” or “milk 
hypersensitivity” or allergy or 
hypersensitivity 
Biomarkers and milk 
tolerance 
 ("biological markers"[MeSH 
Terms] OR ("biological"[All 
Fields] AND "markers"[All 
Fields]) OR "biological 
markers"[All Fields] OR 
"biomarkers"[All Fields]) AND 
("milk, human"[MeSH Terms] OR 
("milk"[All Fields] AND 
"human"[All Fields]) OR "human 
Biomarkers or milk or tolerance 
or “biological markers” or “milk 
tolerance”or immune or 
“immune tolerance” 
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milk"[All Fields] OR "milk"[All 
Fields] OR "milk"[MeSH Terms]) 
AND ("immune tolerance"[MeSH 
Terms] OR ("immune"[All Fields] 
AND "tolerance"[All Fields]) OR 
"immune tolerance"[All Fields] 
OR "tolerance"[All Fields] OR 
"drug tolerance"[MeSH Terms] 
OR ("drug"[All Fields] AND 
"tolerance"[All Fields]) OR "drug 
tolerance"[All Fields]) 
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Appendix 6: The iMAP guidelines – Milk ladder 
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Appendix 7: HCP’s online questionnaire  
Questionnaire: Use of baked milk challenges & milk ladders in clinical practice:     
                                              A worldwide survey of healthcare professionals   
Section 1: Questions 1-7 refer to your clinical practice   
1. What is your professional background?   
 
  
2. Where do you work?   
(select all that apply)   
Primary care/Community     
Secondary care/Hospital     
Tertiary Care/Specialist centre     
Private Practice     
Other (please specify):  
  
  
  
3. In which country do you practice?   
  
4. Do you consider yourself to be an Allergy Specialist in your particular health 
care professional group?   
Yes   
If yes, please tick your training: (select all that apply)   
 Speciality in Allergology/Immunology     
GP    
Allergist/Immunologist    
Paediatric Allergist    
Paediatrician with special interest in Allergy    
Dietitian    
Other  ( please specify ) :   
     
No  
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 PG Cert in Allergy     
 PG Dip in Allergy     
 MSc in Allergy     
 
PhD in Allergy     
Practical experience     
 Other (please specify):  
 
5. What percentage of your weekly work load is spent on dealing with food 
allergies or intolerances?   
<50%   
>50%   
  
6. Do you see infants/children with:   
IgE-mediated CMA   
Non-IgE mediated CMA   
Both   
Not applicable   
  
7. Do you see adults with:   
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IgE-mediated CMA   
Non-IgE mediated CMA   
Both   
Not applicable   
  
Section 2: Questions 8-9 refer to the initial diagnosis of Cow's Milk Allergy  
For this survey Milk Challenge is the term used for deliberate exposure to Cow's Milk for 
the purposes of an initial diagnosis of Cow's Milk Allergy usually after a 2-4 week period of 
avoidance.   
  
8. Do you use baked milk challenges to confirm the initial diagnosis of Cow's 
Milk Allergy?   
         
    Yes     No    
 a. IgE-mediated CMA   
    
 b. Non-IgE mediated CMA       
  
9. If No, which type of milk do you use to confirm the diagnosis of CMA?  
(select all that apply)   
  
Section 3: Questions 10 to 14 are related to the use of 'Baked Milk Food Challenges' to 
test the development of tolerance to Cow's Milk   
These questions refer to baked milk challenges where one food is introduced in increasing 
doses usually performed over a period of one day e.g. eating the same cake in increasing 
amount. These types of challenges are often used to test for resolution of Cow's Milk Allergy 
Formula for infants      
Pasteurized milk for infants      
Pasteurized milk for older children /adults      
Other  ) please specify ( :  
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after an extended period of avoidance and usually contain only one food given over a period 
of a few hours.   
  
10. Do you use baked milk food challenges to determine tolerance in?   
        
    No     Yes    
a. IgE-mediated CMA     
b. Non-IgE mediated CMA     
  
11. If Yes, what kind of milk containing products do you use for these 
challenges?  (select all that apply)   
 
  
12. Where do these challenges take place?   
        
  In hospital/a  At home/outside  Both     Not  
   medical  the medical  applicable    
 setting    setting    
a. IgE-mediated CMA       
b. Non-IgE mediated CMA       
  
13.  What clinical guidelines do you follow when making the decision to carry out these 
challenges in hospital or a medical setting versus at home or outside the medical setting?   
  
Please list in the applicable box:   
   
     
   
Cake      
Biscuits      
Waffle      
Pizza      
Other  ) please specify ( :  
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a. In hospital/a medical setting   
b. At home/outside the medical setting   
 
  
  
14.  Please tick the symptoms that your patients have experienced during these 
challenges in hospital/a medical setting or at home/outside the medical setting? 
(As many as appropriate)  
Hospital/medical setting    
IgE- mediated CMA                                            Non-IgE mediated   o 
Urticaria                                                     o Gastro-oesophageal reflux  
o Angioedema                                              o Diarrhoea  
o Runny nose and eyes                                 o Abdominal pain  
o Nausea                                          o Constipation    
o Vomiting                                              o Atopic eczema   o Diarrhoea                              
o Colic  
o Wheezing                                              o Food aversion o Anaphylaxis                                                     
o  Blood and/or mucus in the stool 
o Other                                                          o  Other                                                      
   Home/outside medical setting    
IgE- mediated CMA                                       Non-IgE mediated     
  
o Urticaria                                                    o Gastro-oesophageal reflux  o 
Angioedema                                              o Diarrhoea o Runny nose and 
eyes                                 o Abdominal pain  
o Nausea                                          o Constipation  
o Vomiting                                              o Atopic eczema   o Diarrhoea                              
o Colic  
o Wheezing                                             o Food aversion o Anaphylaxis                                                     
o  Blood and/or mucus in the stool 
o Other                                                          o  Other                                                      
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Section 4: Questions 15-18 refer to 'Graded Reintroduction of Milk Containing Food'  
Graded reintroduction of milk containing food is the term used for gradual reintroduction 
(increasing the amount of milk protein and decreasing the level of heat denaturation) of 
cow's milk after an extended period of avoidance. This reintroduction is also referred to as 
the 'Milk Ladder' and usually contains a variety of food such as biscuits, cakes, muffin or 
pizza, given over a period of days, weeks or months.   
  
15. Do you use graded reintroduction of milk containing food in determining  
 tolerance to Cow's Milk?   
Yes   
No   
  
16. If No, please click not applicable  
If Yes, where does the graded reintroduction of milk containing food take place?   
        
  In hospital/a  At home/outside  Both    Not  
   medical  the medical  applicable    
 setting    setting    
a. IgE-mediated CMA      
b. Non-IgE mediated CMA      
  
17.  What clinical guidelines do you follow when making the decision to carry out a graded 
reintroduction of milk containing food in hospital/a medical setting versus at home/outside 
of the medical setting?   
   
     
   
a. In hospital/a medical setting   
  
b. At home/outside the medical setting   
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18.  Please tick the symptoms that your patients have experienced during a graded 
reintroduction of milk containing food in hospital/ a medical setting or at home/outside 
the medical setting? (as many as appropriate)  
  
                                    Hospital/medical setting    
IgE- mediated CMA                                                 Non-IgE mediated   o 
Urticaria                                                     o Gastro-oesophageal reflux  
o Angioedema                                              o Diarrhoea o Runny nose 
and eyes                                 o Abdominal pain o Nausea                                           
o Constipation o Vomiting                                              o Atopic 
eczema   o Diarrhoea                              o Colic  
o Wheezing                                             o Food aversion o Anaphylaxis                                                
o  Blood and/or mucus in the stools      
o Other                                                          o  Other                                                                 
                                      Home/outside medical setting    
IgE- mediated CMA                                             Non-IgE mediated     
  
o Urticaria                                                    o Gastro-oesophageal reflux  
o Angioedema                                              o Diarrhoea o Runny nose 
and eyes                                 o Abdominal pain o Nausea                                           
o Constipation  
o Vomiting                                              o Atopic eczema   o 
Diarrhoea                              o Colic  
o Wheezing                                             o Food aversion o Anaphylaxis                                                
o  Blood and/or mucus in the stools      
o Other                                                          o  Other                                                                 
  
  
Section 5: Questions 19-20 refer to your personal opinions  
19.  Do you consider the home/outside the medical setting as a safe place to carry out:   
        
  Baked milk   Graded reintroduction  Both   Not  
   food  of milk containing  safe    
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 challenges    food    
a. IgE-mediated CMA      
b. Non-IgE mediated CMA      
20.  Do you think that the parents are more anxious when food challenges take place:   
        
  At   At   Both     Not  
 hospital/a home/outside  applicable    Please list any 
comments:    
   
medical  the 
medical setting    
 setting     
a. Baked milk      
food  challenges   
b. Graded      
reintroduction  of milk containing food   
 
21.  Can you send us an example of your protocol on baked milk challenges and graded 
reintroduction of milk containing food in hospital/at home/both?   
 
  
  
 
  
No    
Yes If Yes, please email to Yiota.Athanasopoulou@port.ac.uk    
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Appendix 8: SFEC ethical review – HCP’s study  
  
  
Panagiota Athanasopoulou  
School of Health Sciences & Social Work   
University of Portsmouth  
  
yiota.athanasopoulou@port.ac.uk Science Faculty Ethics Committee  
Science Faculty Office  
University of Portsmouth  
St Michael’s Building  
White Swan Road  
PORTSMOUTH  
PO1 2DT  
  
023 9284 3379 ethics-sci@port.ac.uk  
  
6 July 2018  
ETHICAL REVIEW – NO ETHICAL OPINION POSSIBLE – BUT INCLUDE STUDY IN  
PHD THESIS  
  
Study Title: Use of baked milk challenges and milk ladders in clinical practice: a worldwide survey of healthcare 
professionals  
  
Reference Number: SFEC 2018-070 Date Submitted: 29 June 2018  
Thank you for submitting your application to the Science Faculty Ethics Committee (SFEC) for retrospective 
ethical review. Your application has been reviewed by SFEC and cannot issue a retrospective ethical opinion for 
work already completed.  
  
However, given the information previously provided and in discussions we have had with your current (new) 1st 
supervisor, Dr Mackenzie, SFEC was of the view that the failure to submit for ethical review prior to the study 
starting (6 years ago), was a combination of factors relating to conflicting advice from NHS / HRA regarding this 
as a user evaluation which would not require ethical review (the same advice would be provided today), and 
unclear (and unrecorded) advice from the then newly forming SFEC. These clearly indicate that this was a 
genuine oversight / misunderstanding, and primarily not of your making.  
  
Accordingly, it was the view of SFEC, that this study be included in the PhD thesis, and the reference number 
given here, should be used when submitting the thesis for examination.  
  
Good luck completing your thesis, at your viva, and for the future.  
  
Dr Jim House  
Chair, Science Faculty Ethics Committee  
  
  
Information:  
  
Dr Heather Mackenzie - PhD 1st Supervisor  
Holly Shawyer - Faculty Administrator  
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Statement of compliance  
  
SFEC is constituted in accordance with the Governance Arrangements set out by the University of Portsmouth    
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      Appendix 9: Invitation email to Health Professional Organisations                    
                          
                                                                                                                                                                                                   
                                                                                                                                                                                                   
School of Health Sciences 
 University of Portsmouth 
 James Watson West 
 2 King Richard I Road 
 Portsmouth PO1 2FR 
 United Kingdom 
 
 
  
Secretary General  
European Academy of Allergy and Clinical Immunology  
 
 
Friday 21 February 2014 
 
Dear ………. 
Re: Request regarding survey on baked milk challenges 
One of our PhD students, Yiota Athanasopoulou, who is a dietitian by background, at 
the University of Portsmouth-UK, is investigating the use of baked milk challenges in 
clinical practice worldwide. 
  
She has developed a very short questionnaire of 22 questions, which should take no 
longer than 10mins to complete. 
  
I am writing to you to ask if there is a possibility that e.g the European Academy of 
Allergy and Clinical Immunology can send this e-mail link out to its members or if a 
link to the survey could be placed on the EAACI website. 
 
We are very happy to share the results of this survey with EAACI in the newsletter or 
anywhere else where it may be of interest. 
 https://www.survey.bris.ac.uk/portsmouth/sbmc 
 
Please do not hesitate to contact me, should you have any questions. 
 
 
Regards 
 
 
 
Carina Venter 
Secretary: Allied Health Board of the EAACI 
Senior Lecturer, University of Portsmouth 
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Appendix 10: Statistical analysis of HCPs survey 
In this appendix is reported the statistics analysis that indicates if there is an association 
between:  
- The type of milk challenges (BMC or ML), that healthcare professionals use to 
identify the development of baked milk tolerance in IgE  or non-IgE  mediated CMA 
and the setting (hospital or home), that a BMC or ML challenge/introduction is 
performed (chapter 4, 4.2 and 4.3 table)   
 
- Safety of a milk challenge setting in IgE/non-IgE mediated CMA (chapter 4, table 
4.4) 
-  Differences between symptoms and setting of a BMC or ML in IgE and non-IgE 
CMA (chapter 4, table 4.5 and table 4.6).   
-  Parental anxiety according to HCPs’ reports and the setting of milk challenges 
(chapter 4, table 4.7)  
- Differences across countries regarding the setting of BMC and ML in IgE and non-
IgE mediated CMA (chapter 4, table 4.8 and 4.9) 
 
1. Type (BMC/ML) and setting (hospital/home) that healthcare professionals use to 
introduce baked milk in children with IgE and non-IgE mediated CMA (chapter 4, 
4.2 and 4.3 tab1e)  
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
BMC_Setting * 
Ige_NonIge_Mediated 
182 99.5% 1 0.5% 183 100.0% 
 
 
BMC_Setting * Ige_NonIge_Mediated Crosstabulation 
 
Ige_NonIge_Mediated 
Total 
Ige_mediate
d 
NonIge_med
iated 
BMC_Settin
g 
Hospital Count 52 8 60 
% within BMC_Setting 86.7% 13.3% 100.0% 
% within 
Ige_NonIge_Mediated 
55.3% 9.1% 33.0% 
% of Total 28.6% 4.4% 33.0% 
Home Count 8 52 60 
% within BMC_Setting 13.3% 86.7% 100.0% 
% within 
Ige_NonIge_Mediated 
8.5% 59.1% 33.0% 
% of Total 4.4% 28.6% 33.0% 
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Both Count 34 28 62 
% within BMC_Setting 54.8% 45.2% 100.0% 
% within 
Ige_NonIge_Mediated 
36.2% 31.8% 34.1% 
% of Total 18.7% 15.4% 34.1% 
Total Count 94 88 182 
% within BMC_Setting 51.6% 48.4% 100.0% 
% within 
Ige_NonIge_Mediated 
100.0% 100.0% 100.0% 
% of Total 51.6% 48.4% 100.0% 
 
 
 
 
 
 
 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 64.987a 2 .000 
Likelihood Ratio 72.497 2 .000 
Linear-by-Linear 
Association 
11.827 1 .001 
N of Valid Cases 182   
 
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 29.01. 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
ML_Setting * 
Ige_NonIge_Med 
149 81.4% 34 18.6% 183 100.0% 
 
 
ML_Setting * Ige_NonIge_Med Crosstabulation 
 
Ige_NonIge_Med 
Total Ige_med 
NonIge_me
d 
ML_Settin
g 
Hospital Count 19 3 22 
% within ML_Setting 86.4% 13.6% 100.0% 
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% within 
Ige_NonIge_Med 
27.1% 3.8% 14.8% 
% of Total 12.8% 2.0% 14.8% 
Home Count 23 57 80 
% within ML_Setting 28.7% 71.3% 100.0% 
% within 
Ige_NonIge_Med 
32.9% 72.2% 53.7% 
% of Total 15.4% 38.3% 53.7% 
Both Count 28 19 47 
% within ML_Setting 59.6% 40.4% 100.0% 
% within 
Ige_NonIge_Med 
40.0% 24.1% 31.5% 
% of Total 18.8% 12.8% 31.5% 
Total Count 70 79 149 
% within ML_Setting 47.0% 53.0% 100.0% 
% within 
Ige_NonIge_Med 
100.0% 100.0% 100.0% 
% of Total 47.0% 53.0% 100.0% 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 27.366a 2 .000 
Likelihood Ratio 29.083 2 .000 
Linear-by-Linear 
Association 
.464 1 .496 
N of Valid Cases 149   
 
 
 
 
 
2. Statistical analysis of HCPs responses regarding the safety of milk challenges in 
IgE and non-IgE CMA(chapter 4, Table 4.4)  
 
MC_SAFETY * Ige_NonIge Crosstabulation 
 
Ige_NonIge 
Total Ige 
Non 
Ige 
MC_SAFE Safe_home Count 30 72 102 
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TY % within 
MC_SAFETY 
29.4% 70.6% 100.0% 
% within 
Ige_NonIge 
31.3% 81.8% 55.4% 
% of Total 16.3% 39.1% 55.4% 
Nonsafe_ho
me 
Count 66 16 82 
% within 
MC_SAFETY 
80.5% 19.5% 100.0% 
% within 
Ige_NonIge 
68.8% 18.2% 44.6% 
% of Total 35.9% 8.7% 44.6% 
Total Count 96 88 184 
% within 
MC_SAFETY 
52.2% 47.8% 100.0% 
% within 
Ige_NonIge 
100.0% 100.0% 100.0% 
% of Total 52.2% 47.8% 100.0% 
 
 
Chi-Square Tests 
 Value df 
Asymptoti
c 
Significan
ce (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square 
47.524
a 
1 .000   
Continuity 
Correctionb 
45.499 1 .000   
Likelihood Ratio 50.203 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
47.266 1 .000   
N of Valid Cases 184     
 
3. Differences between symptoms and setting of a BMC or ML in IgE and non-IgE 
CMA (chapter 4, table 4.5 and 4.6).   
 
• Association between IgE-mediated CMA symptoms and a BMC setting 
(hospital/home) 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N 
Perce
nt N 
Perce
nt N 
Perce
nt 
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Symptoms (Ige) * 
Setting of BMC 
537 100.0
% 
0 0.0% 537 100.0
% 
 
 
Symptoms (Ige) * Setting of BMC Crosstabulation 
Count   
 
Setting of BMC 
Total Hospital Home 
Symptoms (Ige) Urticaria 68 33 101 
Vomiting 56 34 90 
Angioedema 50 11 61 
Runny nose and eyes 50 14 64 
Nausea 49 17 66 
Wheezing 40 4 44 
Diarrhoea 35 43 78 
Anaphylaxis 33 0 33 
Total 381 156 537 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 57.260a 7 .000 
Likelihood Ratio 65.993 7 .000 
Linear-by-Linear 
Association 
.501 1 .479 
N of Valid Cases 537   
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
9.59. 
 
• Association between IgE-mediated CMA symptoms and ML setting 
(hospital/home) 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N 
Percen
t N 
Percen
t N 
Percen
t 
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Symptoms (IgE) * 
Setting of ML 
304 56.6% 233 43.4% 537 100.0% 
 
 
Symptoms (IgE) * Setting of ML Crosstabulation 
Count   
 
Setting of ML 
Total Hospital Home 
Symptoms (IgE) Urticaria 34 26 60 
Vomiting 25 23 48 
Angioedema 24 10 34 
Runny nose and eyes 20 13 33 
Nausea 21 23 44 
Wheezing 16 5 21 
Diarrhoea 18 36 54 
Anaphylaxis 10 0 10 
Total 168 136 304 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 27.185a 7 .000 
Likelihood Ratio 31.344 7 .000 
Linear-by-Linear Association .743 1 .389 
N of Valid Cases 304   
 
a. 1 cells (6.3%) have expected count less than 5. The minimum expected count is 
4.47. 
 
• Association between non - IgE-mediated CMA symptoms and a BMC setting 
(hospital/home) 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N 
Perce
nt N 
Perce
nt N 
Perce
nt 
Symptoms (Non 
Ige) * Setting of 
BMC 
331 61.6
% 
206 38.4
% 
537 100.0
% 
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Symptoms (Non Ige) * Setting of BMC Crosstabulation 
Count   
 
Setting of BMC 
Total Hospital Home 
Symptoms (Non 
Ige) 
Atopic Eczema 20 44 64 
Abdominal pain 19 42 61 
Diarrhoea 16 38 54 
Gastro-oesoph 
reflux 
13 33 46 
Colic 8 23 31 
Food aversion 7 18 25 
Constipation 6 44 50 
Total 89 242 331 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 7.105a 6 .311 
Likelihood Ratio 8.055 6 .234 
Linear-by-Linear Association 5.009 1 .025 
N of Valid Cases 331   
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
6.72. 
 
 
 
• Association between non - IgE-mediated CMA symptoms and ML setting 
(hospital/home) 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N 
Perce
nt N 
Perce
nt N 
Perce
nt 
Symptoms (Non 
Ige) * Setting of 
ML 
237 44.1% 300 55.9% 537 100.0
% 
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Symptoms (Non Ige) * Setting of ML Crosstabulation 
Count   
 
Setting of ML 
Total Hospital Home 
Symptoms (Non Ige) Atopic Eczema 8 38 46 
Abdominal pain 5 33 38 
Diarrhoea 7 36 43 
Gastro-oesoph reflux 5 31 36 
Colic 3 18 21 
Food aversion 5 13 18 
Constipation 5 30 35 
Total 38 199 237 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 2.392a 6 .880 
Likelihood Ratio 2.146 6 .906 
Linear-by-Linear Association .038 1 .846 
N of Valid Cases 237   
 
a. 2 cells (14.3%) have expected count less than 5. The minimum expected count 
is 2.89. 
 
 
 
 
 
4. Statistical analysis of HCPs responses regarding parental anxiety and milk 
challenge settings (hospital/home)  (chapter 4, Table 4.7)  
 
 
MC_setting_parentalanxiety * MC_type Crosstabulation 
 
MC_type 
Total 
Baked milk 
challenge 
Milk 
ladder 
MC_setting_parent
alanxiety 
Hospit
al 
Count 18 17 35 
% within 
MC_setting_parent
alanxiety 
51.4% 48.6% 100.0% 
% within MC_type 20.0% 19.8% 19.9% 
Home Count 25 27 52 
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% within 
MC_setting_parent
alanxiety 
48.1% 51.9% 100.0% 
% within MC_type 27.8% 31.4% 29.5% 
Both Count 47 42 89 
% within 
MC_setting_parent
alanxiety 
52.8% 47.2% 100.0% 
% within MC_type 52.2% 48.8% 50.6% 
Total Count 90 86 176 
% within 
MC_setting_parent
alanxiety 
51.1% 48.9% 100.0% 
% within MC_type 100.0% 100.0% 100.0% 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square .296a 2 .863 
Likelihood Ratio .296 2 .863 
Linear-by-Linear 
Association 
.071 1 .790 
N of Valid Cases 176   
 
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 17.10. 
 
Statistical analysis milk challenge setting preferences  across HCPs’ country of residence 
in IgE and non-IgE mediated CMA  (table 4.8 and 4.9 ) 
 
BMC setting preferences across HCPs’ country of residence in IgE mediated CMA  
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
BMC_Settings_IgE_me
diated * Country 
96 51.6% 90 48.4% 186 100.0% 
 
 
BMC_Settings_IgE_mediated * Country Crosstabulation 
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Country 
Total USA UK Rest 
BMC_Settings_IgE
_mediated 
Hospit
al 
Count 10 18 26 54 
% within 
BMC_Settings_IgE
_mediated 
18.5% 33.3% 48.1% 100.0
% 
% within Country 55.6% 43.9% 70.3% 56.3% 
Home Count 2 5 1 8 
% within 
BMC_Settings_IgE
_mediated 
25.0% 62.5% 12.5% 100.0
% 
% within Country 11.1% 12.2% 2.7% 8.3% 
Both Count 6 18 10 34 
% within 
BMC_Settings_IgE
_mediated 
17.6% 52.9% 29.4% 100.0
% 
% within Country 33.3% 43.9% 27.0% 35.4% 
Total Count 18 41 37 96 
% within 
BMC_Settings_IgE
_mediated 
18.8% 42.7% 38.5% 100.0
% 
% within Country 100.0
% 
100.0
% 
100.0
% 
100.0
% 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 6.305a 4 .178 
Likelihood Ratio 6.706 4 .152 
Linear-by-Linear Association 1.430 1 .232 
N of Valid Cases 96   
 
a. 3 cells (33.3%) have expected count less than 5. The minimum expected count 
is 1.50. 
 
 
BMC setting preferences across HCPs’ country of residence in non- IgE mediated CMA  
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Crosstabs 
 
 
 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
BMC_Settings_nonIgE_
mediated * Country_ 
89 47.8% 97 52.2% 186 100.0% 
 
 
BMC_Settings_nonIgE_mediated * Country_ Crosstabulation 
 
Country_ 
Total USA UK Rest 
BMC_Settings_nonI
gE_mediated 
Hospit
al 
Count 1 2 5 8 
% within 
BMC_Settings_nonI
gE_mediated 
12.5% 25.0% 62.5% 100.0% 
% within Country_ 6.3% 4.5% 17.2% 9.0% 
Home Count 10 26 17 53 
% within 
BMC_Settings_nonI
gE_mediated 
18.9% 49.1% 32.1% 100.0% 
% within Country_ 62.5% 59.1% 58.6% 59.6% 
Both Count 5 16 7 28 
% within 
BMC_Settings_nonI
gE_mediated 
17.9% 57.1% 25.0% 100.0% 
% within Country_ 31.3% 36.4% 24.1% 31.5% 
Total Count 16 44 29 89 
% within 
BMC_Settings_nonI
gE_mediated 
18.0% 49.4% 32.6% 100.0% 
% within Country_ 100.0% 100.0% 100.0% 100.0% 
 
 
232 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 4.157a 4 .385 
Likelihood Ratio 3.946 4 .413 
Linear-by-Linear Association 1.570 1 .210 
N of Valid Cases 89   
 
a. 3 cells (33.3%) have expected count less than 5. The minimum expected count 
is 1.44. 
 
 
ML setting preferences across HCPs’ country of residence in IgE mediated CMA  
 
 
 
 
Crosstabs 
 
 
 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
ML_Settings_IgE_medi
ated * Country_1 
69 37.1% 117 62.9% 186 100.0% 
 
 
ML_Settings_IgE_mediated * Country_1 Crosstabulation 
 
Country_1 
Total USA UK Rest 
ML_Settings_IgE_m
ediated 
Hospit
al 
Count 5 6 8 19 
% within 
ML_Settings_IgE_m
ediated 
26.3% 31.6% 42.1% 100.0% 
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% within Country_1 35.7% 19.4% 33.3% 27.5% 
Home Count 7 7 8 22 
% within 
ML_Settings_IgE_m
ediated 
31.8% 31.8% 36.4% 100.0% 
% within Country_1 50.0% 22.6% 33.3% 31.9% 
Both Count 2 18 8 28 
% within 
ML_Settings_IgE_m
ediated 
7.1% 64.3% 28.6% 100.0% 
% within Country_1 14.3% 58.1% 33.3% 40.6% 
Total Count 14 31 24 69 
% within 
ML_Settings_IgE_m
ediated 
20.3% 44.9% 34.8% 100.0% 
% within Country_1 100.0% 100.0% 100.0% 100.0% 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 8.716a 4 .069 
Likelihood Ratio 9.181 4 .057 
Linear-by-Linear Association .117 1 .733 
N of Valid Cases 69   
 
a. 2 cells (22.2%) have expected count less than 5. The minimum expected count 
is 3.86. 
 
 
ML setting preferences across HCPs’ country of residence in non- IgE mediated CMA  
 
 
 
Crosstabs 
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Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
ML_Settings_NonIgE_
mediated * Country_2 
80 43.0% 106 57.0% 186 100.0% 
 
 
ML_Settings_NonIgE_mediated * Country_2 Crosstabulation 
 
Country_2 
Total USA UK Rest 
ML_Settings_NonIgE
_mediated 
Hospita
l 
Count 1 1 1 3 
% within 
ML_Settings_NonIgE
_mediated 
33.3% 33.3% 33.3% 100.0% 
% within Country_2 6.7% 2.6% 3.8% 3.8% 
Home Count 11 25 22 58 
% within 
ML_Settings_NonIgE
_mediated 
19.0% 43.1% 37.9% 100.0% 
% within Country_2 73.3% 64.1% 84.6% 72.5% 
Both Count 3 13 3 19 
% within 
ML_Settings_NonIgE
_mediated 
15.8% 68.4% 15.8% 100.0% 
% within Country_2 20.0% 33.3% 11.5% 23.8% 
Total Count 15 39 26 80 
% within 
ML_Settings_NonIgE
_mediated 
18.8% 48.8% 32.5% 100.0% 
% within Country_2 100.0% 100.0% 100.0% 100.0% 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 4.624a 4 .328 
Likelihood Ratio 4.788 4 .310 
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Linear-by-Linear Association .515 1 .473 
N of Valid Cases 80   
 
a. 4 cells (44.4%) have expected count less than 5. The minimum expected count 
is .56. 
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Appendix 11: Advertisement poster for the qualitative study  
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Appendix 12: Participant information Sheet  
Reference No:  SFEC 2016-046                                                            8/03/2016                             Version 1               
Participant Information Sheet 
Title of Study: Investigating parents’ experiences in re-introducing baked milk  
                                foods in children with CMA in UK- A qualitative study 
 
We would like to invite you to take part in our study 
research, looking at the experience of parents 
regarding home-use of baked milk foods (e.g. 
malted biscuits, cakes, muffins) or a milk ladder 
plan in their children who have still allergy to whole 
milk. As a parent/carer your opinions and thoughts 
would be of great values to us. Before you make a 
decision, it is important to understand why this 
research is being done, and what it would involve 
for you. If you wish, you can talk with others about 
this study before deciding whether to take part. 
Please read this leaflet carefully and do not 
hesitate to contact the lead researcher if you need 
further information about this study.         
 
What is this project all about? 
A milk ladder is a process that is used to test if 
your child is able to tolerate small amounts of milk 
that has been highly heated in baked foods such 
as milk malted biscuits, cakes, muffins, etc. 
However, we do not have enough evidence on the 
use of milk ladders in the dietary management of 
children  
 
with cow’s milk allergy at home.  We are interested in finding out what is the impact or outcome of a 
milk ladder into children’s diet at the time that they are still allergic to “raw” milk. Parents will be 
interviewed to express their personal and their 
child’s experience about the usefulness of a milk 
ladder plan in the management of cow’s milk 
allergy.   
 
Why have I been invited to take part?  
You are being asked to take part in this project 
because you have used a milk ladder 
plan/reintroduced baked milk containing foods 
into your child’s diet.   
 
What would taking part involve?  
If you decide to take part in this study you will be asked to be interviewed ONCE through 
telephone/skype call at a date and time of your convenience. We anticipate the interview to last 30 
mins, depending on how much you wish to share. The interview will be anonymised and audio-
recorded. The questions that you will be asked are reported at the last section of this informed sheet.     
 
Are there any expenses? 
You will not be charged for telephone/skype call. As a gesture of thanks every participant will get a 
 
Contact details:  
PhD Researcher: 
Yiota.Athanasopoulou@port.ac.uk 
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₤10 gift voucher for their time commitment and contribution towards this research study.  
 
Do I have to take part?  
It is completely up to you to decide whether to join the study.  If you decide not to take part, this 
will have no affect at all on you or on your child’s care in any way. If you decide to take part and later 
change your mind, you can withdraw any time.  
 
 
What will happen if I take part? 
You will be asked to share your experience with us about the use of baked milk foods into your 
child’s diet.  If you agree to take part, you will be contacted by the lead researcher to arrange a 
mutually convenient day and time for the interview. Before the interview, you will be asked to sign a 
consent form that you are happy to take part. 
 
What are the benefits of taking part in this study?  
The aim of this research is to understand parents’ and children’s experience on the graded 
introduction of baked milk products into the diet of children diagnosed with cow’s milk allergy in the 
UK, from the parents’ perspective.  It is hoped to interview 15 parents who all had to introduce the 
baked milk products at home and gather their perspectives. Although there is no direct benefit to you, 
we hope that taking part in this study will help you get a deeper understanding of this dietary 
management. We hope that the information derived from all participants will help other researchers, 
healthcare professionals and allergy services to provide optimal care to children with cow’s milk 
allergy and contribute to an effective dietary management and treatment with the use of baked milk 
products into the children’s diet in the future. At the end of the research study the results will be 
written up in a report (thesis) and articles may be written for journals and magazines. Talks may also 
be given about the research findings. 
 
What are the disadvantages of taking part in this study? 
We do not anticipate any risk to you from participating in this study. You will be required to give up 
some time to be interviewed at a date and time convenient to you.  Although you will be free to select 
the topics and share as much as you like with the researcher, it is possible you may find some topics 
upsetting. You are free to have some time out or stop the conversation  
 
during the interview and withdraw from the study at any time.     
 
Will my taking part in the study be kept confidential?  
Yes, everything discussed during the telephone/skype interview for the purpose of the study will be 
made anonymous and all information collected will be kept confidential. Your contact details will be 
kept by the lead researcher (so we can get in touch with you) but will not be shared or passed on to 
anyone else. You will be given a unique code for the purpose of data analysis and reporting.  You will 
have the chance to check the accuracy of data held about you, and correct any errors if you wish. 
The data will be stored in locked cabinets at the university and any electronic records will be 
password protected. We will remove any personal identifiable information, when we report the 
study so those reading it will not know who said what.  The researcher will be the only person who 
can access the cabinet and the electronic records. It is possible that some of the data collected may 
also be looked at by the academic supervisors to check that the study is being carried out correctly. 
The researcher has a duty of confidentiality to you as a research participant.  
However, if the researcher finds out during the conversation that you or your child is being 
harmed or exploited, it is their duty to pass on this information to a relevant agency in confidence 
and after discussion with you.  
  
Who is organising the study? 
This is an independent research study carried out as part of a Doctorate studentship sponsored by 
the Faculty of Science at the University of Portsmouth. 
Who has reviewed the study? 
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This study was reviewed by the Faculty of Science Ethics Committee, University of Portsmouth.  
 
What will happen next? 
If you decide to take part in the study, please fill in the Reply Slip, sign the Consent Form and send 
them back by email to yiota.athanasopoulou@port.ac.uk  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to  
speak to the lead researcher, who will be happy to answer your questions: 
 
  PhD researcher 
               Ms Yiota Athanasopoulou, 
               Tel; 02392 844434         
               Email:yiota.athanasopoulou@port.ac.uk 
 
                
 
 
If you remain unhappy and wish to make a formal complaint, you can do this by contacting:  
Dr Chris Markham 
Head of School  
Health Sciences and Social Work 
Tel: 02392 842893  
Email: chris.markham@port.ac.uk 
 
Thank you for taking the time to read the information sheet and looking forward to hearing from 
you soon.   
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Appendix 13: Participants’ demographic questions  
Reference No:  SFEC 2016-046                                                            8/03/2016                             Version 1  
 
 
Study Title: Investigating parents’ experiences in re-introducing baked milk foods  
                               in children with CMA in UK- A qualitative study 
 
                                             Demographic Questions   
 
Date: 
Venue: Skype/telephone interview  
Parents’ details:  
1. Gender:  
Male □ 
Female □ 
 
2. Age: ……………… 
 
3. What is the highest level of education you have completed (or still in progress)?   
Postgraduate degree     □ 
Undergraduate degree □ 
College □  
High school graduate □ 
Less than high school □ 
Other (please specify)…………………………………………………………………………………………………………… 
 
 
4. Are you currently employed?   
Full time □ 
Part time □ 
Stay at home/homemaker □ 
Other (please specify)…………………………………………………………………………………………………………... 
 
Your child’s details 
1. Age: 
 
2. Gender:  
Male □ 
Female □ 
 
3. Diagnosis:  
IgE mediated Cow’s Milk Allergy  □ 
Non-IgE mediated Cow’s Milk Allergy □ 
 
4. Method of CMA diagnosis:  
Positive milk challenge □      
Diagnostic Skin Prick Test   □                   
Serum specific IgE results(blood tests) □  
Clinical history  of symptoms  □ 
 
 
5. Other conditions :   
Asthma □  
Rhinitis  □ 
Eczema  □   
Please specify any others……………………………………………………………………………………………………. 
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6. Other Food Allergies 
Egg □ 
Wheat  □ 
Peanut □ 
Tree nuts □ 
Shellfish □ 
Please specify any others……………………………………………………………………………………………….. 
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Appendix 14: Mothers’ consent form 
 Reference No:  SFEC 2016-046                                                            8/03/2016                             Version 1  
 
Consent Form & Reply Slip 
                                                        Consent Form                                                                                                                                                                                                                                                           
 
Participant Identification Number:     
                                                                                                   
         Study Title: Investigating parents’ experiences in re-introducing baked milk  
                                foods in children with CMA in UK- A qualitative study 
 
Please read each of the following statements carefully and tick each box if you agree and then sign below 
                                                                                                                                    Please tick box 
1. I confirm that I have read and understand the information sheet dated……….                        
(version) for the above study and have had the opportunity to consider  the  
information, ask questions and have had these answered satisfactorily.  
                           
2. I understand that my participation is voluntary. If I decide at any time that I no                          
longer wish to take part in this project I can notify the researcher involved and withdraw  
immediately without giving any reason.                
 
3. I understand that my participation is confidential and my  name will be removed                               
from the interviews and I will be identified by  a unique participant identification number                        
rather than my name.                              
    
4. I understand that my interview will be audio recorded.  
  
5. I understand that my records will be Confidential and anonymised and will be 
 stored securely.   
                    
6.   I agree to take part in this study. 
 
 
Participant’s Signature:                                                                            Date:  
 
                                             Reply Slip  
 
If you are interested in this study please complete date, time and type that you prefer to book your 
scheduled interview:  
 
Your name: ………………………………………………………………………………… 
Your e-mail: ………………………………..…………………………………………….. 
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Date(s) of Interview: ……………………………………………………………………….. 
Time(s) of Interview: ……………………………………………………………………… 
Type of interview:  
Skype □ Please provide your skype detail:…………………………………………. 
…………………………………………………………………………………………………. 
Telephone □ Please provide your telephone number:………………………… 
………………………………………………………………………………………………….. 
 
I agree for the researcher to keep my personal details in order to contact me:   
Yes □       No □ 
Thank you for taking the time to complete the consent form and reply slip. Please return them by 
email at yiota.athanasopoulou@port.ac.uk or post to Yiota Athanasopoulou, PhD researcher, 
SHSSW, University of Portsmouth, James Watson Building, 2 King Richard 1st Road, Portsmouth, 
PO1 2FR in the stamped envelope provided.  
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Appendix 15: SFEC approval letter   
 
 
Yiota Anthanasopoulou  
School of Health Sciences & Social Work  
University of Portsmouth  
 yiota.athanasopoulou@port.ac.uk            Science Faculty Ethics Committee  
Science Faculty Office  
University of Portsmouth  
St Michael’s Building  
White Swan Road  
PORTSMOUTH  
PO1 2DT  
  
T: 023 9284 3379  
ethics-sci@port.ac.uk  
  
Date  25th May 2016  
fAVOURABLE ETHICAL OPINION WITH MINOR CONDITIONS  
  
Study Title: Investigating parents’ experiences in re-introducing baked milk foods in children with CMA in UK- 
A qualitative study      
Reference Number: SFEC 2016-046 (Please quote this in any correspondence)  
  
Thank you for submitting your application to the Science Faculty Ethics Committee (SFEC) dated 09th May 
2016, in accordance with current procedures1.  
  
I am pleased to inform you that SFEC was content to grant a favourable ethical opinion of the above research 
on the basis described in the submitted documents listed at Annex A, and subject to standard general 
conditions2 and the following minor conditions/recommendations:  
1. Please ensure you communicate to participants that once interviews have been completed, they cannot 
withdraw their interview data.  
2. Please ensure you communicate to participants that this is a PhD project.   
3. Please adjust the milk ladder graphic on your PIS. It is difficult to read and parts of it are cut off.   
4. State clearly where the 10GBP voucher can be used.  
5. Please clarify how participants will sign the consent form or will consent be obtained through the reply slip.  
  
There is no requirement for you to confirm these conditions have been met in writing to the committee.   
  
Please note that the favourable opinion of SFEC does not grant permission or approval to undertake the 
research.  Management permission or approval must be obtained from any  
    
host organisation, including the University of Portsmouth or supervisor, prior to the start of the study.  
  
Wishing you every success in your research  
                                                             
1 Procedures for Ethical Review, Science Faculty Ethics Committee, University of Portsmouth, October 2012 (to 
be updated).  
2 After ethical review – Guidance for researchers (Please read).  
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Yours sincerely,  
 
  
Dr Simon Kolstoe  
Vice Chair, Science Faculty Ethics Committee  
  
Information:  
Professor Tara Dean – Supervisor  
Mrs Holly Shawyer - Faculty Administrator  
  
  
Statement of compliance  
  
SFEC is constituted in accordance with the Governance Arrangements set out by the University of Portsmouth    
  
  
After Ethical Review  
  
If unfamiliar, please consult the advice After Ethical Review2 which gives detailed guidance on reporting 
requirements for studies with a favourable opinion, including, notifying substantial amendments, notification of 
serious breaches of the protocol, progress reports and notifying SFEC of the end of the study.  
  
Feedback  
  
You are invited to give your view of the service that you have received from the Faculty Ethics Committee.  If 
you wish to make your views known please contact the administrator at ethics-sci@port.ac.uk 
NNEX A  Documents reviewed  
  
The documents ethically reviewed for this application (SFEC 2016-046)  
   
Document     Version     Date     
A - Ethics Application090516  1  09/05/2016  
B - PhD phase 2 supporting docs090516  1  09/05/2016  
      
      
      
      
      
  
  ANNEX B - After ethical review - Guidance for researchers Guidance for researchers  
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1. This document sets out important guidance for researchers with a favourable opinion from a 
University of Portsmouth Ethics Committee. Please read the guidance carefully. A failure to follow the 
guidance could lead to the committee reviewing and possibly revoking its opinion on the research.   
  
2. It is assumed that the research will commence within 1 year of the date of the favourable ethical 
opinion or the start date stated in the application, whichever is the latest.  
  
3. The research must not commence until the researcher has obtained any necessary management 
permissions or approvals – this is particularly pertinent in cases of research hosted by external 
organisations. The appropriate head of department should be aware of a member of staff’s research 
plans.     
  
4. If it is proposed to extend the duration of the study beyond that stated in the application, the Ethics 
Committee must be informed.  
  
5. If the research extends beyond a year then an annual progress report must be submitted to the Ethics 
Committee.  
  
6. When the study has been completed the Ethics Committee must be notified.  
  
7. Any proposed substantial amendments must be submitted to the Ethics Committee for review. A 
substantial amendment is any amendment to the terms of the application for ethical review, or to the 
protocol or other supporting documentation approved by the Committee that is likely to affect to a 
significant degree:   
(a) the safety or physical or mental integrity of participants   
(b) the scientific value of the study  
(c) the conduct or management of the study.  
  
7.1  A substantial amendment should not be implemented until a favourable ethical opinion has been 
given by the Committee.  
  
8. Researchers are reminded of the University’s commitments as stated in the Concordat to Support 
Research Integrity  viz:  
  
• maintaining the highest standards of rigour and integrity in all aspects of research  
• ensuring that research is conducted according to appropriate ethical, legal and professional 
frameworks, obligations and standards  
• supporting a research environment that is underpinned by a culture of integrity and based on good 
governance, best practice and support for the development of researchers  
• using transparent, robust and fair processes to deal with allegations of research misconduct should 
they arise  
• working together to strengthen the integrity of research and to reviewing progress regularly and 
openly  
  
9. In ensuring that it meets these commitments the University has adopted the UKRIO Code of Practice 
for Research.  Any breach of this code may be considered as misconduct and may be investigated 
following the University Procedure for the Investigation of Allegations of Misconduct in Research. 
Researchers are advised to use the UKRIO checklist as a simple guide to integrity.  
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Appendix 16: CCHMC’s Institutional Review Board (IRB) Approval letter 
 
Institutional Review Board - Federalwide Assurance #00002988 
Cincinnati Childrens Hospital Medical Center 
Date: 12/7/2016 
From: CCHMC IRB 
To: Principal Investigator:Allergy & ImmunologyAmal Assa'ad 
Study ID: 2015-4861 
Re: Study Title: Factors Affecting Oral Food Challenge Outcomes in Children 
The above referenced protocol and all applicable additional documentation provided to the IRB were reviewed 
and RE-APPROVED using an EXPEDITED review procedure set forth in 45 CFR 46.110(b)(1), Category(ies)(see 
below) on 12/6/2016. 
For research involving children, the Committee determined that this research presents: 
  No greater than minimal risk. 
Please note the following requirements: 
Consent Requirements 
Per 45 CFR 46.116 the IRB has waived the requirement to obtain informed consent for all adult participants. 
Parental Permission Requirements 
Per 45 CFR 46.116 the IRB has waived the requirement to obtain parental permission from the parent(s) (or 
guardian) of all child participants. NOTE: If your research is subject to FDA regulations it is not eligible for this 
waiver of parental permission. 
Assent Requirements 
Per 45 CFR 46.116 the IRB has waived the requirement to obtain assent from all child participants. NOTE: If 
your research is subject to FDA regulations it is not eligible for this waiver of assent. 
HIPAA Requirements 
Per 45 CFR 164.512 the IRB has granted a waiver from the requirement to obtain an authorization for the use 
and/or disclosure of protected health information (PHI). This study will be due for continuing review at least 
30 days before 12/5/2017. 
Study Documents 
Factors Affecting Oral Food Challenge Outcomes in Children 
AMENDMENTS: The principal investigator is responsible for notifying the IRB of any changes in the protocol, 
participating investigators, procedures, recruitment, consent forms, FDA status, or conflicts of interest. 
Approval is based on the information as submitted. New procedures cannot be initiated until IRB approval has 
been given. If you wish to change any aspect of this study, please submit an Amendment via ePAS to the IRB, 
providing a justification for each requested change. 
CONTINUING REVIEW: The investigator is responsible for submitting a Continuing Review via ePAS to the IRB at 
least 30 days prior to the expiration date listed above. Please note that study procedures may only continue 
into the next cycle if the IRB has reviewed and granted re-approval prior to the expiration date. 
UNANTICIPATED PROBLEMS: The investigator is responsible for reporting unanticipated problems promptly to 
the IRB via ePAS according to current reporting policies. 
STUDY COMPLETION: The investigator is responsible for notifying the IRB by submitting a Request to Close via 
ePAS when the research, including data analysis, has completed. 
 
Research Categories 
5. Research involving materials (data, documents, records, or specimens) that have been collected, or will be 
collected solely for nonresearch purposes (such as medical treatment or diagnosis). (NOTE: Some research in 
this category may be exempt from the HHS regulations for the protection of human subjects. 45 CFR 
46.101(b)(4). This listing refers only to research that is not exempt.) 
 
Please note: This approval is through the IRB only. You may be responsible for reporting to other regulatory 
officials (e.g. VA Research and Development Office, UC Health - University Hospital). Please check with your 
institution and department to ensure you have met all reporting requirements. 
Statement regarding International conference on Harmonization and Good Clinical Practices: The Institutional 
Review Board is duly constituted (fulfilling FDA requirements for diversity), has written procedures for initial 
and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records 
pertaining to the review and approval process; all in compliance with requirements defined in 21 CFR Parts 50, 
56 and 312 Code of Federal Regulations. This institution is in compliance with the ICH GCP as adopted by 
FDA/DHHS. 
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Appendix 17: Data transfer agreement 
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250 
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Appendix 18: University of Portsmouth SFEC Ethical Review-USA study  
  
  
Panagiota Athanasopoulou  
School of Health Sciences and Social Work  
University of Portsmouth  
  
  
Yiota.Athanasopoulou@port.ac.uk  
  
Science Faculty Ethics Committee  
Science Faculty Office  
University of Portsmouth  
St Michael’s Building  
White Swan Road  
P0ORTSMOUTH  
PO1 2DT  
United Kingdom  
  
T: + 44 (0)23 9284 3379 ethics-sci@port.ac.uk  
  
14 December 2017  
ADVISING OF EXTERNAL ETHICAL FAVOURABLE OPINION  
  
Study Title: Factors Affecting Oral Food Challenge Outcomes in Children  
  
UoP Reference Number: SFEC External ethics - Other - 2017-003.  
  
Institutional Review Board Cincinnati Childrens Hospital Medical Center: 2015-4861   
  
Date Submitted: 30 November 2017  
  
Thank you for advising the Science Faculty Ethics Committee (SFEC) for research you are conducting 
under the favourable opinion of an external ethical review body and international data exchange 
agreement (as detailed at Annex A). All appears to be well, and there is no need to undertake a 
secondary ethical review at UoP, although the standard general conditions for research (See Annex 
B) still apply.  
  
If your research extends to data collected after 12 December 2017, then please ensure that an 
updated favourable ethical opinion is obtained first from the Cincinnati Childrens Hospital Medical 
Center Institutional Review Board. It is not thought that this is the intention, but please bear in mind 
this date in case the data period is extended.  
  
Wishing you every success in your research.  
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Dr Jim House  
Chair, Science Faculty Ethics Committee  
  
Annexes  
  
A - Documents reviewed  
B - After ethical review - Guidance for researchers  
  
Information:  
  
Carina Venter - PhD Supervisor  
Dr Heather Mackenzie - PhD Supervisor  
Rose Barrand - Faculty Administrator  
External - orcra@cchmc.org  
Statement of compliance  
  
SFEC is constituted in accordance with the Governance Arrangements set out by the  
University of Portsmouth     
After Ethical Review  
  
If unfamiliar, please consult the advice After Ethical Review (Annex B), which gives detailed guidance on 
reporting requirements for studies with a favourable opinion, including, notifying substantial amendments, 
notification of serious breaches of the protocol, progress reports and notifying SFEC of the end of the study.  
  
Feedback  
  
You are invited to give your view of the service that you have received from the Science Faculty Ethics 
Committee.  If you wish to make your views known please contact the administrator at ethics-sci@port.ac.uk  
     
ANNEX A  Documents reviewed  
  
The documents ethically reviewed for this application  
   
Document     Version     Date     
A - Email notification to SFEC 30.11.17  n/a  30 Nov 2017  
B - Cover letter from UoP PhD student_Panagiota Athanasopoulou  n/a  30 Nov 2017  
C - IRB approval of continuing review  n/a  30 Nov 2017  
D - Letter from PI, Cincinnati Children's Hospital Medical Centre(Amal 
Assa'ad)  
m/a  30 Nov 2017  
E - IRB_Factors Affecting Oral Food Challenge Outcomes in Children  V1  30 Nov 2017  
F - Data transfer agreement between CCHMC and UoP  n/a  30 Nov 2017  
  
  
    A - 1 ANNEX B - After ethical review - Guidance for researchers  
  
1. This Annex sets out important guidance for researchers with a favourable opinion from a University of 
Portsmouth Ethics Committee. Please read the guidance carefully. A failure to follow the guidance could lead to 
the committee reviewing and possibly revoking its opinion on the research.   
  
2. It is assumed that the research will commence within 1 year of the date of the favourable ethical 
opinion or the start date stated in the application, whichever is the latest.  
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3. The research must not commence until the researcher has obtained any necessary management 
permissions or approvals – this is particularly pertinent in cases of research hosted by external organisations. 
The appropriate head of department should be aware of a member of staff’s research plans.     
  
4. If it is proposed to extend the duration of the study beyond that stated in the application, the Ethics 
Committee must be informed.  
  
5. Any proposed substantial amendments must be submitted to the Ethics Committee for review. A 
substantial amendment is any amendment to the terms of the application for ethical review, or to the protocol 
or other supporting documentation approved by the Committee that is likely to affect to a significant degree:   
(a) the safety or physical or mental integrity of participants   
(b) the scientific value of the study  
(c) the conduct or management of the study.  
  
5.1  A substantial amendment should not be implemented until a favourable ethical opinion has been 
given by the Committee.  
  
6. Researchers are reminded of the University’s commitments as stated in the Concordat to Support 
Research Integrity  viz:  
  
• maintaining the highest standards of rigour and integrity in all aspects of research  
• ensuring that research is conducted according to appropriate ethical, legal and professional 
frameworks, obligations and standards  
• supporting a research environment that is underpinned by a culture of integrity and based on good 
governance, best practice and support for the development of researchers  
• using transparent, robust and fair processes to deal with allegations of research misconduct should 
they arise  
• working together to strengthen the integrity of research and to reviewing progress regularly and 
openly.  
  
7. In ensuring that it meets these commitments the University has adopted the UKRIO Code of Practice 
for Research.  Any breach of this code may be considered as misconduct and may be investigated following the 
University Procedure for the Investigation of Allegations of Misconduct in Research. Researchers are advised to 
use the UKRIO checklist as a simple guide to integrity.  
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Appendix 19: Statistical analysis of immune biomarkers and milk challenges    
Descriptive statistics was used to calculate the mean of SPT wheal size (mm) measurements 
and serum milk sIgE levels (KU/I. Frequency statistics was used to assess and classified 
(positive/negative) the immune biomarkers’ results and baked milk challenge outcomes of 
children with CMA.  
Statistical tests  
   
Descriptive statistics test   
 
Milk 
challenges 
outcome 
SPT Size 
Fresh Milk SPT Size 
Allergen 
MILK Total IgE 
IgECasein_
M IgE b-lact 
N Valid 191 191 191 191 191 191 191 
Missing 86 86 86 86 86 86 86 
Mean  2.6230 4.07 8.3532 89.9709 3.3661 2.5972 
Std. Deviation .501 5.16306 6.249 49.45852 173.9027
7 
15.47108 12.5780
3 
Minimum 1 .00 0 .00 .00 .00 .00 
Maximum 2 22.00 35 647.00 876.00 120.00 100.00 
 
 
Frequency statics tests 
 
1. Milk challenge outcomes 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Positive 91 32.9 47.6 47.6 
Negative 100 36.1 52.4 100.0 
Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
 
 
 
 
 
2. SPT Fresh milk 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid positive 53 19.1 27.7 27.7 
negative 138 49.8 72.3 100.0 
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Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
3. SPT milk extract 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Positive 85 30.7 44.5 44.5 
Negative 106 38.3 55.5 100.0 
Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
 
4. Milk Allergen  
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid positive 109 39.4 57.1 57.1 
negative 82 29.6 42.9 100.0 
Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
 
5. Total milk-IgE  
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid positive 93 33.6 48.7 48.7 
negative 98 35.4 51.3 100.0 
Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
 
6. Milk Casein-IgE  
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Negative (≤0.35 ) 137 49.5 71.7 71.7 
Positive (>0.35) 54 19.5 28.3 100.0 
Total 191 69.0 100.0  
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Missing System 86 31.0   
Total 277 100.0   
 
 
7. Milk β-lactoglobulin IgE  
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Negative (≤0.35) 146 52.7 76.4 76.4 
Positive (>0.35) 45 16.2 23.6 100.0 
Total 191 69.0 100.0  
Missing System 86 31.0   
Total 277 100.0   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sensitivity and specificity using ROC curves for immune biomarkers (SPTs, Milk Allergen, 
milk sIgE) in predicting milk tolerance in CMA children   
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1. SPT fresh milk  
Criterion values and coordinates of the ROC curve [Hide] 
Criterio
n 
Sensitivit
y 
95% CI Specificit
y 
95% CI PP
V 
95%C
I 
NP
V 
95%C
I 
<1 0.00 0.0 - 4.0 100.00 96.4 - 100.
0 
  1.1  1.1 
≤1 49.45 38.8 - 60.1 92.00 84.8 - 96.5 84.
9 
73.7-
91.9 
66.7 61.8-
71.2 
≤2 100.00 96.0 - 100.
0 
0.00 0.0 - 3.6 1.0
0 
    
  
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.707 
Standard Error a 0.0297 
95% Confidence interval b 0.637 to 0.771 
z statistic 6.986 
Significance level P (Area=0.5) <0.0001 
a DeLong et al., 1988 
b Binomial exact 
 
2. SPT milk extract 
Criterion values and coordinates of the ROC curve  
Criterio
n 
Sensitivit
y 
95% CI Specificit
y 
95% CI PPV 95% 
CI 
NPV 95
% C
I 
<1 0.00 0.0 - 4.0 100.00 96.4 - 10
0.0 
  1.00   
≤1 69.23 58.7 - 7
8.5 
78.00 68.6 - 85
.7 
74.1 65.9-
80.9 
73.6 66.8
-
79.4 
≤2 100.00 96.0 - 1
00.0 
0.00 0.0 - 3.6 1.00     
 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.736 
Standard Error a 0.0320 
95% Confidence interval b 0.668 to 0.797 
z statistic 7.376 
Significance level P (Area=0.5) <0.0001 
a DeLong et al., 1988 
b Binomial exact 
 
3. Milk Allergen 
 
Criterion values and coordinates of the ROC curve [Hide] 
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Crite
rion 
Sensitivi
ty 
95% CI Specifici
ty 
95% CI PPV 95% CI NPV 95% CI 
<1 0.00 0.0 - 4.0 100.00 96.4 - 1
00.0 
  1.00   
≤1 68.13 57.5 - 7
7.5 
53.00 42.8 - 6
3.1 
58.9 50.7-
62.9 
69.6 56.2-72.2 
≤2 100.00 96.0 - 1
00.0 
0.00 0.0 - 3.6 1.00     
 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.606 
Standard Error a 0.0351 
95% Confidence interval b 0.533 to 0.675 
z statistic 3.010 
Significance level P (Area=0.5) 0.0026 
a DeLong et al., 1988 
b Binomial exact 
 
4. Total milk IgE 
Criterio
n 
Sensitivit
y 
95% CI Specificit
y 
95% CI PP
V 
95% C
I 
NP
V 
95% C
I 
<1 0.00 0.0 - 4.0 100.00 96.4 - 100.
0 
  1.00   
≤1 58.24 47.4 - 68.5 60.00 49.7 - 69.7 57 49.6-
64.1 
61.
2 
54.1-
67.9 
≤2 100.00 96.0 - 100.
0 
0.00 0.0 - 3.6 1.0
0 
    
 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.591 
Standard Error a 0.0358 
95% Confidence interval b 0.518 to 0.662 
z statistic 2.548 
Significance level P (Area=0.5) 0.0108 
a DeLong et al., 1988 
b Binomial exact 
 
5. M ilk Casein – IgE 
6. Criteri
on 
Sensitivi
ty 
95% CI Specifici
ty 
95% CI PP
V 
95% 
CI 
NP
V 
95% 
CI 
≥1 100.00 96.0 - 100
.0 
0.00 0.0 - 3.6 1.0
0 
    
>1 40.66 30.5 - 51.
5 
83.00 74.2 - 89.
8 
68.
5 
56.9-
78.2 
60.
6 
59-
78.2 
>2 0.00 0.0 - 4.0 100.00 96.4 - 100
.0 
  1.00   
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Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.618 
Standard Error a 0.0320 
95% Confidence interval b 0.545 to 0.687 
z statistic 3.692 
Significance level P (Area=0.5) 0.0002 
a DeLong et al., 1988 
b Binomial exact 
 
6. Milk β-lactoglobulin 
Criterio
n 
Sensitivit
y 
95% CI Specificit
y 
95% CI PP
V 
95% C
I 
NP
V 
95% C
I 
≥1 100.00 96.0 - 100.
0 
0.00 0.0 - 3.6 1.0
0 
    
>1 31.87 22.5 - 42.5 84.00 75.3 - 90.6 64.
4 
51.4-
75.5 
57.
5 
53.5-
61.5 
>2 0.00 0.0 - 4.0 100.00 96.4 - 100.
0 
  1.00   
 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.579 
Standard Error a 0.0307 
95% Confidence interval b 0.506 to 0.650 
z statistic 2.584 
Significance level P (Area=0.5) 0.0098 
a DeLong et al., 1988 
b Binomial exact 
 
²Area Under the ROC Curve 
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